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This chapter serves as an introduction describing concepts such as hydrogels, rapid pro-
totyping and tissue engineering together with the current trends and limitations. This
work was partly published as review article in Biomaterials1 and as a book chapter in
“Biologically Responsive Biomaterials for Tissue Engineering (Springer)” .2
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1.1 | General Frame of Reference
To date, organ and tissue transplantation remains one of the most important while
complex options in order to restore or enhance life expectancy. A recent annual
report prepared by the Scientiﬁc Registry of Transplant Recipients (SRTR) in
collaboration with the Organ Procurement and Transplantation Network (OPTN)
registered 112,905 patients in the USA awaiting transplantation at the end of
2011, while only 26,246 transplantations were performed.3 If we keep the steady
increase in life expectancy in mind, these numbers emphasize the shortage of organ
donors.4 In addition, diseases, infections and rejection of the tissue by the host
often complicate transplantation.5
As such, there is a need for technological development in the ﬁeld of regenerative
medicine, capable of restoring and/or replacing malfunctioning tissues. The ori-
gin of regenerative medicine stems from a variety of medical activity, including
surgery, medical prosthetics, transplantation, and biomaterial scaﬀolds.6 There-
fore, the term ‘regenerative medicine’ refers to a group of biomedical approaches
centrally focussed on human cells with the aim to provide a platform for the
restoration, enhancement and/or establishment of normal, healthy tissue function.
For instance:
• Restoring tissues using therapies based on the administration of biologically
active molecules such as genes, proteins, and antibodies.;
• The injection of stem cells;
• The use of medical prosthetics to substitute for organs or tissue functions;
• Transplantation of in vitro grown organs or tissues;
• . . .
Regenerative medicine not only aims at compensating the donor shortage, but
additionally targets on improving the standard of care.7 Ideally, in structure as
well as in function, the replaced or repaired tissue should be reciprocal to normal
tissue. Additionally, regenerative medicine is not only restricted to therapeutic
applications, but also encompasses diagnostic and research developments (i.e. drug
screening, phatogenicity testing, toxicity testing, . . . ). One of those branches in
regenerative medicine, called ‘Tissue Engineering’, is applied in the present work.
This dissertation is situated within the framework of the IWT-SBO called Hep-
Stem (Functional Human Hepatocytes, Stellate Cells and Sinusoidal Endothelial
Cells from Stem Cells). As a subpart of this national project, this work aimed at
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the exploration and development of 3D biodegradable hydrogel cell carriers, pos-
sessing extended control over the matrix architecture. The developed strategies
are targeted to hepatic tissue engineering applications.
1.2 | The Concept of Tissue Engineering (TE):
an Introduction
1.2.1 Deﬁnition, scope and classiﬁcation
To overcome these problems associated with transplantation, the last few decades,
tissue engineering (TE) has grown as a new inter- and multidisciplinary scientiﬁc
ﬁeld.8 This discipline has rapidly emerged and combines the principles of engi-
neering and life sciences. It holds as main objective the recovery, maintenance
and improvement of tissue performance.8–10 The European Commission on Health
and Consumer Protection deﬁnes TE as the persuasion of the body to heal itself
through the delivery, to the appropriate site, independently or in synergy, of cells,
biomolecules and supporting structures.11
This deﬁnition nicely illustrates the core hypothesis, which serves as the basic
concept of tissue engineering.9
tissue-engineered organ
human body defect
bioreactor
cell isolation, 
cultivation
and proliferation
cytokines,
growth factors, ...
scaffold
Figure 1.1: The workﬂow of the conventional tissue engineering approach.
By and large, two approaches can be distinguished:12 (i) in vitro construction of
bioartiﬁcial tissue employing cells isolated from donor tissue, and; (ii) in vivo ma-
nipulation of the cell growth and function. The former focusses on the development
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of alternatives for tissue transplantation, the study of complex tissue functions and
on tissue morphogenesis ex vivo. The latter aims at the in situ modiﬁcation of
the growth/function of cells. Independent from the methodology, the production
of extracellular matrix (ECM) is the premise for tissue regeneration and repair.
Hence, having cells with the correct/desired phenotype at one’s disposal is crucial.
This aspect is partly translated by material interactions.
Researchers will strive to fulﬁll those afore mentioned objectives through the uti-
lization of:
1. Isolated cells or cell substitutes;13–16
2. Tissue inducing substances,17–19 and/or;
3. Three-dimensional scaﬀolds, either in vivo or in vitro.5,8,10,20
Although, conventionally, the application of a supporting scaﬀold is preferred in
circumstances where the defect acquires certain dimensions. Post-processing cell
seeding and maturation to tissue has therefore been implemented as a commonly
applied TE strategy.20–24 Expanding the cell population and maturation to tissue
is performed in bioreactors, which can be described as devices, in which biological
and/or biochemical processes are manipulated through close control of environ-
mental and process-bound factors such as pH, temperature, pressure, and nutrient
and waste ﬂow.25 The general principle behind the concept of the conventional
TE approach is illustrated in Figure 1.1.
A primary, rough classiﬁcation can be performed based on the mechanical proper-
ties of the target tissue. As such the so-called ‘hard’ and ‘soft’ tissue engineering
relate to this distinction. In order to give an impression on this diﬀerence, Table
1.1 gives some examples of tissues and their elastic moduli. The presented values
were collected from diﬀerent sources.26–28
Table 1.1: Mechanical properties of some hard and soft tissues.
HARD TISSUES SOFT TISSUES
Tissue sample Elastic modulus [GPa] Tissue sample Elastic modulus [kPa]
Vertebral trabecular bone 3.8 Liver 0.4− 6
Tibia trabecular bone 1− 15 Breast 18− 24
Femur trabecular bone 5− 12 Prostate 55− 63
Cortical bone 18− 22 Tendon 0.4GPa
Dentine 11 Skin 10− 20
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1.2.2 Biomaterials for tissue engineering
Throughout history, examples of glass eyes and wooden and gold-ﬁlled teeth can
be found.29 Table 1.2 relates to some important milestones achieved in the his-
tory of implants and their correlated materials.30 From this, we can deduct that
tissue engineering and modern biomaterial development is a rather young science.
Evidently, the mechanical properties of the target tissue will translate into the
screening and/or the design of suitable biomaterials. The deﬁnition of what ex-
actly a biomaterial encompasses has been subtly altered over the last few years.
A biomaterial can be described as every material (natural, synthetic or a combi-
nation) applied for the fabrication of apparatuses, bound for the replacement of
biological systems or to operate in close contact with biological tissues.
Table 1.2: Some milestones in the history of implants.30
YEAR RESEARCHER DEVELOPMENT
Late 18th - 19th century Metal devices for fracture ﬁxations; wires and stems from Fe,
Au, Ag, and Pt
1860-1870 J. Lister Aseptic surgical techniques
1886 H. Hansmann Ni-plated steel fracture-plate
1893-1912 W.A. Lane Steel plates and screws for fracture ﬁxation
1909 A. Lambotte Al, Ag, and Cu plate
1912 Sherman Vanadium plate, ﬁrst alloy exclusive for medical applications
1924 A.A. Zierold Stellite (CoCrMo alloy)
1926 M.Z. Lange 18-8sMo (2-4%) stainless steel for enhanced corrosion resistance
1926 E.W. Hey-Groves Carpenter’s screw for femur neck fracture
1931 M.N. Smith-Petersen Development of ﬁrst femur neck fracture ﬁxation screw, later on
replaced by Vitallium
1936 C.S. Venable, W.G. Stuck Vitallium; 19 w/o Ni stainless steel
1938 P. Wiles First total hip replacement
1946 J. and R. Judet First biomechanically designed hip prosthesis;
ﬁrst application of plastics for joint replacement
1940s M.J. Dorzee, A. Franceschetti Acrylates for cornea replacement
1947 J.Cotton Ti and Ti alloys
1952 A.B. Voorhees, A. Jaretzta, First cotton fabricated artery replacement
A.H. Blackmore
1958 S. Furman, G. Robinson First successful direct heart stimulation
1958 J. Charnley First application of acrylic bone cement for total hip replacements
1960 A. Starr, M.L. Edwards Heartvalve
1970s W.J. Kolﬀ Experimental total heart replacement
1990s Implants which enable bone ingrowth
2000s Introduction of the concept Tissue Engineering
2000s Nanoscale materials
This description focuses on structural biomaterials, however, a recent and widely
adopted deﬁnition broadens the deﬁnition:31 a biomaterial is a substance engi-
neered to take a form, which alone or as part of a complex system, is used to
direct, by control of interactions with components of living systems, the course of
any therapeutic or diagnostic procedure, in human or veterinary medicine.
5
This deﬁnition even incorporates engineered tissues and cells. For simplicity, in
the present work, we refer to biomaterials as the structural materials used in the
ﬁeld of regenerative medicine.
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Figure 1.2: The chemical structure of some natural (1,2) and synthetic (3-5) polymers
applied in the biomedical ﬁeld: 1) alginate, 2) poly(α-amino acids), 3)
poly(glycolic acid) (PGA), 4) poly(lactic acid) (PLA), 6) ethylene oxide
(EO) and propylene oxide (PO) block copolymers.
Biomaterials can be diﬀerentiated based on function or based on the anatomi-
cal purpose. However, they can also be classiﬁed based on the material on its
own. Metals, ceramics, polymers, and composites are the four major biomaterial
classes.32–35 The utilization of metals and ceramics is mostly aimed at the dis-
ciplines of hard tissue engineering.32,33 Polymers however form a versatile group
with a wide variety of tissue engineering applications in both the hard and soft
disciplines. In recent past, a shift from biostable towards biodegradable and/or
bioresorbable biomaterials as a model for TE has occurred. Independent from
their purpose, biomaterials design should exhibit as little as possible adverse body
reactions, a requirement called ‘biocompatibility’.29,36 Because of this, polymer
development for biomedical purposes has boosted over the years. In Figure 1.2,
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the chemical structures of some widely applied natural and synthetic polymers are
provided.
In general, natural polymers will exhibit intrinsic advantages such as biocompati-
bility, posses the ability to present receptor-binding ligands to cells, are biodegrad-
able, and are susceptible to natural remodeling. Nevertheless, antigenicity, instabi-
lity/deterioration, complexity of puriﬁcation and disease transmission should be
considered next to the reduced mechanical properties. The properties (mechani-
cal, degradation, processability) of synthetic polymers on the other hand can more
readily be adjusted but present more diﬃculty with biocompatibility and cell ad-
hesion issues.37
1.2.3 Hepatic tissue engineering
The successful progresses obtained in the tissue engineering of bone, cartilage, and
skin were reached because they do not require an extensive vasculature and due
to their limited metabolic needs. Contrarily, as a highly metabolic tissue, the
liver is, among other, involved in detoxiﬁcation, glycogen storage, protein synthe-
sis, metabolic homostasis, release of proteins, carbohydrates, lipids, and metabolic
wastes.38,39 The heterogeneous structure and functionality of the liver has been
considered second only to the brain in its complexity.40 Figure 1.3 illustrates a
hepatic lobule, the functional unit of the liver and highlights the intricate organi-
zation. For a better understanding on the anatomy and functional aspects of the
liver, readers are referred to more detailed literature.29,40,41
Remarkably, the liver has the capacity to fully restore itself after a signiﬁcant
hepatic tissue loss either from partial hepatectomy or acute liver injury. Therefore,
in classical liver regeneration, a partial hepatectomy resecting ∼70% of the liver
is performed. Next, the remaining lobes enlarge and reconstitute the original
size, orchestrated by a myriad of signals exerting modulatory eﬀects (positive
or negative). Typically, this process takes 5-7 days for rats, but has also been
demonstrated in larger animals and humans.43
Nevertheless, full hepatic failure caused by disease, genetic complications, or ad-
verse drug reactions still make hepatic transplantations necessary. On the other
hand, the in vivo regenerative capacity of mammalian liver supports the hypothesis
that within the correct stimulatory environment in vitro culture of large quantities
of liver tissue should be possible.44 Liver tissue engineering addresses three major
applications:38,41,44
1. Model tissues for drug testing/toxicology;
2. Bioartiﬁcial Liver (BALs)/Liver Assist Devices (LADs), which use functional
hepatocytes to temporarily sustain a patient with a recent dysfunctional
7
Figure 1.3: Structure of a hepatic lobule, the functional unit of the liver.42 The com-
plexity of the structure of this organ is immediately apparent.
transplant, hepatic failure, or the progress towards failure due to a chronic
liver disease. As such, they serve as temporary support;
3. Engineered organs for implantation into patients.
A desired solution is to replace endogenous hepatic function using cells, which are
subsequently seeded on a polymer, cultured in a bioreactor and transplanted later
in vivo. This methodology has demonstrated to maintain functionality for many
weeks.45–47
The major challenge in hepatic tissue engineering is to determine the minimal en-
vironmental signals that are required to grow long-term functional liver tissue.41
Hepatocytes, hepatocyte precursor cells (oval cells or Ito cells), sinusoid endothe-
lial, Kupﬀer, stellate, biliary epithelial, ﬁbroblasts and pit cells make up the bulk of
the liver.38,39 Hepatocytes, anchorage-dependent cells composing 60% of the liver
cells and 80% of the volume, primarily exhibit the characteristic hepatic functions
and require a substratum to survive and function properly.38,44 Tight junctions
and connective tissue such as type I and IV collagen and laminins, connect the
cells.
When working with low-water content polymers, post-processing cell seeding is the
only available seeding mechanism. However, insuﬃcient cell seeding and/or non-
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uniform cell distribution have been reported using this methodology.25,48 There is
thus a need for better and more uniform seeding principles. Enhancing the seeding
eﬃciency can, among other, be accomplished by cell encapsulation strategies. This
method requires a high-water content environment.
1.3 | Hydrogels: a Route to ‘‘Soft” TE
1.3.1 The extracellular matrix
The extracellular matrix (ECM) is the non-cellular, complex meshwork of ﬁbrous
proteins and proteoglycans that is present within all tissues and organs. It provides
the essential physical scaﬀolding for the cellular constituents but also initiates cru-
cial biochemical and biomechanical cues that are required for tissue morphogenesis,
diﬀerentiation and homeostasis.49,50
Fundamentally, water, proteins and carbohydrates make up the ECM, although,
each tissue has its own unique composition and topology. Additionally, the ECM is
not only tissue-speciﬁc but also markedly heterogeneous. A simpliﬁed diagram is
presented in Figure 1.4. Two main classes of macromolecules comprise the ECM:51
1. Proteoglycans - which are composed of glycosaminoglycan (GAG) chains
covalently linked to a speciﬁc protein core (with the exception of hyaluronic
acid). The GAG chains are unbranched polysaccharide chains comprised
of disaccharide repeating blocks (either sulfated or non-sulfated) that adopt
highly extended conformations.52
2. Fibrous proteins - which can be either specialized (i.e. laminins, ﬁbronectins)
or structural (i.e. collagens, elastins) in function.
Generally, proteoglycans form hydrated gels and as such ﬁll the majority of the ex-
tracellular interstitial space within the tissue.53 Small leucine-rich proteoglycans,
modular proteoglycans, and cell-surface proteoglycans form the three main fami-
lies.52 Their functionality stems from the unique buﬀering, hydration, binding and
force-resistance properties, and is quite divers.54–56 Some of these specialized rel-
evances are:49 regulation of the inﬂammatory response, binding and activation of
transforming growth factor beta (TGFβ), modulation of cell adhesion/migration/
proliferation, serve as pro- and anti-angiogenic factor, . . .
Being the most abundant ﬁbrous protein, collagen makes up for up to 30% of the
total protein mass and is the main structural component of the ECM. Collagen has
been reported to regulate cell adhesion, support chemotaxis and migration, provide
tensile strength, and plays a role in direct tissue development.57 Collagen ﬁbers,
predominantly secreted and organized by ﬁbroblasts, are generally a heterogeneous
9
LamininFibronectin Proteoglycan
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Figure 1.4: A simpliﬁed diagram illustrating the composition of the ECM.
mix of diﬀerent types.49 However, within a given tissue, one type usually outweighs
the others.
Altogether, the unique characteristics of the ECM provide the biochemical, biome-
chanical, protective and organizational properties of each organ.
1.3.2 Hydrogels: deﬁnition, classiﬁcation, and general prop-
erties
The term hydrogel stems from “hydro” (water) and “gel” and can be deﬁned as
polymer networks that are insoluble in water, but will swell till an equilibrium vol-
ume while retaining their shape.17 Insolubility is obtained through the formation of
three-dimensional networks (due to so-called cross-links), whereby an equilibrium
exists between dispersing (acting on hydrated chains) and cohesive (limiting water
molecule penetration) forces.58 On the other hand, the presence of hydrophilic
chemical residues such as hydroxyl (-OH), carboxyl (-COOH), amide (-CONH-),
primary amide (-CONH2), sulfonic (-SO3H), and others that can be found within
the polymer backbone or as lateral chains result in the swelling behavior. Next to
contact with aqueous solvents, swelling/shrinking behavior can be designed and
triggered by other stimuli such as temperature, pH, ionic strength, electrical ﬁeld,
or light.17,59,60
By virtue of their interesting properties, hydrogels found a variety of applications,
of which some examples are provided in Figure 1.5.
Hydrogels based on natural or synthetic polymers have been of great interest re-
garding cell encapsulation.58,61–75 For the past decade, such hydrogels have become
especially attractive as matrices for regenerating and repairing a wide variety of
tissues and organs because of their innate structural and compositional similarities
10
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Figure 1.5: Some applications of hydrogels in the biomedical ﬁeld.
to the extracellular matrix.11,17,58,72–130 Depending on the hydrophilicity, they can
absorb up to thousands of times of their dry weight and form chemically stable
or (bio)degradable gels. Thanks to their thermodynamic compatibility with wa-
ter these hydrophilic homopolymers/copolymers/macromers are typically soft and
elastic.7 Depending on the nature of the hydrogel network (i.e. hydrogel network
formation), ‘physical’ and ‘chemical’ gels can be distinguished. The cross-linked
network structure is characterized by their junctions or tie knots. Hydrogels are
called ‘physical’ when the network formation is reversible. In contrast to ‘chemical’
hydrogels, which are established by irreversible, covalent cross-links. Combinations
of both physical and chemical networks can also be achieved, e.g. gelatine modi-
ﬁed with methacrylamide groups.131 Table 1.3 presents some examples of hydrogels
classiﬁed by their preparation method.17,132–134 As a mechanism for the formation
of chemical gels, polymerization remains the most common case and is routinely
induced by irradiation (gamma-rays, electron beams, UV or visible light, X-rays)
of the monomers and/or macromonomers.135
The characteristic properties of hydrogels make them especially appealing for re-
pairing and regenerating soft tissue.71,75–77,123–130,136–139 Nevertheless, one of the
main disadvantages of processing hydrogels is the diﬃculty to shape them in pre-
11
Table 1.3: Some examples of hydrogel network formation mechanisms.
CLASSIFICATION PREPARATION METHOD EXAMPLES
Physical hydrogels Ionic interaction chitosan, alginate, hyaluronan
Hydrogen bonding PVA, gelatin
Crystallization PVA after freeze-thaw cycles
Self-assembly Plu F127, PLGA-PEG-PLGA, PEG-PLGA-PEG
Hydrophobic interactions PNIPAAm, hydroxypropylmethyl cellulose
Chemical hydrogels Polymerization HEMA, NVP, glycidyl acrylate
Reaction of complementary groups glutaraldehyde + chitosan
Enzymes transglutaminase (TGase) + gelatin
designed geometries. The following sections of this chapter will provide a detailed
overview of the diﬀerent rapid prototyping techniques compatible with hydrogel
manufacturing and that allow to accurately shape external and internal geome-
tries. It is the purpose to highlight the advantages, but more importantly also
the current limitations of the distinctive techniques, together with the respective
hydrogels used so far.
1.3.3 Gelatin as hydrogel building block
Proteins serve as structural materials and catalysts. Potentially directing cell mi-
gration, growth and organization during tissue regeneration, as well as stabilization
of encapsulated cells have been important advantages correlated to protein-based
matrices.140 Collagen is the most widely applied tissue-derived natural polymer,
and, as described previously, is a main ECM constituent of mamalian tissues.104
Being a derivative of collagen, gelatin has been extensively explored in a variety
of tissue engineering approaches: it has been used as the main component in the
design of tissue engineering matrices,138,141–145 but also applied as a coating layer
in order to enhance cell-material interactions of less bioactive surfaces.146–152
As a water-soluble protein, gelatin is composed of amide linked amino acids. It
is a linear polymer formed by breaking the natural triple-helix structure of colla-
gen into single strand molecules, having a molecular weight between 15,000 and
250, 000Da.153 The amino acid composition is mainly dominated by glycine, pro-
line and hydroxyproline, which make up for more than 50% of the average amino
acid composition.
Manufacturers oﬀer gelatins in a variety of isoelectric points, of which basic gelatin
(type A, isoelectric point of 7-9) and acidic gelatin (type B, isoelectric point of 4.6-
5.4) are the most commonly used.104,140 Diﬀerences are related to the extraction
process:
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• Type A gelatin is obtained by acidic hydrolysis of collagen (pH 3.8-6);
• Type B gelatin is obtained by alkaline treatment (pH 5-7.4).
Porcine skin
42.12%
Bovine hides
28.67%
Bones
27.43%
Other
1.78%
Figure 1.6: Gelatin volume by raw materials in 2011.
The reduction of the isoelectric point of type B gelatins relates to the amidolysis
whereby asparagine and glutamine amino acids are converted to their respective
acids (aspartic and glutamic acid). These conversions do not or only slightly occur
in acidic medium. Furthermore, ornithine can be derived from arginine under
alkaline conditions.
The principle raw materials are cattle bones and hides, and porcine skins and
bones (Figure 1.6). However, recently, other sources such as ﬁsh derived gelatin
gains interest.154,155 The raw materials are subjected to a series of treatment steps
in order to derive a puriﬁed dry end-product.156 A simpliﬁed workﬂow is provided
in Figure 1.7. Prior to alkali or acid hydrolysis, substances such as minerals, fats,
and albuminoids are removed by chemical and/or physical treatments in order
to derive a puriﬁed collagen. The selected pretreatment will depend on the raw
material source.
Recently, biotechnologically produced recombinant gelatins are receiving atten-
tion.157 As described above, gelatins are harvested by proteolysis under acidic or
alkaline conditions. As a result, heterogeneous mixtures of molecules with diﬀerent
molecular weights and isoelectric points are obtained. Recombinant gelatins, how-
ever, have well-deﬁned molecular weights, amino acid sequences, and isoelectric
points, determined by the gelatin-encoding gene that is incorporated in the ex-
pression system (i.e. yeast cells).157 However, these remain much more expensive
compared to natural gelatin.
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Figure 1.7: Simpliﬁed workﬂow for the extraction of type A and B gelatins.
In the present work, mainly gelatin-based hydrogel building blocks will be re-
searched and designed to explore their potential as hepatic tissue engineering bio-
material. Recombinant gelatins will, however, be excluded from this work.
1.4 | ECM Mimetics: Current Concepts
1.4.1 Scaﬀold-free versus scaﬀold-based tissue engineering
From a cell biology perspective, 2D cell culture models only provide physiologically
compromised cells induced by an unnatural environment,158 and the lack of a 3D
structure will cause cells to form a random 2D mono-layer.22–24 In vivo, cells are
subjected to growth in three dimensions and complex cell-cell interactions. This
observation encouraged a paradigm shift from conventional 2D cell culture models
towards 3D microenvironments.159 To obtain a more realistic understanding of
cell-cell and cell-biomaterial interactions, Kirkpatrick et al.160 proposed the use
of co-culture models in vitro. Independent of the applied strategy, the ultimate
goal of TE remains the same. Nevertheless, regarding the aspect of 3-dimensional
cell migration, proliferation and diﬀerentiation behavior and requisites, one can
distinguish two major premises. Currently both of them are being heavily explored.
The ﬁrst one is based on the presumption that cells require a 3D biomaterial
scaﬀold that closely mimics the corresponding extracellular matrix (ECM).159,161
In this approach, the biomaterial construct acts as a necessary cell guide and
supporting template. The second one ﬁnds its roots in the hypothesis that cells
have a considerable potency to self-organize through cell-cell interactions and is
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referred to as ‘scaﬀold-free TE’.162 While the former theory maximizes the role of
a supporting structure as a cell guide and minimizes the potency to self-assembly,
the latter reverses the importance of both contributions.
1.4.2 Scaﬀolds
Ideally, scaﬀolds can be seen as ECM biomimetic structures with three main ob-
jectives:22,23
1. Deﬁning a space that moulds the regenerating tissue;
2. Temporary substitution of tissue functions, and;
3. Guide for tissue ingrowth.
Biocompatibility
Biodegradability
Porosity
Mechanical
requirements
Cell adhesion,
Proliferation,
Differentiation
Transport
requirements
Biofactor
delivery
Surface
chemistry
Moldability,
Sterilization
Material
Surface modiﬁcation
Bulk modiﬁcation
Design
Production technique
Figure 1.8: Schematic illustration integrating the complex multi-disciplinary needs,
which determine the constraints for the ideal scaﬀold fabrication design.
It is clear that scaﬀold design should meet the needs of some basic requirements
to be able to meet those objectives, including:5,20,22–24
– High porosity (preferably 100% interconnectivity for optimal nutrient/waste
ﬂow and tissue ingrowth);
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– Relevant geometry and pore dimensions (5-10 times the cell diameter);
– Biodegradable with adjusted degradation time;
– Maintaining the mechanical integrity during a preﬁxed time frame;
– It should have suitable cell-biomaterial interactions, and;
– Be easy to manufacture.
Adjusting the mechanical and degradation properties to the desired tissue is essen-
tial. Either enzymatic or non-enzymatic hydrolytic processes control the degrada-
tion proﬁle. Speciﬁcally, TE requires biomaterials that provoke cell interactions
(∼ bioactivity)163 and as little as possible adverse body reactions (∼ biocompat-
ibility).36 Control over the material bioactivity can be achieved by incorporating
growth factors,164 enzymatic recognition sites,165 adhesion factors,136,166 or mate-
rial modiﬁcations.165 Material modiﬁcation is a general term indicating either bulk
modiﬁcation163,167 or surface modiﬁcation.151,152,163 Modifying the bulk properties
is closely related to material biocompatibility, the physical and chemical proper-
ties covering the life-span of the implant,168 while varying the surface chemistry
reﬂects on the initial cell/tissue-material interactions.168,169 Figure 1.8 illustrates
schematically the complex multi-disciplinary interactions inherent towards scaﬀold
fabrication.
In the sub-science of scaﬀolding, both conventional and rapid prototyping (RP)
techniques have been explored (Figure 1.9). Conventional scaﬀold fabrication set-
ups include techniques such as particulate leaching,123,171–173 gas foaming,172–175
ﬁber networking,176,177 phase separation,178,179 melt moulding,180,181 emulsion freeze
drying,182,183 solution casting,184,185 freeze drying119,125,186 and combinations of
those. Conventional/classical approaches are deﬁned as processes that create scaf-
folds with a continuous, uninterrupted pore network. Nonetheless, they completely
lack long-range micro-architectural channels.24 Other reported disadvantages in-
volve low and inhomogeneous mechanical strength, limited porosity and insuﬃ-
cient interconnectivity, inability to spatially design the pore distribution (internal
channels) and pore dimensions, and diﬃculty in manufacturing patient speciﬁc
implants (control over external geometry is limited).24,187 Furthermore, the use of
organic solvents during processing is seen as a second major drawback in addition
to the above-mentioned architectural drawbacks. The presence of organic solvent
residues can pose signiﬁcant constrains related to toxicity risks and carcinogenetic
eﬀects.24 Despite some adaptations, over the years the scaﬀold design remains
process-dependent by means of classical approaches. A more design-dependent
method would be attractive, and this can be attained by RP techniques.
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Figure 1.9: Some typical porous scaﬀold examples fabricated by: (a) melt moulding,
(b) extrusion with gas blowing, (c) particulate leaching, (d) paraﬃn mi-
crosphere leaching, (e) gas foaming, (f) phase separation/freeze drying,
(g) electrospinning, (h) 3D printing, and (i) fused deposition modeling.
Reprinted from170 with permission from Elsevier.
1.4.3 Controlling the external and internal geometry
Solid freeform fabrication (SFF) is the general term covering all techniques that
produce objects through sequential delivery of energy and/or material. When
rapid fabrication of a prototype, a ﬁnished object or a tool is pursued, they are
respectively called rapid prototyping (RP), rapid manufacturing (RM) and rapid
tooling (RT).188
By means of RP, an additive computer-controlled layer-by-layer process gener-
ates a scaﬀold. 3D computer models shape the external design, and such models
can either be designed by computer aided design (CAD) software or by modeling
imaging data (computer tomography (CT), magnetic resonance imaging (MRI)).
On the other hand, the internal architecture is determined by the processing of
the CAD data into a STereoLithography (STL) ﬁle and subsequent slicing of the
STL data (generation of the machine parameters). This directly indicates one of
the greatest assets of RP: direct fabrication of scaﬀolds with a complex, patient
speciﬁc external geometry in combination with a precise control over the internal
architecture (limited by the resolution of the system).22,24,103 Other advantages
comprise: high degree of interconnectivity, possibility to use heterogeneous mate-
rials, high speed due to a high degree of automization and the limited number of
process steps, and a superior cost-eﬃciency.5,103
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Both direct and indirect RP methods exist. In the former case, the scaﬀold is
directly processed from a biomaterial, in the latter case the scaﬀold is processed out
of a RP mould. Worldwide more than 30 diﬀerent RP techniques are being applied
in the most diverse industries, and around 20 of them found applications in the
biomedical ﬁeld.188 Several authors have reviewed this particular subject.5,188,189
Despite the wide diversity of RP technologies, only some of them seem to be
compatible for the processing of hydrogels. The following section describes the
diﬀerent RP scaﬀolding techniques compatible with hydrogels.
1.5 | Rapid Protoyping Hydrogels: Powerful
Aid in Making Scaffold-Based Tissue En-
gineering Work
A primary classiﬁcation of the SFF techniques supporting biomedical applications
can be made hinged on the working principle:
(i) Laser-based systems;
(ii) Nozzle-based systems, and;
(iii) Printer-based systems.
Laser-based systems beneﬁt from the photopolymerization pathway as a basis
to fabricate cross-linked polymeric TE scaﬀolds. The well-known processing of
(pre)polymers by dint of extrusion/dispension supports the second category of RP
systems. The last subclass works with powder beds and deposition of a binder
that fuses the particles, or directly depositing material using inkjet technology.
An important characteristic feature of every technique will be its resolution. Ev-
ery technique is subdued to a lower technical limit size of the smallest details
producible. This so-called lower limit shows a clear relationship with the feasible
scale of the object: the higher the resolution of the smallest details, the smaller
will be its maximum object size.190 However, since not all RP techniques are appli-
cable for the processing of hydrogel materials, some more than others, the amount
of RP technologies is further diluted. Figure 1.10 classiﬁes the diﬀerent RP tech-
niques with biomedical applications. The fabrication of hydrogel scaﬀolds requires
mild processing conditions. Some of the techniques mentioned in Figure 1.10 are
not able to meet those constraints due to the rather harsh processing conditions.
Exploring on all of those techniques is not the purpose of this introductory chapter
in which the hydrogel compatible systems only will be explained in detail.
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Figure 1.10: Classiﬁcation of RP techniques with biomedical applications into laser-,
nozzle-, and printer-based systems.
1.5.1 Laser-based systems
1.5.1.1 Working principles and recent trends of laser-based systems
With the exception of selective laser sintering (SLS), all of the laser-based systems
are suitable for hydrogel processing. Unlike the nozzle- and printer-based systems
that sequentially deposit material, this subclass sequentially deposits light energy
in speciﬁc predeﬁned patterns. This directly implies that only photocross-linkable
prepolymers can be employed to ﬁnally obtain a cross-linked hydrogel network.
SLA: Stereolithography (SLA) is considered to be the ﬁrst commercially available
SFF technique, developed by 3D systems in 1986.190 A SLA apparatus (Fig-
ure 1.11) consists of: a reservoir to be ﬁlled with a liquid photocurable resin, a
laser source (commonly UV light), a system that controls the XY-movement of
the light beam, and a fabrication platform that permits movement in the vertical
plane. Scanning the surface of the photosensitive material produces 2D patterns
of polymerized material through single photon absorption at the surface of the
liquid material. The build-up of a 3D construct is made possible using a layer-by-
layer approach, whereby the fabrication platform moves stepwise in the Z-direction
after a 2D layer is ﬁnished. The step height of the fabrication platform is typi-
cally smaller than the curing depth, ensuring good adherence of subsequent layers.
Post-treatment steps involving washing-oﬀ excess resin, and further curing with
UV light are in most cases necessary. Arcaute et al.191 demonstrated the possibility
to alter the resolution of the cure depth by varying the laser energy, the concentra-
tion of poly(ethylene glycol) dimethyacrylate (PEG-DMA) as photocross-linkable
material, and the type and concentration of the photo-initiator (PI). In addition,
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adjusting the scanning speed inﬂuences the cure depth.
μ-SLA: The working mechanism of micro-stereolithography (μ-SLA) can be con-
sidered the same as that of a normal SLA. The diﬀerence between both involves the
resolution of the system. μ-SLA systems are typically able to build very accurately
(a few microns) objects of several cubic centimeters [134-137].192–195
Fabrication platform
Laser
Lens
Digital Mirror Device
           (DMD)
Coated glass slide
vz
TOP-DOWN
Liquid 
photocurable resin
Fabrication platform
Liquid photocurable 
resin
Laser
vz
Scanner system
(XY-movement)
BOTTOM-UP
Figure 1.11: Scheme of bottom-up and top-down stereolithography setups. The
bottom-up setup shown is an example of a system whereby the laser scans
the surface for the curing of the photosensitive material. In the example
of the top-down setup, dynamic light projection technology is used to cure
a complete 2D layer at once.
Figure 1.11 (left) shows a scheme of a so-called bottom-up setup, in which an object
is built from a fabrication support just below the resin surface. Subsequent layers
are being cured on top of the previous layers by irradiation from above. Although,
to date this is the most applied setup,191,193–198 a top-down approach (Figure 1.11
right) is gaining interest.109,190,192 Top-down setups have a non-adhering, trans-
parent plate acting as the bottom of the liquid reservoir. Polymerization of the
photosensitive material occurs through irradiation from underneath, and the fabri-
cation platform moves in the opposite direction as in the bottom-up approach. In
this way, every newly formed layer is located beneath the previous one. Separating
every newly formed layer from the bottom plate will subject the structure to larger
mechanical forces but on the other hand the reservoir content can be minimized,
the irradiated surface will not be exposed to the atmosphere (cross-linking eﬃ-
ciency limitation due to oxygen will be minimized), recoating the structure with
a new resin layer is not required, and the illuminated area is always smooth.190
Another recent and more fundamental trend in the ﬁeld of SLA is the emerging
use of digital light projection (DLP) technology.192,198–200 The working principle
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is illustrated in Figure 1.11 (right) in the top-down scheme, but is also applica-
ble for bottom-up setups. Projection technology enables the curing of a complete
layer of resin in one go, which obviously reﬂects on the building time. A Digital
Micro-mirror Device™ (DMD) consists of an array of mirrors, which can indepen-
dently be tilted in an on/oﬀ state. In this way the DMD serves as a dynamic mask
that projects a 2D pattern (often designed in PowerPoint slides) on the surface.
Instead of DMD, LCD displays have also been employed as a dynamic mask pro-
jector,201,202 however, DMD oﬀers better performance in terms of optical ﬁll factor
and light transmission.198
SGC: A projection technology somewhat similar to DMD technology is solid ground
curing (SGC) developed by Cubital Inc.203,204 Coating the fabrication platform by
spraying a photosensitive resin is the ﬁrst step in the SGC workﬂow. Meanwhile,
the machine prints a photomask of the layer to be built on a glass plate above
the fabrication platform. The printing process resembles the one applied in com-
mercial laser printers. Solidiﬁcation of the sprayed layer occurs when the mask is
exposed to UV light, only permitting irradiation of the transparent regions. After
the layer is completed, excess liquid resin is removed by vacuum and replaced by
a wax to support the next layer. Before repeating the cycle, the layer is milled ﬂat
to an accurate, reliable ﬁnish for the next layer.
Liquid 
photocurable resin
Near-IR light
Near-IR light
Crosslinked 
resin
Figure 1.12: Working principle of two-photon photopolymerization. In the focal point
of the near-IR laser beams, the photo-sensitive polymer is cross-linked. A
‘true’ 3D object is obtained.
2PP: Two photon-polymerization (2PP) is an emerging state-of-the-art laser-based
technique. In this process, light is used to trigger a chemical reaction leading to
polymerization of a photo-sensitive material. Unlike other light curing systems
(single photon polymerization), 2PP initiates the polymerization through radia-
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tion with near-infrared femtosecond laser pulses of 800 nm (Figure 1.12). In the
focal point, a suitable PI absorbs two photons, with a wavelength of 800 nm, si-
multaneously, causing them to act as one photon of 400 nm, and thus starting the
polymerization reaction.192 The nonlinear excitation nature triggers polymeriza-
tion only in the focal point, while other regions remain unaﬀected. This approach
has potential solidiﬁcation resolutions below the diﬀraction limit of the applied
light. Moving the laser focus enables the fabrication of a direct ‘true’ 3D object
into the volume of the photosensitive material. Creating reproducible micron-sized
objects with feature sizes of less than 100 nm is attainable, thus being superior to
all other SFF techniques regarding accuracy and resolution.205
1.5.1.2 Current limitations and hydrogel feasibility for laser-based sys-
tems
SLA has already been frequently applied to develop porous hydrogel-based scaf-
folds (Table 1.4). Yu et al.206 have described the patterning of 2-hydroxyethyl
methacrylate (HEMA) followed by drying and subsequent rehydration to enable
cell adhesion. Initially, the procedure was applied to create single-layer structures,
however, at present, multiple layers can be superimposed to generate porous 3D
scaﬀolds. Liu et al.70 selected poly(ethylene glycol) diacrylate (PEG-DA) hydro-
gels to construct 3D scaﬀolds layer by layer using emulsion masks. In that study,
three hydrogel layers were fused at a resolution of several hundreds of microns.
Interestingly, the pores were interconnected enabling cell survival through convec-
tive ﬂow of culture medium. However, this procedure is time consuming, requires
a great number of prefabricated masks depending on the required shape and is
not completely automated. Therefore, one can discuss whether this can be con-
sidered as a genuine rapid prototyping technique. Lu et al.198,207 have adopted
the above mentioned procedure to develop scaﬀolds possessing complex internal
architectures and spatial patterns within a Z-range of several hundreds of mi-
crons. Another research group even produced PEG-based scaﬀolds in the millime-
ter scale.191,208–210 Several other research groups also selected PEG-DA as starting
material.71,211 Tsang et al.71 successfully plotted 100μm-sized complex scaﬀold
architectures. The swelling eﬀects of the PEG-DA, however, prevented the fabri-
cation of highly reproducible samples below 100μm. Higher resolutions could be
obtained in the presence of UV absorbers since they prevent the internal reﬂection
of the UV light within the polymer solution. More recently, the feasibility of plot-
ting cell-encapsulated hydrogels has been evaluated. Several research groups have
already reported on the cell encapsulation in photocross-linkable poly(ethylene gly-
col) (PEG) microgels.70,212 In addition to synthetic polymers, photocross-linkable
biopolymers including hyaluronic acid (HA)213 and gelatin109 derivatives have al-
ready been printed with or without cells using SLA.
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Table 1.4: Hydrogel materials explored in laser-based systems.
LASER-BASED
SYSTEMS
HYDROGEL MATERIALS CELL ENCAPSULATION REFERENCE
SLA
Gelatin-methacrylate
 109,192,214
Gelatin-methacrylamide
Hyaluronic acid-methacrylate
Murine ﬁbroblasts (NIH 3T3)
213,215
Murine embryonic stem (ES) cells
Cystein-modiﬁed agarose  216
HEMA  206
PEG-D(MA)
Human hepatoma cells (HepG2)
70,71,191,196,198,212
Hepatocytes
NIH 3T3
Human dermal ﬁbroblasts (HDFs)
Chinese hamster ovary (CHO) cells
Murine OP-9 marrow stromal cells
Mammalian cells
PEG-D(MA)  200,208–211
μ-SLA
Alginate + Acrylated TMC/TMP Chondrocytes 193–195
Gelatin-methacrylamide  192
PEG-DA  214,217
2PP
Gelatin-methacrylamide  192,218–220
Fibronectin
 220
Bovine serum albumin (BSA)
PEG-DA  221,222
In order to enhance the cell-interactive properties of a material, diﬀerent surface
functionalization strategies can be elaborated.71 Luo et al.216 grafted Arginine-
glycine-aspartic acid (RGD)-containing peptide sequences on the surface of scaf-
folds composed of cystein-modiﬁed agarose. Han et al.200 applied a ﬁbronectin
coating on the surface of a PEG-DA scaﬀold to improve the attachment of murine
marrow-derived progenitor cells. However, important limitations of laser-based
systems include both the need for photocross-linkable materials as well as the ef-
fect of the applied UV light on the encapsulated cells.215 Since shrinkage occurs
after post-processing of scaﬀolds developed using SLA, a major drawback is its
limited resolution.197 In addition, due to scattering phenomena of the applied
laser beam, a signiﬁcant deformation occurs when relatively small objects are de-
veloped. The produced hydrogel is often weak upon removal and post-curing is
often essential.
Therefore, μ-SLA was introduced to counter the limitations of SLA from a resolu-
tion point-of-view. For example, Lee et al.193–195 developed a hybrid scaﬀold con-
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sisting of an acrylated trimethylane carbonate/trimethylolpropane (TMC/TMP)
framework and an alginate hydrogel for chondrocyte encapsulation. The encap-
sulated cells retained their phenotypic expression within the structure and the
scaﬀold remained mechanically stable up to 4 weeks after implantation in mice.
Barry et al.217 have combined direct ink writing (DIW) with in situ photopoly-
merization to create hydrogel scaﬀolds possessing μm-sized features. Using this
approach, another research group even realized submicron range structures based
on PEG-DA.214
In addition to SLA techniques, SGC also shows potential to be applied in the
development of porous hydrogel-based scaﬀolds for tissue engineering, as already
indicated before.197 However, up to now, no literature data regarding this appli-
cation and hydrogel processing can be found.
In order to achieve 3D subcellular resolution during scaﬀold development, 2PP can
oﬀer a suitable alternative for SLA. Since this technique was only introduced re-
cently, only few reports can be found in literature regarding the application of 2PP
to produce porous hydrogels. For example, Schade et al.221 developed hydrogel-like
scaﬀolds possessing well-deﬁned 3D structures using a methacrylated polyurethane
and PEG-DA as starting materials. Ovsianikov et al.222 also selected PEG-DA as
starting material for 2PP scaﬀolds. More recently, they evaluated the feasibility
to produce porous scaﬀolds using methacrylamide-modiﬁed gelatin developed in
our research group.223 The results were very recently published and demonstrated
the techniques potential in the processing of biopolymers.218,219 Table 1.8 summa-
rizes more technical details on the implementation of hydrogels in the diﬀerent RP
technologies discussed.
1.5.2 Nozzle-based systems
1.5.2.1 Working principles and recent trends of nozzle-based systems
The class of nozzle-based systems is characterized by a wide diversiﬁcation (Figure
1.10). Fused deposition modeling (FDM), 3D ﬁber-deposition, precision extrusion
deposition (PED), precise extrusion manufacturing (PEM), and multiphase jet so-
lidiﬁcation (MJS) are techniques based on a melting process. Generally, the melt
process involves elevated temperatures, which are undesirable from the perspec-
tive of scaﬀold bioactivity.23 Researchers have therefore tried to bring forth several
other techniques that overcome this limitation by applying a dissolution process,
which is attractive for the processing of hydrogels. Four major nozzle designs
have been described in literature: pressure-actuated, solenoid-actuated, piezoelec-
tric, and volume-actuated nozzles.224,225 These nozzle types can be found in the
following systems.
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PAM: A technique that resembles FDM without the need for heat is the pressure-
assisted microsyringe (PAM) technique, developed by Vozzi et al.226 The setup
consists of a 5-20 (μm)pneumatic-driven glass capillary syringe that can move in
the vertical plane and deposits material on a substrate. The substrate proceeds in
the planar ﬁeld relative to the syringe. Transforming jpeg or bitmap images into a
sequential list of linear coordinates easily allows depositing practically any type of
structure in subsequent layers.227 Material viscosities, deposition speed, tip diam-
eter and the applied pressure correlate with the ﬁnal deposited strand dimensions.
The PAM system has been described in several publications.228,229 Recently, the
fabrication of hydrogel scaﬀolds was successful with the PAM method.230,231
LDM: Proposed by Xiong et al.232 in 2002, low-temperature deposition modeling
(LDM) found his way as a RP system with biomedical applications. The key fea-
ture of this technique is a non-heating liquefying processing of materials.232 Using
temperatures below 0 ◦C, the material solution is solidiﬁed when deposited on the
fabrication platform.233 The material gets extruded out of a nozzle capable of mov-
ing in the XY-plane onto a build platform movable in the Z-direction. Incorporat-
ing multiple nozzles with diﬀerent designs into the LDM technique gave existence to
multi-nozzle (low-temperature) deposition modeling (MDM, M-LDM).224,225,234,235
A multi-nozzle low-temperature deposition and manufacture (M-LDM) system is
proposed to fabricate scaﬀolds with heterogeneous materials and gradient hier-
archical porous structures by the incorporation of more jetting nozzles into the
system.232 Biomolecules can be applied in the LDM process to fabricate a bioac-
tive scaﬀold directly.
3D-Bioplotter™: This 3D dispensing process, displayed in Figure 1.13, has been
introduced by Landers and Mülhaupt in 2000 at the Freiburg Research Centre.236
The technique was speciﬁcally developed to produce scaﬀolds for soft-tissue engi-
neering purposes, and simplifying hydrogel manufacturing. The three-dimensional
construction of objects occurs in a laminar fashion by the computer-controlled
deposition of material on a surface. The dispensing head moves in three dimen-
sions, while the fabrication platform is stationary. It is possible to perform either a
continuous dispensing of microstrands or a discontinuous dispensing of microdots.
Liquid ﬂow is generated by applying ﬁltered air pressure (pneumatic nozzle), or
using a stepper-motor (volume-driven injection (VDI) nozzle). The ability to plot
a viscous material into a liquid (aqueous) medium with a matching density is
the key feature of this process. Low viscous materials in particular beneﬁt from
this buoyancy compensation principle. Since heating is not required, the system
can process thermally sensitive biocomponents, and even cells. Curing reactions
can be performed by plotting in a co-reactive medium or by two-component dis-
pensing using mixing nozzles. The strand thickness can be modulated by varying
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material viscosity, deposition speed (speed in the planar ﬁeld), tip diameter, or
the applied pressure. Constructs build by this plotting technique mostly have
smooth strand surfaces, which are not desired for appropriate cell attachment.
Therefore, further surface treatment is required to render the surface favourable
for cell-adhesion. Recently Kim et al.237 adapted the Bioplotting device with a
piezoelectric transducer (PZT) generating vibrations while plotting PCL. Scaﬀolds
build had a rougher surface and showed better cell adhesion than the ones build
with the conventional setup.
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Figure 1.13: Scheme of 3D-Bioplotter™ dispensing principle. In the 3D-Bioplotter™
system, the nozzle works pneumatically or via volume-driven injection.
This also illustrates the principle of nozzle-based systems in general, where
a nozzle is used for the deposition of material. Key diﬀerence with other
nozzle-based systems is the ability to plot into a liquid medium with
matching density, thus introducing buoyancy compensation.
RPBOD: Ang et al.238 adopted an analogous concept of the 3D-Bioplotter™ tech-
nology to develop a robotic dispensing system: the rapid prototyping robotic dis-
pensing (RPBOD) system. The setup consists of a one-component pneumatic
dispenser.
Robocasting: The laminar deposition of highly loaded ceramic slurries (typically
50− 60 vol% ceramic powder) to build a 3D construct using robotics is called
robocasting.239 Unlike the bioplotting process, in most cases the robocasting setup
has a stationary dispensing head, while the fabrication platform moves in the
planar and vertical ﬁeld. Inks used for robocasting have to ﬂow under stress and
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recover enough stiﬀness such that, when the stress is released, they can bear both
the extruded ﬁlament weight and the weight of successive layers.240,241 Thus, in
contrary to other SFF techniques, the concept of robocasting relies essentially on
the rheology of the slurry and also on the partial drying of the deposited layers.
Building-up constructs from hydrogel material alone is therefore not possible using
this technique.
Direct ink writing (DIW): Direct ink writing (DIW) or direct-write assembly en-
ables a wide variety of materials to be patterned in nearly arbitrary shapes and
dimensions.242–244 Colloidal-based inks are patterned in both planar and 3D forms
with lateral feature sizes that are at least an order of magnitude smaller than those
achieved by ink-jet printing and other rapid prototyping approaches.245 The col-
loidal gels are housed in individual syringes mounted on the z-axis motion stage and
deposited through a cylindrical nozzle (diameter ranging from 100μm to 1mm)
onto a moving XY stage. The inks used in this technique must meet two impor-
tant criteria. First, they must exhibit a well-controlled viscoelastic response, i.e.,
they ﬂow though the deposition nozzle and then ‘set’ immediately to facilitate
shape retention of the deposited features even as it spans gaps in the underlying
layer(s). Second, they must contain a high colloid volume fraction to minimize
drying-induced shrinkage after assembly is complete, i.e., the particle network is
able to resist compressive stresses arising from capillary tension.246
Extruding/aspiration patterning system: The extruding/aspiration patterning sys-
tem oﬀers both extrusion, and aspiration on the basis of Bernoulli suction. The
extrusion and aspiration modes are easily switchable, leading to a variety of appli-
cations in cell patterning by combining extrusion/aspiration and using a thermo-
reversible hydrogel.247 This fabrication method makes it possible to produce cell-
loaded scaﬀolds. One of the advantages is the possibility that cell patterns can be
ﬁlled into another cell matrix. A schematic illustration of an extruding/aspiration
patterning system is given in Figure 1.14. Nozzle and substrate are placed in a
space that controls temperature and humidity. The nozzle is connected to the
dispenser, which regulates the pressure of the compressed air, and the valve. The
system operates in three modes: extrusion, aspiration, and reﬁlling mode. Closing
or opening the valve enables switching between the modes. In a closed conﬁgura-
tion, compressed air is supplied to the nozzle and the hydrogel is extruded onto
the substrate, or reﬁlled into the aspirated groove. By opening the valve, the com-
pressed air is directed through the valve, and the hydrogel solution is aspirated by
Bernoulli suction. To prevent desiccating (to maintain the viability of the cells),
a mist spray is used to create a supersaturated atmosphere inside the box.
The most recent trend is the use of hydrogel systems and cell encapsulation strate-
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Figure 1.14: Schematic illustration of an extruding/aspiration patterning setup. The
main diﬀerence with other nozzle-based systems is established through the
incorporation of a mist spray, thus preventing desiccation of the fabricated
constructs.
gies to fabricate gel/cell hybrid constructs.142,248–253 The 3D-Bioplotter and other
similar techniques can be seen as the most straightforward hydrogel/cell manufac-
turing method for designing complex inner and outer architectures, without the
need for an additional support structure. In some cases, the developed machine
contains multiple nozzles with diﬀerent designs (sometimes even printer-based).
In literature, ‘Cell Assembler’ and ‘Bioassembly Tool’ are common machine names
that have a similar working principle. Work of Chang et al.254 examined the eﬀect
of nozzle pressure and size on cell survival and functionality. A quantiﬁable loss
in cell viability was seen, which was caused by a process-induced mechanical dam-
age to cell membrane integrity. It was suggested by the authors that cells might
require a recovery period after manufacturing.
1.5.2.2 Current limitations and hydrogel feasibility for nozzle-based
systems
An overview of the combination nozzle-based systems/hydrogel materials is sum-
marized in Table 1.5. Lately, cell encapsulation strategies have been frequently
applied to fabricate gel/cell hybrid constructs.248–252 For each hydrogel material,
it is indicated whether or not cell encapsulation experiments were performed. In
addition, Table 1.8 comprises the more technical details, focused on the disad-
vantages speciﬁc for hydrogels. As shown, scaﬀolds produced by a 3D-Bioplotter
have limited resolution and mechanical strength. Material rigidity was shown to
inﬂuence cell spreading and migration speed, as demonstrated by Wong et al.270
Vascular smooth muscle cells displayed a preference for stiﬀer regions, and tended
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Table 1.5: Hydrogel materials explored in nozzle-based systems.
NOZZLE-BASED
SYSTEMS
HYDROGEL MATERIALS CELL ENCAPSULATION REFERENCE
Gelatin/Hyaluronan x 255
Gelatin/Alginate/Fibrinogen
142,256–258
Gelatin/Fibrinogen Adipose-derived stromal cells (ADSC),
Gelatin/Alginate Pancreatic islets, Hepatocytes
Gelatin/Chitosan
Collagen-chitosan-hydroxyapatite x 259
Gelatin Hepatocytes 260
Gelatin-ethanolamide methacrylate, HepG2, NIH 3T3
253
Hyaluronan methacrylate Human intestinal epithelial cells (Int-407)
PCL hybrid with alginate chondrocyte cell line (C20A4) 261
3D BIOPLOTTER Collagen x 250,251
3D BIOASSEMBLY TOOL PCL/PLGA hybrid with acetocollagen, Hepatocytes
141
3D CELL ASSEMBLER Gelatin or hyaluronic acid MC3T3-E1 preosteoblast
Gelatin, agar x 262
PEG-DA/alginate x 263
PEG-DA x 264
Plu® F127 AlaL Multipotent stromal cells (MSCs) 265
Plu® F127
Bone marrow stromal cells (BMSCs)
82,250Human ﬁbroblasts
Bovine aortic endothelial cells (BAECs)
Alginate
82,266,267
Matrigel BMSCs
Methylcellulose Hepatocytes
PEO-PPO-PEO block copolymer Endothelial cells
Agarose
Silicone sealant Silicon SE® x 236
Polyurethanes x 233
RPBOD Chitosan/HA x 238
DIW
Acrylamide/Glycerol/Water x 217
Polyacrylate latex particles in Plu® F127 x 268
PEI-coated silica microspheres x 242
Polyelectrolyte complexes of x 243
polyanions (PAA) and polycations (PEI, PAH)
Titanium diisopropoxide x 244
bisacetylacetonate (TIA) and PVP
(M) - LDM
Gelatin/Alginate/Fibrinogen hepatocytes
248
Gelatin/Alginate/Chitosan Primary rad ADSC
Gelatin, Sodium alginate
Schwann cells
249
Primary neuron cells
Gelatin/Chitosan and type I Collagen x 225
PAM Polyurethane elastomer (Polytek 74-20) x 269
ROBOCASTING Plu® F127 x 240
EXTRUDING/ASPIRATION Mebiol gel(N-isopropylacrylamide Sf-9 insect cells 247
PATTERNING SYSTEM and polyoxyethyleneoxide)
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to migrate faster on surfaces with lower compliance. In addition, the 3D-Bioplotter
technology is a time consuming technique due to the optimization of the plotting
conditions for each diﬀerent material. Ang et al.238 reported 3D chitosan and
chitosan-HA scaﬀolds using the RPBOD. Solutions of chitosan or chitosan-HA
were extruded into a sodium hydroxide and ethanol medium to induce precipi-
tation of the chitosan component. The concentration of sodium hydroxide was
identiﬁed as important in controlling the adhesion between the layers. The scaf-
folds were then hydrated, frozen and freeze-dried. Prior to cell culturing with
osteogenic cells, the scaﬀolds were seeded with ﬁbrin glue. Drawbacks of this tech-
nique largely follow those of the 3D-Bioplotter and analogues. The inks used in
the direct ink writing (DIW) are limited by their ﬂow criteria itself.
Khalil et al.224 developed a multi-nozzle low-temperature deposition system with
four diﬀerent micro-nozzles: pneumatic microvalve, piezoelectric nozzle, solenoid
valve and precision extrusion deposition (PED) nozzle. The system consisted of
an air pressure supply. Multiple pneumatic valves were simultaneously operated
for performing heterogeneous deposition in the development of the 3D scaﬀold.
With this technique, multi-layered cell-hydrogel composites can be fabricated.251
Hydrogels have also been processed with the PAM technique.230,231 Of the 3D
rapid prototyping micro-fabrication methods available for tissue engineering, PAM
has the highest lateral resolution. Recently, it has been demonstrated that the
performance of this method is comparable to that of soft lithography.271 However,
capillaries with a very small diameter require careful handling to avoid any tip
breakage. In addition, pressures are needed to expel the material from a small
oriﬁce. Robocasting relies on the rheology of the slurry and partial drying of
the deposited layers. This implies that a pure hydrogel composition cannot be
processed via this particular technique, being the most fundamental drawback of
the technique. A last nozzle-based system is the extruding/aspiration patterning
system. One of the advantages is that its setup is favourable for cell encapsulation
purposes and the fact that cell patterns can be ﬁlled into another cell matrix.
However, the hydrogel materials require a small temperature hysteresis, so it has
limited applicability.
Concerning the nozzle-based systems in rapid prototyping of hydrogels, several
challenges need to be addressed. Looking at the limited range of materials, the
following topics should be addressed: optimal scaﬀold design, bioactivity of the
scaﬀold as well as the issues of cell seeding and encapsulation possibilities. So,
future development will need to focus on the engineering of new materials, the
scaﬀold design and the input of cell biologists. Keeping this in mind, rapid proto-
typing still remains a promising technique as a methodical interface between tissue
and engineering.
30
Concerning (non home-made) RP devices in general, high equipment purchase
costs can be considered a substantial disadvantage. Therefore, it is also notewor-
thy to mention that very recently open-source low-budget nozzle-based systems
have found their way to this research domain. A hydrogel compatible example is
the Fab@Home ($ 1,000–3,000) system that was developed at Cornell University.
Cohen et al.266 tested a proof-of-concept for in situ repair of osteochondral defects
using alginate as scaﬀolding material. Lixandrao et al.263 demonstrated the feasi-
bility of complex architecture scaﬀolding with the Fab@Home. They constructed
aortic valves based on a PEG-DA/alginate blend.
1.5.3 Printer-based systems
1.5.3.1 Working principles and recent trends of printer-based systems
In literature, ‘printing’ is often used as a general term for both the construction of
a scaﬀold or to indicate printer-based systems. To diﬀerentiate between both, we
deﬁne the latter as manufacturing techniques that implement inkjet technology.
Inkjet printers can be divided in drop-on-demand or continuous ejection types. In
drop-on-demand systems, electrical signals are used to control the ejection of an
individual droplet. In continuous-drop systems, ink emerges continuously from a
nozzle under pressure. The jet then breaks up into a train of droplets whose direc-
tion is controlled by electrical signals.272 Both drop-on-demand and continuous-jet
systems can be operated with droplets ranging in size from 15 to several hundred
microns.272 Many commercial (adapted) printers fall in the former category, and
will only eject ink when receiving a demand signal from the computer. Table
1.6 classiﬁes the existing inkjet printers (modiﬁed from Nakamura et al.273). Like
the nozzle-based systems, building a construct occurs in an additional computer-
controlled layer-by-layer sequence with deposition of material.
Table 1.6: Classiﬁcation of inkjet printers.
Inkjet printers
Electromechanical (piezo-actuated and electrostatic actuated)
Drop-on-demand Electrothermal (thermal actuated)
Electrostatic vacuum
Electro-ﬁeld controlled inkjet
Continuous ejection
Hertz continuous inkjet (mutual charged droplet repulsion type)
3DP™: Prof. Sachs from the Massachusetts Institute of Technology (MIT) in-
troduced the 3D Printing™ technology.274 It is an example of a solid-phase RP
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technology. 3D Printing can be used to fabricate parts in a wide variety of mate-
rials, including ceramic, metal, metal-ceramic composite and polymeric materials.
3D printing is the only of the solid-phase RP techniques compatible with hydrogel
manufacturing. A scheme of a typical 3DP™ setup is given in Figure 1.15. The
technique employs conventional inkjet technology. The workﬂow can be described
in 3 sequential steps: (1) the powder supply system platform is lifted and the fab-
rication platform is lowered one layer; (2) the roller spreads the polymer powder
into a thin layer (excess powder falls in an overﬂow reservoir), and; (3) an inkjet
print head prints a liquid binder that bonds the adjacent powder particles to-
gether. The binder can dissolve or swell the powder particles, causing bonding via
the inter-diﬀusion of polymer chains or via inﬁltration of the binder into the pow-
der.275 Cycling steps 1–3 fabricate a 3D object. A key requirement for 3D printing
is the availability of biocompatible powder-binder systems.22 The powder utilized
can be a pure powder or surface-coated powder, depending on the application of
the scaﬀold. It is possible to use a single, one-component powder, or a mixture of
diﬀerent powders blended together.23 After the ﬁnished construct is retrieved, any
unbound powder is removed, resulting in a complex three-dimensional part. Basic
requirements that the binder system must satisfy: (i) the binder solution must
have a high binder content while still having a low viscosity so that it is capable
of being deposited by the print head; (ii) minimal conductivity may be required
for continuous jet printing heads; (iii) the binder must dry or cure rapidly so that
the next layer of particles can be spread.272
Roller
Powder supply platform Fabrication platform
Inkjet head
(liquid adhesive delivery)
Powder bed
vZ vZ
vY
vXY
Figure 1.15: Schematic representation of a typical 3DP™ setup. A roller spreads a thin
layer of polymer powder over the previously formed layer, and is subse-
quently solidiﬁed by the spatially controlled delivery of a liquid binder.
3D Printing has four steps that can limit the rate of the process: the application of
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the powder layers, the printing of the binder, the inﬁltration of the binder into the
powder and the drying of the binder.272 An important advantage of powder-based
systems is the production of rougher surfaces, which may enhance cell adhesion.22
Zcorp developed a 3D printer (Z402) that uses natural polymers as well as plaster
of Paris in combination with a water-based ink.275,276 This opens perspectives
towards hydrogel manufacturing. A recent detailed review on 3DP™ concerning
all process development steps, such as powder-binder selection and interaction, is
given by Utela et al.277
In 3DP, control over the geometry is realized by two distinct issues: the minimum
attainable feature size, and the variability of part dimensions.272 Both depend
strongly on the binder droplet-powder particle interactions. Factors controlling
the interaction of powder and binder include: powder material, powder surface
treatment, powder size and size distribution, powder shape, powder packing den-
sity, binder material, binder viscosity, binder surface tension, droplet size, droplet
velocity, temperature of the powder and binder, and ambient temperature.272 Fac-
tors that determine the ﬁnal object dimensions are: local and accumulative accu-
racy of deposited layer thickness, accuracy of drop placement, reproducibility of
the spread of the printed droplets, and reproducibility of the dimensional changes
that accompany binder cure. Sometimes, resolution of the machine is mentioned.
Resolution in this context refers to the smallest pores and the thinnest material
structures that are obtainable with the equipment.272
Inkjet printing: This printer-based subclass comprises all liquid-phase inkjet tech-
nologies. It can vary from setups similar to the 3DP™ system in which the powder
bed is replaced by a liquid hydrogel precursor,278 or systems that use direct inkjet
writing.18,279 In the case of direct inkjet writing, the construct is build up by the
deposited liquid itself.
1.5.3.2 Current limitations and hydrogel feasibility for printer-based
systems
Printer-based systems can perhaps be regarded as the least hydrogel/cell suitable
of the systems that allow hydrogel processing. Tables 1.7 and 1.8, summarize the
hydrogel feasibility respectively limitations towards hydrogel manufacturing. Wu
et al.280 described the use of polyethylene oxide (PEO) and poly-ε-caprolactone
(PCL) as matrix materials and a 20% PCL-lipopolysaccharide(LPS)/chloroform
binder solution to create a 3D device for controlled drug release. Top and bottom
layer of the tabular device was made out of slowly degrading PCL, while the
interior layers were composed of PEO bound by printing binder solutions. The
local microstructure of the device could be controlled by either changing the binder
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or by changing the printing parameters (velocity). Typical powder particle size
ranged from 45 to 75μm for PCL and 75-150μm for PEO. The binder droplets
had a diameter in the order of 60-80μm. After 20 hours, signiﬁcant swelling of
the PEO was experimentally observed.
Table 1.7: Hydrogel materials explored in printer-based systems.
PRINTER-BASED
SYSTEMS
HYDROGEL MATERIALS CELL ENCAPSULATION REFERENCE
3DP™
Starch/Cellulose/Dextrose  275,276
Starch/Cellulose ﬁber/
 281
Sucrose/Maltodextrin
Corn starch/Gelatin/Dextran  276
Starch/Polyurethanes/PEG  275
PEO/PCL  280
PLLGA/Pluronic® F127  282
HA/Cellulose/Starch  283
PEG/Collagen/PDL  284
PNIPAM, Collagen bovine aortal endothelial cells 285
INKJET Alginate/Gelatin mouse endothelial cells (ATCC CRL-2581) 278
PRINTING
Fibrin
rat primary hippocampal and cortical cells
286,287human microvasculature endothelial cells
(HMVEC)
Landers et al.236 studied the use of water-soluble polymers, which are bonded to-
gether by means of water-based saccharide glues. Although the choice of powders
and the corresponding adhesives appears to be unlimited, this technology requires
post-sintering or post-curing to improve mechanical as well as environmental sta-
bility.
Lam et al.276 developed a blend of starch-based powder containing cornstarch
(50wt%), dextran (30wt%) and gelatin (20wt%). Distilled water was used as a
suitable binder material. Cylindrical scaﬀolds (∅ 12.5 × 12.5mm) were produced
having either cylindrical (∅ 2.5mm) or rectangular (2.5 × 2.5mm) pores. Using
water as the binder means that the problem of a toxic fabrication environment was
eliminated and the problem of residual solvent in the construct was solved. Other
advantages of using a water-based binder include the possibility to incorporate bi-
ological agents (e.g. growth factors) or living cells. Post-processing of the scaﬀolds
was necessary to enhance the strength of the scaﬀolds and increase the resistance
against water uptake. The scaﬀolds were dried at 100 ◦C for 1 hour after printing
and inﬁltrated with diﬀerent amounts of a copolymer solution consisting of 75%
poly(L-lactide) and 25% PCL in dichloromethane.
Sanjana et al.284 report on the use of ink-jet printing to fabricate neuron-adhesive
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patterns such as islands and other shapes using poly(ethylene) glycol (PEG) as
cell-repulsive material and a collagen/poly-D-lysine (PDL) mixture as cell-adhesive
material. They worked with a positive relief: PEG used as background and anti-
fouling material was bonded covalently to the glass surface while the collagen/PDL
mixture was used as the printed foreground and cell-adhesive material. They also
suggest that the ink-jet printing technique could be extrapolated to building 3D
structures in a layer-by-layer fashion.
Xu et al.286 use the inkjet printing technology for the construction of three-
dimensional constructs, based on ﬁbrin gel. Fibrin was used as a printable hydrogel
to build 3D neural constructs. The ﬁbrin is formed by the enzymatic polymer-
ization of ﬁbrinogen by addition of thrombin and calcium chloride CaCl2. First,
a thin sheet of ﬁbrinogen was plated and subsequently, thrombin droplets were
ejected from the print cartridge onto the pre-plated ﬁbrinogen layer. Fibrin gel
formation was observed immediately after thrombin ejection. Subsequently, NT2
neurons were printed on the gelled ﬁbrin. The whole procedure was repeated 5
times, resulting in a 3D neural sheet.
Koegler et al.282 described the fabrication of 3DP scaﬀolds based on poly(L-lactide-
co-glycolide). Surface chemistry of these scaﬀolds was modiﬁed by reprinting the
top surface with a solution of Pluronic F127 in CHCl3.
Cui et al.287 reported on the fabrication of micron-sized ﬁbrin channels using a
drop-on-demand polymerization. A thrombin/Ca+2 solution together with human
micro-vascular endothelial cells (HMVEC) cells was used as ‘bio-ink’ and sprayed
by the inkjet technology onto a ﬁbrinogen substrate. They suggest that these
constructs show potential in building complex 3D structures. Examples of the
direct use of printer-based systems together with hydrogels are rather limited. In
some cases, the use of an indirect system is mentioned.
Sachlos et al.288 use an indirect approach to produce collagen scaﬀolds with pre-
deﬁned and reproducible complex internal morphology and macroscopic shape by
developing a sacriﬁcial mould, using 3D printing technology. This mould is then
ﬁlled with a collagen dispersion and frozen. The mould is subsequently removed
by dissolution in ethanol and a solid collagen scaﬀold was produced using critical
point drying.
Yeong et al.289 also utilized a similar indirect approach to fabricate collagen scaf-
folds. In addition, they investigated diﬀerent drying routes after removal of the
sacriﬁcial mould with ethanol. The eﬀects of a freeze-drying process after immer-
sion of the scaﬀold in distilled water and critical point drying with CO2 reﬂected
onto dimensional shrinkage, pore size distribution and morphology in general.
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Boland et al.278 described the use of the inkjet printing technique for the construc-
tion of synthetic biodegradable scaﬀolds. They used a 2% alginic acid solution,
a liquid that is known to cross-link under mild conditions to form a biodegrad-
able hydrogel scaﬀold. The ink cartridge was ﬁlled with 0.25M (CaCl2), which
is known to promote the cross-linking of the individual negatively charged alginic
acid chains resulting in a 3D network structure. This cross-linker was printed onto
liquid alginate/gelatin solutions.
The biggest obstacles for RP technologies, thus also printer-based systems, are
the restrictions set by material selection and aspects concerning the design of
the scaﬀold’s inner architecture. Thus, any future development in the RP ﬁeld
should be based on these biomaterial requirements, and it should concentrate on
the design of new materials and optimal scaﬀold design.23 The selected scaﬀold
material must be biocompatible, compatible with the printing process, and it must
be easily manufactured in the form required (powder or liquid).290 In the case
of powder material, the particle size must be controllable. Another issue is the
sterility of the manufacturing process and products and their ability to withstand
sterilization processes.22 Oﬀ course, this plays a pivotal role for all systems when
embedding cells during the process.
Some limitations are caused by material trapped in small internal holes. These
trapped liquid or loose powder materials may be diﬃcult or even impossible to
remove afterwards, and in some cases, these residues may even be harmful to cells
and tissues. Experimental results show that the smoother the surface generated,
the easier the removal of trapped material.22,23 Smoother surfaces are on the other
hand less desirable for cell adhesion purposes.
Limitations of 3DP include the fact that the pore sizes of fabricated scaﬀolds are
dependent on the powder size of the stock material. As such, the pore sizes avail-
able are limited to smaller pore values (< 50μm) widely distributed throughout
the scaﬀold. More consistent pore sizes, including larger pores, can be generated
by mixing porogens (of pre-determined sizes) into the powder prior to scaﬀold fab-
rication. However, incomplete removal of the porogens is sometimes observed due
to incomplete leaching. The mechanical properties and accuracy of 3DP fabricated
scaﬀolds are other considerations that need to be addressed.283
Despite the idea of using a water-based ink in order to eliminate a toxic fabrication
environment, and thus creating an opportunity to incorporate biological agents or
even living cells, toxic post-processing of the constructs is often needed to im-
prove the mechanical properties. Suwanprateeb281 described a double inﬁltration
technique to increase the mechanical properties of natural polymers fabricated
by three-dimensional printing using a water-based binder. The 3DP parts were
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porous in nature since the powder bed was only lightly packed during the process
and only the surface of the powder granules was connected by a binder. Porosity
typically ranged between 50 and 60%. To enhance the performance of the 3DP
parts based on a mixture of 40wt% starch, 15wt% cellulose ﬁber, 25wt% sucrose
sugar and 20wt%maltodextrin, inﬁltration by some other material was performed.
The inﬁltration material used in this experiment was a heat-cured dental acry-
late prepared by mixing triethylene glycol dimethacrylate, 2,2-bis[4(2-hydroxy-3-
methacryloyloxypropyloxy)-phenyl]propane and a polyurethane dimethacrylate in
a 40 : 40 : 20wt% proportion. Benzoylperoxide was used as initiator. After inﬁl-
tration, the specimen was cured at 105 ◦C for 30min. From the results, it was found
that double inﬁltration and curing of 3DP samples increased the performance of
specimens in wet conditions.
Pﬁster et al.275 described the fabrication of biodegradable polyurethane scaﬀolds
by 3D Printing. In this case, the polyurethane formation is the post-treatment
step. Commercially available powder ZP11 (a powder blend of starch, short cellu-
lose ﬁbers and dextrose as a binder) was processed by the printing of an aqueous
ink, which activates the dextrose binder. The resulting objects were very frag-
ile and highly water-soluble. Therefore, the authors selected an additional post-
treatment step involving inﬁltration and partial cross-linking with lysine ethylester
diisocyanate . The starch polyols react with the isocyanate to form network struc-
tures. The obtained structures exhibited much improved mechanical stability. Be-
cause of the presence of starch incorporated in the network, the structures could
swell and the resulting lysine-based polyurethane networks were biodegradable
upon exposure to water and body ﬂuids.
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1.5.4 Preserving the mechanical integritiy of RP processed
hydrogels
As previously mentioned, the mechanical properties of a certain biomaterial play
a partial, although crucial role in its potential success as a scaﬀolding material.
More speciﬁc, it has been generally accepted that in designing a proper scaﬀold
biomaterial, one must strive to translate the mechanical characteristic features
of the target tissue into the mechanical features of the fabricated construct. For
instance, hard tissue regeneration requires strengths of 10-1500MPa, while soft
tissue strengths are typically located between 0.4 and 350MPa.296 As a part of
it, preserving the mechanical integrity of the scaﬀold contributes substantially to
the completion of this demand. The latter appears to be of utmost importance
with respect to hydrogels and will for that reason be discussed in this subsection.
Moreover, it is possible to enhance the control over not only the mechanical proper-
ties, but even the biological eﬀects and degradation kinetics by hierarchical design
of scaﬀolds with micron to millimeter features.283 In the case of hydrogel per-
formance, degradation rates are controlled by hydrolysis, enzymatic reactions or
simply by dissolution of the matrix (e.g. ion exchange in Ca+2 cross-linked alginate
systems).
The process of obtaining a construct with suitable strength starts with the solidiﬁ-
cation and simultaneous shaping of the material in a certain pattern. An overview
summarizing the most frequently applied and diﬀerent solidiﬁcation mechanisms
is given in Table 1.9. Although our discussion focuses on hydrogel materials, other
materials could easily be incorporated into this scheme.
Table 1.9: Classiﬁcation of the most frequently applied hydrogel solidiﬁcation mecha-
nisms in RP processing.
Types of hydrogel solidification 
in RP systems
After scaffold fabrication During scaffold fabrication
Forming physical 
hydrogels
Forming chemical 
hydrogels
Reaction in the
hydrogel
Reaction with
a medium
Precipitation Liquid-solid phase
transition
Post-fabrication treatment
- inﬁltration
- forming chemical 
  hydrogels after the 
  formation of a physical
  network
- reaction with a medium 
  (e.g. sodium alginate in 
  CaCl2-solution)
- ...
- chitosan solution; 
- collagen dispersion; 
- ...
- agar; 
- Pluronic® F127;
- ...
- PEG-D(M)A; 
- hyaluronan meth-
  acrylate; 
- ... 
- ﬁbronectin + 
  thrombin;
- gelatin + EDC 
- ...
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The application of natural as well as synthetic hydrogels in TE and as cell em-
bedding materials has been a review topic of several authors.17,58,65,104 The so-
lidiﬁcation or gelling mechanisms of hydrogels include inherent phase transition
behaviour and cross-linking (ionic or covalent) approaches. Regarding the former
mechanism, careful control over the printing temperatures can provide for some
hydrogels a phase transition from solution to gel state, in particular for polymers
with a lower critical solution temperature (LCST) behaviour (e.g. Plu® F127).
However, this behaviour is reversible. The formation of an ionically cross-linked
network through the use of multivalent counterions, e.g. sodium alginate and Ca+2
ions, provides more control over the mechanical integrity. Nevertheless, these ions
could be leached out in long-term culture, or even be exchanged by other ionic
molecules, compromising the control over the construct properties. Therefore, in
most cases, covalent network formation is required in order to precisely enhance
the mechanical stability and reproducibility of the constructs. The light-induced
radical cross-linking of monomers and/or prepolymer solutions have established
a quasi monopoly as a hydrogel solidiﬁcation strategy in combination with RP
fabrication schemes. In the case of the laser-based systems, this is even the fun-
dament on which the respective techniques are based and those are striking exam-
ples of one-step cross-linking approaches. The chemical structures of some well-
known photo-initiators (PIs) are shown in Figure 1.16. The ﬁrst structure (Figure
1.16(A)) is an example of a D-π-D chromophore, known for its high sensitivity
in 2PP processes.297,298 The π-part is a conjugated backbone symmetrically sub-
stituted at the ends by electron-donating D-parts. Figure 1.16(B) represents the
chemical formula of Irgacure® 2959 (I2959), a commonly applied photo-initiator
thanks to its high biocompatibility. It is known to absorb light in the UV range.
The last structure represents camphorquinone (CQ; Figure 1.16(C)), an initiator
with many dental applications and visible light working range.
Diﬀerent reactive thermo-sensitive thiolated systems were developed in the past.299–306
Thiol, vinyl or allyl ether polymerization display some advantages: mild reaction
conditions, photo-initiator not necessary, low or even no oxygen inhibition eﬀects,
fast process, forming of cross-linked networks with good physical and mechanical
properties307 and degradable in (mimicked) physiological conditions.308
The so-called ‘tandem reaction’ consists of two steps. The ﬁrst step is the occur-
rence of rapid gelation kinetics. The second step involves a covalent curing based
on the Michael-type addition. This technique allows to create covalently bonded
hydrogels in combination with functional cells under physiological conditions, with
no side reactions with bioactive molecules.309
When performing cross-linking in general, be it radical (light, redox, temper-
ature induced) or non-radical (enzymatic, ionic, carbodiimide, glutaraldehyde,
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Figure 1.16: Some typical photo-initiators used for (A) 2PP – an example of a strongly
absorbing two photon absorbing D-π-D chromophore –, (B) general UV
curing – Irgacure® 2959–, and (C) visible light curing – camphorquinone
–.
genipin,. . . ), the toxicity of the cross-linkers should be carefully considered. This
aspect is of crucial importance towards the success of a construct. For instance,
comparing the biocompatibility of genipin and glutaraldehyde as a way to non-
radically cross-link gelatin demonstrated the cytotoxic eﬀect of glutaraldehyde
and to a lower extent that of genipin.72,249 A possible aldol condensation cross-
linking mechanism for genipin was proposed by Liang et al.310 and the authors
also provided evidence for its better biocompatibility compared to carbodiimide
cross-linking with 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDC). How-
ever, genepin has only few applications because of its high cost, and dark blue
staining, which could interfere with cell characterization techniques.249 Thrombin,
on the other hand, did not show any substantial adverse eﬀects.249,256 Next to
those non-radical cross-linking mechanisms, radical cross-linking induced through
light irradiation is accepted as a common strategy. Cytotoxicity studies of several
frequently used UV and visible light initiating systems have been performed.311,312
CQ at concentrations≤ 0.01% (w/w) and low intensity irradiation (∼60mWcm−2;
470–490 nm) appeared to have less toxic eﬀects than isopropyl thioxanthone (ITX)
as visible light initiator. Another promising visible light initiator that absorbs at
512 nm is eosin Y,313,314 although up to date no relevant cytotoxicity studies have
been performed. Out of three diﬀerent Irgacure® initiators, it was the I2959 ini-
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tiating system (∼6mWcm−2; 365 nm) that held the greatest potential at concen-
trations below 0.05% (w/w). Additionally, it was also found that those cytotoxic
eﬀects varied depending on the cell types.312,315 Performing radical cross-linking
reactions without the use of either visible or UV light can also be mediated through
the use of redox systems. Duan et al.316 reported on the negative cooperative eﬀect
of a water-soluble redox initiating system, consisting out of ammonium persulfate
(APS) and N, N, N’, N’-tetramethylethylenediamine (TEMED), on NIH/3T3 ﬁ-
broblasts. The system was used to trigger PEG-DA polymerization. Redox initi-
ating systems have been extensively reviewed before.317
In other cases, the formation of chemical hydrogels can only be attained after
scaﬀold fabrication. Post-fabrication UV curing of a physically cross-linked photo-
sensitive Plu F127 AlaL construct with Irgacure® 2959 as initiator was for instance
performed by Fedorovitch et al.265 in order to acquire a chemical network. This
example directly serves as an easy template into attaining multiple-step cross-
linking. When working with blends of diﬀerent hydrogels and combinations of
physical as well as chemical network formations, multiple-step cross-linking sys-
tems of higher complexity are needed. Very recently, Xu et al.142 demonstrated
a fascinating state-of-the-art example of such an approach by blending gelatin,
sodium alginate and ﬁbrinogen with cells and stepwise cross-linking of the sodium
alginate with a CaCl2 solution and the ﬁbrinogen with a thrombin solution. The
gelatin component served as a necessary co-material blend in to provide sol to gel
phase transition during the fabrication process.249 Other examples can be found
in the work of Xu et al.,256 Zhang et al.,255 Skardal et al.253 and, Yan et al.257
1.6 | Fundamentals on Rapid Prototyping in
Scaffold-Free Tissue Engineering
In general, the application of scaﬀolds in a TE approach is straightforward, but
still subject to some challenges.318,319 These can be divided in two distinct cat-
egories: (i) complications posed by host acceptance (immunogenicity, inﬂamma-
tory response, mechanical mismatch), and; (ii) problems related to cell cultures
(cell density, multiple cell types, speciﬁc localization). It is surprisingly interest-
ing that, during embryonic maturation, tissues and organs are formed without
the need for any solid scaﬀolds.320 The formation of a ﬁnal pattern or structure
without externally applied interventions, in other words the autonomous orga-
nization of components, is called self-assembly.321,322 A premise concerning the
self-assembly and self-organizing capabilities of cells and tissues is worked out in
the ﬁeld of scaﬀold-free TE. This idea poses an answer to the immunogenic reac-
tions and other unforeseen complications elicited through the use of scaﬀolds. One
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way of implementing this self-assembly concept is the use of cell sheet technology,
which was demonstrated by L’Heureux and colleagues for the fabrication of vas-
cular grafts.323,324 In a similar way, the group of Okano engineered long-lasting
cardiac tissue based on cell sheet strategies.325–327 Remarkably, some have already
reached clinical trials.327,328 An alternate approach was selected by McGuigan and
Sefton, who encapsulated HepG2 cells in cylindrical sub-millimetre gelatin mod-
ules, followed by endothelializing the surfaces.72 A construct with interconnected
channels that enabled perfusion was generated through random self-assembly of
the cell/hydrogel modules. However, the implementation of RP technologies oﬀers
another even more fascinating perspective on scaﬀold-free TE, and is commonly
termed ‘bioprinting’ or ‘organ printing’.
Figure 1.17: Schematic illustration explaining the working principle of BioLP. A fo-
cussed laser beam initiates material transfer towards the substrate. Inter-
estingly, a laser absorption layer prevents direct interaction between the
laser and the biological materials. The scheme was reused from329 with
the permission from Springer.
We deﬁne organ printing as the engineering of three-dimensional living struc-
tures supported by the self-assembly and self-organizing capabilities of cells de-
livered through the application of RP techniques based on either laser,329–332
inkjet,273,285–287,333–338 or extrusion/deposition250,253,339–344 technology. An emerg-
ing laser based RP technique called biological laser printing (BioLP) stems from
an improved matrix assisted pulsed laser evaporation direct write (MAPLE DW)
system. The improvement is realized by incorporation of a laser absorption layer
and thus eliminating the direct interaction with the biological materials. The prin-
ciple is illustrated in Figure 1.17. Prior to laser exposure, a cell suspension layer
is formed on top of the absorption layer. Then, a laser beam is focused on the
interface of the target, which causes a thermal and/or photomechanical ejection of
the cell suspension towards the substrate.331 Target and substrate are both able
to move in the planar ﬁeld.
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The workﬂow of inkjet or extrusion based bioprinting can be represented by Figure
1.18. In short, balls of bio-ink are deposited in well-deﬁned topological patterns
into bio-paper sheets. The bio-ink building blocks typically have a spherical or
cylindrical shape, and consist of single or multiple cell types. Several bio-ink
preparation methods have been described.318,320,339,343 In a post-processing step,
the construct is transferred to a bioreactor and the bio-ink spheres are fused. The
bio-paper, a hydrogel, can be removed after construction if required. Bio-printers
can either have a jet design or work like a mechanical extruder.162,345 This implies
that several RP apparatuses described in the previous part can serve as a bio-
printer (e.g. the Bioassembly Tool, 3D-Bioplotter™,. . . ), if sterile conditions can
be acquired. In the case of inkjet technology, individual or small cell clusters are
printed. Despite the advantageous speed, versatility and cost, high cell densities
are diﬃcult to obtain and considerable cell damage is induced.318,345 On the other
hand, extrusion-based bio-printers are more expensive but oﬀer a more gentle
approach towards cells.
Bio-paper
Ball of bio-ink
Merging of the 
bio-ink particles
Nozzle 
(xyz movement)
Figure 1.18: Basic concept of bioprinting bio-ink particles into bio-paper (hydrogel)
sheets. The bio-ink particles are deposited in a tubular geometry (left).
After the deposition is ﬁnished, the construct is transferred to a bioreactor
to fuse the bio-particles and further maturation made possible (right).
In this context, hydrogels are employed as bio-paper and only provide a temporary
support for the deposited bio-ink particles. In other words, the bio-paper is clearly
diﬀerent from scaﬀolds used in classical scaﬀold-based TE. Arai et al.346 made
use of a hydrogel consisting of 2.0% CaCl2, 20wt% PVA and 3wt% hyaluronan
for the deposition of alginate based bio-ink particles. In most cases, this bio-
paper hydrogel will have a sheet-like design (e.g. Figure 1.18). For instance,
Boland et al.285 made use of thermo-sensitive gels to generate sequential layers
for cell printing. The group developed a cell printer, derived from commercially
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available ink-jet printers that enable to place cells in positions mimicking their
spatial location in an organ.334 The printer can put up to nine solutions of cells or
polymers into a speciﬁc place by the use of specially designed software, and print
two-dimensional tissue constructs. Extending this technology to three dimensions
is performed by the use of thermo-reversible gels. These gels were a ﬂuid at 20 ◦C
and a gel above 32 ◦C and serve as bio-paper on which tissue structures can be
printed. Dropping another layer of gel onto the already printed surface could
generate successive layers. The thermo-sensitive gel used for the experiments was
a poly[N-isopropylacryamide-co-2-(N,N-dimethylamino)-ethyl acrylate] copolymer
in a concentration of 10wt% polymer in cold, deionized water.
Figure 1.19: Bioprinting tubular structures with cellular cylinders. (A) Designed print
template. (B) Layer-by-layer deposition of agarose (blue) cylinders and
multicellular pig SMC cylinders (white). (C) The bio-printer outﬁtted
with two vertically moving printing heads. (D) The printed construct.
(E) Engineered pig SMC tubes of distinct diameters resulted after 3 days
of post-printed fusion (left: 2.5mm OD; right: 1.5mm OD). Pictures were
reprinted from339 with permission from Elsevier.
However, collagen used in a sheet-like design appeared to have integrated into the
ﬁnal structure, posing diﬃculties in its removal.343 Depending on the target tis-
sue design, the bio-paper can also have other geometries. For instance, agarose
rods were plotted and easily removed after post-printing fusion of a multicellu-
lar construct in order to fabricate tubular constructs (Figure 1.19).339 Agarose,
being an inert and biocompatible hydrogel, is not remodelled by the cells and
can easily be removed after fusion of the bio-ink. In situ cross-linkable synthetic
ECM (sECM) mimetic hydrogels formed by co-cross-linking PEG-DA and modi-
ﬁed hyaluronic acid (HA)/gelatin to the corresponding thiolated dithiopropionyl-
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hydrazide (DTPH) derivatives were developed as bio-paper by Mironov et al.345
Other examples of hydrogels that served as bio-paper include ﬁbrin, Matrigel™,
ﬁbrinogen, poly(N-isopropylacrylamide) (PNIPAM) and polyethylene glycol tetra-
acrylates.285,287,329,340
It is somewhat unclear as to whether the fabrication of cell/gel hybrid constructs,
which has already been brought up in the previous part, falls under the category of
bioprinting or if it can be regarded, as it is our understanding, as a bridge between
pure scaﬀold-based and pure scaﬀold-free TE strategies. For instance, Skardal et
al.253 methacrylated HA and gelatin, in order to fabricate tubular photocross-
linkable constructs from partially pre-cross-linked hydrogels and cells suspended
within. The importance that is correlated to the biomaterial(s) used, as is clari-
ﬁed in Figure 1.20, notes the primary distinction with pure scaﬀold-free TE. Xu
and colleagues made 3D cell/gel hybrid scaﬀolds from adipose derived stem (ADS)
cells and gelatin/alginate/ﬁbrin hydrogels to model the metabolic syndrome (MS)
in 3D.142 Their work revealed the potential use of this 3D physiological model for
drug discovery and the use of ﬁbrin as an eﬀective material to regulate ADS cell
diﬀerentiation and self-organization into adipocytes and endothelial cells. Never-
theless the importance appointed to the biomaterial, cells are being encapsulated
within the structure, and therefore this approach deﬂects somewhat from pure
scaﬀold-based engineering. Maybe the future shows that this state-of-the-art TE
concept and crossover approach of the two main distinct TE premises leads to
some fascinating results and research.
Figure 1.20: ADC cells, cultured with EGF, in a 3D gelatin/alginate/ﬁbrin scaﬀold to
diﬀerentiate into endothelial cells and adipocytes. (A, B) Immunostaining
with mAbs for mature endothelial cells in green and PI for nuclear in red.
(A) ADC cells within a gelatin/alginate/ﬁbrin construct, and (B) without
ﬁbrin. The pictures were reprinted from142 with permission from Elsevier.
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1.7 | Conclusions
In the course of this introductionary chapter, the emerging ﬁeld of Tissue Engi-
neering has been described. The role of biomaterials within this scientiﬁc ﬁeld
has also been situated. As a small subdevision of this broad ﬁeld, some more
background information on hepatic tissue engineering was given and within this
so-called soft Tissue Engineering segment, especially the potential advantages of
hydrogel biomaterials, and more speciﬁc gelatin hydrogels, was explained.
It has been made clear that a shift from 2D geometries towards 3D scaﬀolds oﬀers
signiﬁcant beneﬁts. As a method of producing 3D geometries, rapid prototyping
was introduced. This is a known technology domain which ﬁrst arose in the au-
tomotive industry, but lately, the applications have been expanding. Several of
these techniques can be used for the construction of 3D scaﬀolds related to tis-
sue engineering. Limitations and future trends correlated to the manufacturing of
hydrogel scaﬀolds by rapid prototyping techniques have been described.
As a relatively new approach, the processing of hydrogels using rapid prototyping
technologies faces still some major disadvantages and/or technological drawbacks.
On the other hand, it is believed that the importance of hydrogels, which enable
cell encapsulation and in some instances the fabrication of cell-gel constructs, will
increase.
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2.1 | Problem Statement
Tissue regeneration and engineering are relatively new developments in the biomed-
ical ﬁeld, which try to give an answer to the chronic organ donor shortage. Mecha-
nistic insight in cell-material interactions have led to the expansion of biomaterial
research for biomedical applications. However, close interactions between funda-
mentally diﬀerent scientiﬁc domains resulting in interdisciplinary feedback loops
are still prone to amelioration. This is especially emphasized in the engineer-
ing of metabolic tissues, in contrast to (mostly hard) tissues such as cartilage
and bone where primarily structural functions should be tackled. Being a highly
metabolic tissue, liver failure (acute and chronic) has a drastic impact on the life
standard. Among other, the liver is involved in detoxiﬁcation, glycogen storage,
protein synthesis, metabolic homostasis, release of proteins, carbohydrates, lipids,
and metabolic wastes. Sometimes, the heterogeneous structure and functionality
of the liver has been considered second only to the brain in its complexity.
Since its structure closely mimicks the extracellular matrix, hydrogel materials
have been considered as suitable candidate materials. As a common guideline,
highest cytocompatibility is mostly achieved by applying naturally derived poly-
mers. Moreover, encapsulation of cells to provide three-dimensional environments
have been reported to beneﬁt cell culture. These ﬁndings are causing a paradigm
shift from seeding toward encapsulation of cells. Gelatins, as a natural protein
49
extracted from collagen, have excellent biocompatibility. It is a bioactive material
of which the production cost is low and readily available in large quantities.
Conventional fabrication techniques for the introduction of porosities have some
drawbacks that can be overcome by using RP techniques and/or electrospraying/
electrospinning. On the downside, hydrogels in general, but speciﬁcally natural
hydrogels (e.g. gelatins), tend to exhibit diﬃculty in shaping ability and in the
maintenance of the mechanical integrity. For instance, internal collapse of the
designed pore network during RP processing is a common problem. As a result,
highly controlled 3D shaping of gelatin matrices is mainly limited to expensive
specialized machinery.
2.2 | PhD Blueprint
In this work, gelatin was selected as a starting material. The aim was to develop
three-dimensional shapes having high dimensional reliability for cell encapsulation
and seeding purposes. Gelatins have a temperature dependent sol-to-gel transition
upon cooling, limiting the biomedical applications at physiological conditions. In
addition, gelatin is a protein composed of a variety of amino acids, containing
various functional side groups.
The layout of the present work can be divided in subparts composed of multiple
chapters that each emphasize speciﬁc questions related to the overall study.
2.2.1 Gelatin hydrogel network formation
In chapter 3, the origin of the applied gelatins is evaluated for their inﬂuence
on the structural, physical and biocompatibility properties. The data from this
chapter serves as background information that supports further experiments. The
formation of chemical networks using photo-initiated polymerization reactions are
described in chapter 4. Two vinyl-based gelatin derivates are compared for their
impact on the network structure, curing kinetics and potential as a cell encapsu-
lation material.
2.2.2 Rapid prototyping as a tool to generate 3D constructs
Chapter 5 provides a study on the 3D printing of cell-laden structures. A post-
fabrication curing strategy (discussed in chapter 4) is evaluated for two photo-
initiators. In this part, special attention is given to the interdisciplinary nature to
relate material, processing and biology parameters together. For this work, a close
collaboration was performed with the lab of Prof. M. Cornelissen. The introdcu-
tion of a porous network will lead to deﬂections in the degradation, metabolite ﬂow
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and mechanical strength of the fabricated constructs. These factors will be dis-
cussed in chapter 6, together with pore network design, cell seeding applications
and the introduction of co-culture systems.
2.2.3 Galactose as biological ligand for hepatic tissue engi-
neering
Chapters 7 and 8 handle gelatin bulk and surface functionalization with a bio-
logical ligand targeted to hepatocyte speciﬁc tissue engineering. Galactosylation of
gelatin free amines is discussed in chapter 7, with respect to the biological response
of HepG2 cells. During chapter 8, a glycomonomer is synthesized which can be
used for the in situ functionalization of either the bulk or the surface. Parameters
aﬀecting the functionalization are investigated.
2.2.4 Reversible networks for the production of microspheres
As an alternative to large geometry printed constructs, the generation of micro-
spheres using all-aqueous solutions by means of the electrospraying technique are
presented in chapter 9. Some preliminary results discuss the potential of the
technique for the spraying of cell suspensions.
2.2.5 Conclusive summary and future directions
An outline summary of the general conclusions of this work are presented in chap-
ter 10. Finally, some interesting future perspectives and opportunities are tackled
as well.
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This chapter stems from an evaluation on potential gelatin batch-to-batch diﬀer-
ences originating due to the selected raw materials and their corresponding ex-
traction treatment. As such, the goal of this chapter is to provide more scientiﬁc
background information, which will be referred to in subsequent chapters.
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3.1 | Introduction
In the ﬁeld of tissue engineering, the selection of an appropriate starting material is
one of the most crucial elements in biomaterials development. Several approaches
can be followed, of which “biomimetism” is based on the hypothesis that organ
functional restoration can be reached if the target tissues are imitated.347
As a key structural ﬁbrous protein, collagen as well as its degradation product,
gelatin, have therefore widely been applied as starting materials.138,143,148,288,348,349
In spite of the identiﬁcation of 29 collagen types to date, Type I contributes for
over 90% of the collagen in the body.347 Type I collagen is found in bones, skins,
tendons, vascular, ligatures, and organs.
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Figure 3.1: The molecular structure of collagen.(A) The polypeptide α-chain adopts a
left-handed helical conformation due to the repeating tripeptide sequences
Gly-Pro-Y or Gly-X-Hyp. This model was generated using a Gly-Pro-Hyp
sequence. (B) Space-ﬁlling model of the α-chain. (C) Representation of the
collagen quaternary structure (tropocollagen) whereby three left-handed
α-chains are twisted into one right-handed triple-helix. (D) The chemical
structure of the main amino acids glycine, proline and hydroxyproline. This
ﬁgure was adopted from.350
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Independent from the type, the primary structure as a regular arrangement of
repetitive tripeptide units of glycine (Gly)-X-Y is a distinctive feature of all col-
lagens (Figure 3.1).347,351,352 Hereby X and Y represents any other amino acid
residue. Nevertheless, the X- and Y-positions are mostly occupied by proline (Pro)
respectively hydroxyproline (Hyp). A left-handed helical conformation is formed:
the α-chain. Collagen α-chains have a MW ∼ 100 kDa. Hydrogen bonds stabilize
the super-coil, while hydrophobic and/or electrostatic interactions between amino
acids at the X- and Y-positions can participate in intermolecular stabilization. On
the other hand, the non-helical domains present at the sides (telopeptides) are
pivotal for the natural cross-linking between chains.
Gelatin is a denatured collagen of which the MW, the isoelectric point (IEP), and
the amino acid composition depends on the source of collagen and the manufac-
turing process. They are derived primarily from Type I collagen that generally
does not contain the amino acid cystein (Cys).347 The amino acid tryptophan
(Trp) is also absent in gelatins.351 Gelatins exhibit an Upper Critical Solution
Temperature (UCST) and thus undergo a ﬁrst order thermo-reversible sol-to-gel
transition at temperatures lower than the critical temperature (∼ 30◦C) for solu-
tions in hydrogen-bond friendly solvents and concentrations larger than the chain
overlap concentration (∼ 2w/v%). During this, a conformational transition from
random coil to triple helix occurs.353–355 Upon cooling, small triple-helical seg-
ments may further aggregate, however, the lateral aggregation typical for collagen
(arrangement of ﬁbrils) does not manifest in gelatin gels.
Despite an extensive exploration of gelatin as a polymer, the exact structure and
functionality are still being discussed today. Notwithstanding the recognition of
batch-to-batch heterogeneity, research comparing gelatin source for cell culture
applications is limited, and gelatins originating from a variety of collagen sources
are employed. For example, Hwang et al.356 applied type A gelatin, while Hong
et al.357 selected type B gelatin for their respective hepatocyte cultures. In addi-
tion, the UCST thermo-reversible material property generates the need for cova-
lent cross-linking strategies. Therefore, a manifold of cross-linking approaches has
been explored, commonly but not exclusively accompanied by a chemical modiﬁca-
tion step.72,109,223,310,358–360 Logically, in the condition of a modiﬁcation approach,
knowledge on the chemical composition of the practiced gelatin will be essential.
In the following chapter, we provide background information on the physico-
chemical properties of gelatins having distinctive origins. Next, the biological
response of HepG2 cells as a function of gelatin origin and gelatin concentration
is assessed as an indication for their cytocompatibility. Finally, two natural cross-
linkers are evaluated in the perspective of future cell encapsulation and bioplotting
55
applications.
3.2 | Experimental Part
3.2.1 Gelatin materials
Gelatins hailed from diﬀerent species and extracted using acid or alkali pre-treatment
were evaluated. One type A gelatin, derived from porcine skin (Bloom value of 202
and approximate IEP of 8.8), and three bovine type B gelatins, derived from diﬀer-
ent raw material sources (Bloom values of 257, 226 and 254 and approximate IEP
of 5), were kindly supplied by Rousselot (Ghent, Belgium). The manufacturers
speciﬁcations are provided in Table 3.1.
3.2.2 Amino acid analysis of gelatin
Amino acid analysis was performed using the protocol Kerkaert et al.361 Brieﬂy,
the gelatins were hydrolysed to the constituent amino acids using HCl solution
(8M), and hydrolysate was subsequently neutralized using NaOH solution (8M)
prior to high-performance liquid chromatography (HPLC) separation. All of the
amino acids were automatically derivatized with 2-orthophtalic dialdehyde (OPA,
Sigma-Aldrich), except proline, which was derivatized with 9-ﬂuorenylmethyl-
chloroformate (FMOC, Sigma-Aldrich), in the injector of an Agilent 1100 system
(Agilent Technologies, Switzerland). Separation of the derivatized amino acids oc-
cured on a Zorbax Eclipse AAA RapidResolution column (4.6× 150mm, Agilent
Technologies) and was ﬂuorometrically detected. Norvaline and sacrosine were
both used as internal standards for the measurements. A ﬂow rate of 2mLmin−1
was applied with a gradient solvent A (45% methanol, 45% acetonitrile, and 10%
water) and solvent B (45mM NaH2PO4 · H2O, 0.02% NaN3, pH 7.8). Samples
values are expressed as averages ± S.D. of three repeated measurements.
3.2.3 Size exclusion chromatography (SEC)
Molecular weights were determined by means of size-exclusion chromatography
(SEC) using a Millipore-Waters 510 pump and a Waters 410 Diﬀerential Refrac-
tometer for detection. Waters Ultrahydrogel columns 250–500 (300× 7.8mm) at
80 ◦C (internal temperature 50 ◦C) were used. Phosphate buﬀer (pH 7.4; 0.2M)
was applied as eluent with a ﬂow rate of 1mLmin−1. Calibration curves were
recorded by means of pullulan standards (10mgmL−1, SDK Showa Denko). Gelatin
samples (10mgmL−1) were injected and their molecular weight and polydispersity
indices were compared.
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3.2.4 Sol-to-gel transition
The UCST sol-to-gel transition was monitored applying rheological experiments
using a Physica MCR 350 (Anton Paar) with plate-plate geometry. In order to
investigate the inﬂuence of mixture concentration on the physical cross-linking of
gelatin solutions, G′ andG′′ were recorded by small strain oscillatory measurements
as a function of the temperature at a constant frequency (1Hz) and strain (0.1%)
for type A and type B gelatins. Mechanical spectra of physically gelled gelatin
samples (1mm thick) were recorded at a constant deformation of 0.1% strain
in the frequency range of 0.1− 100 rad s−1 at 20 ◦C. Prior to the measurements,
the linear visco-elastic range was determined by isothermal measurements of the
storage and loss moduli G′ and G′′ as a function of the deformation (γ = 0.01%
→ 1%) at a constant frequency (1Hz).
3.2.5 Surface topography
Thin gelatin ﬁlms were prepared using a table-top spincoater system (SPIN15,
SPS-Europe B.V.). The protocol consisted of spincoating 50μL from an aqueous
gelatin solution at a speed of 8000 rpm for 60 s on round glass slides (∅ = 15mm).
Thin ﬁlms were prepared from 10− 15− 20w/v% gelatin precursor solutions.
Atomic force microscopy (AFM) was used to analyze the surface topography (see
section 11.2.4). AFM images were obtained in ambient conditions with a mul-
timode scanning probe microscope (Digital Instruments-USA) equipped with a
Nanoscope IIIa controller. Scans (1μm2) were recorded in tapping mode with a
silicon cantilever (OTESPA-Veeco). The recorded images were modiﬁed with an
X and Y Plane Fit Auto procedure.
3.2.6 Inﬂuence of the gelatin type and concentration on the
in vitro cytocompatibility
The eﬀect of gelatin origin and electrical nature on HepG2 cytocompatibility
was investigated by performing titration experiments. HepG2 cells were main-
tained in a humidiﬁed 5% CO2-containing atmosphere (37 ◦C) with cultivation
medium consisting of dulbecco’s modiﬁed eagle medium (DMEM), supplemented
with 10 v% fetal bovine serum (FBS), 50UmL−1 penicillin and 50μgmL−1 strep-
tomycin, all provided by Life technologies. Native gelatins were dissolved in cul-
ture medium at various concentrations in the range of 5− 30w/v%. Prior to cell
mixing, the hydrogel precursor mixtures were pasteurized three times at 70 ◦C.
Subsequently, equal cell numbers (1.5× 106 cellsmL−1) were mixed with these
gelatin solutions and cast in 48-well cultivation plates (Greiner-Bio one). After 24
hours, cell survival was determined by means of 3-(4,5-dimethylthiazol-2-yl)-2,5-
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diphenyltetrazolium bromide (MTT) assay. Cell survival was expressed as percent-
age survival, compared to cells cultivated in absence of gelatin. The MTT assay
was conducted as described by the manufacturer. Brieﬂy, cells were exposed for 4 h
to 0.5mgml−1 MTT (Calbiochem) dissolved in culture medium. After discarding
the solution, the formed formazan crystals were released by treatment (30min)
with isopropanol-0.04N HCL, supplemented with 1 v% Triton X100 (Sigma). The
absorbance was measured at 580 nm with an EL800 Universal microplate reader
(BioTek instruments Inc.).
3.2.7 Cross-linking of gelatin with natural cross-linkers
Two natural cross-linkers were evaluated for the cross-linking of gelatins with the
aim at cell encapsulation and bioplotting. Ten w/v% gelatin type B was prepared
by dissolving 1 g gelatin in 10mL PBS at 40 ◦C. Genipin covalent cross-linking was
carried out at 37 ◦C by blending methyl-(1R,2R,6S)-2-hydroxy-9-(hydroxymethyl)-
3-oxabicyclo[4.3.0]nona-4,8-diene-5-carboxylate (Genipin, Sigma-Aldrich) to ob-
tain a ﬁnal concentration of 4mM. Enzymatic covalent cross-linking was evaluated
using the food enzyme ACTIVA WM®, kindly gifted by Ajinomoto. It consists
out of 99% maltodextrin and 1% microbial transglutaminase (mTGase) with an
enzyme activity of 100U g−1. An enzyme stock solution of 10UmL−1 was pre-
pared, and subsequently added to the gelatin precursor solution to obtain ﬁnal
concentrations of 0.1− 1UmL−1.
The hydrogel precursor solutions were poured in 24 well-plates (Greiner Bio One)
and allowed to cross-link for certain time intervals after which the formed gels
were frozen in liquid nitrogen and freeze-dried. The dry gels were weighed (mdi)
and subsequently incubated at 37 ◦C, immersed in double distilled water. After
equilibrium swelling was reached (e.g. 24 h), the gels were removed, gently dabbed
with paper and weighed again (mhe). Subsequent freeze-drying gave the ﬁnal dry
weight (mde). The loss of dry mass of the hydrogel during incubation at 37 ◦C
enabled us to calculate the gel fraction (see section 11.2.1). For mTGase gels,
the inﬂuence of temperature on the cross-linking was followed using small strain
dynamic oscillatory rheology time sweeps with γ = 0.1% at a constant frequency
of 1Hz. Rheology is described in section 11.2.2.
The cross-linking extend was determined by monitoring the free amine-group con-
tent with the ninhydrin assay. Lyophilized samples were subjected to a 2wt%
ninhydrin (Sigma-Aldrich) solution for 30min at 100 ◦C, after which the optical
absorbance of the solution was recorded spectrophotometrically at a wavelength of
560 nm (Biotek Uvikon XL). A calibration curve with pure, distilled aminoethanol
was established. Finally, cell encapsulation was investigated by mixing HepG2 cells
or primary mouse hepatocytes at a ﬁnal concentration of 1.5× 106 cellsmL−1 and
the cell viability was assessed by MTT assay. Primary mouse hepatocytes were iso-
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lated from adult mouse livers (8-14 weeks of age) using a two-step collagenase per-
fusion method followed by percoll gradient puriﬁcation as described by Goncalves
et al.362 Primary hepatocytes were cultured in William’s E medium (Life Tech-
nologies), supplemented with L-glutamine (292mgmL−1) (Invitrogen), glucagon
(7 ngmL−1) (sigma), insulin (0.5μgmL−1) (sigma), hydrocortisone (25μgmL−1),
epidermal growth factor (EGF) (10 ngmL−1), 10 v/v% FBS (Life Technologies),
50UmL−1 penicillin (Life Technologies) and 50μgmL−1 streptomycin (Life Tech-
nologies).
3.2.8 Statistical analysis
The experimental results are reported as mean ± standard deviation (S.D.). Sta-
tistical analysis was performed with the Student’s t-test and signiﬁcance was de-
termined at p < 0.05.
3.3 | Results and Discussion
3.3.1 Collagen vs. gelatin: the amino acid composition of
type A and type B gelatins
Amino acid analysis of gelatins are variable depending on the raw material and
extraction process, and generally the largest variations can be found in the minor
constituents.347,352 Table 3.1 provides the amino acid composition of one type A
gelatin (porcine origin) and three type B gelatins (bovine origin). As a reference,
the amino acid proﬁles of bovine bone and human bone collagen found in literature
is included. During treatment of collagen to extract gelatin, the amino acid content
is largely undisturbed, therefore the amino acid content of gelatin is quite similar
to that of collagen. Nevertheless, the amino acid composition aﬀects the gelatin’s
chemical and physical properties.
In correspondence to collagen, glycine (Gly), proline (Pro) and hydroxyproline
(Hyp) are the three major contributors to the amino acid composition. The high
content of (hydroxy)proline contributes substantially to the well-known gelling
properties of gelatin.347,352,353 Other amino acids can be regarded as minor con-
stituents. The mammalian gelatins, as they are extracted from Type I collagen
rich sources, were deﬁcit in the amino acids tryptophan (Try) and cystein (Cys).
Ornithine (Orn), a non-essential α-amino acid that is naturally synthesized from
arginine in the liver, could only be found in type B gelatins owing to the alkaline
hydrolysis of arginine during the extraction process. This amino acid has been
reported to be able to mediate hepatocytes albumin and transferrin secretion.363
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Gelatin derivatization mostly occurs via reactions with the amine groups available
on some amino acid side chains (Figure 3.2). Under mild basic conditions however,
the guanidinium group of arginine will be protonated, making nucleophilic attack
impossible, while the imidazole group of histidine reacts, but leads to the formation
of unstable products.364 As a result, type B gelatins have a slightly higher amount
of reactive free amines stemming from Lys, Hly and Orn compared to type A
gelatin: 38 ± 1mmol g−1 for type B vs. 34mmol g−1 for type A gelatins.
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Figure 3.2: Amino acids of gelatin having amine groups in the side chain.
Only small amounts of the aromatic amino acids tyrosine (Tyr) and phenylalanine
(Phe) were found, with higher levels for porcine-derived type A gelatin. Even up to
three-fold in the case of tyrosine (p < 0.02). Mostly non-signiﬁcant diﬀerences were
detected between the proﬁles of the three bovine-derived type B gelatins. However,
the levels of aspartate (Asp) and glutamate (Glu) were signiﬁcantly lower for the
bone derived gelatin (p < 0.05). Comparing both skin derived gelatins from either
porcine or bovine source, and leaving out amino acid diﬀerences originating from
the extraction process (i.e. higher levels of Asp and Glu, and the presence of
Orn in type B gelatins), only the minor constituents Arg and Tyr were higher for
porcine skin gelatin while the amount of Thr was slightly lower.
In contradiction to our amino acid proﬁles, distinct diﬀerences for Arg, Gly, and
Pro were reported by Haﬁdz et al.351 for porcine and bovine skin gelatins. The
authors could not detect His, and both gelatins had low levels of Tyr. It was not
clear whether both gelatins were extracted by the same manufacturer and/or in
the same country. Our mammalian gelatins all had approximately similar levels
of Gly and the imino acids Pro and Hyp, however, ﬁsh derived gelatins are re-
ported to have lower imino acid (Pro, Hyp) content resulting in decreased gelling
potential.347,353
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3.3.2 The inﬂuence of the extraction process on the molecu-
lar weight and molecular weight distribution
During gelatin extraction, cleaving of the triple helical structure occurs on a diﬀer-
ent way depending on the type of pre-treatment (alkaline vs. acidic) and length of
the thermal denaturation-hydrolysis process, resulting in distinct molecular weight
(MW) and molecular weight distribution (MWD) proﬁles. The MWD will depend
on the intra- and inter-molecular covalent cross-linkages present in the starting
raw material, and the balance between the relative amount of unhydrolyzed cross-
linkages and the resulting length of the polypeptide chains. These cross-linkages
stem from a condensation reaction between the amino groups of Lys and an alde-
hyde group formed by an enzymatic oxidation of a Lys or Hly residue.353 Figure
3.3 represents size exclusion chromatography (SEC) elution proﬁles of the four
examined gelatin types.
10 12 14 16 18 20 22
10 12 14 16 18 20 22
time (min)
time (min)
α
β
γ
bovine hides
bovine bones
bovine 
Type B gelatin
Type A gelatin
(porcine skin)
A
B
HMW LMW
Figure 3.3: SEC chromatograms showing the elution proﬁles of three bovine-derived
type B gelatins (A) and one porcine-derived type A gelatin (B). Arrows
indicate peaks/shoulders of α−, β−, γ-chains.
As can be derived from the type B SEC chromatograms, covalent cross-linkages
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between α-chains can survive the manufacturing treatments, leading to fractions
of β-chains (two covalently linked α-chains), γ-chains (three covalently linked α-
chains) and even higher molecular weight (HMW) components. The main peak of
the type B gelatins corresponded to a MW 88 ± 2 kDa (∼ α-chain). In the proﬁle
of the bovine hides gelatin, a clear peak attributed to β- and to a lesser extend
also γ-chains could be observed. These were less pronounced for both other type
B gelatins. Nevertheless, rupture of the peptide bonds in the primary structure
can also occur during pre-treatment and extraction, resulting in subunits of the
original α-chains: the low molecular weight (LWM) compounds. The latter was
more pronounced in the SEC chromatogram of type A gelatin, of which its main
peak corresponded to a MW 45 ± 1 kDa, indicating a more intensive hydrolysis.
As a small remark, not all type A gelatins have a main contribution of LMW
molecules as in our case, as evidenced from the MWD proﬁles of other gelatin
extraction intensiveness.353 The examined type B gelatins had a more narrow
MWD compared to the one of type A gelatin, nevertheless, the polydispersity
indices (PDI) were for all gelatins > 2. The highest fractions of β- and γ-chains
was found for bovine hides gelatin, while the highest amount of LMW molecules
was observed for the porcine skin gelatin.
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Figure 3.4: Dynamic oscillatory temperature sweep recordings of the storage G′ and
loss G′′ moduli for 2w/v% (A) and 5w/v% (B) gelatin solutions illustrat-
ing the transition from ‘gel’ to ‘sol’. Measurements were performed with γ
= 0.1% at a frequency of 1Hz (FN = 0.1N).
3.3.3 The eﬀect of α-chains, HMW and LMW on the gelling
and the G′ value
The gelation property inherent to gelatins stems from the partial recovery of the
triple helical structure of collagen. Measurement of the storage (G′) and loss (G′′)
moduli allows to follow the gelation kinetics in situ. The tan(δ) (ratio of G′′ to
G′) value gives an indication on the resulting gel strength. As illustrated in Figure
3.4, the gelation is concentration, temperature, as well as gelatin type dependent.
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At a concentration of 2w/v%, the temperature inﬂuences only to a very limited
amount the G′′ modulus evolution, while at higher concentrations (i.e. 5w/v%)
the temperature clearly aﬀects the G′′ as well as the G′ moduli, typically indi-
cating the formation of a gel network at lower temperatures. For 2w/v% gelatin
solutions, the tan(δ) value is too high even at a temperature of 5 ◦C to consider
this as a hydrogel network. At a concentration of 5w/v%, we observe a transition
zone between 25− 35 ◦C whereby G′ as well as G′′ signiﬁcantly drop/increase with
increasing/decreasing temperature: the sol-to-gel transition. The higher the dif-
ference between the G′ and G′′ values, the stronger the formed physical hydrogel
network.
Figure 3.5 demonstrates the evolution of the storage modulus G′ as a function of
concentration and gelatin type. Logically, higher concentrations lead to stronger
physical gelation (thus higher G′ values) due to both an increase in solid content
as well as an increase in the formation of hydrogen bonding. Regarding gelatin
type, we observe that physical hydrogels of type A gelatin form softer hydrogel
networks when compared to type B gelatin.
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Figure 3.5: Evolution of the storage moduli (G′) of gelatin hydrogels at 20 ◦C as a
function of the concentration and gelatin type (acid porcine skin vs. alkaline
bovine gelatin).
It should be commented that the G′ of the bovine hides derived type B gelatin
was lower (∼ 2.7 kPa) than both other type B gelatins, however still substantially
higher compared to the porcine skin type A gelatin. As an alternative and indus-
trially accepted measure for the gel strength, the Bloom numbers followed these
ﬁndings.
In general, a lower mean molecular weight lowers the gel strength and viscosity of
the solution. This is clearly illustrated comparing the results of the selected type A
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and B gelatins. However, interestingly, the bovine hides derived gelatin had a sim-
ilar viscosity as the other bovine gelatins (Table 3.1) but lower gel strength despite
having more pronounced β-, and γ-chain peaks in its MWD proﬁle (Figure 3.3).
Some contradiction is found in the literature: Normand et al.365 suggested that
the α-, β- and γ-chains contributed equally to the elasticity. Johnston-Banks366
correlated gel strength to the sum of the α- and β-chains. Others reported the
α-chains as the primordial contributors of the resulting gel strength, and pertur-
bations of the helix reformation could occur due to the presence of subunits, β-,
γ- and highly branched chains (non-linear chains).367,368 The work of Eysturskarð
on the mechanical properties of mammalian and ﬁsh gelatins suggested a posi-
tive correlation with the fraction of β-chains and HMW molecules and a negative
correlation with the LWM molecules.
Our ﬁndings suggest that the acid porcine skin gelatin had a lower G′ due to a
higher fraction of LWM molecules, as well as a higher PDI. For the type B gelatins,
which had similar MW and PDI, the higher fraction of β- and γ-chains present
in the bovine hides gelatin reﬂected in a lower Bloom and G′ value, but similar
viscosity. This correlates to α-chains as the main contributor of gel strength,
while β-, γ- and HMW molecules perturb the helix reformation but contribute to
viscosity.
3.3.4 The eﬀect of MWD on the surface topography
As described in the previous paragraph, the presence of β-, γ-chains and HMW
molecules are proposed to impact the geliﬁcation potential of the hydrogel building
blocks. If this statement would be correct, it can be anticipated that the surface
topography could alter as a result of increased/decreased globular domain forma-
tion during geliﬁcation. As demonstrated in Figure 3.6, AFM images of the three
bovine gelatins reveal less large globular domains for bovine hides gelatin, further
conﬁrming this hypothesis.
Similar results were obtained for other concentrations (10− 15− 20w/v%). Nonethe-
less, the surface wettability, partially inﬂuenced by the surface topography, re-
vealed no statistically signiﬁcant diﬀerences between the four gelatins (data not
shown).
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Figure 3.6: AFM images of physical type B gelatin hydrogels representative for a con-
centration of 10w/v%.
3.3.5 Type A vs. Type B gelatins: in vitro cytocompatibility
Gelatins have since long been applied as cell-interactive matrices for TE purposes.
Generally, gelatin is regarded as a biopolymer with high biocompatibility. The view
most commonly held on gelatin’s non-immunogenic and non-antigenic property is
suggested to be due to the very small amount of aromatic rings from Tyr, Trp,
and Phe amino acids, and the absence of aromatic radicals .347,369 Nevertheless,
no research could be found regarding biocompatibility issues of gelatins stemming
from diﬀerent origin and/or extraction processes.
Figure 3.7 depicts the in vitro cytocompatibility results as a function of the added
amount of gelatin ranging between 5 and 30w/v%. Concentrations < 5w/v%
were excluded since these were not considered relevant for future cell seeding
and encapsulation whereby gelatin-only matrices will be evaluated. A decrease
in cell viability as a function of increasing concentrations could be observed for
all gelatins. Type B gelatins derived from bovine hides and a “combination” of
bovine materials demonstrated viability levels of ≥ 70% up to 30w/v%, whereas
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the one derived from bone only remained ≥ 70% up to 10w/v%. Viability levels
using porcine skin derived gelatin type A were similar to bovine bone derived type
B gelatin and rapidly decreased with increasing hydrogel precursor concentration.
It should be remarked that the described diﬀerences were only investigated for
HepG2 cells.
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Figure 3.7: (A) The eﬀect of gelatin type and concentration on the cell viability of
HepG2 cells. (B) Brightﬁeld microscopy images corresponding to the points
indicated on part A. Scale bar represents 200μm.
We observed a diﬀerence between gelatin type A and gelatin type B, with the
former exhibiting clearly less cytocompatibility. Therefore, further testings on cell
encapsulation of unmodiﬁed gelatins in this chapter will focus on type B gelatin.
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Looking at the amino acid proﬁle, as described before, the fraction of the aro-
matic amino acid Tyr, and to lesser extend also Phe, is signiﬁcantly higher for
the examined type A gelatin. On the other hand, all type B gelatins had similar
fractions of aromatic amino acids. The bovine bone gelatin, which showed lowest
cytocompatibility, had the lowest amount of Asp, Glu and Thr. These values were
close to the values for the porcine type A gelatin, suggesting that not only the
aromatic rings as a general marker but perhaps also these amino acids impose an
inﬂuence on the examined cell type.
Additionally, the MWD of the four gelatins showed clear diﬀerences. Especially in
the LMW domain. Type A gelatin mainly consisted out of LMW molecules (MW
∼ 45 kDa (peak) and ∼ 15 kDa (shoulder)), while the bovine gelatin had the lowest
contribution of LMW molecules but the highest biocompatibility. Furthermore, the
bovine hides and bovine bone gelatin had respectively a clear LMW peak (MW ∼
48 kDa) and shoulder (MW ∼ 24 kDa). Most likely, the extraction process and its
eﬀect on the MW and MWD also impacts the resulting cytocompatibility.
3.3.6 Natural cross-linkers for gelatin: genipin vs. transglu-
taminase
The reversible UCST temperature-dependent sol-to-gel transition of gelatins limits
its applicability in TE applications. In order to guarantee a sustainable TE matrix
at physiological temperatures, researchers developed several cross-linking strate-
gies to form covalent gelatin networks. These can be roughly divided into two
groups, namely strategies employing native gelatin and a cross-linker or strategies
that are based on gelatin modiﬁcations.
Two natural cross-linkers that can form covalent networks are the compound
Genipin and the enzyme transglutaminase. These are considered highly biocom-
patible,310,347,348 and therefore we evaluated their potential use for the cross-linking
of cell-laden gelatin hydrogel precursors.
3.3.6.1 Genipin
Genipin is a natural product obtained from its parent compound geniposide (an
iridoid glucoside), abundantly present in Genipa Americana and Gardenia jas-
minoides Ellis.310,347 The spontaneous cross-linking mechanism of Genipin with
free amino groups of proteins such as Lys, Hyl, Arg and Orn to form dark blue
pigments is still under investigation (Figure 3.8). A mechanism through a nucle-
ophilic attack of the amines of gelatin, inducing an opening of the dihydropiran
ring of Genipin followed by the attack of a second amine on the resulting aldehyde
was proposed.347 Genipin has been used to ﬁx biological tissues or amino-group
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containing biomaterials for biomedical applications, and has been reported to have
enhanced biocompatibility over carbodiimide cross-linking.310
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Figure 3.8: Reaction mechanism of Genipin proposed by Mi et al.
During Genipin cross-linking, the gelatin hydrogels are pigmented brown to dark
blue as seen in Figure 3.8. The cross-linking occurs on a steady, however slow
pace. Table 3.2 presents some values on the conversion and swelling properties.
After a cross-linking time of 60min (t60), only ∼ 9− 14% of the initial free amines
are consumed in the reaction. A plateau value whereby < 35% of the initial NH2
groups are consumed and a maximal gel yield of ∼ 80% is reached (type B gelatin).
For type A the gel yield was lower as this gelatin type has a lower NH2 content and
a lower MW. These results were in close correlation to the experiments of Liang
et al.310 Moreover, it should be put under attention that the standard deviations
(S.D.) are rather big, suggesting a relatively diﬃcult control over the cross-linking
process.
Table 3.2: Evolution of Genipin cross-linking as determined by the ninhydrin assay and
equilibrium swelling experiments for 10w/v% gelatin solutions.
SAMPLE NH2 100 g−1 gelatin CONVERSION [%]† GEL FRACTION [%]†
t0 t60 t300
Type A 33.98 31 ± 2.6 27 ± 2.1 ∼ 21 56 ± 6
Type B 37.04 32 ± 1.9 26 ± 2.0 ∼ 30 80 ± 5
† at t300
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With respect to adopting this strategy, some major drawbacks arise: i) the pig-
mentation could interfere with biological characterizations, especially in the case of
encapsulation purposes (which is one of the present thesis’s aims), mainly limiting
the applicability to cell seeding strategies, and; ii) the poor cross-linking speed and
rather large uncross-linked fraction will impose substantial problems when aiming
at cross-linking rapid prototyped architectures. Therefore, this system was not
further evaluated.
3.3.6.2 Microbial transglutaminase (mTGase)
A second natural cross-linker, which excludes the necessity for gelatin modiﬁca-
tion, is the enzyme transglutaminase (TGase). We applied a calcium-independent
microbial transglutaminase (mTGase) frequently applied in food chemistry as a
‘meat glue’. From the FDA, it received the ‘Generally Recognized As Safe’ (GRAS)
notiﬁcation. Little is known of its potential use as a cross-linker of proteins for
biomedical applications. One application is the use of transglutaminase-gelatin
injectable system, which enables the cross-linking with endogeneous collagen to
create a strong bond between the gel and the tissue ECM.360 As every enzyme,
mTGase has a temperature and pH range and optimum (data sheet Ajinomoto):
• Temperature: 0 ◦C – 65 ◦C (optimum: 50− 55 ◦C);
• pH: 4–9 (optimum: 6–7)
Transglutaminase catalyses the cross-linking of gelatin by reaction between the
γ-carbonyl group of a glutamine residue and the ε-amino group of Lys/Hyl re-
leasing one molecule of ammonia per cross-linking as by-product (Figure 3.9 (A)).
Cysteine is the enzyme’s active center and the formed isopeptide bonds exhibit
high resistance against proteolytic degradation (proteolysis).347,348,360,370
Small strain oscillation time sweeps were recorded at three distinct temperatures
(4− 20− 37 ◦C) for 10w/v% gelatin hydrogel building blocks with a ﬁxed enzyme
activity of 0.1UmL−1 to evaluate the cross-linking potential at temperatures away
from the optimum. The evolution of the storage modulus G′ is presented in Figure
3.9 (B). As anticipated, a cross-linking temperature of 37 ◦C rapidly promotes the
formation of ε-(γ-L-glutamyl)-L-lysine isopeptide bonds. At lower temperatures,
the hydrogel building blocks have already formed a physical network, explain-
ing the initially higher G′ value, interfering with the enzyme mobility and thus
slower/less complete cross-linking. This is also illustrated by equilibrium swelling
experiments (Figure 3.9 (C)). Temperatures below the geliﬁcation point are rele-
vant in the framework of three dimensional prototyping whereby an initial physical
gelation would be necessary prior to chemical cross-linking.
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At elevated temperatures, no signiﬁcant eﬀect of the enzyme concentration on the
gel yield could be observed for the tested concentration range, and gel fractions of
> 85% were measured. Lowering the temperature, for all enzyme concentrations,
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Figure 3.9: The use of mTGase as a natural cross-linker for gelatin hydrogel building
blocks: (A) the formation of isopeptide bonds promoted by transglutam-
inase, (B) rheological time sweep recordings of G′ as a function of the
cross-linking temperature, and (C) the gel fraction as a function of the
cross-linking temperature and enzyme activity. Ten w/v% gelatin type B
solutions were used for all experiments.
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the gel yield plateau value dropped and was only reached for cross-linking periods
exceeding 5 h. In contrast to Genipin, mTGase cross-linking appeared suﬃciently
controllable to be considered as a potential strategy for rapid prototyping appli-
cations. Therefore, some initial cell culture experiments were performed to assess
the applicability for cell encapsulation of HepG2 cells. In accordance to the cyto-
compatibility results presented earlier in section 3.3.5, bovine type B gelatin at a
concentration of 10w/v% was selected for these initial experiments. The results
are presented in Figure 3.10.
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Figure 3.10: The use of mTGase as a natural cross-linker for the production of cell-
laden sheets using 10w/v% gelatin type B as cell embedding matrix. Live
and dead stain of encapsulated HepG2 cells at day 1 (A,a) and day 7 (B,b).
Live and dead stain of encapsulated mouse primary hepatocytes at day 1
(C,c) and day 3 (D,d). Scale bar represents 200μm (A-D), 500μm (a,c),
50μm (b,d).
Initially, HepG2 cells showed promising viability levels (> 95%) after encapsu-
lation in 10w/v% type B gelatin. Unfortunately, the cell survival rate dropped
signiﬁcantly with cultivation time. It is highly likely that the resulting hydrogel
network has a dense skeletal framework and thus interferes on the long-term vi-
ability due to the generation of too highly constricting gels. To solve this, two
options are available: either lowering the gelatin concentration or deactivating the
enzyme after a certain reaction time. Traditionally, mTGase enzyme is inacti-
73
vated by cooking, which cannot be done with cell-laden matrices. While lowering
the gelatin concentration seems appealing and could help in the generation of 2D
cell-laden sheets, this strategy cannot be followed for the production of 3D open
porous Bioplotted cell-laden scaﬀolds. Up to date, we could not ﬁnd a relevant
alternative solution meeting the needs for this work.
Kuwahara et al.360 encapsulated MSCs with high viability in a 10w/v% gelatin
using transglutaminase as a cross-linker, and observed a cell morphology change
from round to network-like structures having high proliferation. In this case, the
authors cited the advantage of using mTGase as this enabled co-crosslinking of the
native collagen with the injected cell-laden gelatin matrix. However, they stated
a potential drawback of applying high gelatin concentration by constricting the
cells as has been observed by Hoshikawa et al.371 in the encapsulation of chondro-
cytes in gelatins. However, for their MSCs (smaller than hepatocytes) they did
not observe adverse eﬀects. Recently, Ijima et al.370 reported the successful use of
gelatin-transglutaminase for the cultivation of encapsulated primary hepatocytes
with promising results. Unfortunately, the gelatin working concentration was not
reported but since the hot gelatin solution was ﬁlter sterilized, it is safe to as-
sume that concentrations far below 10w/v% were applied. These ﬁndings suggest
that mTGase cross-linking could be a promising alternative, however since we are
limited to higher concentrations in order to enable Bioplotting, and these high
concentrations result in too conﬁned networks for hepatocyte-like cells (which are
rather big), this strategy was abandoned.
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3.4 | Conclusions
Four gelatins having diﬀerent origin and extraction processes were investigated
for their diﬀerence on the primary structure, molecular weight (MW), molecular
weight distribution (MWD), geliﬁcation, and in vitro cytocompatibility for HepG2
cells and primary hepatocytes.
The amino acid composition of porcine and bovine derived mammalian raw materi-
als diﬀered mainly in the amount of aromatic amino acids, however, the inﬂuence
of the acid or alkaline pre-treatment proved to be more obvious. Three bovine
type B gelatins had similar amino acid compositions. As a result of the extrac-
tion process, the MW and MWD of the gelatins showed clear diﬀerences. Type A
gelatin mainly consisted of low molecular weight (LMW) molecules, while type B
gelatins all had a clear α-chain peak. The bovine hides type B gelatin addition-
ally had a clear β- and γ-chain contribution. The observed diﬀerences resulted in
variations of the geliﬁcation potential. It was observed that mainly the α-chains
contributed to the ﬁnal gel strength, while the β-, γ-chains and HMW molecules
are able to perturb the physical helix reformation but contribute highly to the
solution viscosity.
Evaluating the cytocompatibility of HepG2 cells in physically cross-linked gelatin
hydrogels, a clear relation between cell death and gelatin concentration could be
observed. An optimal balance between cell viability and gelatin physical prop-
erties is situated at around 10w/v%. Overall, the tested bovine type B gelatin
demonstrated lowest toxicity levels even up to a concentration of 30w/v%.
Finally, the unmodiﬁed gelatins were subjected to two types of natural cross-linkers
to examine the chemical cross-linking needed for cell biology applications. Genipin
cross-linking proved to be diﬃcult to control, thus excluding this approach for
rapid prototyping applications where an extended control over the curing should
be feasible. On the other hand, enzymatic cross-linking using microbial transg-
lutaminase showed promising results. However, the inability to halt the curing
under cell friendly conditions hampers strategies employing cell-laden hydrogels
and enzymatic cross-linking. Nevertheless, for lower gelatin concentrations and
sheet-like structures, enzymatic cross-linking would certainly deserve a thorough
investigation.
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This chapter tackles the synthesis and free-radical initiated photo-polymerization
process of cross-linkable, photo-sensitive, gelatin derivates. The cross-linking strat-
egy is evaluated for its eﬀects on the important hydrogel network properties. This
work was partly, the data on type B gelatin, published in Macromolecular Bio-
science.372
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4.1 | Introduction
In the ﬁeld of tissue engineering, material engineers together with various re-
searchers from other disciplines aim to closely mimic the extracellular matrix
(ECM) composition of a certain target tissue. As such, it is understandable that
naturally derived macromolecules are being employed in this rapidly evolving sci-
entiﬁc ﬁeld. In particular hydrogels, of which the hydrated states resemble that of
the ECM, allow for an easy exchange of gasses, nutrients, and metabolites.7 Gen-
erally, the liquid precursory state can be solidiﬁed by means of physical and/or
chemical cross-linking in the presence of water.
The use of gelatin-hydrogel systems is limited by a reversible temperature de-
pendent sol-to-gel transition (upper critical solution temperature (UCST) thermo-
reversible type of material). As described in the previous chapter, a variety of
chemical cross-linking approaches have been developed over the years to tackle
this limitation. For example, Genipin cross-linking,310,373 carbodiimide chem-
istry,148,310,374 the use of aldehyde cross-linkers,152,375,376 and enzyme-triggered gela-
tion133,155,377,378 strategies have been explored. General agreement regarding one
standard cross-linking protocol that satisﬁes the needs of material scientists and
cell biology experts alike, has yet to be achieved. In most approaches, native
gelatin is used for the formation of a chemically cross-linked hydrogel. One of
the major drawbacks is, however, that cross-linking kinetics are less controllable
and possible cytotoxic side eﬀects of some cross-linkers cannot be ignored (e.g.,
glutaraldehyde379).
Interestingly, the chemical composition of gelatin allows for straightforward mod-
iﬁcations of the inherent functional groups towards desired (reactive) side groups
or coupling with other bioactive ligands.109,223,357–359 This has aided researchers
to modify gelatin for light-activated free-radical cross-linking purposes, which can
be regarded as more controllable and reproducible processes. Hereby, a biocom-
patible photo–initiator (PI) is needed. Several studies have claimed the merits
associated with 2-hydroxy-1-[4-(2- hydroxyethoxy)phenyl]-2-methyl-1-propanone
(Irgacure 2959, I2959) compared to similar PIs.311,312,380 These merits comprise,
among other, a favorable use in biocompatibility studies due to the absence of
toxicity in its native form, while only slight viability decreases are observed in
the activated form. In the case of gelatin, the choice of modiﬁcation is mostly
a derivatization with methacryl-based side groups. Nonetheless, it is known that
acryl-based curing kinetics are considerably faster compared to methacryl-based
ones.381,382 For example, Anseth et al.382 observed up to three orders of mag-
nitude larger kinetic constants comparing the photopolymerization of acrylates
versus methacrylates. However, gelatin modiﬁcation with acryl-based side groups
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has not yet been reported, while it could potentially oﬀer advantages when rapid
curing reactions are desired (e.g., injectable scaﬀolds, cell encapsulation).
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Figure 4.1: Schematic representation of chemical and physical junctions and their char-
acteristic units.
The current chapter evaluates the synthesis and characterization of methacryl-
amide and acrylamide-modiﬁed gelatin. The focus of this study was aimed at
a qualitative and quantitative comparison between both cross-linkable function-
alities in terms of cross-linking kinetics and overall structural properties of the
resultant gels (Figure 4.1). Also, the use of NMR techniques for the determina-
tion of the eﬀective cross-linking eﬃciency was explored and compared with more
conventional swelling experiments.
4.2 | Experimental Section
4.2.1 Materials
Bovine type B gelatin (approximate isoelectric point of 5 and Bloom strength
of 257), isolated by alkaline treatment, and porcine skin type A gelatin, iso-
lated by acidic treatment, were kindly supplied by Rousselot (Ghent, Belgium).
Methacrylic anhydride (Sigma-Aldrich, Belgium), acrylic anhydride (ABCR, Ger-
many), (meth)acryloyl chloride (Fluka, Belgium) were used without further pu-
riﬁcation. Dialysis membranes Spectra/Por (molecular weight cut–oﬀ (MWCO)
12–14 kDa) were obtained from Polylab (Antwerp, Belgium). Sodium phosphate
(dibasic), potassium phosphate (monobasic), and tertiar-butylcatechol were pur-
chased from Acros (Geel, Belgium). 1-[4-(2-Hydroxyethoxy)-phenyl]-2-hydroxy-
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2-methyl-1-propane-1-one (I2959) was obtained from Ciba Specialty Chemicals
(Groot-Bijgaarden, Belgium). A long-wave ultraviolet (LWUV) lamp model VL-
400L (Vilber Lourmat, Marne La Vallée, France) was used for sample curing (UV-A
light, 365 nm, 4mWcm−1). Pullulan standards (P-50, P-100, P-200, and P-400)
were purchased from SDK Showa Denko. N-hydroxysuccinimide and deuterated
solvents were purchased from Sigma-Aldrich (Belgium). HepG2 cells were main-
tained in a humidiﬁed 5% CO2-containing atmosphere (37 ◦C) with cultivation
medium consisting of DMEM, supplemented with 10 v% FBS, 50UmL−1 peni-
cillin and 50μgmL−1 streptomycin, all provided by Life technologies.
4.2.2 Synthesis of cross-linkable gelatins
4.2.2.1 Synthesis of (Meth)acrylamide-Modiﬁed Gelatin
Gelatin was chemically modiﬁed with methacrylamide side groups, as described
by Van Den Bulcke et al.223 The modiﬁcation strategy with acrylic anhydride was
performed in an analogous fashion in order to investigate the diﬀerence between
methacrylamide and acrylamide side groups as photocross-linkable sites. The two
modiﬁcation strategies are schematically represented in Scheme 4.1.
NH2 + O
OO
GELATIN N
H
GELATIN
O
NH2 + O
OO
GELATIN N
H
GELATIN
O
gelatin acrylamide
gelatin methacrylamide
acrylic anhydride
methacrylic anhydride
1 hour, pH 7.8
40°C
1 hour, pH 7.8
40°C
Scheme 4.1: Schematic representation of the methacrylamide and acrylamide modiﬁ-
cation reactions yielding photo-sensitive gelatin derivates.
Typically, 20 g of type B gelatin (7.6 mmol free amines) was dissolved in 200mL
phosphate buﬀer (pH 7.8) at 40 ◦C until complete dissolution was achieved. Next,
0.88mL (7.6mmol, 1 eq , 29 ppm MeHQ radical inhibitor) of acrylic anhydride
or 1.13mL (7.6mmol, 1 eq , 23 ppm topanol A radical inhibitor) of methacrylic
anhydride was added drop-wise to the gelatin mixture during vigorous stirring.
A series of (meth)acrylic anhydride additions (1.9− 3.8− 7.6− 11.4− 15.2mmol)
were performed to investigate the reaction proceedings. The pH of the mixture was
adjusted with NaOH solution (1M) to be kept constant at pH 7.8. After a reaction
period of 1 h under vigorous stirring at 40 ◦C, the mixture was diluted with 200mL
double distilled water until a homogeneous mixture was obtained. The solution
was transferred to dialysis membranes and dialyzed against distilled water for 24 h
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at 40 ◦C. Lyophilization (Christ alpha I-5) yielded the puriﬁed gelatin derivate.
An identical setup was applied for the modiﬁcation of type A gelatin.
The methacrylamide and acrylamide-modiﬁed gelatins were respectively stored
at room temperature and −20 ◦C until further use. The amount of reagent is
expressed as equivalents to the amount of free amines on the gelatin backbone.
The modiﬁcation step with acrylic anhydride was analyzed for ﬁve diﬀerent reagent
additions (between 0.25 and 2 equivalents), and compared to modiﬁcation with
methacrylic anhydride.
4.2.2.2 Preparation of (thin) gelatin ﬁlms
Typically, 0.5− 2 g of gelatin was dissolved in 10mL phosphate buﬀered saline
(PBS, pH 7.4) at 45 ◦C. After complete dissolution, 2mol% (relative to the amount
of double bounds) of an 8mgmL−1 stock solution I2959 in distilled water was
added to the mixture, followed by degassing for at least 5min. The heated gelatin
solution was injected between two parallel glass plates, separated by a 1mm thick
silicon spacer. In order to prevent the sticking of the gels to the glass plates, they
were covered with a thin Teﬂon sheet. Finally, the hydrogel was irradiated on
both sides with UV-A light. The chemically cross-linked gelatin ﬁlms were either
directly used for further characterization, or stored at 5 ◦C.
For a number of characterization techniques, thin gelatin ﬁlms were prepared us-
ing a table-top spincoater system (SPIN15, SPS-Europe B.V.). The spincoating
protocol was described in section 3.2.5. Thin ﬁlms were prepared starting from
diﬀerent concentrations (5, 10, 15 and 20w/v%). Spincoated samples containing
2mol% initiator were UV-A cured unless indicated otherwise. Samples were stored
in a desiccator at room temperature until further analysis.
4.2.3 Characterization of the physico-chemical properties
4.2.3.1 Eﬀect of Modiﬁcation Reagent on the Properties of Cross-Linkable
Gelatins
The amount of free amines, converted into cross-linkable sites is expressed as the
degree of substitution (DS). This value can be calculated from 1H NMR spectra
after gelatin modiﬁcation with either methacrylamide or acrylamide side groups.
The 1H NMR spectra were recorded at 45 ◦C in deuterated water using a Bruker
AVANCE II 500MHz. The degree of substitution was obtained after compari-
son of the integrations of the characteristic peaks of the methacrylamide (5.7 ppm
and 5.95 ppm) or the acrylamide substituent (5.8 ppm and 6.25 ppm) and the in-
tegration of the area corresponding to the combined peaks of valine, leucine and
isoleucine (at 1.2 ppm). The hydrophobic alkyl side chains of the latter amino acids
can be considered chemically inert and their signal serves as an internal standard.
81
These amino acids have a known ﬁxed concentration and can be found in section
3.3.1. The results are expressed as the calculated DS (%) as a function of the
added amount of reagent (in equivalents).
Changes in the molecular weights after the modiﬁcation step were analyzed by
means of size-exclusion chromatography (SEC). The setup and protocol was de-
scribed in section 3.2.3. The results are presented as relative changes to the values
for the respective non-modiﬁed gelatins.
Bulk changes after the introduction of cross-linkable groups were analyzed by
means of FT-IR spectroscopy in attenuated total reﬂection (ATR) mode (Spotlight
400 Imaging System). FT-IR spectra of the gelatins were measured over a fre-
quency range of 750− 4000 cm−1. All spectra were recorded in the spectral range
by accumulation of 64 scans with a spectral resolution of 8 cm−1. Non-modiﬁed
gelatin was chosen as reference sample.
Alterations in the elemental chemical composition due to the modiﬁcation step
were investigated by means of X-ray photoelectron spectrometry (XPS, see sec-
tion 11.2.5). Spincoated samples, before and after modiﬁcation, were analyzed.
Measurements were performed on an ESCA S-probe VG monochromatized spec-
trometer with an Al Kα X-ray source (1486 eV). A survey scan spectrum was
collected and from the peak-area ratios, the relative elemental composition of the
material top layer was determined. The generated data are displayed as a plot
of the electron counts versus the electron binding energy. CasaXPS software was
used for data analysis.
4.2.3.2 Equilibrium swelling and cross-linking eﬃciency
Cross-linked hydrogel ﬁlms (1mm thick, ∅ = 10mm) were freeze-dried and weighed
(mdi). The dry disks were incubated at 37 ◦C, and immersed in double distilled
water. After equilibrium swelling was reached (e.g. 24 h), the disks were removed,
gently dabbed with paper and weighed again (mhe). Subsequent freeze-drying gave
the ﬁnal dry weight (mde). The loss of dry mass of the hydrogel as well as the water
uptake capacity during incubation at 37 ◦C enabled us to calculate the gel fractions
and the swelling rates. During the swelling experiments, changes in macroscopic
geometry were determined with an electronic calliper. He-pycnometry (Accupyc
1330, Norcross, GA) was used for the determination of the volumetric changes.
One cycle consisted out of 10 measurements to obtain an average volume.
The eﬀective cross-linking eﬃciency was studied using high-resolution magic an-
gle spinning (HR-MAS) NMR (see section 11.2.6). Previous work from our group
demonstrated the use of HR-MAS spectroscopy as a powerful tool to characterize
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hydrogel cross-linking.383 Freeze-dried gelatin ﬁlms were cut up into small pieces
and inserted into a 4mm 50μL MAS rotor. Solvent (D2O) was added, causing the
gelatin ﬁlm to swell. The sample was homogenized by manually stirring the solvent
and the gelatin inside the rotor. All 1H NMR spectra were recorded on a Bruker
Avance II spectrometer operating at a 1H frequency of 700.13MHz and equipped
with a 1H, 13C, 119Sn triple resonance 4mm HR-MAS probe. A spinning rate of
6 kHz was used throughout. The samples were characterized using one-dimensional
(1D) 1H spectra and diﬀusion ﬁltered 1D 1H spectra. The 1D 1H spectra were ac-
cumulated from 32 scans of 32768 ﬁd points each with an acquisition time of 1.136 s
and a spectral width of 20.6 ppm. A relaxation delay of 30 s was inserted between
each of the 32 scans to fulﬁll quantitative conditions for integration. The water
signal was suppressed using presaturation during relaxation delay. The diﬀusion
ﬁltered spectra were accumulated from 64 scans of 8192 ﬁd points each with an
acquisition time of 0.284 s with a spectral width of 20.6 ppm. A relaxation delay
between the individual scans was used. A double stimulated echo sequence with
adapted phase cycle was used.384,385 The diﬀusion ﬁlter was optimized to show
only signals of protons bound to an immobile entity (no leftover signals originat-
ing from small compounds, such as solvent, non-reacted molecules, or impurities).
For this purpose, the gradient pulse was applied using a sine bell shape with a
length δ of 2ms and a maximum gradient strength of 0.33Tm−1. Fourier trans-
formation, phasing, baseline correction and integration were done using TopSpin
2.1 software. Gelatin ﬁlms (1mm thick) modiﬁed with either methacrylamide or
acrylamide side groups, with concentrations between 5− 20w/v% were used for
this study. The generated data are expressed as the conversion in function of the
UV-A irradiation dose and the initial gelatin concentration. Each condition was
measured in duplicate.
4.2.3.3 Static contact angle measurements
Static water contact angle measurements were performed on the non-modiﬁed and
modiﬁed spincoated thin ﬁlms in air using the sessile drop method (1μL) on a
contact angle instrument, OCA 20 (Dataphysics, Benelux Scientiﬁc). A video was
collected and Laplace-Young ﬁtting was used in order to determine the contact
angles 30 s after positioning the drop. This method was used to determine the
wettability of gelatin substrates (see section 11.2.3).
4.2.3.4 Atomic force microscopy analysis
Topographical changes induced by the gelatin concentration or the curing con-
ditions were studied by atomic force microscopy (AFM) on spincoated samples.
AFM images were obtained according to the conditions as described in section
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3.2.5. Nanoscope software version 4.43r8 was used for surface roughness analysis
after the recorded images were modiﬁed with an X and Y Plane Fit Auto proce-
dure.
4.2.3.5 Rheological properties of hydrogels
Rheological characterization of cross-linked gelatin ﬁlms (1mm thick) was per-
formed using a Physica MCR 350 (Anton Paar) with plate-plate geometry. The
linear visco-elastic range was determined by isothermal measurements (37 ◦C) of
the storage and loss moduli G′ and G′′ as a function of the deformation (γ =
0.01%→1%) at a constant frequency (1Hz). Mechanical spectra were recorded at
a constant deformation of 0.1% strain in the frequency range of 0.1− 100 rad s−1
at 37 ◦C. Prior to loading, cross-linked samples were incubated in double distilled
water at 37 ◦C for at least 24 h to ensure complete leaching of the non cross-linked
hydrogel fraction.
Additionally, in situ curing of (meth)acrylamide-modiﬁed gelatin precursor solu-
tions (10w/v%) were carried out at 20 ◦C. For this, non-irradiated 2D slabs were
placed between the two plates. Irradiation was realized from the bottom by means
of an optical ﬁber (365 nm).
4.2.4 In vitro cytocompatibility
(Meth)acrylamide gelatin precursor solutions were prepared as previously described
and mixed with HepG2 cells at a ﬁnal concentration of 1.5× 106 cellsmL−1. Prior
to cell mixing, the hydrogel precursor mixture was pasteurized three times at
70 ◦C, while PBS and I2959 stock solutions were ﬁlter sterilized. The cell-gel mix-
tures were cast in 48-well cultivation plates (Greiner-Bio one), cured as previously
described and maintained in 500μL cultivation medium. Medium was refreshed
every 24 h. Prior to the live/dead assay, the hydrogels were washed twice with
PBS and subsequently incubated for 10min with 1mgmL−1 calcein-acetoxymethyl
(calcein-AM) (AnaSpec) and 1mgmL−1 propidium iodide (Sigma). After washing
with PBS, ﬂuorescence was evaluated and recorded using an inverted ﬂuorescence
microscope (Olympus IX81) equipped with Xcellence software (Olympus).
4.2.5 Statistical analysis
All measurements were performed with n ≥ 3, unless otherwise stated, and the
experimental results are reported as mean ± standard deviation (S.D.). Statistical
analysis was performed with the Student’s t-test and signiﬁcance was determined
at p < 0.05. Statistical analysis was used in order to evaluate both the repro-
ducibility of the respective techniques and the signiﬁcance of diﬀerences between
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samples.
4.3 | Results and Discussion
4.3.1 Eﬀect of the reagent on the modiﬁcation of gelatins
Initially, we studied the inﬂuence of the applied reagent, methacrylic versus acrylic
anhydride, on the ﬁnally obtained gelatins. The modiﬁcations as the reaction pro-
ceeds can be followed by expressing the DS as a function of the added amount
of reagent, and the respective eﬀects on the molecular weight and polydispersity
index. Gelatin is a protein composed out of, among other, lysine (Lys), hydrox-
ylysine (Hly), ornithine (Orn), valine (Val), leucine (Leu), and isoleucine (Ile). Of
those, Lys, Hly and Orn contain free amines, which are the reactive sites consumed
during the targeted modiﬁcation step. The 1H NMR spectra given in Figure 4.2
represents the spectra of gelatin (part A), gelatin methacrylamide (part B), and
gelatin acrylamide (part C).
The peaks can be assigned as follows: peak a (1.15 ppm) to the methyl residues
of Val, Leu and Ile; peak b (5.70 ppm) to the methylene protons H2C−C(CH3)- of
methacrylamide grafts conﬁrming successful modiﬁcation with methacrylic anhy-
dride; peak c (5.83 ppm) to the methylene protons H2C−CH- of acrylamide grafts
conﬁrming successful modiﬁcation with acrylic anhydride; peaks (1.45, 1.62, 1.91
and 2.01 ppm) to the methylene residues of threonine (peak 1), alanine (peak 2),
lysine (peak 3), and arginine (peak 4); peaks (2.90, 3.21, 3.44 and 3.85 ppm) to
methylene resonances of aspartate (peak 5), lysine (peak 6), arginine (peak 7),
and proline (peak 8).144 The total amount of free amines present in gelatin B is
0.38mmol g−1, which is in excellent correlation with earlier published data.223 For
type A gelatin, a free amine content of 0.34mmol g−1 was determined (chapter 3,
section 3.3.1) On the other hand, the hydrophobic alkyl side chains of Val, Ile and
Leu can be considered chemically inert, and their methylene signals (at 1.12 ppm)
can be used as an internal standard for the calculation of the DS by means of
1H NMR spectroscopy. The integration of this combined peak (18 protons) corre-
sponds to 3.69mmol g−1 for type B and 3.49mmol g−1 for type A gelatin, allowing
the following formulae to be used to calculate the DS (Equations 4.1 and 4.2):
DSgelA(%) = 0.3492mol/100g× integration at 5.7 or 5.8 ppm
integration at 1.2 ppm
× 100
0.03398mol/100g
(4.1)
DSgelB(%) = 0.3699mol/100g× integration at 5.7 or 5.8 ppm
integration at 1.2 ppm
× 100
0.03798mol/100g
(4.2)
The formula for the calculation of type B gelatin modiﬁcations is slightly altered
in the case of bovine hide and bovine bone derived gelatins, according to their
respective amino acid composition.
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Figure 4.2: 1H NMR spectra representative for gelatin (A), methacrylamide modiﬁed
gelatin (B), and acrylamide modiﬁed gelatin (C).
Figure 4.3 illustrates both the changes in DS (e.g. modiﬁcation curves) and al-
terations in the molecular weight and PDI. For simplicity, the modiﬁcation curves
for the bovine hides and bone type B gelatins were left out since the results were
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analogue to the bovine type B mastercurve.
0 0.25 0.5 1 1.5 2
0
20
40
60
80
100
d
eg
re
e 
of
 s
ub
st
itu
tio
n 
(%
)
added equivalents of anhydride reagent
MA modiﬁcation
AA modiﬁcation
0 
0,5 
1 
1.5 
2 
2.5 
1 
1.2 
1.4 
1.6 
1.8 
2 
2.2 
0.25 0.5 1 2 
relative chang
e in p
olyd
isp
ersity 
added equivalents of anhydride reagent 
MA modiﬁcation
AA modiﬁation
re
la
tiv
e 
ch
an
g
e 
in
 m
ol
ec
ul
ar
 w
ei
g
ht
Type B gelatin
Type A gelatin
A
B
Figure 4.3: Inﬂuence of the applied reagent on the modiﬁcation proceedings (top) and
on diﬀerences in the molecular weights of the puriﬁed end products (bot-
tom).
Statistically signiﬁcant diﬀerences were observed between both modiﬁcation curves,
and the amount of introduced methacrylamide functionalities was higher for the
whole range investigated (p < 0.02). This can most likely be attributed to the in-
creased reactivity of acrylic anhydride compared to methacrylic anhydride. Since
the reaction takes place in an aqueous environment, the anhydrides will decom-
pose. However, the acrylic counterpart will do so more rapidly, leading to a higher
consumption yet lower modiﬁcation degree. Ultimately, these ﬁndings lead us to
state that the modiﬁcation eﬃciency with methacrylic anhydride is signiﬁcantly
higher than that with acrylic anhydride when the same numbers of equivalents are
compared.
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Furthermore, a signiﬁcant increase in the molecular weight (a factor of 1.3–1.5), as
well as the PDI (around 1.3) was observed after the introduction of both functional
groups, compared to the native gelatin (p < 0.03). In contrast, when comparing
methacrylamide modiﬁed gelatins with increasing modiﬁcation degree, no signif-
icant diﬀerences could be found between the modiﬁed products (e.g. the DS did
not impact the molecular weight). However, for the acrylamide modiﬁed products,
an increasing trend could be observed with increasing cross-linkable groups (up till
two-fold that of native gelatin). Diﬀerences between both functional groups be-
came only signiﬁcant for reactions with more than one equivalent of reagent. From
this point onwards, molecular weight as well as the PDI rapidly increased. The
above-mentioned observations could also be explained by the auto-initiated re-
activity of the introduced functionalities. Since after the modiﬁcation, a dialysis
step of at least 24 h at elevated temperatures (40 ◦C) is performed, it would appear
logical that some of the introduced groups react. This would be more pronounced
with increasing functionalities, and/or with increasing reactivity. The described
trends on the molecular weight and PDI were also valid in the case of type A
gelatin derivates (data not shown).
The degrees of substitution for gelatin methacrylamides correlate well with pre-
vious work from our lab, Van den Bulcke et al.,223 who originally established the
synthesis of methacrylamide modiﬁed type B gelatin. Nichol et al.143 fabricated
gelatin type A methacrylamides containing degrees of substitution of 20, 54, and
80% for the generation of cell-laden hydrogels. Hu and co-workers144 coupled
methacrylic acid via EDC-activated amidation and reported a DS of 49% of the
free amino groups. Recently, Hoch et al.386 synthesized a series of highly substi-
tuted type B gelatin methacrylamides by adding methacrylic anhydride in molar
excess up to 20-fold with respect to the gelatin free amino groups. To the best
of our knowledge, the modiﬁcation with acrylamide functionalities has not been
reported yet.
In order to enable further comparison between the two cross-linkable groups, two
respective derivates, of each gelatin type, with similar degree of modiﬁcation were
selected, whereby gelatin modiﬁed with one equivalent methacrylic anhydride was
compared to gelatin modiﬁed with two equivalents of acrylic anhydride. Both prod-
ucts have a DS of ± 66% in the case of type B gelatin, which means each of those
derivatives contains ± 251μmol photo-sensitive groups per gram of gelatin. For
type A gelatin, the DS was ∼ 63% corresponding to ∼ 214μmol photo-sensitive
groups per gram of gelatin. An indirect determination of the modiﬁcation de-
gree based on the spectrophotometric quantiﬁcation of the amount of free amines
was performed shortly after the modiﬁcation step. These tests were especially per-
formed since Michael Addition reactions could occur between the acrylic anhydride
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reagent and the amines on the gelatin backbone. However, these results (data not
shown) correlated well with the NMR method above. This means that the amount
of consumed NH2- groups correlated well with the amount of calculated acrylamide
groups via 1H NMR. Therefore, Michael Addition side reactions were very limited
(< 1− 2%).
800 1200 1600 2000 2400 2800 3200 3600 4000 
frequency (cm-1)
non-modiﬁed gelatin
MA modiﬁcation
AA modiﬁcation
amide A
amide I
amide II
amide III
%
 tr
an
sm
itt
an
ce
Figure 4.4: Changes in the FT-IR spectra of gelatin type B before and after modiﬁca-
tion with either methacrylic (MA) or acrylic (AA) anhydride.
Following material selection, FT-IR spectroscopy and XPS analysis were performed
to gain a better understanding of possible compositional changes. The results are
displayed in Figure 4.4 and Table 4.1. FT-IR analysis clearly showed the key
absorbance peaks: native gelatin was characterized by the amide A peak (N-H
stretching vibration) at 3280 cm−1, the amide I peak (C=O stretch) at 1630 cm−1,
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the amide II peak (N-H bend and C-H stretch) at 1547 cm−1, and the amide III
peak (C-N stretch plus N-H in phase bending) at 1240 cm−1, which are character-
istic peaks of gelatin.387 The incorporation of (meth)acrylamide moieties should
be noticeable by an absorption band typical for vinyl groups (C=C stretching vi-
bration at 1680− 1620 cm−1), however, in our case this peak was concealed by the
signal of the amide I peak. Nevertheless, the intensities of the amide I, II and III
peak increased, which can be attributed to the incorporated amide-bonds coupled
with a C=C stretching vibration. The peak at 3280 cm−1 served as internal ref-
erence. Only some minor diﬀerences could be observed in the rest of the spectra
(indicated by dashed circles).
The relative elemental composition before and after modiﬁcation, as measured
by XPS, is depicted in Table 4.1. For example, for type B gelatins, the relative
amount of nitrogen decreased signiﬁcantly after modiﬁcation from 16.3 to 14.9%
(methacrylamide modiﬁed, p < 0.001) respectively 14.0% (acrylamide modiﬁed,
p < 0.001). The relative amount of carbon slightly increased, while no signiﬁcant
changes in the oxygen signal could be observed. The atomic ratios N/C and
O/C give more intuitive information. Especially for the N /C ratio, a decrease
was expected after modiﬁcation, since the amount of nitrogen remained the same,
while more carbon units were incorporated. Between both modiﬁcations, this ratio
was not signiﬁcantly diﬀerent however it was diﬀerent when compared to native
gelatin (control condition). The O/C ratio is more diﬃcult to interpret since the
amount of both atoms is increasing by the applied modiﬁcation. Therefore, a less
pronounced decrease of the ratio was expected, which was also evidenced by the
data. Derivates of type A gelatin illustrated similar trends.
Table 4.1: Inﬂuence of the applied reagent, acrylic anhydride (AA) versus methacrylic
anhydride (MA), on the elementary composition of the derivatives as deter-
mined by XPS.
SAMPLE SURFACE COMPOSITION [%] ATOMIC RATIO
O 1s C 1s N 1s N/C O/C
Type B Gelatin 18.4 ± 1.2 65.3 ± 1.3 16.3 ± 0.1 0.25 0.28
MA modiﬁcation 18.5 ± 0.6 66.6 ± 0.4 14.9 ± 0.2 0.22 0.27
AA modiﬁcation 18.5 ± 0.3 67.5 ± 0.2 14.0 ± 0.2 0.21 0.27
Type A Gelatin 20.7 ± 0.4 64.2 ± 1.1 15.1 ± 0.9 0.23 0.32
MA modiﬁcation 20.5 ± 0.7 65.3 ± 0.7 14.1 ± 0.1 0.20 0.31
AA modiﬁcation 20.0 ± 0.3 67.1 ± 0.3 13.0 ± 0.4 0.19 0.30
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4.3.2 Eﬀect of cross-linkable group on the reaction behavior
of gelatin: acrylamide versus methacrylamide
The scope of our studies then further focused on the evaluation of two cross-linkable
groups with diﬀerent reactivities. Acrylate functionalities are regarded as the more
reactive group compared to methacrylates.382 To the best of our knowledge, no
study has been performed comparing both methacrylamide and acrylamide reac-
tive groups with the aim to develop gelatin derivatives for biomedical applications.
Comparing acrylamide with methacrylamide modiﬁed gelatin, we anticipated dif-
ferences in cross-linking degree (DC) and the curing kinetics.
4.3.2.1 Hydrogel Swelling studies
A conventional method (swelling studies) was used to determine the sol-gel fraction
of the diﬀerent derivatives developed for a dual reason: (i) to determine the degree
of cross-linking as an indicator of (meth)acrylamide functionality after coupling,
and (ii) to obtain a set of data that can be referenced against a HR-MAS method
which is more powerful to study hydrogels (see below). These values can be used
as a qualitative indication for the cross-linking eﬃciency. Furthermore, the water
uptake capacity or swelling ratio of the hydrogels can be derived. The results are
expressed as the gel fraction and the equilibrium mass swelling ratio (q) according
to following formulas:388
gel fraction(%) =
mde
mdi
× 100% (4.3)
q =
mhe
mde
(4.4)
here, mdi, mde, and mhe represent the weights of respectively the dry gelatin after
cross-linking, the dry gelatin after equilibrium swelling, and the swollen hydrogel
after equilibrium swelling. In Figure 4.5, the gel fractions (part A and part B)
and the swelling ratios (part C and D) of four diﬀerent type B polymer concen-
trations selected to produce hydrogels (5, 10, 15 and 20w/v%) are presented as
a function of the applied UV-A irradiation dose. A relationship can be estab-
lished between the hydrogel swelling, the hydrogel network and mass transport
properties.144 As anticipated, an increasing gelatin concentration and/or irradi-
ation dose increases the ﬁnal gel fraction and decreases the swelling ratio. For
both modiﬁcation reagents and each concentration applied, a plateau value for
the gel fractions is obtained. Typical gel fractions of maximum 97% and ﬁnal
swelling ratios situated between 4 and 25 were obtained for all conditions. In the
case of methacrylamide-modiﬁed gelatin, only the highest concentrations (15 and
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20w/v%) of precursor solution resulted in a measurable gel fraction for an irradi-
ation dose as low as 240mJ cm−2. In contrast, all acrylamide-modiﬁed precursor
solutions yielded hydrogel networks. Furthermore, the minimal irradiation dose
required to obtain the plateau gel fraction value was substantially lower in the case
of acrylamide containing gelatins. These observations further prove the premise
of a more reactive cross-linkable group, conﬁrming the successful gelatin modiﬁ-
cation in both cases. The high swelling ratios up to 16 for the acrylamide- and 25
for the methacrylamide-functionalized fully cured gelatins illustrate the high wa-
ter absorption capacity of these hydrogels. Furthermore, these data demonstrate
the possibility to adjust the swelling behavior of cross-linked gelatins over a broad
range by controlling the irradiation dose and mass fraction.
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Figure 4.5: Cross-linking behavior of (A, C) methacrylamide versus (B,D) acrylamide
modiﬁed type B gelatin based on swelling studies. (A, B) Gel fraction
(%)as a function of UV-A exposure and (C,D) swelling ratio as a function
of UV-A exposure.
As for the type A gelatin derivates, similar trends are observed, whereby reactivity
and ﬁnal gel yields are enhanced for the acrylamide variant. Figure 4.6 presents
the equilibrium swelling experimental data for type A gelatin (meth)acrylamides.
The discrepancy between both photocross-linkable moieties is predominantly ex-
pressed at a hydrogel precursor concentration of 10w/v% whereby for the gelatin
methacrylamide even at an irradiation dose of 7200mJ cm−2 the gel yield plateau
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value is not yet reached in contrast to the acrylamide variant. With regard to the
diﬀerence between type A and type B gelatin building blocks, generally, the type
B derivates displayed improved cross-linking kinetics leading to higher gel yields.
As expected, the swelling ratios are slightly higher for type A gelatins although
still in the same order of magnitude.
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Figure 4.6: Cross-linking behavior of (A, C) methacrylamide versus (B,D) acrylamide
modiﬁed type A gelatin based on swelling studies. (A, B) Gel fraction
(%)as a function of UV-A exposure and (C,D) swelling ratio as a function
of UV-A exposure.
The work of Hoch et al.386 reported gel fractions between 70− 85% for bovine type
B methacrylamide gelatins having a DS of around 68%, concentrations between
10 and 20wt% and an irradiation dose of 9000mJ cm−2. Given the lower concen-
tration of PI used, these results are comparable with the present study whereby
higher gel fractions are obtained at lower irradiation dose. In accordance, hydro-
gel water uptake capacities were lower compared to the values obtained in the
present study, which can be correlated to the lower gel fractions. Swelling studies
performed on gelatin methacrylamide having a lower DS value (49%) resulted in
higher swelling ratios, as has been reported by Hu et al.144 The mass swelling ra-
tios in the work of Nichol et al.143 on porcine skin type A gelatin methacrylamide
were similar to our ﬁndings. From this, the advantage of a more rapidly curing
gelatin derivate having good swelling properties could be useful, for instance in
the ﬁeld of rapid prototyping. Additionally, UV exposure times can be decreased
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which could potentially beneﬁt cytocompatibility.
4.3.2.2 Rheological analysis of cross-linked hydrogels
Despite the semiquantitative information that can be obtained from swelling tests,
a quantitative description of the eﬀective (chemical) cross-linking degree cannot be
derived from these studies. These data are, however, very relevant when comparing
cross-linkable groups of diﬀerent reactivity or various amounts of one single type of
cross-linkable entity. Rheological time-sweep tests coupled with in situ photocross-
linking were performed to observe the increase in storage moduli (G′) as the gel
network is formed. Figure 4.7 depicts the observed eﬀects for both types of cross-
linkable groups using 10w/v% type B hydrogels while keeping all other conditions
ﬁxed.
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Figure 4.7: The cross-linking kinetics of type B gelatin (meth)acrylamides moni-
tored by rheological time-sweep recordings for the storage moduli (G′) of
10w/v% hydrogel precursors. Dashed line represents acrylamide-modiﬁed
gelatin (i.e., AA modiﬁcation), full line represents methacrylamide-modiﬁed
gelatin (MA modiﬁcation). The zone in between arrows indicates UV irra-
diation.
From the obtained data, some interesting ﬁndings were deduced: (i) Acrylamide-
modiﬁed gelatin directly starts to cross-link upon irradiation with UV-A. This is in
contrast to the methacrylamide-modiﬁed gelatins, which showed a small lag phase
before an increase in storage modulus could be observed. (ii) The slope of the curve
is steeper for the acrylamide variant indicating faster cross-linking kinetics. (iii)
The strength of the acrylamide based hydrogels was higher at any given time point.
(iv) In both cases, post-curing occurs after halting UV-A irradiation. All of the
above mentioned observations suggest a faster and more complete (i.e. more groups
consumed) network formation in the case of the acrylamide-modiﬁed gelatins. It
should be noted that the UV-A light source used in this rheological setup had a
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diﬀerent intensity and wavelength as the one used to produce the 2D ﬁlms. Hence,
despite the correctness of the sigmoid trends observed in the curing rates, kinetics
as determined with this setup cannot be translated directly to predict curing under
the other setup. It is however clear that the observed trends remain valid.
4.3.2.3 Analysis of cross-linked hydrogels by HR-MAS NMR spectroscopy
In addition to the rheological evaluation, quantitative HR-MAS NMR spectroscopy
was performed in order to derive the absolute cross-linking eﬃciency. Changes in
the intensities of the geminal 1H (meth)acrylide resonances of H2C−C(CH3)– (5.7
and 5.95 ppm) and H2C−CH– (5.8 and 6.25 ppm) were followed as a function of the
irradiation dose, in this way quantitatively determining the conversion of respec-
tively the methacrylamide and the acrylamide groups (Figure 4.8). The samples
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Figure 4.8: Eﬀective cross-linking eﬃciency expressed as double bond conversion for
(A) methacrylamide and (B) acrylamide-modiﬁed gelatin (type B). Values
are based on HR-MAS 1H NMR studies. (C) Examples of such data ob-
tained with the resonances typical for the (meth)acrylamide shown as inset.
still contained the remaining sol fraction, and the corresponding resonance inte-
grals were used to quantitatively calculate the total amount of reacted groups
versus the total amount of available groups (i.e., the conversion). The combined
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data from the swelling studies and HR-MAS 1H NMR measurements demonstrated
that a measurable gel fraction could be derived once > 5% of the double bonds
were converted, which corresponded to a gel fraction of around 40% for type B
gelatins. This stipulates that very low double bond conversions are suﬃcient for
forming hydrogel networks. In correlation to the rheological ﬁndings, a delay in
conversion for the methacrylamide-modiﬁed gelatins was observed, while a direct
steep increase characterized the acrylamide conversion. In addition, it could be
proven that even after obtaining the ﬁnal gel fraction value (i.e., the plateau value
during swelling studies), the absolute conversion further increased signiﬁcantly (p
< 0.02). These results strongly implicate the existence of a non-linear correlation
between the qualitative and quantitative methods to monitor cross-linking eﬃ-
ciencies. When deﬁning the cross-linking eﬃciency as a measure for the amount
of reacted groups, one clearly overestimates this value when solely relying on re-
sults of swelling studies. It should be commented that the conversion values are
depicted in reference to the initially available cross-linkable groups. When mea-
suring hydrogels in fully swollen state (i.e., when the sol fraction will have leached
out), these values will increase signiﬁcantly. For example, a 10w/v% hydrogel will
result in a conversion degree of > 90% only taking the gel fraction into account
(compared to a value around 60% when the feed components are considered).
Nevertheless, both sets of data yield very useful information about the network
formation as a function of the applied irradiation dose. As previously mentioned,
the acrylamide-modiﬁed gelatins cross-link faster, leading to gels with a higher
conversion degree and better mechanical properties.
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Figure 4.9: Correlation between the conversion degree and gel fraction of gelatin type
B acrylamide (AA) and gelatin type B methacrylamide (MA). Exponential
regression was performed on the total population (i.e., for four concentra-
tions and for both modiﬁcations.)
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In a last part of this comparative study into the reactivity diﬀerences between
acrylamide and methacrylamide-modiﬁed gelatin we were interested to establish a
possible correlation between the degrees of reacted groups, the gelatin modiﬁcation
type, the gel fractions, and the precursor concentration. Figure 4.9 displays a
scatter diagram in which every (gel fraction, conversion) combination is plotted for
type B gelatins, thus excluding the irradiation dose factor. For both modiﬁcations,
the data sets of the four concentrations were grouped. Regression analysis revealed
an exponential correlation between the gel fractions and the conversion degrees (R2
> 0.95). Both data sets followed the same trend. In other words, knowing the
correlation, one can predict the eﬀective amount of reacted groups thus providing
information about the gel fraction, or vice versa, independent of the precursor
concentration or the modiﬁcation type. Of course, this correlation can only be
derived in cases where the same DS is used.
In accordance to the swelling studies, the conversion factors for the type A gelatins
were lower than for type B derivates, as depicted in Figure 4.10. Despite having
slightly lower DS values, the (gel fraction, conversion) pairs for (meth)acrylamide-
modiﬁed type A gelatins by and large follow the exponential correlation further
proving the above-mentioned hypothesis.
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Figure 4.10: Eﬀective cross-linking eﬃciency expressed as double bond conversion for
type A (meth)acrylamide-modiﬁed gelatins. Values are based on HR-MAS
1H NMR studies at a curing dose of 7200mJ cm−2.
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4.3.3 Eﬀect of cross-linkable group on the physico-chemical
hydrogel behavior: acrylamide versus methacrylamide
Most often, dynamic force measurements are used to determine the visco-elastic
behavior of hydrogels. The storage (G′) and loss (G′′) moduli were recorded over a
frequency range of 0.1− 100 rad s−1 at 37 ◦C after equilibrium swelling was reached.
For all measured conditions, the storage moduli were 5-10 times higher than the
loss moduli, indicating an elastomeric hydrogel network. No signiﬁcant inﬂuence of
frequency changes could be observed for both kinds of moduli, indicative of cross-
linked systems. As shown in Table 4.2, the storage moduli are closely correlated
to the concentration of the precursor mixture, and to the combined actions of the
swelling capabilities and the amount of reacted groups in the ﬁnal hydrogels.
Both moduli increased with increasing concentration, where higher cross-linking
densities per volume could be obtained, resulting in a stronger ability to resist
deformation. Comparing the data from both modiﬁcation types, it could not
only be conﬁrmed that acrylamide-modiﬁed gelatins resulted in a faster cross-
linking, but also that the resulting hydrogels were signiﬁcantly stronger compared
to the methacrylamide-modiﬁed counterparts at equal curing conditions. A broad
range of storage moduli was obtained ranging between 7 and 152 kPa for the
acrylamide- and between 1.5 and 107 kPa for the methacrylamide-functionalized
type B gelatins. Type A gelatins had substantially lower mechanical strength with
G′ values ranging between 0.9 and 20 kPa.
It should be noted that the stiﬀness of gelatin hydrogels can be adjusted by varying
the amount of photo-sensitive groups as has been demonstrated in the work of
Hoch et al.,386 Van den Bulcke et al.,223 and Nichol et al.143 Especially the work
of the former illustrates the possibility to fabricate high stiﬀness gelatins (up to
368 kPa) by increasing the DS up to 98%, which could become promising for
engineering of “stiﬀ” soft tissues. As indicated by the present results, stiﬀer gelatin
hydrogels can also be obtained by varying the cross-linkable group, broadening
possible applications. On the other hand, cross-linked methacrylamide gelatins
were observed to be stable in the work of Van den Bulcke et al.,223 indicating
potential as drug delivery matrix for wound healing.
When describing the nanostructure of cross-linked hydrogel materials, generally,
the polymer volume fraction in the swollen state (v2,s), the average number molec-
ular weight between cross-linking points (M c), and the network mesh size (ξ) rep-
resent three important parameters. The polymer volume fraction in the swollen
state (v2,s) and the volumetric swelling ratio (Q) both describe the amount of
liquid that can be imbibed in a hydrogel:132,389
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v2,s =
Vp
Vg
=
1
Q
=
1
ρgelatin
q
ρH2O
+ 1
ρgelatin
(4.5)
where, Vp is the polymer volume, Vg the hydrogel volume at equilibrium swelling,
q the mass swelling ratio, and ρgelatin and ρH20 the densities of gelatin and water.
ρgelatin was estimated to be 1.36 g cm−3 based on reports from literature.144,157,390
The volumetric swelling ratio Q was used to determine the average molecular
weight between cross-links (M c) as network chains in all the hydrogels used in this
experiment follow Gaussian statistics model (Figure 4.11):391
G =
cRT
M c
×
(
1− 2M c
Mn
)
×Q−13 (4.6)
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Figure 4.11: Log G versus log Q of all modiﬁed type B gelatin hydrogels used for the
calculation of the molecular weight between cross-linking points.
where R is the universal gas constant, T is the absolute temperature, G is the shear
modulus, c is the concentration of gelatin in the solution, and Mn the average
molecular weight of gelatin. The hydrogel shear modulus may be derived from the
mean peak value of the storage modulus G′.374 An estimation of the average mesh
size (ξ), expressed in A˚, of the gelatin hydrogels at the equilibrium swollen state
was based on the knowledge of M c, using the following formula:144,392
ξ = 2α′ ×
(
M c
Mr
) 1
3
×
(
2.21A˚
)
×Q 13 (4.7)
here, Mr is the average molecular weight of one amino acid (estimated to be
100 gmol−1). α′ is an expansion factor assumed to be 2.0 based on reports of
gelatin conformation in solution similar to our conditions.157,392 Multiplication of
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the freely rotating root-mean-square end-to-end distance, (Mc
Mr
)
1
3 × (2.21A˚), with
2α′ gives the experimental root-mean-square end-to-end chain distance.392 Finally,
the cross-linking density (ρχ) was calculated according to:388,391
ρχ =
1
vM c
(4.8)
in which v denotes the speciﬁc volume of gelatin (0.735 cm3 g−1).
Corresponding to the experimentally determined data from the swelling studies
and shear storage moduli, a summary of the calculated physico-chemical parame-
ters is presented in Table 4.3.
Table 4.3: Inﬂuence of modiﬁcation type, gelatin methacrylamide (MA) and gelatin
acrylamide (AA), and gelatin concentration on v2,s, Q, M c, ξ, and ρχ.
SAMPLE TYPE
DS
[%]
INITIAL
CONC.
[%, w/v]
v2,s Q
M c
[gmol−1]
ξ
[A˚]
ρχ
(×10−4)
[mol cm−3]
T
Y
P
E
B
G
E
LA
T
IN
MA 66 ± 1.0 5 0.029 34.45 15 429 357 0.88
10 0.067 14.89 7 411 187 1.83
15 0.108 9.30 5 562 139 2.44
20 0.116 8.62 2 707 94 5.02
AA 66 ± 2.8 5 0.045 22.27 10087 250 1.35
10 0.090 11.15 4 969 139 2.73
15 0.118 8.45 4 016 114 3.39
20 0.142 7.05 2 609 87 5.22
T
Y
P
E
A
G
E
LA
T
IN MA 64 ± 2.9 10 0.050 19.86 19 454 334 0.70
15 0.089 11.22 13 611 231 1.00
20 0.100 10.03 11 172 202 1.22
AA 61 ± 3.2 10 0.064 15.51 15 067 271 0.90
15 0.092 10.85 12 026 215 1.13
20 0.111 9.01 9 977 184 1.37
As anticipated, increasing concentrations aﬀect the hydrogel structure leading to
decreasing mesh sizes. As an example, the average mesh size of a methacrylamide
modiﬁed type B gelatin hydrogel decreases from 357 to 94 A˚ when the gelatin con-
centration is increased from 5 to 20w/v%. In general, the acrylamide-modiﬁed
gelatins results in hydrogels with a tighter network structure as evidenced by: (i)
smaller (volumetric) swelling ratios, (ii) lower average molecular weights between
adjacent cross-links, (iii) lower average mesh sizes, and (iv) higher cross-linking
densities. It is important to stress that the determined cross-linking densities ac-
count for the physical as well as the chemical junction knots. According to the data
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derived from HR-MAS experiments, the cross-linking density of chemical junction
knots can also be derived and compared. It was noticed that the contribution to
the cross-linking density due to reaction of the (meth)acrylamide functionalities
decreases with increasing concentration. For example, approximately half of the
total cross-links in a 20w/v% gelatin type B hydrogel can be attributed to chemi-
cal junctions, while for a 5w/v% hydrogel the contribution gets as high as almost
90%. In summary, the contribution of chemical structuring due to double bond
conversion, to the hydrogel network properties will decrease with an increasing
concentration.
As for the topography of the hydrogels, AFM images were recorded for all hydrogel
samples developed. Typical images for 10w/v% hydrogels are represented in Fig-
ure 4.12. As can be seen, no large diﬀerences could be distinguished between non-
modiﬁed gelatin with either of the modiﬁcations. Concerning the roughnesses of
the samples, methacrylamide modiﬁcation slightly decreased the roughness, while
for the acrylamide modiﬁcation roughness values slightly increased. The observed
trends were, however, not statistically signiﬁcant.
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Figure 4.12: AFM images of (A) non-modiﬁed gelatin, (B) gelatin methacrylamdie, and
(C) gelatin acrylamide. Images all represent 10w/v% type B hydrogels.
The roughness is expressed by the Ra values as determined from 1μm2
scan areas.
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4.3.4 In vitro cytocompatibility study: acrylamide versus
methacrylamide-functionalized gelatin
For a number of applications, fast curing materials could be beneﬁcial or even
required (i.e., rapid prototyping technologies). In the present study, we evalu-
ated acrylamide side groups as a fast curing alternative for the more conventional
methacrylamide gelatins. With regard to biological applications, preliminary cell
encapsulation cytocompatibility testing was performed using HepG2 cells. Addi-
tionally, the inﬂuence of gelatin precursor concentration was taken into account
since we anticipated the impact on the network structure and material stiﬀness.
Type B gelatins were selected for the evaluation of both cross-linkable functional-
ities, since these revealed lower cytotoxicity compared to type A gelatin (chapter
3, section 3.3.5). Figure 4.14 represents live/dead staining ﬂuorescence images for
10 and 20w/v% (meth)acrylamide hydrogels. The results for viable cell counts
are represented by Figure 4.13.
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Figure 4.13: Viability values (%) of encapsulated HepG2 cells at day 1 and 3 of the
respective hydrogels (type B gelatins).
As a ﬁrst observation, it is clear that for both derivatives, a concentration of up to
10w/v% poses no adverse eﬀects on the encapsulated cells, and cell viabilities of
> 90% were observed. However, increasing the gelatin concentration resulted in
a small drop of the cell viability, which was more pronounced for the acrylamide-
modiﬁed gelatins. This experimental setup was mainly used to pinpoint qualitative
trends to diﬀerentiate gelatin concentration and modiﬁcation type. These obser-
vations can be explained as follows: both material derivatives and concentrations
used were cross-linked using the same irradiation dose (1800mJ cm−2) to enable
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Figure 4.14: HepG2 cells with live (green) and dead (red) cell stain encapsulated in
gelatin methacrylamide (A) and gelatin acrylamide (B) of diﬀerent type
B gelatin concentration after 1 and 3 days of cultivation. Scale bar 500μm.
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material comparison. As such, it would be expected that a drop in cell viability
caused by stiﬀening the construct would be more pronounced for the acrylamide
derivatives since these will possess the highest G′ values. Additionally, Michael
Addition reaction of the residual acrylamide groups could increase toxicity due to
reaction between the acrylamide and -NH2 function of proteins. We anticipate this
eﬀect to be more pronounced at higher concentrations. However, one should keep
in mind that the irradiation dose for gelatin acrylamide can be reduced without a
signiﬁcant loss in gel fraction.
McGuigan and Sefton72 encapsulated HepG2 cells in non-modiﬁed gelatin con-
structs which were subsequently cross-linked using glutaraldehyde (0.025%). They
observed a signiﬁcant loss in cell viability due to the applied glutaraldehyde.
Material-cell cytocompatibility studies on gelatin methacrylamides for diﬀerent
gelatin mass fractions demonstrated favorable cytocompatibility using porcine
chondrocytes.386 Promising results were also obtained in the micropatterning of
NIH 3T3 ﬁbroblasts using gelatin methacrylamides with cell viabilities of 92% in
5% gelatin methacrylamide.143 The authors furthermore reported on the loss in
cell viability as a function of increasing gelatin mass concentration, being a similar
eﬀect compared to our tests. In the present study, the use of gelatin methacryl-
amide as well as gelatin acrylamide as a promising matrix material for biological
applications was demonstrated.
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4.4 | Conclusions
The present investigation focused on unravelling possible diﬀerences in (i) the
curing kinetics of various vinyl-based gelatin precursors undergoing photopoly-
merization and (ii) the physico-chemical properties of the obtained networks. Two
photocross-linkable side-groups, methacrylamide and acrylamide, were successfully
introduced using the gelatin primary amine functions. The acrylamide derivate
was identiﬁed as the more reactive analogue. As a result, curing times could be
decreased and stronger hydrogels could be produced as compared to the methacryl-
amide counterpart. In addition to the classical swelling studies, HR-MAS 1H NMR
spectroscopy was used to unravel the absolute conversion degree. Comparison be-
tween both of the aforementioned techniques indicated a non-linear correlation
between the results of both techniques. Interestingly, when excluding the irradia-
tion dose factor, the (conversion, gel fraction) pairs for both modiﬁcations follow
the same exponential trend. It was shown that a conversion of > 5% of the in-
troduced groups was necessary to obtain a stable hydrogel (type B derivates). At
this stage, the amount of gelatin that remained in the matrix was already 40%.
Rheological time-sweeps revealed a direct conversion of the acrylamide moieties
following irradiation, however, gelatin methacrylamide curing showed a lag-phase.
More fundamentally, it could be concluded that a tighter network can be generated
when using gelatin acrylamide. As a result, a decrease in average mesh size could
be calculated at the nanomolecular level, while this translated towards a decreased
(volumetric) swelling capacity at the macroscopic scale. In this way, hydrogels can
be engineered with a predesigned network density which is important, for instance,
in the ﬁelds of drug delivery and cell biology.
It has been shown that highly viable (> 90%) cell-laden constructs could be
obtained using 10w/v% (meth)acrylamide gelatins. Therefore, the acrylamide
derivative could be a promising alternative to the more conventional methacryl-
amide derivative in terms of curing kinetics.
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Constructs with High Cell Viability
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The current chapter describes the general workﬂow regarding the generation of 3D
open porous (cell-laden) gelatin scaﬀolds on a parametric base. This work was
previously published in Biomaterials.393
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5.1 | Introduction
In recent years, biocompatible cell culture substrates have been extensively revised.
A steady paradigm shift from conventional 2D cell culture models toward 3D mi-
croenvironments has been observed.159 Cell responses due to the microenvironment
(mechanical and chemical) tend to diﬀer between both models.394 Developments
in (rapid) prototyping techniques, which were already well established in other
industries (e.g. automotive industry), have enabled researchers to expand their
in vitro tissue models towards highly controlled three-dimensional (porous) scaf-
fold architectures.1,5,142,190,329,395 Three-dimensional porous scaﬀold designs allow
for improved cell-cell contact, cell-matrix interactions, and increased cell densi-
ties.1,396 Furthermore, more eﬃcient blood vessel ingrowth and enhanced oxygen,
nutrient and waste diﬀusion are plausible.
Post-fabrication cell seeding beneﬁts from these advantages but is often correlated
with insuﬃcient seeding eﬃciency and/or a non-uniform cell distribution.25,48 To
tackle these problems, combining prototyping techniques with high-water content
polymers and cell encapsulation strategies can serve as an alternative. Neverthe-
less, the generation of cell-laden prototyped scaﬀolds remains challenging and is
mainly limited to hydrogel processing.1 During processing of cell-laden hydrogel
mixtures two major disadvantages can be described: ﬁrst, the loss of cell via-
bility due to dispensing pressure and nozzle diameter, which has been described
by Chang and Sun397 for the encapsulation of HepG2 during alginate plotting,
and second, hydrogel mechanically stable construct built-up without internal pore
collapse remains the main challenge, even in the absence of cells.82,224,260 Gen-
erally, the latter is tackled by blending gelatins with other hydrogel materials,
and/or co-deposition of thermoplastic materials.76,141,142,248,249,253,257 For instance,
Schuurman et al.398 recently opted for blending of hyaluronic acid and/or co-
deposition of poly-ε-caprolactone in order to be able to process 20w/v% gelatin
hydrogels without internal collapse. Another approach consist of printing sacriﬁ-
cial material at the future pore locations.395
Additionally, enhanced control over matrix stiﬀness and liquid ﬂow (e.g. shear
stress responses) is reported applying 3D culture models.46 In this manner, close
interactions between biological, chemical and engineering cues are important in
the feedback process for the generation of, for example, drug screening tools or
implantable devices (Figure 5.1). For example, Chang et al.397 developed an in
vitro drug screening system via integration of a 3D cell-laden alginate hydrogel
environment integrated within a microbioreactor.
Besides the previously mentioned advantages of 3D porous scaﬀolds, the introduc-
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Figure 5.1: Schematic illustration of multi- and interdisciplinary workﬂow related to
the use of rapid prototyping in the ﬁeld of tissue engineering.
tion of pores has been reported to enhance both cell proliferation and albumin
production of HepG2 cells in porous alginate hydrogels.356 Earlier work demon-
strated good in vitro cytocompatibility of photosensitive gelatin methacrylamides
for the encapsulation of ﬁbroblasts, myoblasts, chondrocytes endothelial cells, and
cardiac cells.143,398–400 Taking all this into account, the generation of a highly viable
cell-laden gelatin scaﬀold with suﬃcient mechanical stability would be desirable.
The Bioplotter technology enabled researchers to generate hydrogel-based con-
structs. The present study aims to develop a 3D microenvironment applying
post-processing photo-induced free radical cross-linking of cell-laden gelatins. An
evaluation of two photo-initiating systems is performed, introducing a novel photo-
initiator, and a parametric study on the printing of (cell-laden) gelatin hydrogels
is presented.
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5.2 | Experimental Part
5.2.1 Materials
5.2.1.1 Cell culture
HepG2 cells were maintained in a humidiﬁed 5% CO2-containing atmosphere
(37 ◦C) with cultivation medium consisting of DMEM, supplemented with 10 v%
FBS, 50Uml−1 penicillin and 50μgml−1 streptomycin, all provided by Life tech-
nologies.
5.2.1.2 Hydrogels
Bovine type B gelatin (approximate iso-electric point of 5 and Bloom strength of
257), isolated by alkaline treatment, was supplied by Rousselot (Ghent, Belgium).
Photosensitive gelatin, gelatin methacrylamide, was synthesized (Scheme 4.1) as
described in detail (chapter 4). The puriﬁed gelatin methacrylamide had a degree
of substitution of 62%, as determined by 1H NMR (Bruker AVANCE II 500MHz)
in deuterated water (Sigma- Aldrich) at 45 ◦C. Prior to use, the hydrogel build-
ing blocks were sterilized by ethylene oxide (EO) treatment (cold cycle, Maria
Middelares hospital, Ghent, Belgium).
5.2.1.3 Photocross-linking presets
Two types of photo-initiators (PIs) were used in this study: (i) 1-[4-(2-Hydroxy-
ethoxy)-phenyl]-2-hydroxy-2-methyl-1-propane-1-one (Irgacure® 2959, I2959) was
obtained from Ciba Specialty Chemicals (Groot-Bijgaarden, Belgium); (ii) 2,2’-
Azobis[2-methyl-N-(2-hydroxyethyl)propionamide] (VA-086) photo-initiator was pur-
chased from Wako Specialty Chemicals. I2959 or VA-086 stock solutions in PBS
were ﬁlter sterilized and added to the culture medium or hydrogel building blocks
to create respectively ﬁnal concentrations of 2mol% or 20mol% (with respect to
the amount of double bonds). These precursor solutions were thoroughly degassed
for at least 10min prior to loading with HepG2 cells. A LWUV lamp model VL-
400L (Vilber Lourmat, Marne La Vallée, France) was used for (cell-laden) hydrogel
sample curing (UV-A light, 365 nm, 4mWcm−2).
5.2.1.4 Rheological evaluation of gelatin methacrylamides
The eﬀects of the applied PI on the in situ curing of gelatin methacrylamide
precursor solutions (10w/v%) as well as recordings of the mechanical spectra of
cross-linked ﬁlms (1mm thick) were investigated following the protocol described
in section 4.2.3.5. In order to investigate the inﬂuence of mixture concentration
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and cell densities on the physical cross-linking of (cell-laden) gelatin methacryl-
amide solutions, G′ and G′′ were recorded as a function of the temperature at a
constant frequency (1Hz) and strain (0.1%) for diﬀerent gelatin methacyrlamide
concentrations (5− 20w/v%) and cell densities (0− 2.5 × 106 cellsmL−1). Ad-
ditionally, shear stress and viscosity measurements as a function of shear rate (0
→ 2000 s−1) and temperature (15 → 37 ◦C) of (cell-laden) gelatin methacrylamide
solutions were obtained by rotational viscosimetry at a gap size of 400μm.
5.2.1.5 Equilibrium swelling experiments
Information on the PIs eﬀects on cross-linking and swelling behavior was evaluated
by equilibrium swelling experiments, as described in section 4.2.3.2.
5.2.2 3D strand deposition of gelatin methacrylamide
hydrogels
Three-dimensional porous scaﬀolds were produced by sequential strand (also called
strut or ﬁber) deposition using the Bioplotter pneumatic dispensing system (En-
visiontec, GmbH, Gladbeck, Germany). A detailed description can be found
elsewere236,262 and in the techniques chapter section 11.1.2. ‘Strut’ and ‘strand’
are alternative terms commonly used to indicate the deposited ﬁber. Brieﬂy, the
Bioplotter operates as a three-axis dispensing machine that deposits (cell-laden)
hydrogel precursors pneumatically on a stationary platform. Designed computer
aided design/computer aided modeling (CAD/CAM) models are translated into a
numerical code (NC code) by the Bioplotter software and contain the information
for the layer-by-layer scaﬀold build-up. Since gelatins have a temperature depen-
dent sol-gel transition, temperature control was of utmost importance. Therefore,
two adaptations on the device were performed to ameliorate the processing of
gelatin hydrogels:
(i) The syringe heating mantle was adjusted to ensure a homogeneous plotting
temperature till the tip of the dispensing needle;
(ii) The stationary platform was equipped with Peltier elements which enabled
cooling of the platform to temperatures far below the gelling point.
In the present research, a parametric study on the obtained strand diameters
as a function of the gelatin methacrylamide initial concentration (5− 20w/v%),
the applied pressure (0− 5 bar), temperature (24− 30 ◦C), nozzle internal diam-
eter (150− 200μm), nozzle type (cylindrical vs. conical), and plotting speed
(0− 1000mmmin−1) was performed. Constructs were conﬁgured in a 0◦/90◦ ﬁber
lay-down pattern. The fabricated constructs were examined using light microscopy,
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to extract information regarding the pore networks. A Zeiss (KS 100, Axiotech)
light microscope in combination with an Axiovision digital camera was used for
top view, cross-section, and side-view imaging. Image processing was performed
using Carl Zeiss AxioCam software.
5.2.3 Printing of cell-laden gelatin methacrylamide constructs
Hydrogel precursor solutions were prepared as previously described, and mixed
with HepG2 cells to create a cell density of 1.5 × 106 cellsmL−1. The cell-gel
mixtures were transferred into a syringe and loaded into the Bioplotter. In order
to perform a parametric study on the plotting process, the mixtures were dis-
pensed at various plotting speeds, air pressures, and temperatures. Finally, after
optimization, 1− 3mm thick constructs of 13× 13mm were created with a layer
thickness of 150− 200μm and ﬁber spacing of 350μm and 550μm. The Bioplotter
was placed in a ﬂow cabinet, however, since other materials are being processed by
the device (e.g. poly-ε-caprolactone), the risk of scaﬀold contamination was lim-
ited by autoclaving all materials in direct contact with the cells prior to process-
ing. Furthermore, speciﬁc measures against bacterial contamination were taken
by equipping the syringe inlet with a 0.2μm sterile air ﬁlter (TETPOR AIR 50,
Parker). Constructs were printed on sterile glass cover slips, transferred to 6-well
culture plates (Greiner-Bio One), cured as previously described, and maintained
in 4mL cultivation medium. Medium was refreshed every 24 hours.
5.2.4 Finite element simulation of syringe needle ﬂow of
gelatins
Finite element ﬂuid ﬂow simulations were conducted in COMSOL 4.0a (Comsol,
Palo Alto, CA) using a mesh of free tetrahedral elements and boundary conditions
of 1 bar inlet pressure and atmospheric pressure at the outlet. An incompressible,
non-Newtonian ﬂuid model was used to simulate the ﬂow of noncross-linked gelatin
using a power-law, shear-rate dependent relationship. The density, constants n
(the ﬂow behavior index) and K (the consistency coeﬃcient) were empirically
obtained. Gelatin solutions were assumed to obey a power-law following:
τ = Kγ˙n (5.1)
with, τ the shear stress, γ˙ the shear rate, K the consistency coeﬃcient, and n
the ﬂow behavior index. For Newtonian ﬂuids, n = 1, while for shear thinning
ﬂuids, 0 < n < 1. Smaller n values represent more shear thinning behavior.
Dynamic oscillatory rheometry data was curve ﬁtted and the obtained coeﬃcients
112
are used as the n and K values. Zero-shear viscosity is also reported as product
of n and K. All simulations were found to be grid-independent and convergence
criterion independent after mesh settings were studied, and all discretization errors
converged to zero.
5.2.5 Scaﬀold characterization
5.2.5.1 Micro-computed tomography (μ-CT)
The printed scaﬀolds were also scanned in a micro-CT setup at the UGhent Cen-
tre for X-ray Tomography (UGCT) using a VARIAN Paxscan 2520V Flatpanel
detector and a Feinfocus X-ray tube. The resulting tomography data has been
reconstructed at a voxel size of 8μm. A detailed description on the system can be
found elsewhere.401 Extra information is included section 11.3.2.
5.2.5.2 Scanning Electron Microscopy (SEM)
Gelatin methacrylamide scaﬀolds were freeze-dried to remove the aqueous phase.
Scaﬀolds containing HepG2 cells were ﬁxed with 2% glutaraldehyde in PBS at 4 ◦C,
thoroughly rinsed with double distilled water, dehydrated with ethanol dilution
series, and freeze-dried overnight. The dry scaﬀolds were subsequently coated
with a (approximately) 20 nm thin gold layer. SEM images were recorded using a
tabletop SEM (PHENOM™, FEI Company). The technique is described in section
11.3.1.
5.2.5.3 Live/Dead ﬂuorescense staining
Cell-laden scaﬀolds were washed twice with PBS and stained following the protocol
in section 4.2.4. Then the probes were discharged and the scaﬀolds were thoroughly
rinsed (2× 5 minutes) with PBS. To visualize and determine the ratio of living and
dead cells, ﬂuorescence was evaluated and recorded using an inverted ﬂuorescence
microscope (Olympus IX81) equipped with Xcellence software (Olympus).
5.2.5.4 Immunohistochemistry staining
The cell-laden scaﬀolds were embedded in paraﬃn after ﬁxation in 4% paraformalde-
hyde at room temperature. Sections of 5μm thickness were used for the diﬀerent
stainings.
PAS stain - After hydration, the sections were exposed to 1% periodic acid
for 15min, washed (3 × 5min) in PBS and exposed to Schiﬀ reagent (Sigma) for
30min in dark. After rinsing in water, the sections were stained using hematoxylin.
113
IHC staining - Endogenous peroxidase of the hydrated sections was quenched us-
ing 3% H202 for 1 h. Subsequently, the samples were treated with blocking reagent
(1% BSA, 0.2 v% Tween 20 in PBS) for 30min and then incubated for 2 h with
the primary antibody (dilution 1:100). Next, the samples were incubated with the
secondary antibody (dilution 1:200) for 30min and visualized by the activity of
conjugated horseradish peroxidase using a 3,3-diaminobenzidine tetrahydrochlo-
ride substrate. Finally, the sections were counterstained with hematoxylin. For
hepatocyte nuclear growth factor 4 alpha (HNF4α), Ki67 and proliferating cell
nuclear antigen (PCNA), the entire procedure was preceded by antigen retrieval
using citrate buﬀer (pH 6.00). Goat anti-human albumin antibody (p20, Santa
Cruz), rabbit anti-human HNF4α (H-171, Santa Cruz), mouse anti-human Ki67
(M7240, Dako) and mouse anti-human PCNA (PC10, Novo Castra) were used as
primary antibodies.
5.2.6 Statistical analysis
Unless stated otherwise, all characterizations were performed at least in tripli-
cate. Data analyses were performed applying the commercially available statistical
package GraphPad Prism 4. Diﬀerences between groups were explored by one-way
ANOVA, followed by a Student t-test.
O
OH
O
HO
hν
O
OH
O
HO
+
hν
N N
O
NH
HO
O
HN
OH
O
N
HHO
+    N22
I2959
VA-086
A
B
Scheme 5.1: Radicals generated from I2959 photo-dissociation (A). Radicals generated
from VA-086 photo-dissociation (B).
5.3 | Results
5.3.1 Eﬀect of photo-initiator type on the network properties
and cell viability
To overcome the UCST material behavior of gelatin, gelatin was modiﬁed with
methacrylamide side groups to yield a photosensitive gelatin derivate, as described
previously. In the present part of our study, we opted not to apply acrylamide
modiﬁed gelatins in order to exclude potential premature cross-linking as well as
to avoid a mismatch in mechanical properties with encapsulated cells. In a ﬁrst
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series of experiments, the applicability of a less known PI (VA-086) was compared
to the use of the widely well-known PI I2959. The radicals generated due to PI
photo-dissociation are schematically shown in Scheme 5.1.
The applied concentration of a biocompatible PI should be the lowest concentration
that still ensures desired cross-linking kinetics. Optimization of the VA-086 PI with
respect to the ﬁnally obtained gel strengths, gel fractions, and curing kinetics led
to a concentration of 20mol% (in respect to the amount of double bonds on gelatin
methacrylamide). In Figure 5.2 and 5.3, a comparison between the in situ curing
kinetics and ﬁnal gel strength of the two applied PIs is illustrated.
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Figure 5.2: The cross-linking kinetics of gelatin methacrylamides monitored by rheo-
logical time-sweep recordings for the storage moduli (G′) of 10w/v% hy-
drogel precursors. Full line represents cross-linking using 2mol% I2959 as
photo-initiator, dashed line represents cross-linking using 20mol% VA-086
as photo-initiator. The zone in between the arrows indicates UV irradia-
tion.
First of all, in all cases, a curing lag time was observed. This meant that the
substantial increase in storage moduli G′, indicating chemical cross-linking, was
not observed simultaneously with the start of UV-A irradiation. Furthermore, an
after-curing eﬀect could be observed indicating continued cross-linking after UV-A
irradiation was stopped. Secondly, the use of VA-086 demonstrated less eﬃcient
curing rates and lower curing end-point at “UV-A oﬀ” despite the 10-fold higher
concentration. It is highly probable that this can be attributed to the generation
of distinctive radicals, of which the tertiary alkyl radical intermediate next to a
stabilizing carbonyl functionality has high stability thus exhibiting lower reactivity
(Scheme 5.1). On the other hand, comparing the storage moduli of the equilibrium-
swollen hydrogels, only a slightly lower mechanical strength was observed for the
latter (10.5± 1.7 kPa versus 14± 0.6 kPa). It should be remarked that the use of
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VA-086 PI results in increased porosity by means of N2 gas evolution as a result
of the UV induced radical formation, as can be seen in Figure 5.3.
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Figure 5.3: Mechanical spectra of equilibrium swollen 10w/v% gelatin methacrylamide
hydrogels prepared with two photo-initiators. Samples were measured at
37 ◦C with FN = 0.1N and γ = 0.1%. Inset images represent cell-laden 2D
sheet samples.
Figure 5.4 demonstrates the evolution of the gel yield and water uptake capaci-
ties as a function of the UV-A irradiation dose for both PIs on 1mm thick 2D
ﬁlms. For both PIs, a steep increase up to an irradiation dose of 2400mJ cm−2 oc-
curred, followed by a non-signiﬁcant gel yield increase up to ≥ 90%. Additionally,
equilibrium mass swelling ratios (q) decreased with increasing irradiation dose.
The inﬂuence of the applied photo-initiator on the cell viability was initially eval-
uated by encapsulation in 2D sheets (1mm thick). The results are represented by
the live/dead images from Figure 5.5. No signiﬁcant diﬀerences were observed at
day 1 after encapsulation, and for both photo-initiators HepG2 cells maintained
their viability. At day 3 respectively day 7 after encapsulation, cell viability demon-
strated a modest signiﬁcant improvement for the VA-086 cross-linked 2D sheets (p
< 0.01 respectively p < 0.001) likely due to a lower cross-linking density as radical
generation is less eﬃcient.
5.3.2 Parameters aﬀecting scaﬀold architecture
Scaﬀold architecture, and speciﬁcally pore architecture will greatly inﬂuence over-
all construct strength and nutrient/waste ﬂows. However, it is the deposited strut
(diameter), which will impact the porosity, strength and layer height. On the
other hand, the solution viscosity, applied pressure, XY plotting speed, needle
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Figure 5.5: Live (green) and dead (red) stain illustrating the eﬀect of the applied
photo-initiator (I2959 versus VA-086) on the viability of encapsulated
HepG2 in 10w/v% gelatin methacrylamide ﬁlms. The irradiation dose
was 1800mJ cm−2. Scale bar represents 500μm.
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type and diameter, cell density and temperature drop, mainly control the strut di-
ameter itself. All those parameters are closely interconnected and need parametric
optimization to ensure a reproducible plotting process.
5.3.2.1 Rheological evaluation
As mentioned, solution viscosity will greatly impact the overall performance of
the ﬁber deposition process. Therefore, a rheological study for the evaluation of
concentration, temperature and cell density eﬀects was performed to gain an in
depth insight on the plotting. Figure 5.6 depicts rheological data on (cell-laden)
gelatin mixtures. The shear rate dependent behavior of liquid gelatin solutions is
provided for increasing gelatin concentrations (Figure 5.6 A) and increasing cell
densities (Figure 5.6 B), illustrating the non-Newtonian liquid behavior. Addi-
tionally, the temperature dependence of the solution viscosity is demonstrated in
Figure 5.6 C and D for respectively increasing gelatin concentrations and increas-
ing cell densities. Finally, cross-over points, i.e. the temperature at which the
sol-to-gel transition occurs, was investigated and presented in Figure 5.6 E and F.
The solutions all showed shear thinning behavior, and as expected, solution vis-
cosity dropped with decreasing gelatin concentration and increasing temperature
(Figure 5.6 A and C). During cross-over point determination, the contributions of
“liquid” and “gel” on the mixture rheology can be followed. The gel point decreased
from 35 ◦C to 32 ◦C after decreasing the gelatin concentration from 20w/v% to
5w/v%. Furthermore, below the gel point, the ratios of the loss moduli to the
storage moduli (i.e. the loss factor tan(δ)) increased for decreasing gelatin concen-
tration, indicating more “liquid-like” behavior. Especially 5w/v% storage moduli
decreased signiﬁcantly, limiting the overall plotting potential. However, since the
ﬁnal aim is the construction of hybrid constructs, it was interesting to investigate
the inﬂuence of increasing cell densities on the rheological behavior of gelatin so-
lutions. Ten w/v% was selected since highly viable cell encapsulation of HepG2s
could be performed and plotting with high shape ﬁdelity remained possible. The
blending of cells proved to impact solution viscosity as a result of a particle-like
component. For temperatures above the geliﬁcation point, the viscosity was de-
creased by a factor of 2 up till a cell density of 1.5 × 106 cellsmL−1. Increasing
the cell density further to 2.5 × 106 cellsmL−1 increased this factor to 4. Below
the geliﬁcation point, in order to obtain similar viscosities (i.e. physical gelation),
cell-gel mixture temperatures had to be decreased by > 4 ◦C when increasing the
cell density to 2.5 × 106 cellsmL−1. From the evolution of the elastic (i.e. storage
moduli) and viscous (i.e. loss moduli) contributions of the cell-laden hydrogels
(Figure 5.6 F), it could be derived that the diﬀerentiation due to alteration of
the storage moduli was more pronounced, ultimately rendering higher physical
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Figure 5.6: Rheological data representing the inﬂuences of gelatin methacrylamide con-
centration and cell density on the physical properties of the gelatin(-cell)
precursor solutions. Rotational viscosimetry measurements (A-D) illustrat-
ing i) the inﬂuence of gelatin methacrylamide concentration on the shear
stress as a function of shear rate (A) and viscosity as a function of tem-
perature (C); ii) the inﬂuence of the cell density on the shear stress as a
function of shear rate (B) and viscosity as a function of temperature (D).
Oscillatory measurements representing the cross-over points between the
gel and sol state (G′ = G′′, Tgel) for diﬀerent concentrations (E) and diﬀer-
ent cell densities (F). For the graphs on cell density inﬂuences (B, D, F),
a 10w/v% gelatin methacrylamide solution without cells was selected as
control condition.
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gelation without cells while only a subtle shift in the gel point was noticed.
5.3.2.2 Pressure, needle type, temperature and cell density aﬀect de-
posited strand diameter
Figure 5.7 explores the potential impact of inlet pressure, needle internal diameter,
plotting temperature and cell density on the diameter of dispensed 10w/v% (cell-
)gel strands. As can be derived from these graphs, combining these data allows
targeting of a desired strut diameter. The data additionally clearly illustrates
the viscosity drop resulting in increasing strut diameters in the case of cell-laden
hydrogel dispensing. Therefore, these data correlate well with the rheological
analysis. Inlet pressure and plotting temperature (aﬀecting viscosity) proved to
be the utmost important parameters. Additionally, the needle type (conical versus
cylindrical) and gelatin building block concentration aﬀects the diameter of the
dispensed strands (data can be found back in the Techniques chapter, section
11.1.2.1).
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Figure 5.7: Evolution of the deposited strut diameters as a function of the applied plot-
ting speed and dispensing inlet pressure for cylindrically shaped needles.
A gelatin methacrylamide concentration of 10w/v% was used for all ex-
periments. Plotting at 27.5 ◦C with a needle internal diameter of 200μm
(A) and 150μm (B). The inﬂuence of the plotting temperature of cell-gel
hybrid mixtures is illustrated for a needle internal diameter of 150μm (C,
D). Dashed lines represent the needle internal diameter.
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The temperature/viscosity inﬂuence was anticipated from the rheological data and
therefore the Bioplotter device was altered. Two major changes made plotting more
reproducible:
1. First of all, as depicted schematically in Figure 5.8, the original cooling/heating
mantle of the dispensing head was extended till ∼ 1mm from the needle tip
outﬂow, and;
2. The stainless steel build platform was coupled to Peltier elements and ven-
tilators to enable cooling.
The ﬁrst adaptation rendered a homogeneous solution viscosity till outﬂow, allow-
ing plotting at lower solution temperature. The second adaptation proved to be
necessary when trying to plot hydrogels with a concentration < 20w/v%. The
cooling (down to ∼ 5 ◦C) ensured enhanced physical cross-linking and thus layer-
build up. Without cooling, 10 and 15w/v% constructs collapsed completely due
to insuﬃcient mechanical integrity.
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Figure 5.8: Images representing the plotting of 10w/v% constructs (A-C). To ensure a
stable plotting process, the heating mantle was adjusted till the tip of the
dispensing syringe, as schematically illustrated in the cross-section of the
mantle in (D). Light microscopy image demonstrating the porous nature
of the ﬁnalized scaﬀolds in top view (E). Theoretical construct dimensions
and scaﬀold build-up in cross-section (F).
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5.3.2.3 Pore architecture and curing kinetics of 3D porous gelatin meth-
acrylamide scaﬀolds
Combining the above-mentioned results, a parameter set of processing conditions
was extracted for the plotting of 3mm thick scaﬀolds as can be found in Table 5.1.
Table 5.1: Processing conditions for the 3D ﬁber deposition of (cell-laden) gelatin hy-
drogel precursors.
PARAMETER GELATIN CONCENTRATION
10w/v% 15w/v% 20w/v%
Cells [× 106mL−1] - 1.5 1.5 - -
Needle gauge G30 G30 G27 G27 G27
∅ [μm] 150 150 200 200 200
Material temperature [ ◦C] 27.5 24.5 24.5 28.5 30
Layer height [μm ] 110 110 160 170 180
Pressure [bar ] 3 3 0.5∗/1 4 4
XY-speed [ mmmin−1] 450 400 600 550 550
Z-speed [ mmmin−1] 500 700 700 300 300
Preﬂow [ sec] 0.2 0.1 0.1 0.2 0.2
Postﬂow [ sec] 0.2 0.2 0.05 0.2 0.1
Corner delay [ sec] 0.2 0.1 0.05 0.2 0.1
Pullback time [ sec] 0.5 0.5 0.5 0.5 0.5
Interstrut distance [ mm] 0.60 0.80 0.80 0.60 0.60
∗ For conical needle scape
For the 10w/v% gelatin constructs, a needle with 150μm internal diameter was
selected, while for higher concentrations a needle of 200μm was preferred. As
described during the rheology results, temperature had to be adjusted from 27.5 ◦C
for 10w/v% hydrogels to 30 ◦C for the plotting of 20w/v% hydrogels in order to
ensure optimal sol-to-gel ratio. These cell-free constructs were used for analysis of
the pore architecture and chemical cross-linking kinetics. Figure 5.8 represents the
dispensing process of 10w/v% gelatin hydrogels and schematically describes the
theoretical architecture of a scaﬀold. In analogy to the 2D curing of gelatin ﬁlms,
curing kinetics of 3D plotted structures was evaluated as a function of the UV-A
irradiation dose, as well as the initial gelatin concentration. Figure 5.9 summarizes
the gel yields and equilibrium mass swelling ratios for the swelling studies on 3D
porous scaﬀolds.
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Figure 5.9: Inﬂuence of the initial gelatin methacrylamide concentration on the cross-
linking kinetics of 3mm thick printed scaﬀolds. Full lines represent the gel
fraction values, dashed lines represent the equilibrium mass swelling ratio
q.
Generally, the observed trends from 2D swelling studies were translated to the 3D
constructs. However, some small diﬀerentiations could be noticed:
1. The ﬁnally obtained (i.e. full curing) gel fraction values were slightly higher
for the 3D constructs compared to 2D sheets;
2. Remarkably, at any evaluated irradiation dose the swelling ratios were higher
than their 2D counterparts, despite the higher gel yields of the latter, and;
3. Curing of 3D constructs occurred at a faster rate compared to 2D ﬁlms.
These observations were valid for both PI types.
Finally, pore geometry and overall strand deposition architecture was evaluated
for varying gelatin concentrations (Figure 5.10). Light microscopy images reveal
the highly regular deposition of strands regarding top view (Figure 5.8 E and 5.10
A).
It should be remarked that ﬁnal strand diameter dimensions will slightly increase
compared to the ones derived in Figure 5.7, due to the immersion-based cross-
linking step. Additionally, equilibrium swelling will further increase these dimen-
sions corresponding to their swelling ratio. Cross-sections of constructs with in-
creasing gelatin concentration (Figure 5.10 B, E, and F) reveal partial collapse
of subsequent strands due to the combined eﬀects of ﬂow behavior/geliﬁcation of
the deposited strands and gravitational forces. The lower the concentration, the
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Figure 5.10: Scaﬀold pore architecture is inﬂuenced by the hydrogel concentration.
Light microscopy and SEM images representing 10w/v% scaﬀold pore
geometry in top view (A, a), cross-section (B, b), and side view (C, c).
Cross-section images of 15w/v% (E, e) and 20w/v% (F, f) scaﬀolds.
White arrows indicate partial collapse of the subsequent layers. Scale
bars indicate 200μm. Schematic representation of the deposited strand
geometry as a function of initial concentration and plotting temperature
(D), accompanied by a cross-section SEM image indicating the strut ge-
ometry of 20w/v% scaﬀolds (d). Scale bar of (d) indicates 400μm.
more this phenomenon occurred. At 5w/v%, complete collapse of the subsequent
layers was observed, and are therefore left out of consideration. Figure 5.10 C
illustrates a side view for 10w/v% scaﬀolds indicating the complete collapse of
the meander feature (also indicated by the SEM image Figure 5.10 c) at the sides
of the scaﬀold. SEM images corresponding to the respective microscopy images
(Figure 5.10 a-f) clearly demonstrate the impact of plotting concentration on the
pore architecture. Increasing the gelatin concentration will result in faster phys-
ical gelation and therefore, more spherically deposited strands and pores. This
is schematically illustrated in Figure 5.10 D. Three-dimensional reconstruction of
micro-computed tomography data (Figure 5.11) revealed a regular material depo-
sition matrix (green) with an interconnected pore network (yellow) for a 10w/v%
construct. It is clear that the pore volume is still interconnected, which conﬁrms
the successful printing of gelatin methacrylamide hydrogels. The pore volume has
the largest dimensions along the Z-axis closely resembling the designed dimen-
sions, while along the XY-axis (volumes in between every 0◦/90◦/0◦ ﬁbers) the
pore volume is somewhat less than the theoretically designed d3 (Figure 5.8 F and
Figure 5.11).
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Figure 5.11: Micro-computed tomography reconstruction of hydrated 10w/v% scaf-
folds. Gelatin methacrylamide material architecture is represented in the
top part (green), while the scaﬀold pore network is visualized in the bot-
tom part (yellow).
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5.3.3 Plotting of cell-laden 3D constructs
5.3.3.1 Pressure, needle type, PI and UV-A irradiation dose aﬀect cell
viability
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Figure 5.12: Cell-gel ﬂow during syringe needle deposition. (A) Evolution of HepG2
viability during the printing process as a function of the applied inlet
pressure and needle type. (B) Heat map of the shear stress at 1 bar inlet
pressure for a conical needle (a) and cylindrical (b) needle, obtained by
ﬁnite element modeling of noncross-linked cell-gel (10w/v%) mixture.
Figures are to scale for needle internal diameter of 200μm.
Based on earlier performed cell tests, 10w/v% gelatin methacrylamide was se-
lected for the printing of cell-laden constructs. Prior to the printing of full sized
constructs, parameters inﬂuencing cell viability were investigated in order to select
the most appropriated conditions to construct a highly viable cell-laden scaﬀold.
First, the inﬂuence of needle type (conical vs. cylindrical), needle internal diame-
ter, and dispensing pressure on the viability of HepG2 cells was examined (Figure
5.12 A). It appeared that cell viability was dependent on the applied needle type,
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with enhanced viability levels for conically shaped needles. For all tested needles,
higher inlet pressures resulted in decreased cell survival. In the case of cylindri-
cally shaped needles, cells printed with bigger needle internal diameter maintained
higher cell survival than those printed with a smaller diameter. The highest vi-
abilities, > 97%, were observed at low dispensing pressures (≤ 1 bar) using a
conical needle type (∅ = 200μm). Nevertheless, at higher inlet pressures, viability
dropped faster compared to the cylindrical needle type.
To understand the discrepancy between the two needle types, ﬁnite element anal-
ysis (FEA) simulations were performed. Figure 5.12 B (a and b) shows heat maps
of the simulated ﬂuid ﬂow induced shear stresses for both needle types using the
same inlet pressure (1bar). Empirical data used in the FEA simulations were
determined by rheology (example presented in Figure 5.13) and the derived pa-
rameters are presented in Table 5.2. Additional FEA results can be found in the
Techniques chapter, section 11.1.2.1.
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Figure 5.13: Empirical determination of ﬂow behavior index, n, and consistency coef-
ﬁcient, K, from rheological data.
With increasing temperature, a decrease in the consistency coeﬃcient K was ob-
served, indicative for the decreasing viscosity as temperature increases. On the
other hand, K increased with increasing gelatin concentration but decreased with
increasing cell density. As such, consistency coeﬃcient is a strong function of
concentration (hydrogel building block and cell density) and temperature.
The ﬂow behavior index n was for all conditions < 1 conﬁrming non-Newtonian
shear thinning behavior whereby the apparent viscosity (ηapp) is a function of the
shear rate:
ηapp = Kγ˙
n−1 (5.2)
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Table 5.2: Flow behavior index n, consistency coeﬃcient K, and zero-shear viscosity η
describing gelatin solutions of various concentration and temperature.
GELATIN SAMPLE
T
[◦C]
n
K
[Pa.sn]
η
[Pa.s]
5 w/v%
35.0
0.9719 0.0029 0.0028
10w/v% 0.9565 0.0219 0.0209
15w/v% 0.9558 0.0352 0.0336
20w/v% 0.9593 0.1025 0.0983
10w/v%
no cells
0.5 × 106 cellsmL−1
1.5 × 106 cellsmL−1
2.5 × 106 cellsmL−1
35.0
0.9565
0.9784
0.9804
0.9789
0.0219
0.0097
0.0079
0.0049
0.0209
0.0094
0.0077
0.0047
10w/v%
no cells
1.5 × 106 cellsmL−1
27.5
24.5
0.7950
0.7957
0.2403
0.2110
0.1910
0.1678
15w/v% 28.5 0.8295 0.3837 0.3182
20w/v% 30.0 0.8332 0.4215 0.3512
The ﬂow behavior index did not display a similar strong dependency with the
concentrations. Only upon decreasing the temperature, a notable decrease in n
was observed. Furthermore, these data nicely illustrate the necessary processing
temperature drop for the printing of cell-laden mixtures in order to obtain similar
ﬂow behavior as without cells.
Highest shear stresses were obtained for the conical needle type. However, shear
stress built-up was only observed close to the ﬂuid outlet (≤ 1mm), limiting the
passage time for this region. On the other hand, ﬂow through a cylindrical needle
type resulted in lower peak shear stresses but for an increased passage length (>
16mm). These data stress that, besides feedback based on rheology and geliﬁcation
behavior, the selected conditions had to incorporate feedback based on cell viability
as well (Figure 5.1).
Since curing of 3D constructs occurred at a faster rate compared to 2D ﬁlms,
the inﬂuence of UV-A irradiation dose on cell survival was evaluated as well.
When using the conventional PI I2959, a gradual improvement of cell viability
with decreasing UV-A irradiation dose (without impairing scaﬀold stability) was
observed in the cell-laden scaﬀolds.
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As illustrated in Figure 5.14, viable cell fractions of 55.7± 7.3%, 70.6± 12.6%
and 89.1± 2.1% were determined for UV-A irradiation doses of 5400, 2700 and
1350mJ cm−2 respectively. An irradiation dose of 1800mJ cm−2, yielding long-
term stable cell-laden scaﬀolds, was selected for further evaluation. A comparison
between I2959 and VA-086 PIs was made and cell survival values for cells encap-
sulated in 2D disks and printed 3D constructs are provided in Figure 5.15. For
the VA-086 PI, a signiﬁcant increase (p < 0.01) in viability is observed for 3D
fabricated constructs, as well as increasing viability when compared to 2D sheet
encapsulation (p < 0.01).
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E1350 mJ/cm2 2700 mJ/cm2 5400 mJ/cm2
500 μm 100 μm
500 μm 500 μm 500 μm
Figure 5.14: Optimal scaﬀold parameters and the eﬀect or UV-A irradiation dose on
the cell viability. The optimized parameters for the generation of gelatin
scaﬀold yield optimal scaﬀold characteristics (A, B). HepG2-gelatin con-
structs were cured using I2959 and an irradiation dose of 1350 (C), 2700
(D) and 5400 (E) mJ cm2. After 24 hours, cell survival was evaluated
using a live/dead assay. Scale bar indicates 500μm (A, C-E) and 100μm
(B).
5.3.3.2 The production of highly viable cell-laden scaﬀolds: the result
of balancing parameters
As the rheological and geliﬁcation behavior altered, processing conditions were
adjusted based on the data derived from the above-mentioned studies. The selected
conditions are summarized in Table 5.1. The ﬁnal decision to use VA-086 as photo-
initiator with a UV-A irradiation dose of 1800mJ cm−2 lead to an excellent cell
viability of 98.6± 1.3% at day 1, 98.8± 1.5% at day 7 and 98.9± 0.8% at day
14 within the gelatin scaﬀold (Figure 5.16).
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Figure 5.15: Viability of encapsulated HepG2 for 2D sheets versus 3D printed scaﬀolds
using two diﬀerent photo-initiators. (*) p < 0.01
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Figure 5.16: High viability cell-laden gelatin scaﬀolds. HepG2-gelatin constructs, cured
using the VA-086 PI, with well deﬁned dimensions were obtained as shown
by the BF image (A). Cell viability within the scaﬀold was evaluated at
day 1 (B), day 7 (C) and day 14 (D) using a live/dead stain. Scale bar =
500μm.
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The cell viability was constant in time and scaﬀold stability was maintained for
at least 21 days as demonstrated by the BF image and live/dead stains. SEM
images of cell-laden constructs are represented by Figure 5.17. Cells on the outer
part of the strands were covered by a hydrogel layer and had a round morphology.
As described by several authors, round morphology of HepG2 cells is taught to
enhance and prolong heptocyte function.402–404
A B
C D E
Figure 5.17: SEM images of encapsulated HepG2 cells in 10w/v% gelatin methacryl-
amide plotted constructs. The scaﬀolds were ﬁxed with glutaraldehyde
and lyophilized to remove the liquid fraction prior to sample loading.
Multiple cells visualized on the surface of a strut (A, B). Scale bars rep-
resent 50μm. Examples of single cells covered by a gelatin layer (C, D)
and an example of a cell cluster (E). Scale bars represent 20μm.
At all investigated time points, the cells displayed viable and euchromatic nuclei as
indicated by HE staining (Figure 5.18 A, a). Moreover, the cells maintained their
potential to express liver speciﬁc functions such as the production of albumin
(Figure 5.18 B, b) and HNF4α (Figure 5.18 C, c) and the storage of glycogen
(Figure 5.18 D, d). Also the maintenance of proliferative capacity was conﬁrmed
both by positive Ki67 and PCNA staining (Figure 5.18 E, F).
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Figure 5.18: Representation of the cell morphology and phenotype maintenance in cell-
gelatin constructs 14 days post-fabrication. Cell morphology was exam-
ined using hematoxyilin/eosin stainings (A, a). IHC staining for albumin
(B, b) and HNF4α (C, c) and PAS (D, d) were performed to asses pheno-
typical behavior. IHC staining for Ki67 (E) and PCNA (F) were assessed
to conﬁrm proliferation. Scale bars indicate 50μm (a-d, E, F), and 500μm
(A-D).
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5.4 | Discussion
In the previous chapter, the use of I2959 PI initiated gelatin (meth)acrylamide
hydrogels, as HepG2 encapsulation matrix material was assessed as sheets. The
materials demonstrated high cell survival levels.372 From all PIs used for the
photo-initiated free-radical polymerization of cell-laden hydrogels, I2959 is most
commonly applied for several reasons:311,398,405
1. It is slightly water soluble, enabling applications in aqueous environments;
2. In the absence of UV-A irradiation, no signiﬁcant cytotoxic eﬀects are cor-
related to the use of this PI, and;
3. The generation of radicals is highly eﬃcient thus reducing the required con-
centration for cross-linking down to a level with lead to acceptable cell sur-
vival levels.
However, the search for even better PIs remains. For instance, Rouillard et al.405
evaluated a variety of water soluble PIs in order to increase the viability of bovine
chondrocytes during 2D encapsulation in methacrylated alginate. From their re-
search, the potentially superior cell viability levels using a newly introduced bio-
compatible PI, VA-086, was postulated. Unfortunately, a quantitative comparison
on the cross-linking lacked. Furthermore, to the best of our knowledge, studies
broadening the applicability of this PI toward other cell types are limited to hu-
man microvasculature endothelial cells (HUVEC) and bone marrow stromal cells
(BMSCs) using methacrylated alginate.406 The current study presents quantita-
tive data comparing this novel photo-initiator with the conventional I2959 PI for
the encapsulation of HepG2 cells in gelatin methacrylamides. The gel yield and
water uptake capacity were examined as two important factors aﬀecting network
properties and overall cross-linking. Fine-tuning resulted in a 10-times higher PI
concentration in order to reach comparable hydrogel network properties, illustrat-
ing the lower eﬃciency of VA-086. This was further conﬁrmed by the decreased
in situ cross-linking kinetics assessed by recordings of the increasing storage mod-
uli during UV-A irradiation. Final gel strength, however, only slightly decreased.
Cell-laden two-dimensional ﬁlms demonstrated a modest, signiﬁcant (p < 0.04)
improvement in cell viability. These data further conﬁrm the applicability of VA-
086 as an alternative, highly biocompatible PI for cell encapsulation purposes. For
both PIs, increasing the irradiation dose decreases the equilibrium mass swelling
ratios (q) and increases the gel yield since more chemical network junctions are
built in, resulting in tighter network structures (as discussed in the chapter 4).
Due to the low production costs, its natural origin, and excellent biocompatibility,
gelatin is a widely explored biomaterial.141,142 Nevertheless, application-wise, the
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limited manufacturability causes diﬃculty for the fabrication of complex porous
3D architectures using low-cost dispensing approaches. In order to enable 3D ﬁber
deposition of (cell-laden) gelatin methacrylamide, an in depth evaluation of the
rheological properties was performed. From these data, it was demonstrated that
next to the hydrogel building block concentration, the incorporation of cells al-
tered the rheological properties. As such, these parameters will aﬀect the printing
process since the viscosity as well as the geliﬁcation potential is altered. These
ﬁndings emphasize the importance of precise temperature control of the printing
solution as well as the printing substrate. Small adaptations to the Bioplotter de-
vice enabling improved temperature control on the build platform (i.e. enhanced
physical gelation due to cooling) and improved control over the printing solution
till needle tip were performed. Finally, 3D porous (cell-laden) gelatin methacryl-
amide constructs could be generated in the range of 10− 20w/v% gelatin. Lower
concentrations lead to severe internal pore collapse, mainly caused by insuﬃciently
fast physical gelation. The printing speed, the needle internal diameter, the plot-
ting temperature and the applied pressure were optimized to obtain a set of data
on the deposited strut diameters. Keeping oxygen diﬀusion and metabolite trans-
port in mind, especially the processing window resulting in strand diameters of
≤ 200μm was of particular interest. Hereby, the successful photo-initiated cross-
linking of 3D porous constructs was conﬁrmed. Compared to sheets, cross-linking
was enhanced, but remarkably higher swelling degrees were obtained. Most likely,
this can be attributed to the smaller dimensions of the deposited strands on one
hand, and the corresponding increased surface area on the other, compared to the
rather bulky (1mm thick) sheets.
Fedorovitch et al.82 plotted alginate hydrogels describing the collapse of internal
pore networks during layer-by-layer deposition. Very recently, gelatin methacry-
lamides were plotted using the Bioplotter device.398 However, construct built-up
using only-gelatin containing mixtures proved impossible up to 20w/v% gelatin
due to severe viscosity issues stemming from diﬃcult temperature control. As a
result, the authors had to blend viscosity-enhancing hyaluronic acid in order to
build mechanically stable 3D porous scaﬀolds. Other researchers plotted gelatin
applying viscosity-enhancing additives such as alginate, chitosan, ﬁbrinogen, or co-
deposition of polyester biomaterials.141,248,249,257,258,261,398 Wang et al.260 plotted
20w/v% glutaraldehyde cross-linked gelatin but had to decrease the temperature
of the printing solution below 20 ◦C resulting in a highly physically gelated printing
solution, thus high pressure and high internal diameter dimensions were necessary.
In the present paper, gelatin methacrylamides were successfully printed in a range
of concentrations, without severe internal collapse or the need for stabilizing co-
deposition of other materials. As a result of our adaptations and parametric ap-
proach, gelatin-only 3D scaﬀolds having a 100% interconnected pore network could
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be fabricated. Our results contrast with other studies whereby viscosity-enhancing
additives were obligatory to obtain porous constructs, without compromising scaf-
fold architecture.
For the printing of cell-gel hybrid constructs, a 10w/v% concentration was selected
based on earlier performed experiments. Only partial pore collapse occurred for
this concentration, still revealing an 100% interconnected pore network. Therefore,
easy diﬀusion of culture medium through the photo-initiated cross-linked gelatin
methacrylamide construct can be achieved. Furthermore, the obtained constructs
can undergo biodegradation stemming from enzyme secretion of living cells. To
enable the creation of cell-laden constructs, it was clear that a careful adjustment
of the plotting parameters was needed in order to meet two goals:
1. The creation of well-deﬁned scaﬀolds with an interconnected pore network,
and;
2. Optimal cell viability within the construct.
To meet both goals, the inﬂuence of diﬀerent parameters on cell survival was in-
vestigated by a step-by-step approach enabling us to understand the individual
parameters inﬂuencing both the construct and the cell behavior. The ﬁrst inves-
tigated parameters aﬀecting cell viability were the needle type, the needle size
and the inlet pressure. A signiﬁcant pressure and needle type dependence of the
cell viability was observed. At low inlet pressure, conically shaped needles are
preferred over cylindrically shaped ones. However, this advantage disappears at
higher inlet pressures. Finite element ﬂuid ﬂow simulations can help to ﬁnd an
explanation. A higher peak shear stress was obtained by ﬂow through the conical
needle. However, keeping in mind the substantially lower passage distance and
higher overall ﬂow velocity, the passage time of cells in this high shear regime is
substantially reduced compared to ﬂow through a cylindrical needle. It is our be-
lieve that at lower pressures (i.e. higher passage time) cells will be more aﬀected
by the increased passage of high shear for the cylindrical needle, while at higher
pressures, the signiﬁcantly lower passage time for the conical needle cannot longer
make up for the substantially higher shear stresses induced. As a result, initially
higher viability levels are obtained for the conical type, however, pressure increase
will result in a more pronounced viability drop compared to the cylindrical type.
Aguado et al.407 evaluated cell viability drops caused by mechanical membrane
disruption due to injection. Their data suggested that extensional ﬂow at the en-
trance of the syringe needle (i.e. higher shear stress) was the main cause for acute
cell death. Our ﬁndings on needle type as a function of dispensing pressure could
provide mechanistic insight into the role of mechanical forces during construct
printing.
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The second investigated parameter was the inﬂuence of the UV-A irradiation dose
on cell survival for I2959 PI. In the absence of a radical initiator, short exposure
to long-wave UV irradiation did not prove to be cytotoxic.380 As expected, the
presence of a radical initiator can compromise cell survival. Lower irradiation
doses resulted in improved cell survival. Subsequently, we aimed to compare I2959
with VA-086 PI for an irradiation dose of 1800mJ cm−2. The results indicated
a signiﬁcantly higher fraction of viable cells when using the VA-086 PI, and this
fraction was even higher than the viable fraction observed with I2959 PI for lower
irradiation doses of 1350mJ cm−2. These conclusions are in close correlation to the
results of Rouillard et al.405 on the encapsulation of chondrocytes in methacrylated
alginate. As such, the lower cytotoxicity of the generated radicals due to photo-
dissociation of VA-086 make it a good candidate for photo-initiated cross-linking
of other cell-laden biomaterials.
As illustrated in Figure 5.1, our ﬁndings stress the importance of feedback loops
between diﬀerent scientiﬁc domains in order to fabricate cell-laden constructs hav-
ing the appropriate properties combined with high cell viability. Although the
individual improvements in cell survival sometimes seem quite modest, the syn-
ergistic eﬀect of the combined adjustments eventually lead to the fabrication of
highly viable cell-laden gelatin methacrylamide scaﬀolds having a 100% inter-
connected pore network. Previously, the generation of 3D hepatocyte-gelatin
constructs cross-linked with glutaraldehyde were reported to have a viability of
93%.260 However, increasing the gelatin concentration up to 20w/v% and nee-
dle internal diameter to 300μm was necessary, resulting in strands of > 350μm
with lower dimension ﬁdelity. In our approach, we avoided exposure to toxic glu-
taraldehyde by the use of photo-curable gelatins, resulting in somewhat higher cell
survival rates (98%). Additionally, softer matrices could be generated (10w/v%
constructs), still possessing an interconnected pore network and smaller strand di-
mensions. Furthermore, the SEM images of cell-laden constructs revealed a round
cell morphology, preferential and typical for encapsulated HepG2 cells.
Although cell survival is an important criterion, in our opinion this methodology
does not cover full evaluation for the overall quality of a cell-laden construct. To
validate the construct, it was necessary to demonstrate the cells’ capability of dis-
playing their normal cell behavior post-construction of the scaﬀold. For HepG2
cells, a hepatocellular carcinoma cell line, this includes maintained expression of
hepatocyte markers and proliferative capacity. The cell-laden scaﬀold was there-
fore analyzed as such. The expression of albumin, HNF4α, Ki67 and PCNA was
conﬁrmed, indicating that cell behavior was not impaired due to the printing pro-
cess and exposure to increased ﬂuid shear stresses for the duration of the study.
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5.5 | Conclusion
The RP Bioplotter technique provides a useful tool for the printing of cell-laden
constructs. Precise temperature control during the printing process results in the
possibility to fabricate constructs displaying an interconnected pore network in
the range of 10− 20w/v% gelatin methacrylamide. Control over the deposited
strand dimensions can be guaranteed due to the physical properties of gelatin meth-
acrylamide hydrogels and machine operating parameters. As a result, constructs
having the desired stiﬀness and high shape reliability can be designed. Further ap-
plying a feedback strategy combining engineering, chemistry and biology, enabled
the printing of cell-laden gelatin methacrylamide hydrogels without the need for
viscosity-enhancing additives. The induced shear stress, curing irradiation dose
and the applied photo-initiator are inﬂuential for the resulting cell viability. High
viability, > 97%, constructs displaying a maintained expression of liver speciﬁc
functions were obtained using the novel VA-086 photo-initiator.
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Current chapter serves as an extension on the previous chapter. The network
properties of 3D printed constructs are evaluated. The plotting of cell aggregates
is presented with the aim for subsequent seeding to obtain co-culture systems. The
formation of hepG2 and primary hepatocyte cell aggregates and their subsequent
embedding in gel-MOD hydrogel ﬁlms for modular tissue engineering purposes was
published in PLOS one.408 However, since this mainly governs cell biology, the
data produced for this article is only given where relevant. For the complete study,
we refer to the PhD thesis of Elien Gevaert.
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6.1 | Introduction
Hepatocytes are characterized by a rapid decrease in viability and metabolic func-
tions once isolated from their native micro-environment. This presents limitations
for clinical, engineering and research purposes. Achieving a prolonged maintenance
of hepatocyte phenotype could e.g. help in the development of a tissue engineered
construct, BAL, more eﬃcient transplantation or more reliable in vitro models
thereby improving drug toxicity screening. Cultivation of hepatocytes in the form
of aggregates, thus enhancing cell-cell contact in a 3D environment, is a proposed
approach to improve hepatocyte performance.409 Diﬀerent studies have reported
an improvement of many metabolic functions, including cytochrome P450, albumin
secretion, urea production and glutathione S-transferase activity.409,410 These cell-
aggregates could potentially serve as building blocks in liver repair and be assem-
bled using embedding in appropriate biomaterals, while preserving mass transport
of nutrients and metabolites.320,411
The 3D Bioplotter device, ﬁrst introduced by Landers and Mülhaupt in 2000, has
since frequently been applied to fabricate 3D cell substrates for biomedical ap-
plications. Using the Bioplotter, the scaﬀold internal pore architecture can be
designed. In addition, the nutrient waste and metabolite ﬂow, as well as degra-
dation rates are aﬀected by the hydrogel network microscopic and macroscopic
properties.364,388,396,412,413 These are important parameters when aiming at, for
instance, drug release applications.
Nonetheless, in the development of hydrogel constructs, 0◦/90◦ patterns are typ-
ically selected for the layer-by-layer material deposition pattern.82,262,265,398 Very
recently, Almeida et al.414 demonstrated that rapid prototyped platforms hav-
ing distinct scaﬀolding features and/or material properties (PLA, PLA/calcium
phosphate glass, chitosan) led to distinct macrophage morphology and cytokine
proﬁle. For both sets of parameters, macrophages were mostly aﬀected by the ma-
terial properties and only slightly by the scaﬀolding features (e.g. pore geometry).
Liver pathology shows a correlation to the mechanical properties of the liver tissue.
For instance, Yeh et al.415 graded ﬁbrosis of human livers and found a correlation
between the ﬁbrosis severity and elastic modulus of the tissue. Other research
demonstrated myoﬁbroblastic diﬀerentiation of hepatic stellate cells with increas-
ing substrate stiﬀness.416 Schuurman et al.398 tailored the mechanical properties
of gelatin-HA constructs by selection of the precursor concentration. However, lit-
erature on scaﬀold lay-down pattern related to construct mechanical properties is
limited for hydrogels. Hutmacher et al.417 reported a clear inﬂuence of architecture
on the compressive moduli of PCL scaﬀolds processed by FDM technology.
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The following chapter compares micro- and macroscopic network properties of 2D
ﬁlms with 3D bioplotted constructs. Variations in the pore network architecture
are evaluated in the framework of compressive strength, while hydrogel precursor
parameters are related to degradation and drug release properties. Next, the plot-
ting of cell aggregates is tackled and optimized to obtain high viability aggregate
assembly into 3D shapes. As a ﬁnal part, co-culturing of 3D embedded HepG2
aggregates and seeded HUVECs is illustrated. This is schematically presented in
Figure 6.1.
 
cell seeding
aggregate
encapsulation
Figure 6.1: Schematical illustration of the co-culture of embedded aggregates with
seeded cells. In the confocal images, cells were stained for the cell nuclei
(DAPI, blue), the actin skeleton (phalloidin, red), and the focal adhesion
points (vinculin, green).
6.2 | Materials and Methods
6.2.1 Preparation of hydrogel sheets and fabrication of 3D
printed constructs
GelA-MA, gelA-AA, gelB-MA and gelB-AA were synthesized according to the
protocol described in section 4.2.2. Hydrogel sheets having a thickness of 1mm
were generated by injection of gelatin derivate solution containing photo-initiator
as described in section 4.2.2.2. 3D ﬁber deposition of gelB-MA and gelB-AA
precursor solutions to obtain 3D open porous scaﬀolds was performed employing
the optimized parameters from chapter 5. SEM images were recorded according
to section 5.2.5.2.
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6.2.2 Properties of modiﬁed gelatin ﬁlms and 3D constructs
6.2.2.1 Uniaxial unconﬁned compression
The mechanical properties of porcine liver and 3D plotted constructs were studied
using a TA500 Texture Analyser (Lloyd). Freshly isolated pig livers were cut
into small pieces (∼ 1× 1× 0.5 cm3) for uniaxial unconﬁned compression testing.
Specimen samples were collected with and without capsule, i.e. from the outer
and inner parts. GelB-MA and gelB-AA scaﬀolds (1× 1× 0.5 cm3) were swollen
to equilibrium before measurements. Samples were compressed (1mmmin−1) until
a strain of 25% was reached. A load cell of 100N was applied and a preload of
0.01N prior to data collection was selected. Next, the stress (MPa) corresponding
to each strain (%) was collected and the compression modulus was calculated from
the slope of the initial linear part of the compression curve.
6.2.2.2 In vitro degradation
The in vitro degradation behavior of hydrogel ﬁlms and scaﬀolds was studied
by enzymatic degradation. Freeze-dried samples (∼ 5− 10mg) were reswollen in
0.5mL Tris-HCl buﬀer (0.1M, pH 7.4) in the presence of 0.005w/v% NaN3 and
5mM CaCl2 at 37 ◦C. Collagenase (enzym activity of 388Umg−1, Sigma-Aldrich)
stock solution of 200UmL−1 in Tris-HCl was prepared and added to the sam-
ples to obtain ﬁnal concentration of 2Umg−1 gelatin. At diﬀerent time intervals,
the degradation was stopped by the addition of ethylenediamine tetraacetic acid
(EDTA) solution (0.2mM, Sigma Aldrich) and subsequent cooling of the sample
on ice. The partially degraded scaﬀolds were washed with ice-cooled Tris-HCl
buﬀer and double distilled water, and freeze-dried for the determination of the gel
fraction.
6.2.2.3 Release of polysaccharides and proteins
The release properties of gelatin ﬁlms and scaﬀolds were investigated by monitoring
the release of two model ﬂuorescein isothiocyanate (FITC) labeled molecules: (i)
dextranes as a model for polysaccharide release (FITC-DEX) ,and; (ii) bovine
serum albumin as a model for polypeptide release (FITC-BSA). Samples were
prepared as described above, with the addition of 10mgmL−1 of the FITC labeled
molecules. Samples were incubated in distilled water at 37 ◦C. At diﬀerent time
intervals, the cumulative release of DEX and BSA molecules was monitored by
means of spectrophotometric absorbance measurements using an UVIKON XL
UV-VIS spectrophotometer (BioTek).
Dextran release - Three FITC labeled dextranes were studied to investigate
inﬂuences of the molecular weight: 4 000Da (FITC-DEX4000), 40 000Da (FITC-
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DEX40000), and 250 000Da (FITC-DEX250000).
BSA release - FITC-BSA with a MW of 66 kDa (FITC-BSA70000) was evaluated.
6.2.2.4 Dynamic Vapor Sorption (DVS)
A Dynamic Vapor Sorption apparatus (DVS-1, Surface Measurment Systems) was
used for examination of the water vapor sorption and desorption behavior of hydro-
gels. The apparatus is placed in a temperature-controlled housing. Samples were
exposed to stepwise changes (10%) of the relative humidity (RH) (RH 0− 100%)
at 37 ◦C, and the water sorption/desorption proﬁle was determined gravimetrically
(Cahn microbalance)
6.2.3 Cell culture and characterization
6.2.3.1 Micro-aggregate formation
Primary mouse hepatocytes were isolated from adult mouse livers (8-14 weeks of
age) using a two-step collagenase perfusion method followed by percoll gradient
puriﬁcation as described by Goncalves et al.362 Primary hepatocytes were cul-
tured in William’s E medium (Life Technologies), supplemented with L-glutamine
(292mgmL−1) (Invitrogen), glucagon (7 ngmL−1) (sigma), insulin (0.5μgmL−1)
(sigma), hydrocortisone (25μgmL−1), EGF (10 ngmL−1), 10 v/v% FBS (Life
Technologies), 50UmL−1 penicillin (Life Technologies) and 50μgmL−1 strepto-
mycin (Life Technologies). HepG2 cells were maintained in DMEM Glutamax
supplemented with 10 v/v% FBS, 50UmL−2 penicillin and 50mgmL−2 strepto-
mycin, all provided by Life Technologies. Both the HepG2 cells and the primary
hepatocytes were maintained in a humidiﬁed 5% CO2-containing atmosphere at
37 ◦C.
To produce the agarose micro-wells for the formation of micro-aggregates, sterilized
powder Ultrapure Agarose (Life Technologies) was dissolved (3w/v%) and heated
in PBS. The liquid agarose solution was added to the mold and left to solidify
at room temperature. After cooling, the gels were separated from the moulds
and subsequently transferred into 12 well culture plates. Single cell suspensions
of various densities were seeded into the micro-wells. After seeding, formation of
micro-aggregates was supported by centrifugation for 1min at 1500 rpm to let the
cells settle into the bottom of the micro-wells. Culture medium was replenished
24 h after seeding. Cells were left in culture for 3 days to allow formation of stable
micro-aggregates.
For the embedding in gelatin hydrogels, aggregates were mixed with predissolved
gel-MOD precursor solutions to obtain a denstity of 2300 aggregatesmL−1 Aggregate-
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gel mixtures were further processed as previously described.
6.2.3.2 3D printing of aggregate-laden gelatin methacrylamides and
HUVEC seeding
For the ﬁber deposition of aggregate-laden gelB-MA solutions, a hydrogel building
block precursor concentration of 15w/v% containing 2300 aggregatesmL−1 was
selected using the plotting setup as described in section 5.2.3. VA-086 was used
as photo-initiator, as described in section 5.2.1.3.
HUVEC-Umbil Vein, pooled amp-P1 (CC-2519, Lonza) cells were cultivated in
endothelial growth medium, ordered as EBM Bulletkit (CC-3124, Lonza). At day
20, P8 HUVECs were seeded on the aggregate-laden (HepG2) scaﬀolds: 250 000
HUVECs per 1/4 scaﬀold in 48 well plates in a total volume of 300μL. After 24 h,
the scaﬀolds were transferred to new wells (total volume 500μL). Seeding and
further cultivation of the scaﬀolds occurred in endothelial growth medium.
6.2.3.3 Characterization of the aggregates
Assesment of the viability was performed according to the protocol described in
section 4.2.4. PAS and IHC stainings were performed following the description
from section 5.2.5.4.
To assess albumin secretion, media samples were collected at diﬀerent time points.
After omitting cross-reactivity for bovine albumin, the amount of secreted albu-
min was determined using a mouse albumin enzym-linked immunosorbent assay
(ELISA) quantitation kit or a human albumin ELISA quantitation kit (Bethyl
laboratories, Inc., UK) and normalized for the amount of cells using an MTT
assay.
Cytochroom P450 3A4 (Cyp3A4) activity of the primary hepatocyte aggregates
was analyzed using a P450-GloTM-CYP3A assay (Promega) according to the man-
ufacturer’s protocol for cell-based assays. After 72 h exposure to hydrocortisone,
an inducer of Cyp3A4, the aggregates were cultured for 1 h in media containing
luciferin-isopropyl alcohol (1:1000). After 1 h, an equal volume of the liquid was
transferred to a 96 well plate and incubated with an equal volume of detection
reagent. After 20 min, luciferase activity was detected using a Wallac 1420 Victor
multilabel counter (PerkinElmer). The detected luminescence was normalized for
the amount of cells (MTT assay). Background subtraction was performed with
culture medium considered as negative control.
6.2.3.4 Real time-PCR
Total RNA was extracted from the aggregates using TRI Reagent (Sigma-aldrich)
and treated with DNAse digestion kit (Invitrogen). RT Core Kit (Eurogentec)
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was used to synthesize cDNA, according to the manufacturer’s protocol. A 7500
Fast Real-Time polymerase chain reaction (RT-PCR) system (Applied Biosystems)
and a SYBR Green PCR kit (Eurogentec) was used to perform the RT-PCR, all
according to the manufacturer’s instructions. Glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH) expression was used as stable housekeeping marker. The
2−ΔΔCt method was used to determine the relative gene fold changes, compared to
gene expression in two dimensional cultures. The primer sequences were previously
described and taken from Roelandt et al.418
6.2.3.5 Confocal Fluorescence Microscopy (CFM)
Aggregate-loaded (HepG2) scaﬀolds having HUVECs seeded on top were analyzed
by CFM measurements in wet conditions. The images were collected on a Leica
SP5 laser scanning confocal microscope with a 40X 1.25 oil immersion objective.
Digital Z slices were reconstructed using Velocity image analysis software.
Prior to the measurements, the actin skeleton, focal adhesion points and cell nuclei
were stained using the actin cytoskeleton and focal adhesion staining kit from Mil-
lipore (FAK100). Samples were stained at 28 days of cultivation. The cells were
ﬁxed with 4% paraformaldehyde in PBS for 20min at room temperature, washed
(2 × 5min with PBS containing 0.05% tween20) and permeabilized with 0.1%
Triton X-100 in PBS for 5min. After washing (2 × 5min with PBS containing
0.05% tween20), the samples incubated for 30min in blocking buﬀer (PBS + 1%
BSA), and subsequently incubated with the anti-vinculin antibody (1:100 in block-
ing buﬀer) for 1 h, the secondary antibody FITC-goat anti-mouse IgG antibody
(GAM) (1:500 in blocking buﬀer) and tetramethyl rhodamine-conjugated phal-
loidin (1:500 in blocking buﬀer) for 1 h, and 4’,6-diamidino-2-fenylindool (DAPI)
(1:1000 in PBS) for 5min. Extensive washing with PBS containing 0.05% tween20
(3 × 10min) was performed after each incubation step.
6.2.4 Statistical analysis
All measurements were performed with n ≥ 3, unless otherwise stated, and the
experimental results are reported as mean ± standard deviation (S.D.). Statistical
analysis was performed with the Student’s t-test and signiﬁcance was determined
at p < 0.05. Statistical analysis was used in order to evaluate both the repro-
ducibility of the respective techniques and the signiﬁcance of diﬀerences between
samples.
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6.3 | Results and Discussion
6.3.1 Scaﬀold internal pore architecture: theoretic design vs.
practical dimensions
Three scaﬀold designs were fabricated, to study the deﬂections from the theoret-
ically designed lay-down pattern. Units representing the theoretical design are
displayed in Figure 6.2: (i) two 0◦/90◦ patterns whereby one has a shifted pattern,
i.e. each 0◦ and 90◦ layer are shifted so that in top view these are located precisely
in the middle of the interstrut voids, and; (ii) a pattern whereby each subsequent
layer is rotated by 45◦. The theoretical models were drawn using COMSOL soft-
ware.
«normal» «shift»
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Figure 6.2: Theoretical scaﬀold designs viewed from 3 diﬀerent angles.
The idealized models clearly demonstrate the inﬂuence of only adapting the layer
deposition pattern. While the material strut volumes are kept identical, the void
architecture is altered substantially. In Figure 6.3, optical microscopy (A-C) and
SEM images (D-I) of the 3D printing outcome of these designs are displayed. The
scaﬀolds were plotted using a 20w/v% precursor solution. The 0◦/90◦ “normal”
pattern has been described in chapter 5, and a good agreement with the designed
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Figure 6.3: Scaﬀold desing for the 3D printing of 20w/v% precursor solutions using
G27 needle: optical microscopy (A-C) and SEM images (D-I). Scale bars
represent 250μm (A-C), 350μm (D-F) and 260μm (G-I).
geometry can be expected. For the 0◦/90◦ “shift” pattern, porosity in top view
is diﬃcult to visualize with optical microscopy, but looking at the SEM pictures,
it can be deduced that the ﬁnal geometry closely resembles the objective. On
the other hand, the 0◦/45◦ pattern is best visualized in top view. Especially in
cross-section (I), the cutting position greatly aﬀects the obtained image (cutting
deformation). These cutting defects are also seen in the cross-sectional image of
the 0◦/90◦ “normal” scaﬀold (G). Nonetheless, this particular pattern resulted in
a slightly lower shape ﬁdelity. Overall, an acceptable shape ﬁdelity is observed.
The water vapor uptake was studied at 37 ◦C to investigate the diﬀerence between
10w/v% 2D sheets and 3D scaﬀolds (0◦/90◦ “normal” pattern). The increase in
hydrogel masses (%) as a function of the relative humidity (RH, %) results in
a typical DVS plot as presented in Figure 6.4. Especially for RH ≥ 80%, the
hydrogel mass rapidly increases. The results are summarized in Table 6.1. Since
the bulk material composition remained the same for both the 2D sheet and the
3D scaﬀold, it was expected to obtain by and large similar vapor uptake values at
high RH. As can be deduced from the table, at higher target RH values (≥ 50%)
the mass change converges for both samples. However, the macropores present in
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Table 6.1: Comparing dynamic vapor uptake of 10w/v% 2D sheets and 3D 0◦/90◦
“normal” scaﬀolds. Mass change (%) during sorption as a function of the
relative humidity (RH, %).
TARGET RH [%] Δm - dry [%]
2D SHEET 3D SCAFFOLD
0 0.00 0.00
10 2.44 6.40
20 4.88 8.74
30 6.91 10.18
40 8.80 11.48
50 10.34 12.95
60 12.76 15.52
70 15.99 17.81
80 23.92 27.56
90 35.60 37.68
100 63.19 67.52
3D scaﬀolds result in a slightly higher water vapor uptake at low RH values. This
can be attributed to the increased surface area.
Our ﬁndings are in close correlation to previous experiments performed in our
group on cryogenic scaﬀolds exploring the eﬀect of scaﬀold hydrogel concentration
and porosity (i.e. the work of Vanvlierberghe et al.412).
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Figure 6.4: Typical DVS diagram representing the change in mass (%) of 10w/v% 3D
constructs in function of the relative humidity (RH, %).
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6.3.2 Hydrogel material properties and the designed internal
pore network aﬀect scaﬀold mechanical properties
In chapter 4, two photocross-linkable gelatin hydrogel building blocks were com-
pared for their shear moduli of 2D sheets (1mm thickness). For scaﬀolds, com-
pression measurements are more meaningful. Some typical stress-strain curves for
liver samples and 20w/v% gelB-MA constructs are depicted in Figure 6.5 A-B.
The compression moduli of 3D constructs fabricated from gelB methacrylamide
(gelB-MA) and gelB acrylamide (gelB-AA) as a function of the hydrogel build-
ing block concentration are presented in Figure 6.5 C. As discussed, the scaﬀold
build-up pattern exerts an inﬂuence over the void/material geometry. Therefore,
we anticipate an eﬀect on the mechanical properties of the constructs. Figure 6.5
D demonstrates the impact of the layer deposition pattern on the compression
moduli of 20w/v% 3D printed constructs.
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Figure 6.5: Stress-strain curves of liver samples (A) and 20w/v% 3D constructs. Com-
pression moduli gelatin scaﬀolds in function of the precursor concentration
and photocross-linkable function for 0◦/90◦ patterns (C) and in function of
the ﬁber lay-down pattern for 20w/v% constructs (D). All scaﬀolds were
cross-linked with an UV irradiation dose of 7200mJ cm2. All compression
tests were performed using a speed of 1mmmin−1 at 37 ◦C.
The scaﬀolds were constructed using G30 (10w/v%) or G27 (15 and 20w/v%)
needles following the parameters from chapter 5. The cross-linking kinetics, as
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compared between methacrylamide and acrylamide gelatins, largely followed the
ﬁndings of 2D ﬁlms. However, faster curing was observed, as discussed in chapter
5 for methacrylamide constructs, with even faster curing rates for the acrylamide
variant (i.e. a gel fraction of 92.3± 2.6% was reached at 240mJ cm−2). In line
with the expectations, increasing concentrations lead to constructs with increased
compression moduli. In contrast to the 2D ﬁlms on the other hand, the discrepancy
between constructs of diﬀerent hydrogel concentration are less pronounced. More-
over, despite the slightly increased compression moduli of gelB-AA constructs,
the diﬀerence was not signiﬁcant. It is presumed that the relatively high curing
dose for 3D printed constructs, levels oﬀs the diﬀerences. It can be expected that
smaller exposure windows to UV-A light would enable tuning of the construct me-
chanical properties. Contrarily, when evaluating the layer pattern with respect to
the resulting compressive strength, the “shift” pattern demonstrated a signiﬁcant
reduction in compressive strength.
Freshly isolated pig liver tissue samples were subjected to an identical measurement
protocol, since the recorded mechanical properties of poroviscoelastic materials will
greatly be aﬀected by the measurement protocols. The livers were collected at the
KU Leuven, transported on ice, cut in pieces and measured in the hours upon
collection to limit changes in the mechanical properties. Two types of samples
were analyzed: samples containing the capsule (i.e. the outer parts), and samples
without capsule (i.e. the inner tissue). As can be seen in the averaged stress-strain
curves, samples without capsule have a slightly higher compression strength. This
can be attributed to the high density of arteries and veins present in the inner liver
tissue. When taken the average for both types of samples, a compression modulus
of 0.76± 0.3 kPa was calculated. This value is lower than the value for 10w/v%
gelB-MA constructs (1.4± 0.2 kPa).
Research studies towards the mechanical properties of animal and human livers
mostly target static material properties. Reports on dynamical approaches are
much less. For instance, the linear viscoelastic properties by means of oscillatory
shear experiments demonstrated a storage modulus increase from 1 kPa to 6 kPa
with increasing frequency, and in addition, an increase in storage and loss modulus
is observed with increasing preservation times.419 This value corresponds to a
5w/v% fully cured gelB-MA hydrogel (chapter 4). Unfortunately, adapting the
bioplotter device enabled us to process modiﬁed gelB hydrogel building blocks with
a lower limit at around 10w/v%.
In our experiments we conducted uniaxial compression experiments in order to
compare (pig) liver tissue to gelB-MOD hydrogel scaﬀolds. Yeh et al.415 reported a
compression modulus of 0.64± 0.08 kPa of healthy liver tissue and 1.65± 0.11 kPa
for ﬁbrotic tissue (5% preload strain) using ultrasonic imaging. Our results sug-
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gest that 10w/v% gelB-MA hydrogels were closest to the value of pig liver, and
that this value can be lowered even further when taking the scaﬀold pattern into
consideration.
Finite element simulations were performed on the theoretical designs in order to
obtain a qualitative understanding on the diﬀerences between scaﬀold desing un-
der uniaxial compression. Qualitative heat mappings of the resulting Von Mises
stresses at a deformation of 10% are given in Figure 6.6. The images give a quali-
tative impression of the localized surface stress magnitudes and ﬁeld displacements
upon compression. As can be seen, highest local stress distributions are observed
for the highly regular 0◦/90◦ “normal” and the 0◦/45◦ “normal” patterns. For the
shifted pattern, the surface stresses are more homogeneously distributed. Despite
the qualitative nature, the images correspond with the compression data.
«normal» «shift»
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Z
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Figure 6.6: Qualitative heat mapping of the relative Von Mises stress proﬁle comparing
scaﬀold design upon a deformation of 10%. Black lines show the initial
design.
6.3.3 Enzymatic degradation behavior of gelatins: 2D ﬁlms
versus 3D constructs
The enzymatic degradation behavior of gelatin (meth)acrylamide hydrogels was
studied to investigate the eﬀect of the gelatin precursor, hydrogel building block
concentration, and to compare 2D ﬁlms and 3D scaﬀolds. The degradation was
evaluated by determination of the gel yield after incubation in collagenase solution
(Figure 6.7).
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The results can be summarized as follows: (i) gelA derivates degrade faster than
gelB derivates; (ii) gel-MA hydrogels degrade faster than gel-AA hydrogels; (iii)
3D scaﬀolds degrade faster than 2D ﬁlms; (iv) increasing the hydrogel precursor
concentration leads to slower degradation rates, and; (v) 0◦/45◦ scaﬀolds degrade
slightly slower. These results suggest that the degradation rates can be tailored
not only by varying the material properties, but also by changing the internal
macroscopic pore network of 3D scaﬀolds.
0
20
40
60
80
100
0 100 200 300 400
g
el
 fr
ac
tio
n 
(%
) 
degradation time (min) 
gelB-MA 
gelB-AA 
0 
20 
40 
60 
80 
100 
0 100 200 300 400
g
el
 fr
ac
tio
n 
(%
) 
degradation time (min) 
gelA-MA 
gelA-AA 
0 
20 
40 
60 
80 
100 
0 100 200 300 400 
g
el
 fr
ac
tio
n 
(%
) 
degradation time (min) 
10 w/v% 
15 w/v% 
20 w/v%  
0 
10 
20 
30 
40 
50 
0°/90° 0°/90° "shift" 0°/45°/90° 
g
el
 fr
ac
tio
n 
(%
) 
10 w/v% 
20 w/v% 
C
A
D
B
Figure 6.7: Enzymatic degradation behavior of 10w/v% gel-MA and gel-AA 2D ﬁlms
(A,B) and 3D scaﬀolds as a function of gelB-MA concentration and scaﬀold
design (C,D). For (D), values represent a degradation time of 195min.
6.3.4 Release of polysaccharides and proteins: 2D ﬁlms ver-
sus 3D constructs
The cumulative release of dextranes (DEX), as a model polysaccharide, and bovine
serum albumin (BSA), as a model protein, from gelatin matrices was followed over
a period of 5 days (Figure 6.8). The eﬀects of release molecule, gelatin precursor
type and concentration, and construct geometric shape (2D ﬁlms vs. 3D scaﬀolds)
were analyzed.
Dextranes having distinct molecular weights were released from 10w/v% gelB-MA
2D ﬁlms (A). With increasing molecular weight, the cumulative release is slowed
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down, as would be expected due to increasing hydrodynamic radii of the release
solutes. At a release time of 5 days, > 90% of the FITC-DEX4 000 was released
while only ∼ 40% of the FITC-DEX250 000 was released. The release of FITC-
DEX40 000 was also investigated for 3D constructs for two hydrogel building block
concentrations (C). With increasing gelatin fraction, the release is inhibited sub-
stantially while only a slightly faster release was achieved compared to 2D sheets.
The former could be attributed to the decrease in hydrogel network mesh size,
while the latter could be explained by the increased surface area of 3D constructs.
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Figure 6.8: Release proﬁles of FITC-DEX (A,C) and FITC-BSA (B,D) in function
of the release time. The eﬀect of dextran molecular weight on the release
behavior for 10w/v% gelB-MA 2D ﬁlms (A). The eﬀect of gelatin precursor
type (gelB-MA vs. gelB-AA, 10w/v% 2D ﬁlms) on the release of bovine
serum albumin (B). The release proﬁles for gelB-MA 3D scaﬀolds as a
function of the hydrogel building block concentration (C,D).
Apart from dextranes, BSA was released from 10w/v% gelB-MA and gelB-AA 2D
ﬁlms (B). As would be expected, release from gelB-AA hydrogels occurs at a slower
pace compared to gelB-MA hydrogels. Similar observations as for dextran release
from 3D scaﬀolds were derived for BSA release from 3D scaﬀolds (D). However,
the diﬀerence between 10w/v% and 20w/v% hydrogels was more pronounced.
Generally, less complete release of BSA was observed compared to dextran release.
All release proﬁles displayed a rapid initial release rate followed by a gradual
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increase over time. In chapter 4, the mesh sizes of 10w/v% gel-MA and gel-AA,
and 20w/v% gel-MA were respectively determined to be 18.7, 13.9, and 9.4 nm
(Table 4.3). Armstrong et al.420 determined the hydrodynamic radii of a series of
macromolecules. The authors reported hydrodynamic radii of 1.86, 4.78, 11.46, and
3.51 nm for DEX9 500, DEX40 000, DEX250 000, and BSA66 000. Combining our mesh
size determinations and their hydrodynamic radii calculations partially explain our
release proﬁles. The lower release of BSA despite comparable hydrodynamic radius
with DEX40 000 can logically be ascribed to increased electrostatic and hydrophobic
interactions, leading to longer retention of the BSA molecules whitin the gelatin
matrices.
Our results suggest that these systems could be used for sustained release of pro-
teins and polysaccharides. The hydrophilicity of hydrogels has been shown to be
favorable for preserving the native structure and functionality of the incorporated
protein and the high water content and soft consistency of hydrogels minimizes
mechanical irritation upon administration.157
6.3.5 Towards co-culture systems: the use of micro-aggregates
6.3.5.1 Micro-aggregates improve hepatic phenotype
Micro-aggregates were fabricated based on agarose microwell technology. By vary-
ing parameters such as micro-well diameter, cell number and cell type, aggregates
with diﬀerent dimensions could be obtained and aggregate diameters varied be-
tween 100 and 300μm for HepG2 cells and between 50 and 200μm for primary
hepatocytes. An example of HepG2 aggregates is illustrated in Figure 6.9.
A          B
Figure 6.9: Live/dead staining of HepG2 micro-aggregates at day 3 (A) and day 7 (B)
of cultivation. Scale bar represents 100μm.
HepG2 and primary hepatocyte micro-aggregates demonstrated a clear and signif-
icant upregulation of hepatocyte functions, such as albumin, connexin32 (Cx32),
hepatocyte nuclear factor 4α (HNF4α), E-cadherin, cyp3A4, and cytochrome
1A2 (cyp1A2), in comparison with two dimensionally cultured cells. In addi-
tion, hepatocyte performance is inﬂuenced by aggregate size and the number of
cells/aggregate. Since an in depth discussion on these ﬁndings falls out of the
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scope of this work, we refer to the PhD dissertation of Elien Gevaert from the
group of Prof. Dr. R. Cornelissen.
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Figure 6.10: Evaluation of micro-aggregates after encapsulation in a gelatin hydrogel.
(A) Live/dead stain of aggregates encapsulated in gelatin hydrogel at day
10. Scale bar = 50μm (B) Stainings of the immobilized micro-aggregates
at day 10 after isolation. Scale bar = 50μm. (C) Cumulative albumin
secretion determined by ELISA assay. Data are mean ± S.D., n = 3. (D)
Real-time PCR for gene expression analysis for encapsulated and non-
encapsulated aggregates. Data are mean RQ ± S.D., n=3. *p < 0.05; **p
< 0.01.
Aggregates (∅ 100μm) were encapsulated and cultured in a 10w/v% gel-MA hy-
drogel and gene expression and cell metabolism was compared with non-encapsulated
aggregates (Figure 6.10). The viability of the immobilized aggregates compared
to the non-encapsulated aggregates indicated that primary hepatocytes are not
aﬀected by the encapsulation procedure. Most of the aggregates maintained their
rounded morphology while some cellular outgrowth was observed at day 10 of
culture (A,B).
Similar gene expression proﬁles between encapsulated (black bars) and non- en-
capsulated (white bars) aggregates were found for HNF4α, Cyp3A4, Cyp1A2,
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E-cadherin and connexin 32 (Cx32) indicating that gelatin encapsulation did not
aﬀect aggregate performance. Stainings of encapsulated aggregates demonstrate
that expression of albumin and HNF4α protein was maintained during 10 days.
Figure 6.10 C depicts the cumulative albumin secretion proﬁle of the immobi-
lized aggregates and indicates that albumin is secreted for the whole period under
investigation (21 days). Altogether, these results indicate that encapsulation of
the hepatocyte aggregates in a gelatin hydrogel is possible without adverse conse-
quences for their characteristics.
6.3.5.2 3D printing of aggregate-laden constructs
To use aggregates as building blocks for modular tissue engineering, there is a need
to organize and immobilize these small aggregate structures on a larger scale while
cells remain alive and maintain their appropriate function.
Table 6.2: Processing conditions for the 3D ﬁber deposition of aggregate-laden 15w/v%
gelatin hydrogel precursors with conical needle types.
PARAMETER 15w/v% gelB-MA
Experiment 1 Experiment 2
Aggregates [mL−1] 2300 2300
Needle gauge G27 G25
∅ [μm] 200 250
Material temperature [ ◦C] 27.5 27
Layer height [μm ] 170 200
Pressure [bar ] 0.1 0.1
XY-speed [ mmmin−1] 500 750
Z-speed [ mmmin−1] 500 500
Preﬂow [ sec] 0.05 0.05
Postﬂow [ sec] 0.05 0.05
Corner delay [ sec] 0.1 0.1
Pullback time [ sec] 0.5 0.5
Interstrut distance [ mm] 0.80 0.80
One such technique comprises encapsulation of the aggregates in a 2D sheet, as
discussed above. However, internal macroscopic porosity is deﬁcit in this approach.
Another strategy capable of organizing cellular deposition in predeﬁned patterns is
the 3D bioplotter. Previously, we demonstrated the impact of cells on the plotting
solution viscosity and therefore the plotting temperature (chapter 5). It was also
shown that for single cell suspensions, gelatin hydrogel building blocks of 10w/v%
are preferred over higher concentrations (chapter 3). Initial encapsulation testing
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with aggregates (HepG2 as well as primary mouse hepatocyte) on the other hand,
revealed acceptable cell viability levels even up to 20w/v% gelB-MA (data not
shown). Altogether, a precursor solution of 15w/v% was selected for the printing
of HepG2 cell aggregates. Two sets of experiments were performed, of which the
plotting parameters are presented in Table 6.2.
The plotting of aggregate-laden constructs applied conical needle types in order to
limit the shear stress forces. As a ﬁrst remark, it should be noted that the optimal
plotting temperature for aggregate-laden solutions did not show the substantial
drop as compared to single cell suspensions. Nonetheless, a critical plotting pa-
rameter appeared to be the needle internal diameter. Diﬀerences between the
parameter sets of experiment 1 and 2 can be attributed to the diﬀerence in needle
gauge. Constructs printed using the parameter set of “experiment 1” resulted in
constructs with a higher cell loss and whereby the aggregate integrity was aﬀected.
This is illustrated by the live/dead staining in Figure 6.11.
Figure 6.11: Live/dead staining of HepG2 micro-aggregates after 3D printing. Scale
bar represents 500μm.
It is clear that the aggregates were torn into smaller pieces, and the largest pieces
had a reduced cell viability. The ratio of needle to aggregate diameter ratio was
only a factor of two. Therefore, printing was repeated with a larger needle to
aggregate diameter ratio (a factor of 2.5). This ratio proved capable of producing
high viability aggregate-laden scaﬀolds with aggregate shapes intact. Figure 6.12
represents brightﬁeld and live/dead stainings for these aggregate-laden constructs
at day 6 (A,B), day 14 (C,D), and day 20 (E-H) of cultivation.
The micro-aggregates could be printed with high viability (> 90%) and maintained
their spherical morphology during the cultivation period (20 days). The brightﬁeld
image of day 20 (E) shows that some aggregates slowly migrate out of the scaﬀold.
Once out the scaﬀold, the cells grow into a normal monolayer as illustrated by the
brightﬁeld images (G,H). These ﬁndings could be interesting when targeting cell
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transplantation purposes.
A
A
DC
B
FE
G H
Figure 6.12: Images representing the printing and cultivation of aggregate-laden scaf-
folds at day 6 (A,B), day 14 (C,D), and day 20 (E-H) of cultivation.
Brightﬁeld images (A,C,E,G,H) and live/dead staining images (B,D).
CFM image of a live/dead stain (F). Scale bar represents 500μm (A-
E,G,H) and 200μm (F).
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The principle was ﬁrst introduced by Mironov in the framework of organ print-
ing using speroids as building blocks for macroscopic assembly.320 Very recently,
Faulkner-Jones et al.421 applied a valve-based rapid prototyping approach to print
a stem cell suspension for the generation of micro-aggregates. In the previous
chapter, single cell printed solutions proliferated into aggregate-like morphologies
during cultivation as seen in Figure 5.16 (D, day 14 of cultivation). Our present re-
sults demonstrate the easy generation of cell-aggregates and subsequent assembly
into 3D shapes, opening perspectives for modular tissue engineering.
6.3.5.3 HUVEC seeding on aggregate-laden scaﬀolds
Finally, in the last part of the present study, cell seeding on 3D scaﬀolds was
performed. At day 20 of the aggregate-gel hybrid scaﬀold culture, HUVECs
were seeded. Figure 6.13 represents live/dead stainings of the co-culture HUVEC
seeded/HepG2 aggregate scaﬀolds at day 28 of culture.
A
DC
B
Figure 6.13: Live/dead staining of printed HepG2 micro-aggregates and seeded HU-
VECs at day 28 of cultivation. Image of the meander feature (A), the
deposited ﬁbers remain intact (B,C), cells are attached to the scaﬀold
surface (D). Scale bar represents 500μm.
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The scaﬀold mechanical integrity remains up to 28 days of cultivation. The seeded
cells colonized the scaﬀold surface. Some aggregates demonstrated a slight loss in
cell viability. It should be noted that the micro-aggregates grew over the cultivation
period, probably explaining the slight loss in viability due to hampered nutrient
and metabolite waste/ﬂow.
Confocal ﬂuorescence microscopy (CFM) imaging was conducted to diﬀerentiate
cells on the surface area and aggregates on the scaﬀold inside. Staining for the cell
nuclei (DAPI staining, blue), the actin cytoskeleton (phalloidin staining, red), and
the cells focal adhesion points (vinculin staining, green) are represented by Figure
6.14. Overlay images of the stainings with brightﬁeld images illustrate the scaﬀold
strand boundaries and location of the cells (A,B). The cells on the outer parts of
the scaﬀold (HUVECs) demonstrate a spread morphology, whereas the aggregates
reveal a more compact and rounded morphology as would be expected.
Hepatocytes tend to rapidly loose their phenotypic expression. Bhandari et al.44
demonstrated a co-culture system with 3T3 ﬁbroblast cells to modulate the func-
tion and viability of primary isolated rat hepatocytes. The hepatocytes within
the co-cultures maintained their viability, possessed well-formed canalicular sys-
tems, and displayed functional markers. Using cell-sheet technology, Sasagawa et
al.16 demonstrated the beneﬁt of co-cultures. When sparsely cultured HUVECs
were sandwiched between myoblast sheets, the inserted HUVECs sprouted and
formed network structures in vitro and additionally, endothelial cell connections
through the layers and capillary-like structures were found in a ﬁve-layer construct.
Tuleuova et al.422 demonstrated an improved hepatic diﬀerentiation when co-
culturing hepatic stellate cells with mouse embryonic stem cells (mESCs). While
the predictive value of these systems is still under investigation, these co-culture
models can help to unravel complex cell-cell and cell-material interactions by de-
veloping more sophisticated in vitro systems.160 Although our ﬁndings suggest
that more complex 3D shaped constructs show potential for co-culture approaches
thereby combining cell encapsulation, cell seeding, and rapid prototyping, future
research (PCR assays) will need to be conducted to prove if a synergistic eﬀect
can be demonstrated.
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Figure 6.14: CFM imaging of HUVEC seeded Hepg2 aggregate-laden scaﬀolds. Over-
lay with brightﬁeld images (A,B). Dapi, vinculin and phalloidin staining
of HUVEC cells (a-c, a’-c’) and overlay (d,d’). Dapi, vinculin and phal-
loidin staining of HepG2 aggregate (e-g, e’-g’) and overlay (h,h’). Images
recorded at 40 X magniﬁcation (a-d), and 63 X magniﬁcation (a’-d’).
161
6.4 | Conclusion
It was demonstrated that using a combination of material properties and scaﬀold
design, the mechanical properties, degradation behavior and polysaccharide/protein
release can be tailored. The 3D printing of 3D models having distinct macroscopic
internal pore networks proved successful with good to high shape ﬁdelity. This
parameter exerted its main inﬂuence on the scaﬀold mechanical properties.
The 3D assembly of cell micro-aggregates with high viability was feasible using
the 3D bioplotter technology. For this, a crucial parameter revealed to be the
needle internal diameter. Finally, a proof-of-principle experiment demonstrating
the successful co-culture of aggregate-laden scaﬀolds and seeded HUVECs shows
promising results for future research.
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This chapter explores the applicability of liver-speciﬁc galactose moieties for en-
hancement of encapsulated cell performances. This chapter is based on an article
published in Macromolecular Bioscience423 more related to the biological aspects,
and a ‘to be submitted’ article more related to the synthesis and material charac-
terization.
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7.1 | Introduction
Currently, acute or chronic liver failure demands the development of alternatives
to the gold standard, liver transplantation, to support, or take over (at least tem-
porarily) liver function in order to overcome the organ shortage. One such al-
ternative includes bio-artiﬁcial liver (BAL) systems, which can be deﬁned as a
bioreactor charged with a hepatoma cell line or isolated primary hepatocytes. As
an extracorporeal device, the charged cells process blood or plasma and aim to
support patients suﬀering from acute liver failure by assisting in failing detoxi-
ﬁcation, and synthetic and regulatory functionality.424–426 Low availability and
diﬃculty to govern a suitable functionality for extended periods hampers the ap-
plication of primary hepatocytes. Contrarily, hepatoma-derived cell lines, such as
HepG2 cells, are more robust and can easily be upscaled and cultured for extended
periods of time.425,426 On the downside, functionality comparable to primary hep-
atocytes of human origin is not reached, but may still be suﬃcient to bridge the
time between disease and transplantation. In addition, genetic manipulation of the
cells could bypass these problems, increasing their potential for the development
of extracorporeal devices.425,427
Various natural, synthetic and semi-synthetic ECMs have been employed as sub-
strates for hepatocyte culture.38,428,429 For the most part, hepatocytes adhere well
to natural ECMs (i.e. collagen, ﬁbronectin, laminin and matrigel), however they
have the tendency to exhibit low liver speciﬁc function levels typical for cell ded-
iﬀerentiation.430,431 As such, they exhibit ﬂattened and spread cell morphology,
whereas a round morphology has been correlated with enhanced hepatocyte func-
tion.402,403 Furthermore, round morphologies are preferential in order to prolong
hepatocyte function maintenance and have been observed using cell encapsula-
tion strategies.404,432 Hydrogels, of which the hydrated states resemble that of
the ECM, are suitable scaﬀold materials for cell encapsulation and allow for an
easy exchange of gasses, nutrients and metabolites.1,7 In vitro culturing or in
vivo transplantation then facilitates the repopulation of site defects or the pro-
duction of growth factors and/or other molecules that will aﬀect the targeted cell
population.140
Carbohydrates, on the other hand, can serve a key role in molecular recogni-
tion processes, including speciﬁc recognition of cells and intracellular communica-
tion.433 Therefore, the design of synthetic glycopolymers that maintain natural
carbohydrate functions has drawn a lot of attention in recent years. The asialogly-
coprotein receptor (ASGPR), a transmembrane receptor that recognizes galactose
or N-acetyl-β-galactosamine as a speciﬁc ligand, was discovered on the surface of
mammalian hepatocytes and characterized by Ashwell et al.434 In addition, more
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abundant than the surface receptor, this receptor is also present in the internal
membranes of rat hepatocytes.435 As a result, the development of synthetic gly-
copolymers with pendant galactose moieties has been investigated intensively for
liver engineering or liver targeting.436,437 For example, galactose moieties were
introduced onto gelatin,357 hyaluronic acid,136 chitosan,436 alginate,438 and colla-
gen.439 In general, the presence of galactose-containing moieties improved hep-
atocyte adhesion and hepatocyte speciﬁc functions by promoting the formation
of round adherent cells.440,441 Cho et al.404,430 described the eﬀects of galactose
moieties for galactose-carrying synthetic ECMs investigating the geometry, type,
density, and orientation of the galactose units on the hepatocyte attachment and
function through receptor-mediated interactions between ASGPR and galactose
moieties along glycopolymer chains. Hong et al.357 assessed a galactosylated
gelatin cross-linked by carbodiimide chemistry for the seeding of primary hepato-
cytes. Nevertheless, galactose density was neither quantiﬁed nor varied. Usually,
these studies are mainly focused on eﬀects after cell seeding on a galactosylated
biomaterial.136,439 To our knowledge, reports on galactose inﬂuence on encapsu-
lated cells are limited.
In this chapter we report on the evaluation of cross-linkable galactosylated gelatin
(gelGAL-MOD) as a substrate for cell encapsulation. The objective of this study
was dual: ﬁrst, the synthesis of galactosylated gelatin methacrylamide with varying
galactose densities by modiﬁcation of gelatin with (i) lactobionic acid, and (ii)
methacrylic anhydride. Hereby, the inﬂuence of carbohydrate moieties on the
radical polymerization process will be investigated. Secondly, using HepG2 cells
as a model, viability and functionality of encapsulated cells using the previously
synthesized galactosylated gelatin methacrylamides is compared to galactose-free
gelatin methacrylamide.
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Figure 7.1: Schematic representation of the experimental setup of this chapter.
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7.2 | Experimental Part
7.2.1 Synthesis and characterization of cross-linkable galac-
tosylated gelatin (gelGAL-MOD)
7.2.1.1 Galactosylation of gelatin hydrogel building blocks
Bovine type B gelatin (approximate iso-electric point of 5 and Bloom strength of
257), isolated by an alkaline process, and porcine type A gelatin (approximate iso-
electric point of 8.8 and Bloom strength of 202), isolated by an acid process, was
supplied by Rousselot (Ghent, Belgium). The amount of free amines available for
reaction was determined to be respectively 0.34mmol g−1 gelA and 0.38mmol g−1
gelB (see section 3.3.1). As shown in Figure 7.2, galactoslysated gelatin meth-
acrylamide (gelGAL-MOD) was developed by a two-step reaction. First, the free
amines available on gelatin were derivatized with 4-O-β-D-galactopyranosyl-(1,4)-
D-gluconic acid (lactobionic acid, LA) in the presence of EDC/NHS to produce
amide bonds. Brieﬂy, 10 g gelatin is dissolved in 100mL phosphate buﬀer (0.1M,
pH 7.8) at 40 ◦C. The carboxylic acid groups of 1.37 g LA (3.8mmol, Sigma-
Aldrich) were ﬁrst activated using 1.1 g 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
(EDC, 5.7mmol, Sigma-Aldrich) and 0.44 g N-hydroxysuccinimide (NHS, 3.8mmol,
Sigma-Aldrich) in 5mL MES buﬀer (0.1M, pH 6). The amount of LA is expressed
as % LA added, relative to the amount of initially available free amines. After
15min, the activated LA mixture was added drop-wise to the preheated gelatin
solution. The reaction mixture was allowed to react for one hour to produce gel-
GAL.
Further functionalization with methacrylic anhydride, and subsequent dialysis and
freeze-drying was performed according to the protocol described in section 4.2.2.
Non-galactosylated gelatin methacrylamide (gel-MOD) was used as reference for
further characterizations.
7.2.1.2 Direct method for determination of the galactosylation degree
A direct determination of the degree of galactosylation (DG) was performed with
the Amplex Red Galactose/Galactose Oxidase Assay Kit (Invitrogen). First, a
working solution of 100μM Amplex Red reagent containing 0.2UmL−1 horse
radish peroxidase (HRP) and 4UmL−1 galactose oxidase was prepared accord-
ing to the manufacturer’s protocol. A 50mM Tris-HCl reaction buﬀer (pH 7.2,
1mM CaCl2) was used for the preparation of the gelGAL solutions (freeze-dried
samples were applied). GelGAL-MOD suspensions (25mgmL−1 Tris-HCl buﬀer)
were heated for one hour at 37 ◦C until complete dissolution. To 50μL heated
protein solution, 250μL reaction buﬀer and 300μL working solution were added.
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The sample solution was incubated at 37 ◦C for 30min. Finally, the absorption
was measured at 572 nm (BioTek, UVIKON XL) and 37 ◦C. All measurements
were performed in triplicate. Similar measurements were performed, in which the
gelatin solutions were replaced by a series of solutions with known concentration
of galactose (dilution series from 2μM to 250μM of LA). The degree of galactosy-
lation (DG) is deﬁned as the ratio of the amount of galactosylated amines to the
amount of total amines present in unmodiﬁed gelatin.
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Figure 7.2: Chemical structure of gelGAL and gelGAL-MOD developed in this study
for cell encapsulation of HepG2 cells. gelGAL is a galactosylated
gelatin modiﬁed with lactobionic acid (LA), while gelGAL-MOD is a
methacrylamide-functionalized gelGAL modiﬁed with methacrylic anhy-
dride.
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7.2.1.3 Indirect method for determination of the modiﬁcation degrees
A second colorimetric method using o-phthalic dialdehyde (OPA, Acros, see sec-
tion 11.4.2) was performed according to the protocol of Van Vlierberghe et al.359
Gelatin, gelGAL, gel-MOD and gelGAL-MOD suspensions (25mgmL−1 double
distilled water at 37 ◦C) were prepared for measuring the amount of free amines
remaining after each reaction step to determine the degrees of galactosylation
(DG) and substitution (DS). The degree of substitution (DS) is deﬁned as the ra-
tio of the amount of methacrylated amines to the amount of total amines present
in unmodiﬁed gelatin. A calibration curve was obtained by standards contain-
ing n-butylamine (5μM to 250μM, Acros). All measurements were performed in
triplicate.
7.2.1.4 Fourier transform-infrared spectroscopy
Bulk changes were analyzed by means of Fourier Transform-Infrared spectroscopy
(FT-IR) in attenuated total reﬂection (ATR) mode (Spotlight 400 Imaging System)
according to the protocol described in section 4.2.3.1.
7.2.1.5 X-ray photoelectron spectrometry
Alterations in the chemical composition due to the modiﬁcation steps, as well
as diﬀerences between the gelatin types, were investigated by means of X-ray
photoelectron spectrometry (XPS). Gelatin, gel-MOD and gelGAL-MOD samples
were analyzed. Additional to survey scans recorded as described in section 4.2.3.1,
the C 1s core signal was also collected (detail scan). The generated data are
displayed as a plot of the electron counts versus electron binding energy in a ﬁxed,
small energy interval. CasaXPS software was used for data analysis.
7.2.1.6 Preparation of gelatin-based hydrogels
Sheets of gel-MOD and gelGAL-MOD solutions were prepared according to the
protocol reported in section 4.2.2.2.
7.2.2 Characterization of the physico-chemical properties
7.2.2.1 High resolution-magic angle spinning NMR spectroscopy
The eﬀective cross-linking eﬃciency was studied using high-resolution magic angle
spinning (HR-MAS) NMR. Previously, this technique proved to be a powerful tool
to characterize hydrogel cross-linking (Chapter 4). 1D 1H HR-MAS NMR spectra
of 10− 20w/v% type A (galactosylated) gelatin methacrylamide (gelA-MOD and
gelAGAL-MOD) and type B (galactosylated) gelatin methacrylamide (gelB-MOD
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and gelBGAL-MOD) were recorded as described in section 4.2.3.2. The generated
data are expressed as the conversion in function of gelatin type and concentration.
Each condition was measured in duplicate.
7.2.2.2 Equilibrium swelling studies
Equilibrium swelling experiments, according to section 4.2.3.2, were performed to
evaluate the inﬂuence of galactosylation on the free-radical cross-linking properties
of gelatin methacrylamides. Thus gel-MOD was used as reference condition for
comparison to gelGAL-MOD cross-linking.
7.2.2.3 Rheological properties of hydrogels
Gel strength of gelA-MOD and gelB-MOD hydrogel ﬁlms were compared by record-
ings of the storage modulus G′. The inﬂuence of the galactosylation on the cross-
linking was investigated by in situ curing of 2D slaps. Rheometer setup and used
protocols have been described in section 4.2.3.5.
7.2.3 Cell culture and encapsulation in the hydrogels
7.2.3.1 Cell encapsulation in gelatin-based hydrogels
HepG2 cells were encapsulated in modiﬁed gelatin derivates according to the pro-
tocol described in section 4.2.4. All gelatin products were sterilized by an ethylene
oxide treatment (cold cycle, Hospital Maria Middelares, Ghent, Belgium). The
chemically cross-linked gels were maintained in 500μL cultivation medium which
was replenished every 24 hours.
7.2.3.2 Viability tests for encapsulated HepG2 cells
MTT assay: The cells were washed with PBS. A 5mgmL−1 solution of MTT
(Calbiochem) in PBS was diluted 10 times with the cultivation medium and,
subsequently, ﬁlter sterilized. The cells were incubated in the MTT solution
(500μL/well) for 4 h, protected from light in a 5% CO2 incubator at 37 ◦C. The
reagent was discarded by centrifugation (1000 rpm, 5min), and the cells were
treated for 30’ with 500μL isopropanol-0.04N HCL supplemented with 1 v% Tri-
ton X100 (Sigma) to rupture the cells and dissolve the formed formazan crystals.
Subsequently, 200μL of each sample was transferred to a 96-well plate and the ab-
sorbance measured at 580 nm with an EL800 Universal microplate reader (BioTek
instruments Inc.). Cells in suspension were considered to be a positive control.
Accordingly, 300, 000 cells/well were seeded in a 48-well suspension plate and kept
in 500μL cultivation medium per well. At each time point, namely days 1, 3 and
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7 after encapsulation, we calculated the relative cell number compared to the con-
trol. Within one experiment, three separate wells were sampled per time point for
each condition, and each experiment was repeated three times, independently.
Live/Dead ﬂuorescence staining: Cell viability imaging of HepG2 cells encap-
sulated in gelMOD and gelGAL-MOD was performed using Live/Dead ﬂuorescence
staining according to the protocol from section 4.2.4.
7.2.4 Functionality of encapsulated HepG2 cells
7.2.4.1 Enzyme-linked immunosorbent assay (ELISA) for detection of
serum albumin secretion
Culture medium was collected at various time points and the amount of secreted
albumin was determined using a human albumin ELISA quantitation kit (Bethyl
Laboratories) according to the manufacturer’s instructions. The speciﬁcity for
human albumin was veriﬁed using unconditioned cultivation medium and no cross
reactivity with bovine albumin was detected. The obtained values were normalized
with the present cell numbers, determined using a standard curve and MTT assay.
7.2.4.2 Histochemistry and immunohistochemistry
Histochemistry and immunohistochemistry stainings were performed in a similar
fashion as previously described in section 5.2.5.4.
7.2.4.3 Real-time PCR
On days 1, 3, 7, 14 and 21 of the experiment, RNA was extracted using the TRI
Reagent (Sigma-aldrich). Potential genomic DNA contaminants were removed
using a DNAse digestion kit (Invitrogen), and cDNA was created using a RT Core
Kit (Eurogentec) according to the manufacturer’s instructions. A real-time PCR
was performed using a SYBR Green PCR kit (Eurogentec) and a 7500 Fast Real-
Time PCR system (Applied Biosystems), again according to the manufacturer’s
instructions. Primer eﬃciency was evaluated by means of standard curves, and
the purity of the products was examined on the basis of melting curves. The
RNA levels were normalized using GAPDH as a stable housekeeping marker and
the relative gene fold changes. This can be compared to the gene expression of
the control culture, which was determined using the 2−ΔΔCt method. The primer
sequences were previously described and taken from Roelandt et al.418
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7.2.5 Statistical analysis
All measurements were performed with n ≥ 3, unless otherwise stated, and the
experimental results are reported as mean ± standard deviation (S.D.). Statistical
diﬀerences were explored by a one-way analysis of variance (ANOVA) followed by
a Student t-test.
7.3 | Results and Discussion
7.3.1 Characterization of galactosylated gelatin methacryl-
amide
Conversion of the gelatin free amines occurred according to the scheme from Figure
7.2. As illustrated, the modiﬁcation scheme consists out of two subsequent steps.
In the ﬁrst part of this work, derivatization of gelatin free amines with LA was
studied in depth. Two distinct methods were used to determine the degree of galac-
tosylation. Applying the galactose oxidase assay (Amplex Red assay) determines
directly the galactose content, while using ortho-phtalic dialdehyde (OPA) assay
leads to an indirect estimation of the galactosylation degree. The indirect method
involves determination of the free amine content before and after modiﬁcation.
Figure 7.3 depicts the degree of galactosylation for gelA and gelB.
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Figure 7.3: Synthesis of galactosylated gelatin methacrylamide: Degree of galactosyla-
tion (i.e. % amines initially present converted to galactose moieties) as a
function of the amount of added lactobionic acid (n = 3).
The results demonstrate a signiﬁcantly higher degree of galactosylation when us-
ing OPA. Hence less galactose-containing moieties were detected using galactose
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oxidase. It is known that steric hindrance lowers the apparent activity of enzymes.
For instance, Schumacher et al.442 observed a signiﬁcant decrease in galactose
oxidase activity, comparing galactose to lactose quantiﬁcation, due to steric hin-
drance of the β-glycosidic bond present in lactose. Our standard curve was based
on LA concentrations, therefore limiting the mentioned eﬀects. However, the co-
valent bonding to gelatin relatively increases steric hindrance, possibly explain-
ing the underestimation of the amount of galactose-containing moieties using a
direct quantiﬁcation assay. Moreover, the OPA assay allows us to additionally
quantify the amount of incorporated methacrylamide functionalities using a sin-
gle determination method. The degree of galactosylation is proportional to the
added amount of LA and comparable modiﬁcation eﬃciencies for gelA and gelB
were obtained. The absolute amount of incorporated galactose-containing units
ranged from 20.9− 92.4μmol/g−1 for type A and 21.6− 95.5μmol/g−1 for type B
gelatin. Hong et al.357 coupled lactobionic acid to gelatin by intermediate deriva-
tization of gelatin carboxylic groups with ethylenediamine, followed by reaction of
the terminal amines with lactobionic acid. However quantiﬁcation of the reaction
proceedings were not mentioned.
0 
10 
1 1 2 2 
20 
30 
40 
50 
60 
70 
80 
90 
100 
gelBMOD-GAL gelBGAL-MOD 
d
eg
re
e 
of
 m
od
iﬁ
ca
tio
n 
(%
) 
methacrylic anhydride
lactobionic acid 
*
added equivalents of activated lactobionic acid
**
** ** ** **
***
***
Figure 7.4: Synthesis of galactosylated gelatin methacrylamide: Inﬂuence of the modi-
ﬁcation sequence on the degrees of modiﬁcation (i.e. % converted amines)
as a function of the amount of lactobionic acid added. The amount of
methacrylic anhydride added was kept at 1 equivalent with respect to the
amount of initial free amines. *p < 0.05, **(*) p > 0.05
Secondly, methacrylamide functionalities were incorporated to allow the forma-
tion of chemically cross-linked networks to overcome the temperature dependent
sol-to-gel transition of gelatins (Figure 7.2 step 2). It should be noted that the
sequence of modiﬁcation steps had an important inﬂuence on the overall galactosy-
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lation degree as illustrated in Figure 7.4. Modiﬁcation with methacrylic anhydride
prior to galactosylation (gelMOD-GAL samples) yields relative galactosylation de-
grees similar to the above-mentioned results, i.e. when expressed relative to the
amount of residual free amines after the ﬁrst step. In other words, leading to
lower absolute galactosylation degrees (approximate factor 3) relative to the na-
tive available free amines and thus lower absolute galactose content. On the other
hand, the modiﬁcation with methacrylic anhydride on the methacrylation degrees
(DS) was not signiﬁcant: for gelBMOD-GAL gels a DS of 64± 1.3% was reached,
while for gelBGAL-MOD gels a DS of 61± 1.5% was quantiﬁed (p < 0.05). Non-
galactosylated gelatin methacrylamide (gelB-MOD) had a DS of 65± 0.9%. These
values correlate well with previous work from our lab performed by Van Den Bul-
cke et al.,223 who originally established the synthesis of methacrylamide modiﬁed
gelatin, and Van Vlierberghe et al.443 , who reported a methacrylation degree of
65%. We obtained methacrylation degrees for both gelatin type A and gelatin
type B within the range of 15− 85%. Data on the DS as a function of the added
amount of methacrylic anhydride was described in Chapter 4.
Table 7.1: Inﬂuence of gelatin type and gelatin modiﬁcation on the surface composition
determined by XPS analysis.
SAMPLE NAME SURFACE COMPOSITION [%] ATOMIC RATIO
O 1s C 1s N 1s N/C O/C
gelA 20.7±0.1 64.2±1.1 15.1±0.9 0.23 0.32
gelB 18.4±1.2 65.3±1.3 16.3±0.1 0.25 0.28
gelBGAL∗ 20.4±0.6 64.4±0.6 15.2±0.6 0.24 0.32
gelB-MOD∗ 18.5±0.6 66.6±0.4 14.9±0.2 0.22 0.27
gelBGAL-MOD∗ 20.5±0.3 64.9±0.2 14.6±0.2 0.22 0.31
∗ modiﬁcations of type B gelatin
Alterations in the chemical composition due to the modiﬁcation steps were studied
using XPS spectroscopy. The results are summarized in Table 7.1. The covalent
coupling of lactobionic acid increased both the oxygen content and the O/N atomic
ratio respectively from 18.4% to 20.5% and from 0.28 to 0.32. This would be
expected after the introduction of a disaccharide structure. Additionally, the in-
troduction of methacrylamide side groups results in a decrease of the N/C atomic
ratio. Further insight was obtained by curve ﬁtting of the high-resolution C 1s
peaks. Generally, chemical identities are assigned to certain component peaks.
However, it should be noted that proteins consist out of a broad spectrum of
chemical functionalities.
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Therefore, assignment of chemical identities to certain component peaks of the
observed C 1s envelopes was deliberately over-simpliﬁed to decomposition into
three peaks according to:444
1. A peak at 285.0 ± 0.1 eV corresponding to C-C and C-H bonds (peak 1);
2. A peak at 286.7 ± 0.1 eV attributed to C-O, C=O, C-N groups (peak 2),
and;
3. A peak at 288.5 ± 0.1 eV due to O-C=O and N-C=O functional groups (peak
3).
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Figure 7.5: XPS C1s signals of gelB modiﬁcations: non-modiﬁed gelatin (A), gelBGAL
(B), gelB-MOD (C) and gelBGAL-MOD (D).
The high-resolution carbon spectra are presented in Figure 7.5 and their values
summarized in Table 7.2. The spectra demonstrate the changes in the chemical
environment of the carbon atoms for each step in the modiﬁcation process. In gen-
eral, modiﬁcation involved a decrease of peak 2 and 3 and an increase of peak 1
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when compared to non-modiﬁed gelatin. On the other hand, comparing galactosy-
lated gelatins with methacrylamide modiﬁed gelatins, peaks 2 and 3 are increased
while peak 1 decreases.
Table 7.2: Decomposition of the gelatin type B C 1s envelope in diﬀerent components
(in percentages).
SAMPLE NAME RELATIVE INTENSITIES OF C 1s [%]
285 eV 286.7 eV 288.5 eV
gelB 45.6±1.2 32.2±1.3 22.3±0.1
gelBGAL 48.6±1.6 31.3±0.9 20.1±0.6
gelB-MOD 54.4±0.6 27.9±0.4 17.7±0.2
gelBGAL-MOD 51.1±0.3 29.8±0.2 19.1±0.2
Figure 7.6 shows the FT-IR spectra of gelatin, LA and gelBGAL. Gelatin was found
to show characteristic absorptions at 3280 cm−1 (amide A peak, N-H stretching
vibration), at 1630 cm−1 (the amide I peak, C=O stretch), at 1547 cm−1 (the
amide II peak, N-H bend and C-H stretch) and at 1240 cm−1 (the amide III peak,
C-N stretch plus N-H in phase bending).387 The IR spectrum of LA exhibited a
gelatin type B
 
lactobionic acid
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Figure 7.6: Changes in the FT-IR spectra before and after modiﬁcation with lactobionic
acid.
broad OH absorption occurring in the region between 3400 and 2400 cm−1, and
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a distinctive band at 1740 cm−1 due to the carbonyl stretching (C=O) of the
carboxylic groups. In the IR spectrum of gelBGAL, the carbonyl stretching of LA
disappeared due to the amide bond formation between carboxylic groups of LA
and amine groups of gelatin. All peaks of amides A, I, II, and III of gelBGAL
slightly shifted to 3292, 1640, 1559 and 1245 cm−1, respectively, when compared
with those of gelatin, an indication of the conformational change after reaction
with LA.
7.3.2 Eﬀect of galactosylation on the cross-linking kinetics
of modiﬁed gelatins
As previously described, in this work we selected a chemical modiﬁcation strategy
of gelatins with methacrylamide functionalities in order to circumvent the lim-
itations derived from the temperature dependent hydrogel properties. For this,
I2959 was selected as biocompatible PI, which will generate free radicals upon
UV irradiation. However, it has been described by some authors that the pres-
ence of carbohydrate moieties can hamper radical formation and propagation due
to their antioxidant property as free-radical scavenger.445,446 Therefore, compar-
ing gel-MOD with gelGAL-MOD for their cross-linking properties, we anticipated
diﬀerences in the cross-linking degree and curing kinetics.
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Figure 7.7: Eﬀects of gelatin type on the curing properties of modiﬁed gelatins: In-
ﬂuence of gelatin type, modiﬁcation, and concentration on the amount of
reacted cross-linkable groups quantiﬁed by 1D 1H HR-MAS NMR spec-
troscopy (*p < 0.01, ** p < 0.05).
7.3.2.1 Evaluation on the cross-linking eﬃciency by HR-MAS NMR
Initially, HR-MAS NMR spectroscopy was performed in order to derive the abso-
lute cross-linking eﬃciency. The resonances of H2C=C(CH3)- (δ = 5.7 ppm and
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5.95 ppm) were used to quantitatively determine the conversion of the methacryl-
amide groups as described in more detail in section 4.3.2.3. The data are presented
in Figure 7.7.
Gelatin type A methacrylamides (gelA-MOD and gelAGAL-MOD) and type B
methacrylamides (gelB-MOD and gelBGAL-MOD) were compared in function of
the gelatin building block concentration. In analogy to gel-MOD hydrogel building
blocks, also for gelGAL-MOD solutions increasing the concentration leads to an
increased amount of reacted cross-linkable groups. As a ﬁrst general remark, the
reactivity of type A gelatins was signiﬁcantly lower compared to type B gelatins,
ultimately resulting in lower gel stiﬀness (Figure 7.8). Second, the introduction of
galactose-containing units signiﬁcantly lowered the amount of reacted methacryl-
amide functionalities conﬁrming the hypothesis of galactose as free-radical scav-
enger. It should be commented that the obtained conversion values are depicted
in reference to the initially available cross-linkable groups. When measuring hy-
drogels in fully swollen state (i.e. the sol fraction will be leached out), these values
will increase since gelatin chains containing unreacted groups are leached out.
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Figure 7.8: Eﬀects of gelatin type on the curing properties of modiﬁed gelatins: Inﬂu-
ence of gelatin type and concentration on the storage moduli (G′) at 37 ◦C
of fully cured gel-MOD hydrogels. Prior measurement, the hydrogels were
swollen to equilibrium at 37 ◦C. Recordings occured at a constant defor-
mation of 0.1% strain in the frequency range of 0.1− 100 rad s−1 at 37 ◦C.
7.3.2.2 Equilibrium swelling studies
To determine the relative degree of cross-linking in function of the irradiation
dose, and to investigate the eﬀect of galactose-content as an indicator of free-
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radical scavenging, equilibrium swelling experiments were performed. The results
are expressed as the gel fraction and the equilibrium mass swelling ratio q. The
loss of reactivity/eﬃciency reﬂects upon the ﬁnal gel fraction obtained. As seen
in Figure 7.9 A, the gel fraction as a function of irradiation dose for 10w/v%
gelBGAL-MOD, containing ± 25% galactose moieties, is reduced signiﬁcantly
compared to 10w/v% gelB-MOD. Additionally, higher irradiation doses in the
case of gelBGAL-MOD hydrogels were necessary before a substantial gel could be
formed, i.e. 480mJ cm−2 vs. 1200mJ cm−2. The plateau value, i.e. the irradiation
dose at which point the gel fraction did not signiﬁcantly increase anymore, shifted
towards higher values. These data suggest not only a decreased cross-linking but
also a slower one. Logically, the decreased gel yields led to greater swelling ratio
q at equal curing conditions (Figure 7.9 B).
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Figure 7.9: (A) Inﬂuence of galactose on the radical polymerization of 10w/v%
gelBGAL-MOD as a function of the UV-A exposure (n = 3) (p < 0.05).
Gelatin methacrylamide (gelB-MOD, 10w/v%) was selected as a reference.
(B) Gel fraction and swelling ratio q at an irradiation dose of 7200mJ cm−2.
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The scavenging eﬀect was further investigated by increasing amounts of added
(free) LA. The gel fractions and swelling ratios were monitored and are displayed
in Figure 7.10. As anticipated, higher amounts of LA decrease the ﬁnally obtained
gel fractions and increase the equilibrium swelling ratios. This can be attributed
to an increase in scavenging activity upon increasing galactose-content. However,
the eﬀect on the swelling ratio is more pronounced compared to the eﬀect on the
gel fraction. For example, when incorporating 25% of LA (with respect to the
amount of initially free amines present) the gel fraction drops with 11% while the
swelling ratio increases with 74% (Figure 7.9). The high swelling ratios up to 17
for the gelBGAL-MOD fully cured hydrogels illustrate the high water absorption
capacity of these modiﬁed gelatins. Furthermore, the gel yield and swelling ratio
can be manipulated by controlling the irradiation dose and galactosylation degree.
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Figure 7.10: Inﬂuence of galactose presence on the radical polymerization of 10w/v%
gelatin methacrylamide (gelB-MOD) hydrogels as a function of the
amount of added (free) lactobionic acid - expressed as equivalents to the
amount of native gelatin free amines (n = 3).
Gel yields around 70% for 10w/v% methacrylamide modiﬁed gelatins (DS 68%)
and an irradiation dose of 9000mJ cm−2 have been reported by Hoch et al.386 The
mass swelling ratios in the work of Nichol et al.143 were similar to our ﬁndings.
Inﬂuences of gelatin galactosylation on the curing properties have not been found
in the literature. The present work describes the changes in photo-initiated curing
properties as a result of galactosylation and oﬀers a more mechanistic insight in
the hampered curing as a result of free-radical scavenging.
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7.3.2.3 Rheological analysis of galactosylated gelating methacrylamide
Recordings of the storage moduli (G′) as a function of the gelatin concentration
have been provided in Figure 7.8. A broad range of moduli was obtained ranging
between 13 and 110 kPa for the type B gelatins and between 1 and 25 kPa for the
type A gelatins. It should be kept in mind that adjusting the amount of photo-
sensitive groups enables to change the stiﬀness of methacrylamide modiﬁed gelatin
hydrogels as has been demonstrated in the work of Hoch et al.386 and Nichol et
al.143 The mechanical spectra for both gelB-MOD and gelBGAL-MOD indicated
a slight drop in gel strength (G′gel−MOD = 13.5 ± 0.6 kPa vs. G′gelGAL−MOD = 9.2
± 1.5 kPa).
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Figure 7.11: The cross-linking kinetics of type B gelatin methacrylamides monitored by
rheological time-sweep recordings for the storage moduli (G′) of 10w/v%
hydrogel precursors. Dashed line represents gelBGAL-MOD, full line rep-
resents gelB-MOD. The zone in between arrows indicates UV-A irradia-
tion.
Rheological time-sweep tests coupled with in situ photocross-linking were per-
formed to observe the increase in storage moduli (G′) as the gel network is formed.
Figure 7.11 depicts the observed eﬀects for both gelB-MOD and gelBGAL-MOD
using 10w/v% hydrogels while keeping all other conditions ﬁxed. Next to the pre-
viously described general properties of methacrylamides (the small lag phase and
the post-curing after the beginning and ending of the irradiation), the gelB-MOD
curve demonstrated a steeper slope and G′ of gelBGAL-MOD hydrogels was lower
at any given time point.
All of the above mentioned observations conﬁrm the slower and less complete
(i.e. less groups consumed) network formation in the case of the gelBGAL-MOD
hydrogels.
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7.3.3 Viability and functionality of the encapsulated cells
7.3.3.1 Galactosylation does not aﬀect the viability of encapsulated
cells
Comparing studies on gelatins remains challenging for researchers. Since gelatin is
derived from the natural ECM constituent collagen, batch-to-batch variations as
well as manufacturers extraction protocol diﬀerences remain plausible and could
aﬀect cell biology. Furthermore, as described in chapter 1 and 3, the extraction
pre-treatment will highly impact the electrical nature, and as such the isoelectric
point of the ﬁnally obtained gelatin. Type A gelatins will have isoelectric points
between 7 and 9, while type B gelatins are situated around 5. In physiological
conditions, gelA will carry a net positive charge, while gelB carries a net negative
charge. Figure 7.12 A depicts live/dead stainings of HepG2 cells encapsulated in
10w/v% gelA-MOD, gelB-MOD, and gelBGAL-MOD. The degree of substitution
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Figure 7.12: Viability assessment of encapsulated HepG2 cells in the hydrogels. (A)
Live (green) and dead (red) ﬂuorescence staining of encapsulated HepG2
cells in 10w/v% gelatins: gelatin methacrylamide type A (gelA-MOD)
and type B (gelB-MOD), galactosylated type B gelatin methacrylamide
(gelBGAL-MOD). Scale bar represents 500μm. (B) Live/dead assay of
encapsulated HepG2 cells in 10w/v% gelB-MOD and gelBGAL-MOD.
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(methacrylamide functionality) was respectively 64 ± 2.9% (gelA-MOD), 65 ±
0.9% (gelB-MOD) and 61 ± 1.5% (gelBGAL-MOD).The galactosylation degree
for the gelBGAL-MOD hydrogel was 25.2 ± 0.6%. As can be seen, the photo-
initiated free radical polymerization did not signiﬁcantly alter cell survival during
encapsulation. For gelA-MOD, cell survival was somewhat lower, in analogy to
the titration experiments from chapter 3.
The cell viability was determined after the encapsulation and cross-linking of the
hydrogel building blocks by applying UV-A light in the presence of I2959. Cell
viabilities were compared for both the gelB-MOD and gelBGAL-MOD hydrogels
(Figure 7.12 B). The data are mean percentages ± S.D. (n = 3). Viable cell
fractions (relative to the total amount of encapsulated cells) of 91.5 ± 3.4% at
day 1 and 94.2 ± 2.5% at day 7 for the gelB-MOD, and 91.6 ± 4.3% at day
1 and 89.2 ± 5.2% at day 7 for the gelBGAL-MOD. No signiﬁcant (p > 0.05)
improvement on the cell viability of encapsulated HepG2 could be observed for
the galactosylated gelatin. In following experiments, gelA was excluded since both
gelA (Section 3.3.5) and gelA-MOD showed lower viability levels.
As demonstrated by previous work, increasing the hydrogel precursor concentra-
tion leads to decreased mesh sizes (i.e. the distance between adjacent junction
knots), resulting in increased network densities (i.e. tighter hydrogel networks).
Tighter networks will, in turn, also have an impact on macroscopic properties,
leading to increased mechanical strength and reduced swelling. Furthermore, the
amount of reacted methacrylamide functions due to free-radical photocross-linking
rises with increasing gelatin concentrations. As a consequence, cells will be sub-
jected to fewer mechanical stresses, and might beneﬁt from better nutrient/waste
diﬀusion when encapsulated in lower concentration hydrogels. We can conclude
that cell viability is, among other things, dependent on the hydrogel precursor
concentration and, consequently, on network density, mechanical strength, and
swelling properties. Based on these preliminary cell tests, the decision was made
to perform all further evaluations only using the 10w/v% hydrogels. Overall, good
and stable cell survival was achieved. The functionalization of the methacrylamide
modiﬁed gelatin hydrogel building blocks with galactose-containing side groups did
not alter cell viability, suggesting that the introduction of other moieties (e.g. cell
recognition motifs) might also be successful. The fraction of viable cells within
both the galactosylated and non-galactosylated gelatin hydrogels (compared with
the control) remained constant, suggesting that the hydrogels had no adverse ef-
fects on cellular proliferation.
182
7.3.3.2 Albumin secretion as a function of the galactosylation degree
The eﬀect of galactosylation on the functionality was ﬁrstly evaluated by moni-
toring the albumin secretion of HepG2s encapsulated in gelBGAL-MOD hydrogels
possessing varying galactosylation degrees (Figure 7.13). The DG was varied be-
tween 0% (gelB-MOD, control condition) and 25% in order to establish the eﬀect
of galactose pendant moieties. While no clear eﬀect of galactose introduction was
observed at day 1 and 3, a dose/concentration dependent eﬀect of galactosylation
was observed after a cultivation period of 7 days. It was clear that 25% galacto-
sylation signiﬁcantly improved the albumin secretion of the encapsulated cells by
a factor of 3, compared to the non-galactosylated gelatin derivate (gelB-MOD).
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Figure 7.13: The eﬀect of the galactosylation degree on the secretion of albumin by
HepG2 cells encapsulated in 10w/v% gelBGAL-MOD.
The rate of albumin secretion in vitro is 10− 100 times lower than the rate in
vivo and has been reported to decrease rapidly over time for primary hepatocytes.
Hong et al.357 compared the seeding of primary hepatocytes on collagen-coated 2D
monolayer and on 3D galactosylated gelatin sponges. As a result of 3D cultivation,
the formation of spheroids was promoted and the albumin secretion enhanced
compared to the rate of the monolayer. Our ﬁndings indicate that encapsulation
in a galactosylated gelatin matrix is able to signiﬁcantly enhance the secretion
of serum albumin, which oﬀers potential for use as liver-speciﬁc encapsulation
material since cell density can be increased.
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7.3.3.3 Galactosylation improves the functionality of encapsulated HepG2
cells
Based on the albumin secretion results, gelBGAL-MOD possessing a degree of
galactosylation of ± 25% was selected for in depth immunohistochemistry and
real-time PCR studies. Non-galactosylated gelatin methacrylamide (gelB-MOD)
was selected as control condition. The IHC results revealed the expression of
albumin (Figure 7.14 A-C) and HNF4α (Figure 7.14 D-F) throughout the entire
cultivation period in the modiﬁed hydrogels. The PAS staining (Figure 7.14 G-I)
indicated the storage of glycogen granules in the cytoplasm at all of the investigated
time points in the modiﬁed hydrogels. No diﬀerences in the staining of hepatocyte
speciﬁc proteins (IHC albumin and HNF4α) and the storage of glycogen (PAS
staining) were found between the gelB-MOD and gelBGAL-MOD hydrogels.
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Figure 7.14: Maintenance of the hepatocyte phenotype of the HepG2 cells in the hydro-
gels: IHC and PAS staining of HepG2 cells in 10w/v% gelBGAL-MOD.
The pictures A-C represent staining for albumin at day 1 (A), day 3 (B),
and day 7 (C). The pictures D-F represent staining for HNF4α at day 1
(D), day 3 (E), and day 7 (F). The pictures G-H represent staining for
glycogen at day 1 (G), day 3 (H), and day 7 (I). Pictures a-i are magni-
ﬁcations. Scale bar represents 50μm (A-I) and 10μm (a-i). The ﬁgure
shows the pictures of one representative experiment from three.
Quantitative gene expression analyses of albumin, TTR and HNF4α were per-
formed using a real-time PCR analysis. The albumin (p < 0.05), HNF4α (p <
184
0.01) and TTR (p < 0.05) expressions were signiﬁcantly downregulated at day 1
after cell encapsulation in the gelB-MOD. However, at longer incubation times
(day 3 to day 21), a gradual gene expression recovery towards the control levels
(at day 7) was observed and maintained for all three of the genes studied (Fig-
ure 7.15). For the gelBGAL-MOD hydrogel, gene expression analyses of albumin,
TTR and HNF4α using a real-time PCR analysis revealed gene expression levels
comparable to the control at day 1. Over time (up to day 21), the levels increased
signiﬁcantly (p < 0.05 for albumin and TTR and p < 0.01 for HNF4α) compared
to the control for all three of the genes tested.
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Figure 7.15: Real-time PCR analysis of HepG2 cells in a 10w/v% gelB-MOD and
gelBGAL-MOD hydrogels: gene expression levels of albumin (A), TTR
(B) and HNF4α (C). The RNA levels were normalized using GAPDH
as a stable housekeeping marker, while the relative gene fold changes,
compared to the gene expression of the control culture, were determined
using the 2−ΔΔCt method. The data are the mean RQ ± S.D., n = 3.
*p< 0.05; **p < 0.01; ***p < 0.001.
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Many papers have reported on an improvement of hepatocyte functions via ASGPR-
mediated interactions.357,438 Although the physiological function of the ASGPR is
the receptor-mediated endocytosis of galactose/N-acetylgalactosamine-terminated
ligands, it is also known to improve the hepatocyte phenotype. In most exper-
imental setups (except in the work of Yang et al.438), cell seeding, and not cell
encapsulation, was considered. Indeed, galactose functionalized gelatin sponges,
chitosan, and polystyrene scaﬀolds have all been reported for the successful cul-
tivation of hepatocytes.357,404,430,441,447,448 In the present work, we wanted to in-
vestigate whether the galactose-ASGPR interaction inﬂuences the functionality of
encapsulated cells.
The positive IHC staining for albumin (considered to be an important synthesis
product of hepatocytes) and HNF4α (a transcription factor for the expression of
hepatocyte speciﬁc genes), and the positive PAS staining, indicate the sustained
functionality of the encapsulated cells. Importantly, quantiﬁcation of the gene ex-
pression for albumin, HNF4α and TTR, with the latter being another important
synthesis product of hepatocytes, indicated the occurrence of a recovery period be-
fore the cells reached physiological gene expression levels in the non-galactosylated
hydrogel. Very interestingly, for the galactosylated hydrogel, the gene expression
of hepatocyte speciﬁc genes was even improved on and maintained over time.
Furthermore, the hydrogels had no adverse eﬀects on cellular proliferation, as sup-
ported by the positive Ki67 staining.
7.3.3.4 Characterization of the hepatocyte cell clusters
In a ﬁnal part of the study, an examination of the general cell morphology af-
ter encapsulation was performed. The data (Figure 7.16 A, a-c) revealed cells
with a round morphology and euchromatic viable nuclei, as indicated by the
hematoxylin/eosin staining (Figure 7.16 A, a,a’). The cells formed clusters from
day 3 onwards (Figure 7.16 A, b-c, b’-c’). In general, a better cell morphology
was observed for the clusters compared to the individual cells, indicating the im-
portance of cell-cell contact. The cluster formation and the constant viable cell
fraction over time (Figure 7.12 B) suggest that the encapsulated cells proliferate
at the same rate as the control. Proliferation was conﬁrmed by positive Ki67 cell
staining (Figure 7.16 A, d-f).
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Figure 7.16: Cell morphology and spheroid characterization. (A) The
hematoxylin/eosin and Ki67 IHC staining of HepG2 cells in 10w/v%
hydrogels. The pictures a-c represent hematoxylin/eosin stained cells at
day 1 (a,a’), day 3 (b,b’) and day 7 (c,c’) after encapsulation in 10w/v%
gelB-MOD. The pictures d-f represent IHC staining for Ki67 at day 1
(d,d’), day 3 (e,e’) and day 7 (f,f’), and show the proliferating cells. Scale
bar represents 50μm (a-f) and 10μm (a’-f’). The ﬁgure shows pictures
from one representative experiment of three. (B) Boxplot representing
the spheroid diameter in gelB-MOD and gelBGAL-MOD hydrogels at
day 3 and day 7. (C-D) Representative brightﬁeld images recorded at
day 7 after encapsulation in gelB-MOD (C) and in gelBGAL-MOD (D).
In both hydrogel types, spheroids were formed starting at day 3 post-encapsulation.
The spheroids were characterized at days 3 and 7 with respect to their mean di-
ameter and morphology. Although spheroids with highly variable diameters were
observed, no signiﬁcant diﬀerences in mean spheroid diameter were measured be-
tween the two hydrogel types. The mean spheroid diameter increased signiﬁcantly
(p < 0.05) between days 3 and 7, ranging from 76.73μm to 91.20μm for gelB-
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MOD and from 79.26μm to 96.09μm for gelBGAL-MOD. This further conﬁrms
the ability of cells to proliferate upon encapsulation within the hydrogels under
evaluation. Examination of the overall spheroid morphology revealed more pro-
nounced spheroid delineation in the gelBGAL-MOD (Figure 7.16 D) than in the
gelB-MOD (Figure 7.16 C).
As already mentioned, the interaction between sugar moieties (in this case galac-
tose and ASGPR) is known to promote the formation of round cells and spheroids,
thereby improving hepatocyte speciﬁc functions.438,440,441 In this study, the forma-
tion of spheroids with highly variable diameters was observed in both hydrogels,
and no signiﬁcant diﬀerences in mean spheroid diameter were observed. This is
in contrast to the data described by Yang and co-workers,438 where a more pro-
nounced spheroid formation could explain the improved hepatocyte function after
encapsulation in a galactosylated alginate gel. However, the spheroid morphology
in the two hydrogels utilized herein was diﬀerent. A more pronounced delineation
of the spheroids was observed in the galactosylated hydrogels, suggesting more
established cell-cell contact. We concluded that the observed improvement in the
hepatocyte functions must be related to the improved quality (better cell-cell con-
tact) of the spheroids formed in the galactosylated hydrogel.
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7.4 | Conclusion
In the present chapter, material properties as well as cell biology eﬀects caused by
the introduction of galactose-containing moieties was evaluated. First, the intro-
duction of galactose pendent moieties on the backbone of photo-sensitive gelatins
was investigated. Second, the eﬀects of the galactosylation on (i) the physico-
chemical properties of gelatins undergoing photopolymerization and (ii) the bio-
logical responses of encapsulated cells were examined.
A range of galactosylated gelatin methacrylamides was designed, having galactosy-
lation degrees up to 25% with respect to the free amines available on gelatin. The
presence of galactose was shown to hamper the cross-linking eﬃciency related to
the photopolymerization of the methacrylamide functions. As a result, conversion,
gel yields en storage moduli decreased, while the equilibrium mass swelling ratios
increased. Additionally, type A based gelatins exhibited lower hydrogel stiﬀness
and decreased gel yields compared to type B gelatins.
For encapsulation in type A gelatin, cell survival levels were lower compared to
type B gelatins. The photopolymerization triggered curing strategy did not signiﬁ-
cantly aﬀect cytocompatibility, and it has been shown that highly viable (> 90%)
cell-laden constructs could be obtained for 10w/v% gelB-MOD and gelBGAL-
MOD hydrogels. The introduction of galactose moieties did not aﬀect cell survival,
however, albumin secretion was upregulated up to three-fold at day 7 for a galac-
tosylation degree of 25%. Additionally, galactosylated gelatin methacrylamides
demonstrated signiﬁcant improvement of hepatocyte speciﬁc function expression.
Therefore, in combination with the tuneable hydrogel properties, the developed
materials show promising potential for encapsulation of hepatocyte-like cells aim-
ing for liver-like tissue engineering applications.
Building further on the obtained data, the possibility that the eﬀects described
above are only the consequence of transduction events taking place upon the
ligand-receptor interaction must be taken into account. It has been reported that
the interaction between glycopolymers and ASGPR can both regulate integrin-
mediated signaling via the inhibition of FAK phosphorylation, and inﬂuence hep-
atocyte survival signaling. Moreover, the binding of the ASGPR to a galacto-
sylated substrate may block receptor degradation via a post-translational mech-
anism.404,441 These reports indicate that diﬀerent signal transduction events are
triggered upon ASGPR binding. It is thus plausible that only the interaction be-
tween the immobilized ligand and its receptor is suﬃcient to improve hepatocyte
functions via the modulation of intracellular pathways. The latter hypothesis could
be a crucial subject for further investigation, since understanding the signal trans-
190
duction events taking place might, in general, contribute to the maintenance of in
vitro hepatocyte functionality. Moreover, the in-depth evaluation of the galacto-
sylated gelatin hydrogel with primary hepatocytes is an important topic for future
research.
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The present chapter describes the bulk and surface galactosylation of gelatins via
an intermediate photocross-linkable monomer. For this, plasma treatment was
explored as a potential surface activation step.
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8.1 | Introduction
Conventionally, bulk modiﬁcation of gelatins occurs via either the free carboxylic
or the free amine functionalities available on the backbone of the amino acid se-
quence.223,358,359,449 As a logical drawback, increasing the modiﬁcation degree is
limited to the amount of those free functional groups. Previously (chapter 7),
we demonstrated the impact of bulk galactosylation on the functional behavior
of HepG2 cells. By means of carbodiimide chemistry, galactose content could be
tailored to a certain extend, limited not only by the amount of free amines but
furthermore also by the necessary amount of photocurable methacrylamide groups
that were also introduced via the free amines. Hong et al.357 increased the gelatin
free amine content from 0.33 to 0.41mmol g−1 gelatin prior to galactosylation by
reaction of gelatin free carboxylic groups with ethylene diamine. The ﬁnal amount
of galactose groups was not quantiﬁed. Our results indicated a relatively low
reaction eﬃciency for the galactosylation of gelatins.
The question arises whether an inhibitory eﬀect could occur with increasing galac-
tose content, thus alternative strategies are desired in order to control the galac-
tosylation over a broad range of concentrations. Narain et al.450 synthesized
cyclic sugar methacrylate monomers for the atom transfer radical polymerization
(ATRP) in methanol/water mixtures using PEO-based macroinitiators. The cyclic
sugar ring was preserved, being an important advantage when aiming for molecular
recognition applications. Via this pathway, bulk copolymerization of cyclic galac-
tose methacrylate monomers with photocross-linkable hydrogel precursors should
be possible and serve as an alternative bulk modiﬁcation strategy.
Plasma techniques cover plasma-treatment, post-plasma irradiation grafting, plas-
ma syn-irradiation grafting and plasma polymerization, and allow surface targeted
modiﬁcation.169,451 Applying Ar, O2, N2, or NH4 plasmas results in the introduc-
tion of radicals, oxygen containing functional groups, or nitrogen containing func-
tional groups on the surface.169,451 These functionalities can be applied for further
modiﬁcation with bioactive ligands. Our group grafted 2-aminoethyl methacry-
late as intermediary step for the immobilization of proteins on PCL surfaces to
increase their biocompatibility and cell interactions.148 Ying et al.452 reported
the covalent coupling of galactose-containing molecules to post-plasma irradiation
grafted acrylic acid on hydrophobic PET surfaces using carbodiimide chemistry.
To our best knowledge, the post-plasma irradiation grafting of galactose-carrying
molecules on hydrogel surfaces has not been reported so far. Altogether, limited
studies are known about the use of plasma treatments on hydrogels for biocom-
patibility enhancements. Such studies focused mainly on the eﬀect of the applied
plasma treatment on hydrogel biocompatibility, instead of using plasma treatments
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as an intermediary step for post-plasma grafting of bioactive ligands. For exam-
ple, chitosan was treated with oxygen plasma to increase surface hydrophilicity by
Wang et al.453 However, the eﬀects of the plasma treatment were not permanent
due to an aging process involving reorientation of polar functional groups. Nitro-
gen treated gelatin ﬁlms increased mouse ﬁbroblast cell adherence and prolifera-
tion.454 These examples can be regarded as non-cell speciﬁc surface modiﬁcation
approaches.
In this chapter we report on the evaluation of galactose bulk and surface functional-
ized gelatin methacrylamides. The synthesis of 2-lactobionamidoethyl methacry-
late monomer and its subsequent copolymerization with or grafting on gelatin
methacrylamide hydrogels is examined. For the grafting, a post-plasma UV-
induced grafting process is introduced. The hypothesized grafting strategy ap-
plied is depicted in Figure 8.1. The objective was focused on gaining insight on
the grafting conditions related to the resulting galactose densities, surface wet-
tabilities, and topographical changes. Secondly, using primary hepatocytes, the
eﬀect of the grafting step is evaluated toward cell attachment morphology.
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Figure 8.1: Post-plasma surface grafting of gelatin with LAEMA monomer. (A) Argon
plasma treatment of gelatin ﬁlms followed by exposure to air. (B) UV-
induced graft polymerization of LAEMA monomer from gelatin surfaces.
(C) Chemical structure of the grafted polymer chains (pLAEMA).
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8.2 | Experimental Part
8.2.1 Synthesis of 2-lactobionamidoethyl methacrylate
2-lactobionamidoethyl methacrylate (LAEMA) was synthesized according to the
method reported by Narain et al.450 with slight modiﬁcation (Figure 8.2). Lac-
tobionolactone was prepared by repeated vacuum distillations of 15 g lactobionic
acid (LA, Sigma-Aldrich) in 150mL of anhydrous methanol at 50 ◦C. Conversion
was followed by thin layer chromatography (TLC) using 65:25:15 EtOH:H2O:HAc
(Rflactobionolactone = 0.57, Rflactobionicacid = 0.8). Freshly prepared lactobionolactone
(10.0 g, 29.4mmol) was immediately dissolved in 20.0mL methanol at 50 ◦C and
cooled to room temperature before the addition of 15.0mL methanol solution of
2-aminoethyl methacrylate hydrochloride (10 g, 60.4mmol, AEMA, Polysciences)
and 10.0mL of triethylamine (71.8mmol). The mixture was kept stirring at room
temperature overnight. The ﬁnal product was precipitated in 2-propanol followed
by dichloromethane washing and dried under vacuum. Final yield of LAEMA
was 72%. Characterization of the LAEMA monomer by both 1H and 13C NMR
spectroscopy (Figure 8.3) conﬁrmed its high purity (> 99%).
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Figure 8.2: Synthesis of LAEMA monomer by the ring-opening reaction of lactobiono-
lactone with 2-aminoethyl methacrylate at 20 ◦C.
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8.2.2 Synthesis of gel-MOD and hydrogel ﬁlm preparation
Bovine type B gelatin (Rousselot, Ghent) was chemically modiﬁed with methacryl-
amide side groups, as described in section 4.2.2. The degree of substitution, i.e.
the amount of free amines converted to methacrylamide functionalities, was 63%
as determined by 1H NMR spectroscopy.
gel-MOD-LAEMA - Gelatin methacrylamide solutions containing diﬀerent con-
centrations of the LAEMA monomer were casted in ﬁlms following the protocol
from section 4.2.2.2. These samples will be referred to as gel-MOD-LAEMA.
gel-MOD - Substrates for LAEMA grafting were prepared by covalent coupling
of the gel-MOD precursor mixtures to pre-activated glass cover slips, in order to
prevent substrate ﬂoating. The glass cover slips were thoroughly rinsed with n-
hexane and ethanol and dried. Subsequently, the clean cover slips were treated
with a 2 v/v% solution of 3-(trimethoxysilyl)propyl methacrylate (Sigma-Aldrich)
in 95% EtOH (pH 5 with acetic acid) for 3min, rinsed with 100% EtOH and
baked at 110 ◦C for 10min, leaving free methacrylate groups on the glass to react
with gel-MOD during UV exposure. The gelatin hydrogel ﬁlms were incubated
overnight at 37 ◦C to remove the unreacted fraction. The ﬁlms were dried under
vacuum and stored at 5 ◦C prior to use.
8.2.3 Gel-MOD surface galactosylation
8.2.3.1 Argon plasma pre-treatment of gelatin ﬁlms
Prior to the grafting process, (hydro)peroxides were introduced on the gelatin
surfaces. Dry gelatin ﬁlms were therefore subjected to an Argon plasma in a
cylindric dielectrical discharge plasma reactor (Model Femto, version 3, Diener
Electronic, Germany) for 60 s. More info can be found in section 11.1.3. The
Argon pressure was kept at 0.8mbar and the applied power was 100W. In order
to enable the reaction of free radicals on the surface with oxygen to generate
(hydro)peroxides, the treated surfaces were exposed to the ambient atmosphere
for 10min prior to the UV grafting. The introduced active sites were subsequently
used as initiating groups for the UV-induced graft polymerization.455,456 In this
article, gel-Ar will be used to refer to these samples.
8.2.3.2 Grafting of LAEMA on gelatin surface
The pre-activated dry gelatin ﬁlms were immersed in an aqueous LAEMA solution.
The LAEMA solution was always freshly prepared and degassed at least 1 h prior
to the grafting step. To investigate possible eﬀects of the monomer concentration
on the grafting eﬃciency, the LAEMA concentration was varied from 0.1M to
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0.2M. The ﬁlms were placed for diﬀerent incubation times in a custom-made glass
6-well plate with a quartz cover. In this article, we will refer to these samples as
gel-LAEMA x, where “x" indicates the grafting time (in minutes). Finally, the
ﬁlms were thoroughly rinsed with doubly distilled water, incubated overnight at
37 ◦C, and dried under vacuum.
8.2.4 Evaluation of the modiﬁcation strategies
8.2.4.1 Equilibrium swelling experiments
gel-MOD-LAEMA samples with varying concentrations of copolymerized LAEMA
were subjected to equilibrium swelling experiments as described in section 4.2.3.2.
8.2.4.2 Galactose oxidase assay
The Amplex Red Galactose/Galactose Oxidase Assay Kit (Invitrogen) was used
for the quantitative determination of the copolymerized and grafted amounts of
LAEMA monomer. The protocol has been described in section 11.4.3. For the
quantiﬁcation of the LAEMA amount copolymerized with gel-MOD (gel-MOD-
LAEMA samples), the samples were ﬁrst incubated overnight in a solution of
collagenase (2Umg−1 gelatin, Sigma) in Tris-HCl buﬀer (0.1M, pH 7.4). All mea-
surements were performed in triplicate. Similar measurements were performed, in
which the sample ﬁlms were replaced by a series of solutions with known concen-
tration of galactose (dilution series from 2− 250μM of LAEMA).
8.2.4.3 Infrared spectroscopy
Changes due to the copolymerization of LAEMA with gel-MOD were characterized
using FT-IR spectroscopy in ATR mode, according to section 4.2.3.1.
8.2.4.4 Rheological characterization
Mechanical spectra of equilibrium swollen gel-MOD-LAEMA ﬁlms and the in situ
monitoring of the UV irradiation curing of gel-MOD-LAEMA mixtures were per-
formed as described in section 4.2.3.5.
8.2.4.5 Static contact angle measurements
Static water contact angle measurements were performed to analyze the eﬀect of
the grafting procedure on the wettability of the substrate surface. Measurements of
gelatin, gel-Ar, and gel-LAEMA surfaces were performed according to the protocol
described in section 4.2.3.3. Each sample was measured at least in triplicate and
each sample condition was analyzed in duplicate (n ≥ 6).
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8.2.4.6 X-ray photoelectron spectrometry
X-ray photoelectron spectrometry (XPS) was used to study alterations in the
chemical composition of the surfaces caused by the argon plasma treatment and
post-plasma grafting with LAEMA monomer. Gelatin, gel-Ar, and gel-LAEMA
samples were analyzed. The setup is described in section 4.2.3.1. A survey scan
spectrum was collected and from the peak-area ratios, the relative elemental com-
position of the material top layer was determined. The C 1s core signal was also
collected. The generated data are displayed as a plot of the electron counts versus
electron binding energy in a ﬁxed, small energy interval.
8.2.4.7 Atomic force microscopy
Topographical changes induced by the argon plasma treatment and LAEMA graft-
ing steps were studied by atomic force microscopy (AFM). AFM images were ob-
tained in ambient conditions using the setup described in section 3.2.5. Surface
scans of 15μm2 were recorded in tapping mode with a silicon cantilever (OTESPA
- Veeco).
8.2.5 Preliminary cell seeding experiments
Primary mouse hepatocytes were isolated and cultured as described in section
6.2.3.1. Preliminary cell seeding experiments were performed on gel-MOD, gelGAL-
MOD, and gel-LAEMA samples (500 000 cells/sample), and brightﬁeld images were
recorded after 4 h post-seeding.
8.2.6 Statistical analysis
All measurements were performed with n ≥ 3, unless otherwise stated, and the
experimental results are reported as mean ± standard deviation (S.D.). Statistical
analysis was performed with Student’s t-test and signiﬁcance was determined at p
< 0.05.
8.3 | Results and Discussion
8.3.1 Synthesis of LAEMA monomer
Both the bulk as well as the surface functionalization of the gel-MOD samples is
based on the polymerization of a cyclic photocross-linkable galactose-containing
monomer. As a disaccharide aldonic acid, lactobionic acid was selected as precursor
to prepare a polymerizable glycomonomer. It comprises a galactose and a gluconic
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acid linked via an enzymatically hydrolyzable glycosidic bond. The ﬁrst step in the
synthesis of LAEMA involved a conversion of lactobionic acid to lactobionolactone.
This was performed by dissolving LA in dry methanol at 50 ◦C followed by vacuum
distillation. Complete conversion was achieved by repeated distillation cycles and
monitoring of the conversion by means of TLC. Next, dry lactobionolactone was
reacted with AEMA to yield the LAEMA monomer. 1H and 13C NMR spectra of
the achieved puriﬁed LAEMA monomer are presented in Figure 8.3.
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Figure 8.3: Assigned 1H (A) and 13C (B) NMR (D2O) spectra for 2-
lactobionamidoethyl methacrylate monomer.
Two-dimensional NMR spectroscopy measurements were performed in order to
assign the peaks. The spectra conﬁrm the successful synthesis of the LAEMA
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monomer and can be assigned as in Figure 8.3. A reasonable yield (∼ 72%) was
reached (purity was > 97 %). Deng et al.457 synthesized a series of glycopolymers
by RAFT homo- and copolymerization reactions of 2-aminoethyl methacrylamide.
For the latter, a yield of ∼ 60% was achieved. The slightly lower yield can be
attributed to the slightly lower activity of the 2-aminoethyl methacrylamide pri-
mary amine compared to AEMA. Narain et al.450 achieved a yield of ∼ 78% for
the synthesis of LAEMA. Our yield is in good agreement with those reports.
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Figure 8.4: Changes in the infrared spectra of gel-MOD after copolymerization with
LAEMA monomer to obtain gel-MOD-LAEMA hydrogels.
8.3.2 LAEMA can be copolymerized to increase galactose
bulk content
In this chapter, two applications using LAEMA monomer for the galactosyla-
tion of gel-MOD are evaluated. In this part, the copolymerization of LAEMA
monomer with gel-MOD macromonomer is evaluated. Prior to UV-induced free
radical polymerization, varying amounts of LAEMA were mixed into gel-MOD
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precursor solutions to result in gel-MOD-LAEMA hydrogels.
Typical infrared spectra of cross-linked gel-MOD hydrogel ﬁlms, uncross-linked
LAEMA monomer, and cross-linked gel-MOD-LAEMA hydrogels are displayed in
Figure 8.4. The characteristic peaks of gelatin have been discussed previously.
For LAEMA, a broad absorption in the region between 3400 and 2600 cm−1 (N-
H, O-H stretch), the peak at 1705 cm−1 due to the carbonyl stretching (C=O),
and the C-O stretch at 1035 cm−1 characterize the monomer. This is in close
correlation to the infrared spectrum reported by Yoon et al.458 For gel-MOD-
LAEMA, the characteristic gel-MOD peaks were more abundant compared to the
peaks stemming from LAEMA copolymerization. However, it is clear that LAEMA
was successfully incorporated in the hydrogel networks.
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Figure 8.5: The copolymerization of 10w/v% gel-MOD with LAEMA as a function of
the added amount of LAEMA: equilibrium swelling studies (A,B), quan-
tiﬁcation of the copolymerized LAEMA (C), and eﬃciency of the LAEMA
copolymerization (D). All samples received 14 400mJ cm−2 of UV-A irra-
diation.
The copolymerization of gel-MOD macromonomer with LAEMA monomer was
initially studied by means of swelling experiments and galactose/galactose oxidase
amplex red assay. Since sugar moieties (or even short chains) are introduced,
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we anticipated some inﬂuence on gel yield and swelling behavior. As described
in chapter 7, galactose can act as a free radical scavenger, thus inhibiting the
photocross-linking to some extend while also increasing the swelling ratio. On
the other hand, LAEMA will actively participate in the polymerization by its
own methacrylate groups. Figure 8.5 summarizes the results for the equilibrium
swelling studies (A,B) and the quantiﬁcation of the incorporated LAEMA units
(C,D) in function of the amount of LAEMA.
Varying the amount of LAEMA from 0, i.e. gel-MOD, to 0.5 equivalents (rela-
tive to the amount of free amines on gelB) did not signiﬁcantly decrease the gel
yield (Figure 8.5 A). Only for concentrations higher than 1 equivalent, a small
decrease in gel yield could be observed (p ≤ 0.03). On the other hand, the wa-
ter uptake capacity did increase with increasing LAEMA concentration (Figure
8.5 B). This suggests that more LAEMA is eﬀectively built-in into the hydrogel
network, thereby increasing the swelling potential, as is conﬁrmed by the galac-
tose oxidase assay (Figure 8.5 C). The copolymerization eﬃciency was highest for
0.25 equivalents of added LAEMA (which is by and large similar to the degree
of galactosylation of 25% reported in chapter 7). For the other concentrations,
the eﬃciency was situated ∼ 60− 70%. Perhaps this is governed by the increased
radical scavenging of the galactose moieties at higher concentrations, while for
lower concentrations the increased cross-linkable moieties outweigh the scavenging
eﬀects, thereby reaching an optimal concentration.
Despite the more or less similar gel yields obtained, a clear increase in swelling po-
tential could be observed. Therefore, the resulting equilibrium swollen gel-MOD-
LAEMA hydrogels have decreased storage moduli G′ with increasing LAEMA
content (data not shown). More interesting however is the curing behavior in situ.
Storage moduli G′ recordings during UV-induced cross-linking are presented in
Figure 8.6 in function of the LAEMA concentration.
In line with our anticipations, the increase in storage moduli of gel-MOD-LAEMA
precursor solutions upon curing was inﬂuenced by the LAEMA monomer con-
centration. In general, it could be concluded that the curing is slowed down by
the addition of LAEMA. For high concentrations, i.e. 1 and 2 equivalents, the
LAEMA content also aﬀected the starting value of G′ prior to irradiation. On
the other hand, for the 0.5 equivalents of added LAEMA, the after curing proved
more pronounced. As a small remark, it should be noted that the intensity of the
UV probe was higher compared to similar recordings in previous chapters. There-
fore, the control condition (gel-MOD) has a steeper increase during UV irradiation
when compared to previous ﬁgures. This however, does not aﬀect the correctness
of the observed trends.
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Figure 8.6: The copolymerization of 10w/v% gel-MOD with LAEMA as a function of
the added amount of LAEMA: in situ recordings of the increase in storage
moduli G′ upon UV-A irradiation.
Our ﬁndings demonstrate that tailoring of the bulk galactose content of photosen-
sitive gelatins can be achieved by means of copolymerization with a polymerizable
glycomer. It should be kept in mind that the polydispersity will be high and the
inﬂuence of LAEMA incorporation on cell biology is still subject to future research.
8.3.3 Two-step LAEMA immobilization on gelB-MOD sur-
faces
As a second modiﬁcation approach, LAEMA monomer was applied for the graft-
ing on gel-MOD surfaces. In previous work, we reported on the grafting of
AEMA monomer onto polyester substrates using plasma surface activation.148
Post-plasma UV-induced irradiation grafting of monomers onto gelatin substrates
could not be found in literature. Nonetheless, Yoon et al.458 successfully grafted
LAEMA monomer on gold nanoparticles via ATRP. Lopez and coworkers459 func-
tionalized PET surfaces with galactose moieties by NH3 plasma treatment, con-
version of the surface free amines to carboxyl functions and coupling with galac-
tosamine using carbodiimide chemistry.
We selected a surface functionalization consisting out of two ensuing steps: (i) gel-
MOD substrates were subjected to argon plasma, followed by oxygen exposure to
introduce (hydro)peroxides, and; (ii) the introduced (hydro)peroxides consequently
serve as initiating sites for the grafting of LAEMA monomer via exposure to UV
irradiation. This is schematically presented in Figure 8.1.
In a ﬁrst set of experiments, a suitable plasma treatment time was searched for.
Initially, the static contact angle (SCA) advancement provided a ﬁrst criterium.
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The surface wettability has to be high enough to ensure good contact with the
grafting medium later on. At the same time, the introduced (hydro)peroxides will
increase the surface wettability (at the condition of similar roughnesses). Figure
8.7 A illustrates the decreasing SCA, i.e. increasing wettability, due to increasing
plasma treatment times.
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Figure 8.7: Inﬂuence of argon plasma treatment on gelatin surfaces (A) and recovery
of the static contact angles after respective grafting with 0.2M LAEMA
monomer (*p < 0.05).
The increasing wettability of gel-MOD surfaces after 30 s, 60 s, and 120 s was not
statistically signiﬁcant. Still, the wettability was improved when compared to
non-treated samples. Figure 8.7 B summarizes the recovery of the SCA after the
grafting step. LAEMA grafted samples will be referred to as gel-LAEMA. Two
plasma treatment times were selected: 30 s and 60 s. A plasma treatment time
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of 60 s resulted in a signiﬁcantly decreased SCA after the grafting step, while
for a treatment of 30 s, the SCA after grafting could not be distinguished from
non-modiﬁed surfaces. As such, a treatment time of 60 s was selected for further
investigation. As a small remark, it should be noted that at this point the reduced
SCA could be attributed to either changes in the topographical roughness or due
to a more eﬃcient grafting step. However, this was not investigated in detail.
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Figure 8.8: The eﬀect of UV exposure time and LAEMA concentration on (A) the
grafted concentration of galactose moieties on the gel-LAEMA surfaces as
determined by the galactose oxidase assay, and (B) the wettability of the
gel-LAEMA surfaces as determined by static contact angle measurements.
Next, the immobilization of LAEMA monomer onto gel-MOD surfaces as a func-
tion of the graft solution concentration and UV irradiation graft time was eval-
uated. The amount of grafted LAEMA units and the outcome on the resulting
contact angles is given in Figure 8.8. Grafting times of 15− 120min and graft
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solution concentrations of 0.1 and 0.2M were evaluated. As expected, increasing
both parameters results in increased amounts of grafted LAEMA monomer. As for
the static contact angles, the wettability increased with increasing concentration
and UV exposure times.
Due to the grafting, pLAEMA chains are ented on top of the gelatin surfaces,
thereby altering the chemical composition of the surface top layer. Data collected
by XPS survey scans (Figure 8.9 and Table 8.1) and C 1s detail scans (Figure 8.10
and Table 8.2) give insight in these compositional changes.
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Figure 8.9: XPS survey spectra of (A) gel-MOD, (B) gel-Ar, and (C) gel-LAEMA120.
Due to the argon plasma treatment, the relative amount of oxygen is increased. It is
believed that the radicals that are introduced by the argon plasma will readily react
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Table 8.1: Inﬂuence of gelatin surface functionalization on the surface composition de-
termined by XPS analysis.
SAMPLE NAME SURFACE COMPOSITION [%] ATOMIC RATIO
O 1s C 1s N 1s N/C O/C
gel-MOD 18.5±0.6 66.6±0.4 14.9±0.2 0.22 0.27
gel-Ar 22.8±1.2 69.1±1.2 8.6±2.3 0.12 0.33
gel-LAEMA30 30.7±0.5 64.7±0.1 4.7±0.6 0.07 0.48
gel-LAEMA60 31.2±0.7 65.8±1.1 3.2±0.5 0.05 0.47
gel-LAEMA120 33.4±1.4 63.4±1.8 3.2±0.5 0.05 0.53
pLAEMA∗ 40.6 56.3 3.1 0.05 0.72
∗ theoretical values
with oxygen from the air, thus forming oxygen-rich functionalities. Immobilization
of LAEMA monomer alters the chemical composition of the surface, which will
converge to the theoretical composition of pure pLAEMA (indicating a complete
coverage with a layer thickness that equals or is larger than the XPS depth of
analysis).
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Figure 8.10: XPS C 1s signals of gelatin methacrylamide hydrogels: cross-linked gel-
MOD (A), gel-Ar (B), and gel-LAEMA with grafting times of 30 min (C),
60 min (D), and 120 min (E).
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Compositional changes as a result of the surface modiﬁcation steps are demon-
strated nicely in the decomposition of the C 1s envelopes (Figure 8.10). For sim-
plicity, three peaks were assigned for the deconvolution, as has been described
previously.
Table 8.2: Decomposition of the C 1s envelope in diﬀerent components (in percentages).
SAMPLE NAME RELATIVE INTENSITIES OF C 1s [%]
285 eV 286.7 eV 288.5 eV
gel-MOD 52.1±1.4 26.9±0.8 21.0±0.9
gel-Ar 60.4±1.6 24.3±1.0 15.3±1.2
gel-LAEMA30 47.6±0.8 37.5±1.3 14.9±2.1
gel-LAEMA60 46.1±1.1 41.2±1.0 12.7±1.6
gel-LAEMA120 44.5±0.3 47.4±1.7 8.1±1.9
pLAEMA∗ 43 50 7
∗ theoretical values
In correlation to the survey scan data, the C 1s peak attributions also converge
to the theoretical value of pLAEMA. Since there still exist a discrepancy over a
grafting time of 2 h, the results propose the idea of grafting clusters instead of
a homogeneous coverage of the sample surface. This was further investigated by
AFM mappings and roughness analysis (Figure 8.11).
The plasma treatment etched the surface of gel-MOD hydrogels, leading to a slight
drop in surface roughness (not signiﬁcant). Upon grafting, clusters of pLAEMA
are formed on the surface. With increasing grafting time, these clusters grow
bigger and surface roughness is increased. It can be seen that the dimensions of
these clusters are polydispers and at a grafting time of 2 h, almost a complete
coverage is reached. These data, together with the XPS measurements conﬁrm
the successful grafting of LAEMA monomer on gelatin hydrogel surfaces.
Previous work in our group demonstrated a suﬃcient argon plasma treatment time
of 30 s for the grafting of AEMA on PCL surfaces.148,444 The work of Prasertsung
on nitrogen and oxygen plasma treatments of gelatin surfaces advocated improved
L929 mouse ﬁbroblast adhesion and proliferation.454,460 However, the surface chem-
istry recovered over time. The present ﬁndings recommend longer argon plasma
treatment times for gelatin hydrogels, in case grafting of monomers is targeted.
For the immobilization of galactose moieties on several substrates, conventionally,
plasma grafting of carboxyl or amine-containing monomers (e.g. acrylic acid) is
applied in combination with a second step mostly involving carbodiimide cou-
pling.404,430,448,459 In our setup, direct immobilization of (polydispers) clusters
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containing galactose moieties is made possible. The UV irradiation time and graft
solution concentration can be adjusted to obtain diﬀerent grafting densities.
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Figure 8.11: Evolution of the surface topography following the diﬀerent modiﬁcation
steps as determined by AFM analysis: (A) cross-linked gel-MOD served as
a reference, (B) gel-Ar after 60 sec plasma treatment, (C-D) gel-LAEMA
samples with increasing UV-grafting times of 30 min (C), 60 min (D), and
120 min (E). (F) Represents the evolution of the surface roughness (Ra)
as determined by AFM analysis on scan areas of 15μm2 (p < 0.05).
8.3.4 Preliminary cell seeding
Primary mouse hepatocytes were seeded on gel-MOD, gelGAL-MOD (DG = 25%),
gel-LAEMA30 and gel-LAEMA60 to investigate hepatocyte morphology. Colla-
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gen coated tissue culture plastic (TCP) was used as positive control condition.
Brightﬁeld images recorded 4 h post-seeding are given in Figure 8.12.
A
D
CB
E
a
d
cb
e
Figure 8.12: Brightﬁeld images of primary mouse hepatocytes seeded on collagen
(A,a), gel-MOD (B,b), gelGAL-MOD (C,c), gel-LAEMA30 (D,d) and gel-
LAEMA60 (E,e). Scale bar represents 200μm (A-E) and 50μm (a-e).
It can be seen that hepatocytes attached to the surfaces, with highest cell at-
tachment rates for gel-MOD and gelGAL-MOD and decreased attachment for the
gel-LAEMA samples. Nevertheless, the latter samples promoted the formation of
aggregates and attachment of aggregate-like clusters instead of the monolayer-type
attachment observed with the gel-MOD and gelGAL-MOD samples. Increasing
round morphology is demonstrated with the presence of galactose moieties com-
pared to plain gel-MOD. As explained in the introduction of chapter 7, round
morphologies are desired. Our ﬁndings are in correlation with reports from lit-
erature.448,452 Several authors have demonstrated that diﬀerent cell attachment
morphologies (HepG2 cells) can be achieved by plasma treatment with or without
galactose immobilization (via carbodiimide chemistry) on PET and PNIPAAM
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surfaces.448,459 Silva et al.461 proved that plasma modiﬁcation of chitosan surfaces
improved the biocompatibility. Additional experiments have yet to be performed
to investigate long-term cultivation inﬂuences on hepatic phenotypical expression,
however, our ﬁrst experiments suggest that surface grafted galactose moieties im-
pair the attachment strength based on the observations during these preliminary
screening.
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8.4 | Conclusion
Liver-like cells can be targeted by means of the ASGPR receptor on the cell
membrane. We demonstrated the potential of a cross-linkable glycomonomer, 2-
lactobionamidoethyl methacrylate, for bulk as well as surface functionalization of
gelatin matrices. Both strategies make use of UV energy. Manipulation of the
UV irradiation dose and LAEMA concentration enables to control the amount of
introduced galactose moieties.
The developed substrates can be regarded as an extension of the simpler bulk
galactosylation strategy described in chapter 7. The modiﬁcation strategies allow
for easy preparation of galactosylated substrates whereby either the bulk or the
surface can be functionalized starting from gel-MOD macromonomer and LAEMA
monomer.
In depth biological characterization of the presented modiﬁcation strategies still
has to be performed. By this, it would be interesting to investigate if there is
a certain barrier at which any more galactose units do not further improve the
biological response, or if there even exists an adverse eﬀect.
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9 | Clean Production of Gelatin-Based
μ-Particles Using Electrospraying
in Dripping Mode: a Parametric
Study Towards Microencapsulation
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This chapter explores the production of hydrogel microparticles by means of electro-
spraying. This technique is theoretically not a rapid prototyping technique, however
it is also not considered to be a conventional technique. Together with electrospin-
ning, these techniques oﬀer possibilities for the production of three-dimensional
cell substrates. In this chapter we focussed on the potential as microencapsulation
technique.
215
9.1 | Introduction
Microcarriers have been frequently used in a broad range of medical applications
(e.g. for embolization therapy).462 Most appealing are the applications as drug de-
livery vehicles463–466 or cell encapsulation matrices.467,468 Other applications could
be aimed at cell expansion, delivery of bioactive agents via secondary incapsulation
in hydrogel systems, and incorporation of microparticles to introduce porosity in
TE matrices. However, the production of microcarriers with a homogeneous size
distribution continues to be challenging. A variety of techniques have therefore
been established as a fabrication route towards such carriers, including: droplet
formation, desolvation, coacervation and emulsiﬁcation methods.469 The most un-
complicated methods remain droplet formation techniques, established by simple
gravitational forces, coaxial air/liquid ﬂow, vibrating capillary, rotating systems
and, more recently, electrostatic potential.
In electrospraying, a liquid precursor droplet is formed at the tip of a nozzle. When
the nozzle is maintained at high electrical potential, a charge is induced on the
surface of the droplet, forcing the liquid to be dispersed into ﬁne droplets. Nearly
monodisperse beads, with sizes ranging from hundreds of micrometers down to tens
of nanometers can be fabricated, depending on the processing parameters.470,471
Furthermore, the biological activity of protein-based electrosprayed particles re-
mains intact.472 Several atomization modes can be established (see section 11.1.4),
and are a function of the applied ﬁeld strength and ﬂow rate.473 The three most
encountered modes are:
1. Dripping modes;
2. Cone-jet modes, and;
3. Multi-jet modes.
Dripping modes are characterized by a direct ejection of liquid fragments from
the nozzle tip. The ejected fragments can take the shape of regular large drops,
ﬁne droplets, elongated spindles, or even irregular geometries. In the case of
jet modes, the liquid ejects in the form of a continuous jet, which breaks into
droplets only at some distance from the tip of the nozzle. Key parameters that
determine the outcome of an electrohydrodynamic atomization (EHDA) process
are: the applied voltage, the working distance, the feed rate, the nozzle diam-
eter, and the physical/chemical properties of the precursors. Moreover, stable
electrospraying processes are diﬃcult to establish for high surface tension solu-
tions (e.g. water solutions) because high nozzle-ground voltage diﬀerences are
required for EHDA, while the corresponding electric ﬁeld strength exceeds the
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electric breakdown threshold of the surrounding gaseous medium (e.g. air) and
triggers corona discharge.474 Poncelet et al.475 studied the eﬀect of needle gauge,
viscosity, and ﬂow rate on alginate microbead size and droplet formation. Zhou
et al.476 applied electrospraying in order to scale up hepatocyte encapsulation in
collagen/terpolymer microbeads. Recently, Xie and Wang477 studied the eﬀect of
an ancillary electric ﬁeld in order to achieve mono-dispersed microencapsulation of
living cells in a 2% sodium alginate aqueous solution. Wang et al.478 used a high-
voltage electrostatic droplet generator to examine drug encapsulation properties
in alginate/poly-L-arginine/chitosan ternary complex microcapsules.
Alginates are linear polysaccharides consisting out of 1-4 linked α-D-guluronic acid
(G) blocks, β-D-mannuronic acid (M) blocks, and alternating MG blocks. Alginate
hydrogels have been frequently applied in cell encapsulation strategies and in the
preparation of drug delivery vehicles.83,84,102,194,476,477,479 Alginate gelation can be
triggered with multivalent cations (Ca2+, Ba2+, Cu2+), which induce the formation
of a cross-linked gel network through ionic interactions with the carboxylic groups
of the G blocks.480–482 On the other hand, gelatin is regarded as a biocompatible,
bioactive, biodegradable and low cost biomaterial.469,483 A combination of sodium
alginate, for improved stability (however no cell interaction),484,485 and gelatin type
B, for enhanced cell interactions, was selected as starting blend for this work.
To the best of our knowledge, up to this date, electrospraying of all-aqueous gelatin-
sodium alginate blend solutions is not yet reported. The study in this chapter had
as main objective to examine whether it is possible to obtain a stable electrospray
process speciﬁcally for all-aqueous gelatin-sodium alginate blends. The inﬂuence of
key electrospray parameters and material properties, on bead size, size distribution
and bead morphology was investigated. Hydrogel beads obtained in the present
study may ﬁnd applications in cell microencapsulation, cell culture systems, and
for controlled drug release. Finally, microencapsulation of HepG2 cells during
electrospraying was evaluated.
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9.2 | Materials and Methods
9.2.1 Materials
Bovine type B gelatin (iso-electric point = 5, Bloom strength = 257), was sup-
plied by Rousselot (Ghent, Belgium). Alginic acid sodium salt from brown algae
(high M content, Aldrich) and calcium chloride dihydrate (ACS reagent, ≥ 99%,
Sigma-Aldrich) were used without further puriﬁcation. Dulbecco’s Modiﬁed Eagle
Medium (DMEM) was purchased from GIBCO Invitrogen co.
For a number of experiments, gelB was thiolated using Traut’s reagent (Figure 9.1).
An analogues reaction protocol as for obtaining gelatin (meth)acrylamides was
applied. Brieﬂy, 10 g gelB was dissolved in phosphate buﬀer (pH 7.8) at 40 ◦C to
obtain a 10w/v% solution. The solution was thoroughly degassed. Subsequently,
523mg (3.8mmol, i.e. 1 equivalent with respect to the amount of gelatin free
amines) of 2-iminothiolane hydrochloride (Traut’s reagent, Sigma-Aldrich) was
added. After one hour of reaction under constant degassing and stirring, the
solution was dialyzed and freeze-dried as previously described (section 4.2.2). The
degree of substitution was determined according to the OPA assay to be ± 70%.
NH2 +GELATIN NH
GELATIN
NH2+Cl-
S NH2+Cl- SH
Figure 9.1: Traut’s reagent reacts with gelatin free amines to obtain a thiolated gelatin
derivate.
Rheological characteristics of the gelatin-sodium alginate solutions were measured
at 35 ◦C using a Physica MCR 350 (Anton Paar) with plate-plate geometry. The
eﬀective viscosity was determined over the shear rate range = 1− 1000 s−1. Five
diﬀerent measurements were performed on each solution. Mean averages (± SD)
of shear viscosity at 100 s−1 were chosen for comparison between the diﬀerent
solutions.
9.2.2 Electrospraying: description of the setup
Gelatin-sodium alginate solutions with varying total concentrations (2→ 10w/v%)
were prepared using distilled water at 40 ◦C. A 0.1M CaCl2-cross-linking medium
in distilled water was prepared at room temperature. For electrospraying, the
gelatin-sodium alginate solutions were loaded in a 10mL syringe connected to a
stainless steel needle using a Teﬂon tube (inner diameter of around 1.0mm). The
cross-linking medium was poured in glass petri dishes to obtain a CaCl2 bath. A
homemade ESP device was employed in a way that allowed the simple production
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CaCl2 - solution
gelatin/sodium alginate
mixture
continuous ﬂow
(syringe pump)
droplet/sphere 
formation}
DC generator
collector
Figure 9.2: Schematic illustration of the experimental setup. A syringe continuously
dispenses material at a given feed rate. The applied potential diﬀerence
between the needle and the collector plate causes the material to be broken
into a discontinuous droplet feed. The height diﬀerence allows droplet
reshaping. Formed droplets were directly crosslinked in a CaCl2 bath.
of microcarriers. Figure 9.2 represents a schematic illustration of the experimental
setup. More information can be found in section 11.1.4. All experiments were
conducted in triplicate at a temperature of 35 ◦C. Steady state ﬂow of the diﬀer-
ent polymer solutions was obtained using a syringe pump (Model Multy Phaser
NE 1600, New Era Pump Systems Inc), which controlled the ﬂow rate of the
polymer solution. The stainless steel needle protrudes from a metallic electrode,
connected to an adjustable DC power supply (Inc-Model Series EL 50P00, Glass-
man High Voltage) capable of generating DC voltages in the range of 0− 50 kV.
A grounded counter/collector electrode (aluminum plate, 27× 70 cm) was located
at 10 cm apart from the metallic tip. Drop (re)formation was allowed over a dis-
tance of 9 cm prior to immersion and collection of the formed beads in the CaCl2
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bath. The whole device is located inside a wooden cupboard provided with a safety
mechanism of total power-cut in case the doors open during the process.
9.2.3 Parametric study for the spraying of gelatin-sodium
alginate beads
A parametric study was performed in order to study inﬂuences of typical elec-
trospray parameters. These included: gelatin-sodium alginate ratio (9:1; 3:2;
6:1; 1:1), gelatin-sodium alginate total concentration (2− 5− 7− 10w/v%), nee-
dle gauge (G23, G25, G27, G30), applied voltage (4 → 20 kV), and ﬂow rate
(1 → 5mLhour−1). After bead formation, the beads were isolated using centrifu-
gation. Half of the beads were used as such in order to perform analysis in wet
conditions, the other half were dried and stored at room temperature until further
analysis.
9.2.4 Characterization of the fabricated beads
9.2.4.1 Bead size and size distribution
Every condition from the parametric study setup was examined using light mi-
croscopy, to extract information regarding bead dimensions, size distributions,
and bead shapes in the wet state. A Zeiss (KS 100, Axiotech) light microscope
in combination with an Axiovision digital camera was used. Images were taken
and measurements performed using Carl Zeiss AxioCam software. All images were
taken at 5 times magniﬁcation. Beads of every condition were randomly selected.
Matlab (2009b) was used to analyze the obtained results.
9.2.4.2 Bead morphology
Besides light microscopy images of the beads in wet condition, scanning electron
microscopy (SEM) images were taken on dry bead samples using a tabletop SEM
(PHENOM™, FEI Company). Beads were analyzed for morphology and shrinkage
after drying. Prior to SEM analysis, all samples were coated with a (approxi-
mately) 20 nm thin gold layer.
9.2.4.3 Bead composition and stability
Gelatin leaching behavior was studied using FT-IR in attenuated total reﬂection
(ATR) mode (Spotlight 400 Imaging System). The infrared spectra of the samples
were measured as described in section 4.2.3.1. Spectra of newly fabricated bead
samples (blancs) were compared with the spectra of the same samples taken after
immersion in DMEM culture medium for a period of 24 hours at 37 ◦C (300 rpm).
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The obtained spectra were evaluated using Spectrum 100 software. ATR mapping
was performed over an area of 40μm2. The collected data were analyzed for
correlation with the respective FT-IR spectra of pure gelatin type B and pure
sodium alginate. The results are displayed as a surface mapping of the correlation
coeﬃcient.
Survey and C 1s detail XPS scans were collected as described previously in sections
4.2.3.1 and 7.2.1.5. The spectra recorded from sodium alginate and gelatin type B
were chosen as references. Relative changes of the high-resolution carbon spectra
were studied between both pure components and generated μ-particles. The C-C,
C-H peak was calibrated at 285 eV and the high-resolution spectra were ﬁtted with
3 peaks in order to achieve a good ﬁtting. The generated data are displayed as a
plot of the electron counts versus electron binding energy in a ﬁxed, small energy
interval.
9.2.5 Preliminary cytocompatibility tests of electrosprayed
HepG2 cells
Some key electrospraying parameters were evaluated for their inﬂuence over HepG2
cell survival rates. Investigated parameters were the applied voltage, the feed
mixture composition, the nozzle internal diameter, and the cell density. Gelatin-
sodium alginate solutions were pasteurized three times at 70 ◦C, while the CaCl2-
cross-linking solution was ﬁltered (0.22μm Millex GS ﬁlter unit). To improve cell
viability, hydrogel and CaCl2 solutions were prepared using 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) buﬀer (pH 7.4) supplemented with 0.1%
D-glucose (Merck). Hydrogel precursor solutions were subsequently loaded with
HepG2 cells to obtain ﬁnal concentrations of 1.5 → 5 × 106 cellsmL−1.
9.2.6 Statistical analysis
All measurements were performed with n ≥ 50, unless otherwise stated, and the
experimental results are reported as mean ± standard deviation (S.D.). Statistical
analysis was performed using a Student t-test and signiﬁcance was determined at
p < 0.05.
9.3 | Results and Discussion
9.3.1 Viscosity measurements
Alginate beads, fabricated and cross-linked in aqueous media with divalent cations,
are an established route for cell, drug and other biomolecules encapsulation pur-
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poses. The simplest formation method for Ca2+-alginate beads is based on drop-
wise addition, using a syringe, of an aqueous alginate solution into a CaCl2 bath.486
In this setup, the needle gauge, and the solution viscosity will control bead dimen-
sions. Six gelatin-sodium alginate solutions were examined in the parametric study.
Table 9.1 summarizes the used blend compositions and sample names that will be
referred to in the following discussion.
Table 9.1: Compositions of the gelatin-sodium alginate solutions for electrospraying.
COMPOSITION w/v%
SAMPLE NAME Hydrogel Precursor NaCl NEEDLE GAUGE
Gelatin Type B Sodium alginate
G9A1 9 1 - G27 (a), G30 (b)
G6A4 6 4 - G30
G4.2A2.8a 4.2 2.8 - G30
G4.2A2.8b 4.2 2.8 1 G30
G4.2A2.8c 4.2 2.8 2 G30
G6A1 6 1 - G25 (a), G27 (b), G30 (c)
G3A2 3 2 - G23 (a), G25 (b), G37 (c), G30 (d)
G1A1 1 1 - G25 (a), G27 (b), G30 (c)
For viscid ﬂuids, Weber extended the theory of Rayleigh and demonstrated that
droplet breakup showed a direct proportionate with the viscosity, and an inverse
proportionate with the density and surface tension.487 Thus, solution viscosity
is regarded as a key electrospraying parameter. Viscosity sweeps for shear rates
1 s−1< γ < 1000 s−1 were performed. Higher viscosity solutions will lead to larger
bead diameters produced.488 Temperature was kept constant at 35 ◦C, since this is
representative for the cabin temperature at which all solutions were electrosprayed.
The results are presented in Figure 9.3 (shear viscosity) and Figure 9.4 (shear
stress). At a shear rate of 100 s−1, average shear viscosity was 0.021 (± 0.004)
Pa.s, 0.073 (± 0.002) Pa.s, 0.085 (± 0.003) Pa.s, 0.85 (± 0.007) Pa.s, 0.33 (±
0.003) Pa.s, and 0.12 (± 0.001) Pa.s for the respective solutions G1A1, G6A1,
G9A1, G6A4, G4.2A2.8a, and G3A2. As can be derived from Figure 9.3, diﬀerence
intervals between the solutions remain stable over the shear rate range measured.
Shear viscosity gradually increased with increasing total concentration for solu-
tions of the same gelatin-sodium alginate ratio (G3A2, G4.2A2.8, G6A4, 3:2 ratio).
Comparing the values of G6A1 and G6A4 (increasing alginate content), and on the
other hand G1A1, G6A1, and G9A1 (increasing gelatin content) , demonstrated
clearly the eﬀect of viscosity increase attributed to increasing alginate contents.
From literature, it is known that sodium alginate solutions with a concentration
larger than 5w/v% are diﬃcult to prepare, and drop formation will be reduced
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Figure 9.3: Shear viscosity at 35 ◦C as a function of gelatin and sodium alginate content.
with increasing viscosity of the liquids.487 These results were unmistakably trans-
lated into the manufacturability for electrospraying. Since G6A4 was too viscous,
even at elevated temperatures of 35 ◦C, to result in steady state ﬂow imposed by
the syringe pump, this precursor solution will further not be taken into account.
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Figure 9.4: Inﬂuence of gelatin-sodium alginate ratio and concentration on the shear
stress at 35 ◦C.
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9.3.2 Droplet formation: The eﬀect of electrospinning pa-
rameters on the size of the beads
Electrospraying, as well as electrospinning, is considered to be a cost-eﬀective
and versatile technique for the production of biomaterial matrices for numerous
applications. When the needle is charged at a high DC voltage of positive polarity,
the continuous ﬂow of liquid gelatin-sodium alginate is broken into separate drops
and pulled towards the ground (negative polarity), as illustrated in Figure 9.5. The
polarity can also be exchanged, i.e. the solution at a negative polarity. Generally,
the imposed surface charge density on pendant droplets is limited (termed Rayleigh
limit), and beyond this limit, EHD forces overcome the surface tension forces of
the droplets.471
A
B
C
Figure 9.5: Electrospraying at work: (A) the voltage clamp connected to a G30 needle
spraying a 7w/v% gelatin-sodium alginate (6:1 ratio), (B) droplet forma-
tion, and (C) a close-up of the droplet formation.
In the ﬁrst part of the present chapter, the inﬂuence of some key droplet formation
parameters on the outcome of the spraying process was investigated. Gelatin will
form a physical hydrogel at room temperature, complicating the electrospraying
(and electrospinning) processes. In addition, gelatin can be regarded as a kind of
polyelectrolyte, which possesses many ionizable groups. Acids can ionize the amine
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and carboxylic functional groups. Therefore, the use of other than pure water-
based solvents for the electrospinning of gelatin is often applied.483,489,490 There
are few high polarity organic solvents available for the strong polarity biopolymer
that gelatin is. Various toxic solvents, such as 2,2,2-triﬂuoroethanol (TFE), triﬂu-
oroacetic acid (TFA), 1,1,1,3,3,3-hexaﬂuoro-2-propanol (HFP) and aqueous solu-
tions of acetic acid, or ethyl acetate, are some examples. However, electrosprayed
gelatin remains water soluble, and therefore not suitable for longer-term appli-
cations at physiological conditions. In order to overcome this drawback, sodium
alginate was blend in, which could be cross-linked by the simple addition of Ca2+
cations and allowed for a fast ionic cross-linking. Additionally, gelatin could be
thiolated, which enables slow disulﬁde bridge formation, which can be broken un-
der mild conditions such as cystein addition. This strategy was selected for the
generation of insoluble (but reversible) hydrogel networks. Furthermore, the ex-
clusion of toxic solvents, which would be diﬃcult to remove after the process, was
desired. Thus, in order to be successful, working at elevated temperatures was
necessary to avoid the addition of ﬂuorinated solvents or acetic acid, commonly
used for the spinning of gelatin solutions. The device cabin was adapted so that a
temperature of 35 ◦C was guaranteed, which allowed the processing of all-aqueous
solutions.
9.3.2.1 Eﬀect of the voltage and needle internal diameter on the bead
dimensions
In Figure 9.6, the inﬂuence of the applied voltage and nozzle internal diameter as
key processing parameters on the obtained bead dimensions is illustrated.
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Figure 9.6: Bead sizes in function of the applied voltage and needle gauge for G3A2
condition. All samples were electrosprayed at a constant ﬂow rate of
1mLhour−1.
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Comparable to the eﬀect of voltage variation, needle gauge fulﬁlls a pivotal role.
A 3:2 gelatin to sodium alginate solution was selected for in depth examination
of needle gauge and applied voltage eﬀects: samples G3A2a-d. The solutions
were sprayed at a feed rate of 1mLhour−1 for all tested conditions. For the
same solution, we observed three diﬀerent behaviors for the needles investigated
(Figure 9.6). For gauge 23 (∅ = 0.33mm), an initial plateau value was observed
till a voltage of 10 kV, from which point bead size rapidly decreased till a second
plateau (> 12 kV). Gauge 25 and 27 (∅ = 0.25mm and 0.2mm) on the other hand
showed statistically signiﬁcant eﬀects over the whole voltage range investigated,
with decreasing bead dimensions when increasing the applied voltage. However,
decreasing the needle internal diameter even further (gauge 30, ∅ = 0.15mm)
lessened the eﬀect and showed only a signiﬁcant inﬂuence for voltages < 10 kV.
From this point on, bead sizes reached a plateau value, which converged to the
smallest value for G27 spraying. Interestingly, standard deviations increased with
increasing needle internal diameter for voltages higher than 8 kV, and the mean
diameters were nearly the same size or larger than the needle internal diameter,
correlating to the dripping mode. In other words, selection of the needle internal
diameter and the applied voltage will impact the electrospray stability and bead
size ranges that can be generated.
Figure 9.7: Bead size (left colomn) mapping for G9A1 samples as a function of the
applied voltage and ﬂow rate, and corresponding standard deviations (right
colomn), sprayed using G27 (A) and G30 (B) needles.
226
9.3.2.2 The interplay of solution composition, applied voltage, and nee-
dle diameter
Comparing the bead sizes, and correlated standard deviations, obtained for sample
G9A1 applying G27 needle (Figure 9.7 (A)) and G30 needle (Figure 9.7 (B)), gives
an impression of the needle gauge, applied voltage, and ﬂow rate eﬀects on the
process results. For this particular composition, needle gauge had a signiﬁcant
impact on the resulting bead sizes and stability of the process. The stability can
be evaluated looking at the bead size standard deviations, which are presented on
the right. Gauge 23 needle (∅ = 0.33mm, G23) generated almost similar bead
sizes produced over the voltage and ﬂow rate ranges investigated. An example
is shown in Figure 9.8 (A). In contrary, using gauge 30 needle (∅ = 0.15mm,
G30) enabled us to signiﬁcantly manipulate the ﬁnal sizes through variation of
the remaining electrospraying parameters. Lowering the needle diameter generally
resulted in the production of smaller particles, having smaller standard deviations.
Only for the lowest applied voltage (i.e. 12 kV), bead sizes were larger compared to
identical conditions using G27 needle. As can be clearly deduced from Figure 9.7
(B), optimal voltage conditions were located between 16− 18 kV, with acceptable
standard deviations for the ﬂow rate range investigated. Nearly monodispers,
homogeneous microcarriers were generated, as can be seen in Figure 9.8 (B, C).
A B C
D E
1000 μm 1000 μm 1000 μm
1000 μm 1000 μm
Figure 9.8: Light microscopy images of gelatin-sodium alginate beads. (A) G9A1a,
12 kV, 3mLhour−1 (844± 19μm); (B) G9A1b, 16 kV, 4mLhour−1
(230± 31μm); (C) G9A1b, 16 kV, 2mLhour−1 (348± 24μm); (D)
G4.2A2.8a, 18 kV, 3mLhour−1 (389± 48μm); (E) G4.2A2.8a, 16 kV,
5mLhour−1 (270± 71μm); Scale bar indicates 1000μm.
Moghadam et al.487 reported the increase in average bead size through increasing
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needle gauge for electrosprayed sodium alginate solutions, however for larger nozzle
internal diameters, this eﬀect became negligible. As we have shown, larger needles
limit the eﬀect of ﬂow rate and applied voltage variations for voltages > 12 kV on
mean bead diameter. For gauge 30 needles, mean diameter could be controlled in
the range of 200− 1600μm, which opens perspectives when a certain bead size is
demanded. A 1w/v% sodium alginate solution fed through a 200μm needle gave
particles with sizes between 300− 1900μm for voltages between 0− 9 kV.487 This
means that mean bead size with simple gravitational droplet formation is around
2mm when applying G27 needle. In our case, we obtained a composition whereby
gelatin is incorporated, explaining the need for higher voltages in order to obtain
a similar bead diameter range.
Electrospray precursor solutions containing the same amount of sodium alginate,
however lower gelatin content were prepared to evaluate the eﬀect of gelatin content
on the spraying over a voltage range of 4− 20 kV for three needle diameters. Figure
9.9 gives the data points for the spraying at 12 kV.
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Figure 9.9: Inﬂuence of gelatin content on the bead diameter. Results represent data
at 12 kV sprayed at a ﬂow rate of 1mLhour−1.
As can be seen, decreasing the gelatin content enables to drastically decrease the
average bead diameter. This can be attributed to the poor ﬁber-forming potential
of gelatins due to the polyelectrolytic nature as well as the formation of hydrogen
bonds. Furthermore, similar as the three diﬀerent behaviors observed for diﬀerent
needle internal diameters, as discussed in the previous paragraph, the voltage
exerted an analogous inﬂuence over the three precursor solutions (data not shown).
Two liquid precursors of higher viscosity than G9A1 sample were also subjected
to the same voltage and ﬂow rate range. Initially, a composition of equal total
concentration (10w/v%) but diﬀerent gelatin to sodium alginate ratio (3:2) was
prepared for electrospraying: sample G6A4. However, since G6A4 was too highly
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viscous at the processing temperature, constraining microcarrier generation, inves-
tigation of this particular composition was postponed. As previously mentioned,
viscosity was around ten times higher than G9A1 sample. In order to make electro-
spraying possible, solutions with the same 3:2 ratio but lower total concentration
were prepared. For the 7w/v%, sample G4.2A2.8a, beads within the same size
range could be obtained (Figure 9.10). However, for some of the conditions tested,
tail formation appeared. The appearance of these so-called ‘tear-like’ microcarriers
is illustrated in Figure 9.8 (E), and has been observed in literature with electro-
spraying of pure alginate solutions. Suksamran et al.488 reported the formation of
‘large tail particles’, ‘long rod gel beads’, ‘small semi-circle particles’, and ‘small
tail particles’ in their macroscopic evaluation of alginate particles produced by an
electrospraying process. Light microscopy images from 2w/v% sodium alginate
microcarriers, produced by electrospraying in the dripping mode, showed similar
tail-like macroscopic features for some of the beads.477 It is suggested that sodium
alginate solution viscosity and cross-linking medium (Ca2+ concentration) inﬂu-
ences the shape of the beads produced. In addition, since we worked at elevated
temperatures, this eﬀect is probably combined by a (more pronounced) partial
dehydration, limiting drop sphere (re)formation. Adjusting the distance between
the needle tip and the cross-linking bath can however also modify the sphericity
of the beads. Since the relaxation time will be altered, this is especially the case
for highly viscous solutions. Despite this, in our case doubling the distance had
no signiﬁcant impact on the macroscopic features of the tail (data not shown).
Figure 9.10: Bead size (left colomn) mapping as a function of applied voltage and ﬂow
rate, and corresponding standard deviations (right colomn) for G4.2A2.8a.
Interestingly, standard deviations for sample G4.2A2.8a tend to be smaller, indi-
cating even lower dispersity levels or a more stabilized electrospraying process as
compared to G9A1 (Figure 9.10 right). In general, higher voltages lowered bead
sizes, as has been reported in literature. This has been explained by Xie et al.:477
the electrical ﬁeld suppresses the surface tension since the electrical polarization
forces act in the opposite direction of surface tension. This surface charge-electrical
229
ﬁeld interaction will lead to an acceleration of the liquid precursor in the direction
of the gravity, opposite from the nozzle, ultimately obtaining smaller droplets. For
voltages between 0− 9 kV, a ﬂow rate of 50mLhour−1 and a sodium alginate con-
centration of 3w/v%, mean bead sizes ranged between 1− 2mm. Since we employ
larger voltages, and lower ﬂow rates, it is expected to obtain much smaller bead
sizes. However, in our case, lowering the ﬂow rate in between the 1− 5mLhour−1
range did not seem to signiﬁcantly aﬀect the bead sizes for sample G4.2A2.8a.
This is somewhat in contrast to literature, were experimental results show how
the feed rate can control the mean diameter sizes.491 Normally, higher ﬂow rates
result in larger particles. Most likely, this contradiction can be explained by a
combinatory eﬀect of solution viscosity and syringe pump eﬀectiveness: for high
viscosity shear thinning samples, viscosity limits the ﬂow rate decrease applied by
the syringe pump. By this experimental setup we were able to demonstrate that
altering the blend composition makes it possible to change the macroscopic shape
of the generated beads.
Blend concentration demonstrated to inﬂuence the mean particle sizes. This can
be deduced by comparing Figure 9.10 and 9.6. Lowering the hydrogel building
block concentration, while keeping the blend ratio constant, resulted in a decrease
of the mean particle diameters. A possible explanation is related to a reduction of
the surface tension forces caused by decreasing polymer concentrations, ultimately
leading to size reduction of the generated droplets. Liu et al.492 conﬁrmed in their
work on controlling the numbers and sizes of beads, generated in electrospun ﬁbers,
that beads in ﬁber mats, were mainly caused by lower surface tensions. Lowering
their polymer concentration, either many beads or many microspheres appeared
and the process became electrospraying.
Nevertheless, among all the examined parameters, the applied voltage had the
most pronounced eﬀect on the size reduction of the beads. Increasing the voltage
led to an increase in the droplet frequency, while the size was reduced. Concur-
rently, decreasing the ﬂow rate can also increase the dripping frequency since the
dispensed liquid will have more time to be charged, but this eﬀect was less pro-
nounced in the 1− 5mLhour−1 range. On the other hand, needle gauge impacts
on the electrospray stability that can be obtained.
9.3.3 Eﬀect of NaCl on the bead macroscopic geometry
The formation of macroscopic ‘tear-like’ features has been mentioned in the former
paragraph. This can be mostly contributed to the sodium alginate component,
which impacts the viscosity and elasticity of the blend solution. Additionally, the
sodium alginate compound is converted to calcium alginate upon immersion in
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the cross-linking bath, which ‘freezes’ the macroscopic morphology of the network.
Ideally however, spherical beads should be produced with a narrow size distribution
in order to get homogeneous conditions favorable for cell culturing, drug delivery,
etc. Proper solvent selection for improved ionization is a standard methodology.
For instance, including acetic acid in the solvent mixture could be such an example
strategy. We evaluated the incorporation of NaCl salt into the solution (samples
G4.2A2.8b and c).
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Figure 9.11: Bead diameter histograms for G4.2A2.8a (A), G4.2A2.8b (B), and
G4.2A2.8c (C) accompanied by representative microscopy images. All
samples were produced with a ﬂow rate of 5mLhour−1 at 12 kV. Respec-
tive mean diameters are 735(±103)μm, 316(±17)μm, and 286(±13)μm.
Black arrows indicate ‘tear-like’ deformations. Scale bars indicate
1000μm.
Increasing the salt concentration from 0 to 2% resulted in smaller, nearly monodis-
perse, and spherical beads. This eﬀect is summarized with histograms and visual-
ized with representative light microscopy images (Figure 9.11). Adding a minimal
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amount of salt (1%) already evinced the signiﬁcant eﬀect on bead dimensions,
which reduced mean diameter more than half of the former condition (0%). Ad-
ditionally, size distribution was narrowed drastically and the deformation eﬀect
reduced. Further increasing the salt amount till 2% decreased these parameters
to a lesser extent. Interestingly, spherical beads were obtained which were charac-
terized by a very narrow size distribution, as can be seen in Figure 9.11 (C). Up
to date, a study on the eﬀect of salt addition was not yet reported. Nonetheless,
we demonstrated a drastic impact on bead shape, size, and size distribution. As a
possible hypothesis, the salt could be responsible for delaying the bead formation
in the cross-linking medium. Therefore, the beads would have a longer time period
to recover to spherical shape. On the other hand, it is likely that the rayleigh limit
is lowered therefore smaller beads are obtained at equal ﬁeld strength.
9.3.4 Bead morphology
Above mentioned results indicate that macroscopic features could be modiﬁed:
spherical beads, tear-like beads, spindle-like beads (Figure 9.12 A-C). Next to
bead size, size distribution, and shape, the microscopic features of microcarriers
play a pivotal role. In order to characterize microscopic morphological properties,
SEM images of dry bead samples were taken with diﬀerent magniﬁcations. As
expected, the formation of a thin skin layer was observed. Indeed, when gelatin-
sodium alginate solutions are exposed to a direct addition of bivalent calcium ions,
nearly instant formation of a heterogeneous alginate gel will occur.482 In our case,
this meant a fast phase separation and the formation of an outer shell rich of
Ca2+-alginate.
Intriguingly, the skin conﬁguration appeared diﬀerent depending on the gelatin-
sodium alginate composition. For samples G9A1, G6A1 and G1A1, a thin, but
dense, ﬁlm covering the complete beads was observed (Figure 9.12 (A,D)). When
this thin layer was scraped oﬀ, a porous structure was revealed. It is hypothesized
that this ﬁlm is formed by phase separation and cross-linking of the alginate frac-
tion, leaving an inner part mainly composed of (uncross-linked) gelatin. The outer
microscopic morphology (skin) is comparable to that of pure alginate beads.488
As will be proven later on, this so-called skin consists primarily out of calcium-
alginate for our beads. Large beads (i.e. larger than 500μm) demonstrated a
non-complete covering, suggesting that in those cases the alginate content is in-
suﬃcient to contain the whole bead or/and phase separation is hindered (data
not shown). Contrary, sample G4.2A2.8a consisted of a similar dense skin, how-
ever, protrusions were observed. These are cluster-like areas of diﬀerent material
composition (i.e. gelatin protrusions) (Figure 9.12 (B,E)). As a result, the surface
roughness is increased substantially. In addition, the drying process of these beads
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Figure 9.12: SEM images of some beads representative for conditions G9A1 (a,d),
G4.2A2.8 (b,e), G3A2 (c,f).
resulted in beads having a heterogeneous shrinking. Even so, upon re-swelling, the
initial macroscopic conﬁguration was reformed. This appearance is in accordance
to literature, for example it has been observed in SEM images of chitosan/gelatin
composite microcarriers produced by an emulsiﬁcation method.467 Finally, sam-
ples G3A2 demonstrated characteristics of both skin type formulations (Figure
9.12 (C,F)).
9.3.5 Bead composition and stability
FT-IR measurements (Figure 9.13 and 9.14) and XPS analysis (Figure 9.15) were
performed in order to examine the ‘skin’ composition and to reveal the presence of
the two blend components before and after swelling. In what follows, the results
displayed confer to beads that were fully swollen at 37 ◦C for at least 4 h in distilled
water.
The FT-IR spectrum of pure gelB was characterized by the amide A peak (N-
H stretching vibration) at 3280 cm−1, amide I peak (C=O stretch) at 1630 cm−1,
amide II peak (N-H bend and C-H stretch) at 1547 cm−1, and amide III peak (C-
N stretch plus N-H in phase bending) at 1240 cm−1, which are the distinguishing
features of gelatin. The spectrum of pure sodium alginate was characterized by
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Figure 9.13: FT-IR spectra of gelB, sodium alginate and electrosprayed beads after
incubation at 37 ◦C for 24 h.
the peak at 3213 cm−1 (OH stretch), the peak at 1597 cm−1 (COOH stretch), and
the peak at 1025 cm−1 (C-O-C stretch). The averaged (over an area of about
40μm2) spectrum of the μ-particles revealed the presence of the major alginate
peaks. However, some smaller peaks stem from the presence of gelatin as the
second component (indicated by arrows).
From the average FT-IR signals displayed in Figure 9.13, it is clear that both
components remain present in the μ-particles. However, it would be more inter-
esting to have an indication about the localization of both components across the
analyzed surface. Therefore, ATR mapping results were correlated with the spec-
tra of the pure blend components (Figure 9.14). For all samples, the correlation
with alginate (corr. coeﬃcient > 0.9) was better than compared to gelatin (0.75
< corr. coeﬃcient > 0.88), indicating a surface mainly composed of alginate. As
can be derived from the correlation mapping, regions with lower alginate correla-
tion coeﬃcient corresponded to regions with higher gelatin correlation coeﬃcient.
These ﬁndings, which could not be derived from the averaged signals, conﬁrm the
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Figure 9.14: ATR mapping on microparticles. Correlation of the particle FT-IR spec-
trum with the spectra of pure sodium alginate (A) and pure gelatin type
B (B). A surface area of 40μm2 was scanned.
postulated hypothesis of a skin layer mainly composed of sodium alginate, with in
some cases gelatin-rich protrusions.
More quantitative information concerning the surface composition can be obtained
by XPS analysis. XPS survey spectra and high-resolution carbon 1s spectra were
collected and are presented in Figure 9.15. In Table 9.2, the elemental composition
of the diﬀerent samples is given. The presence of the N 1s core signal can be used
as an indication for the presence of gelatin in the skin that surrounds the particles.
Pure alginate does not contain nitrogen, while pure gelatin contains 16% nitrogen.
The nitrogen content of the beads was situated around 4%. On the other hand,
the Ca signal, which is an indication for the ionic network formation of the algi-
nate fraction, is about 3%, while the sodium signal completely disappears. These
ﬁndings altogether correlate with previous indications about the skin formation.
A phase separation occurs during the Ca2+ cross-linking step with the formation
of a skin layer (top nm range) mainly composed of a Ca2+-alginate network, with
some gelatin embedded.
Table 9.2: Elemental composition derived from XPS analysis.
SAMPLE NAME SURFACE COMPOSITION [%]
O 1s C 1s N 1s Na (Auger peak) Ca 2p
Gelatin 18.4 65.3 1 6.3 - -
Sodium alginate 29.2 63.8 - 7.3 -
μ-particles 30.9 62.9 3.5 - 2.7
Further insight can be gained comparing the high-resolution carbon 1s signals of
the pure components (gelatin and alginate) with the blend (e.g. produced beads).
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Figure 9.15: XPS surface scan spectra (A) and high-resolution carbon 1s spectra of the
particles (B), gelatin type B (C), and sodium alginate (D).
It should be noted that assigning a chemical bond to certain component peaks
is extremely diﬃcult in the case of biomolecules, since a broad range of chem-
ical functionalities is present. To simplify the quantitative comparison between
the three examined samples, only 3 peaks were assigned (Figure 9.15 B-D), as
previously mentioned.
The amide/carboxyl peak is most pronounced in the case of gelB (± 20%), while
almost not detected in the case of alginate (± 4%). This is logical since gelatin
is a protein (= polyamide) containing both amides and carboxyl functionalities,
while the amount of carboxyl functionalities in alginate is rather low and amides
are not present. In the case of the microcarriers, this component increased till ±
12%, further conﬁrming that gelatin is also present on the microcarrier surface.
An important question that rises is related to the stability of the generated micro-
carriers. Since initially only cross-linking of the sodium alginate fraction occurs, is
the sodium alginate skin layer suﬃcient in order to maintain integrity at physio-
logical conditions? Therefore, dry beads were re-swollen in PBS or DMEM culture
medium and incubated at 37 ◦C for over 72 h. Light microscopy and SEM images
were recorded, and their composition was evaluated with coomassie brilliant blue
staining and infrared measurements. Staining of all beads revealed the prevalence
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of gelatin inside the microcarriers. After incubation, a color intensity drop for
samples from condition G9A1 was observed (Figure 9.16). Also the correlation
of the recorded infrared spectra with that of pure gelB decreased. Some of the
beads even lacked any coloring, indicating a total loss of the gelatin fraction. This
was observed particularly for beads with sizes around 400− 500μm (intermedi-
ate sizes), and larger beads. This can be explained by the absence of a complete
alginate layer for larger beads, while for beads with intermediate sizes, upon re-
swelling the gelatin fraction swelled to such extent that the alginate skin layer
was broken and the inner part was released: so-called ‘ghost’ beads. An example
is given in Figure 9.16 A, and SEM analysis revealed that only the skin was left
(Figure 9.16 B). For smaller beads, this was not observed, and beads remained in-
tact. When gelatin content was decreased and sodium alginate content increased
(conditions G4.2A2.8 and G3A2), swelling of the gelatin fraction was insuﬃcient
to break the alginate layer (Figure 9.16 C). Infrared analysis demonstrated a small
decrease in correlation coeﬃcient with gelatin after incubation, however, this was
less pronounced compared to the decrease found with condition G9A1. This was
further conﬁrmed by XPS analysis whereby the N 1s signal dropped to 2− 3%.
??????? ?????????????
? ? ?
Figure 9.16: Images of coomassie stained microbeads: (A) G9A1b (18 kV, 1mLh−1),
(C) G4.2A2.8c (12 kV, 5mLh−1). (B) Scanning electron microscopy of a
so-called ghost bead for G9A1b.
Another strategy consisted out of a double cross-linking strategy whereby an initial
fast cross-linking occurred due to ionic curing of the alginate fraction, followed
by a slower curing of thiolated gelatin (e.g. adding H2O2 in the Ca
2+-bath).
By doing this, the fabricated beads can still be dissolved via non-enzymatical
pathways, which could be beneﬁcial for instance when trying to recollect attached
or encapsulated cells. In addition, it is possible to increase gelatin content and
decrease alginate content without the disadvantages described above. Thus, almost
no decrease in gelatin content is observed. Examples are given in Figure 9.17.
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Figure 9.17: Images of G6A1b sample (with thiolated gelatin) sprayed at 16 kV and
3mLh−1 before (A) and after (B) staining with coomassie. And after
incubation at 37 ◦C for 72 h (C,D).
9.3.6 Eﬀect of electrospraying variables on cell survival
Next to potential applications, such as drug delivery vehicles, cell seeding matrices,
. . . electrospraying is steadily emerging as a cell encapsulation strategy. The cell-
laden carriers can then, for example, further be used for the loading of BAL devices,
or for embedding in other hydrogels aiming at large-geometry shaping (modular
tissue engineering).
9.3.6.1 Inﬂuence of the blend composition on the HepG2 cell viability
At ﬁrst, the inﬂuence of the hydrogel precursor concentration on the obtained
viability was evaluated. In literature, good cell viability is reported for the spraying
of cell-laden sodium alginate solutions. Therefore, a 2w/v% sodium alginate
solution was selected to serve as positive control condition. Figure 9.18 gives some
live/dead stainings. In general, electrospraying parameters had to be drastically
altered in order to result in a fraction of viable cells. Therefore, lower applied
voltages and ﬂow rates were used.
As a ﬁrst observation, cells encapsulated during the spraying of alginate had a
tendency of migrating toward the bead/ﬂuid interface. In some cases this was
relatively well pronounced (as seen for the 2w/v% alginate condition). Gelatin
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Figure 9.18: Live/dead ﬂuorescence images of HepG2 cells encapsulated during the
electrospraying process. For all conditions, a voltage of 6 kV, a ﬂow rate
of 1mLh−1, a G27 needle and a cell density of 2.5× 106 cellsmL−1 were
applied. (4 X magniﬁcation)
containing solutions had a tendency to result in a more homogeneous encapsulation
distribution of the loaded cells. On the downside, it appeared that with increasing
gelatin content, cell survival rates decreased. For a gelatin concentration of 6w/v%
(G6A1) it is clear that almost all cells died during the process, while for a gelatin
concentration of 1w/v% (G1A1) acceptable viability could be reached (> 80%).
Electrospraying of sodium alginate solutions up to 2w/v% have been reported to
result in an acceptable viability.477 Zhang et al.493 proposed concentrations of >
1.5w/v% to obtain good results. Hepatocytes have successfully been encapsulated
in other than alginate solutions using a modiﬁed collagen at a concentration of
1.5mgmL−1.476 No reports were found on polymer concentration eﬀects for other
polymers than alginate. In general, it is expected that the cell viability will drop
with increasing concentration. Furthermore, the conductivity of gelatin is higher
than that of alginate, which could explain the diﬀerences. However, the underlying
mechanisms are still subject to further research and the experiments should be
repeated for in depth characterization.
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9.3.6.2 HepG2 cell density and needle internal diameter compete
In contrast with the plotting of cell-laden suspensions, increasing the cell density
during electrospraying will not aﬀect the process in a negative way. The viscosity
reduction will even aid, potentially making the process easier. In Figure 9.19 A, the
inﬂuence of increasing the cell density on the fractional cell survival is illustrated.
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Figure 9.19: Live/dead ﬂuorescence images of HepG2 cells encapusulated during the
electrospraying of G1A1 solutions as a function of the cell density for
G27 needle sprayed at 6 kV (A), and as a function of the needle internal
diameter and voltage for a cell density of 5.0× 106 cellsmL−1 (B). (4 X
magniﬁcation)
Our ﬁrst experiments suggest that an improved cell viability can be reached with
increasing the cell density. In literature, cell densities from 1.0× 106 cellsmL−1 and
higher are common. One report suggests to work at elevated cell densities between
3.0− 5.0× 106 cellsmL−1 for the encapsulation of cells in alginate solutions, since
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higher densities resulted in better encapsulation eﬃciency.493 In our experiments
we did not evaluate the cell encapsulation eﬃciency as a function of the cell density,
however, our ﬁndings demonstrate the inﬂuence on the obtained cell survival.
Furthermore, the eﬀect is not absolute. The images represent spraying with G27
needle, whereby higher cell density results in a higher cell survival. However, when
smaller needle internal diameters (i.e. G30) are used for the spraying, a lower cell
density is preferred (i.e. 2.5× 106 cellsmL−1) to obtain optimal viability. This is
illustrated in Figure 9.20. Most likely, shear stress induced eﬀects play a role.
9.3.6.3 Inﬂuence of the applied voltage on the HepG2 viability
As previously discussed, increasing the voltage and decreasing the needle internal
diameter will generally lead to smaller beads. This is illusttrated in the live/dead
stainings from Figure 9.19 B. Figure 9.20 gives a summary on the combined eﬀects
exerted by the applied voltage, needle internal diameter, and cell density for G1A1
samples.
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Figure 9.20: Summary of the inﬂuences of some key spraying parameters on the cell
survival rate of encapsulated HepG2 cells directly after spraying.
In the case where no voltage is applied, cell survival is situated around 95%, as
indicated by the dashed line. It can be seen that by applying a voltage, cells
are aﬀected. The voltage put on the cell-laden suspension can either be positive
or negative by inverting the polarity. Some experiments demonstrated that by
applying a negative polarity instead of a positive polarity, cell viability dropped
substantially at day 1 after microencapsulation (to < 10%). Most likely, the in-
herent cell membrane polarity is disrupted resulting in apoptosis of the sprayed
cells. This should be subject to future research.
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Furthermore, the applied voltage had a more pronounced eﬀect for lower cell den-
sity solutions, suggesting that perhaps cell-cell contact aids to overcome the in-
duced electrical ﬁeld. Between 6 and 8 kV, no major diﬀerences could be observed.
As an important remark, it should be stressed that the ﬁndings on the cell en-
capsulation during the electrospraying process are the result of initial experiments
without multiple repetitions. Therefore, the experiments should be repeated and
studied in more detail in order to conﬁrm our hypotheses.
9.4 | Conclusion
In this work, a parametric study for the electrospraying of all-aqueous biopoly-
mer solutions was performed. The possibility to electrospray all-aqueous gelatin-
sodium alginate microcarriers proved successful due to processing at elevated tem-
peratures. Nearly monodispers microcarriers with varying sizes could be fabricated
in the 150− 1600μm range. The absence of any toxic components, such as ﬂu-
orinated alcohols, makes it a clean fabrication technique suitable for numerous
medical applications. Furthermore, macroscopic and microscopic features of the
generated microcarriers could be varied. In this perspective, blend composition
demonstrated its impact on the surface morphology. Solution viscosity appeared
to have a substantial impact on the manufacturability of the electrospray process.
Out of all the investigated parameters especially the applied voltage revealed to
be a pivotal parameter for the size of the generated beads, while the addition of a
salt drastically improved microcarrier shapes and sizes.
Finally, some initial experiments on microencapsulation of HepG2 cells were per-
formed. From these results, decreasing the polymer concentration (especially the
gelatin fraction), decreasing the needle internal diameter and increasing the cell-
loading density led to an improvement of the ﬁnal cell viability. Overall, applying a
voltage decreased the cell survival. Despite the acceptable viability levels reached
for certain conditions, these experiments should be subjected to repetition before
ﬁnal conclusions can be drawn.
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10 | General Conclusions and Future
Opportunities
10.1 | General conclusions
The present research was focussed on the application of gelatin-based hydrogel
systems for liver tissue engineering purposes. Some questions were postulated and
studied:
1. What is the eﬀect of the gelatin composition, i.e. origin?
2. How does the selection of a chemical modiﬁcation strategy in order to obtain
irreversible networks aﬀect the hydrogel network properties?
3. Is it possible to fabricate gelatin-only constructs using the 3D Bioplotter,
with the aim at cell encapsulation?
4. How does the 3D printing aﬀect mechanical strength, degradation and pro-
tein /polysaccharide release behavior?
5. Can gelatins be modiﬁed for speciﬁc targeting of hepatocyte-like cells?
6. Can electrospraying oﬀer a suitable alternative for micro-encapsulation?
In chapter 3, four gelatins having diﬀerent origin and extraction processes were
investigated for their diﬀerence on the protein primary structure, MW, MWD,
geliﬁcation, and in vitro cytocompatibility for HepG2 cells. It was demonstrated
that they displayed diﬀerent material properties. Cytocompatibility experiments
revealed a preference for type B gelatins over type A gelatins for the encapsula-
tion of HepG2 cells. In addition, increasing the gelatin hydrogel building block
concentrations led to a reduction of the HepG2 cell viability.
Gelatins exhibit a reversible temperature dependent sol-to-gel transition (Upper
Critical Solution Temperature (UCST) type of material), limiting its applications
at physiological conditions. In order to overcome this drawback, a chemical mod-
iﬁcation strategy consisting out of the incorporation of photocross-linkable func-
tionalities was explored. Two vinyl-based side groups (methacrylamides and acry-
lamides) were introduced and compared for their inﬂuence on the resulting hy-
drogel network properties. This topic was discussed in chapter 4. This study
proved the capacity of the UV-A induced free radical polymerization strategy
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to manipulate the hydrogel swelling/mechanical properties and the hydrogel net-
work mesh sizes. Acrylamide-functionalized gelatins exhibited improved cross-
linking eﬃciency, leading to faster curing kinetics, lower swelling ratios, higher
mechanical strength, and smaller network mesh sizes compared to methacyrlamide-
functionalized gelatins. Other parameters, such as the hydrogel building block
concentration, UV-A irradiation dose and gelatin type (A vs. B) can also be used
in the tailoring towards desirable hydrogel network properties. Encapsulation of
HepG2 cells inside 10w/v% 2D sheets displayed high viability for both func-
tionalized gelatins. However, at higher hydrogel building block concentrations,
methacrylamide functionalized gelatins yielded higher cell viabilities.
Another major concern when working with hydrogels, and speciﬁcally with natu-
rally derived hydrogels, is the diﬃculty to shape these hydrogels into predeﬁned
patterns. Nonetheless, in recent years a paradigm shift from 2D towards 3D cell
culture models occurred. In chapters 5 and 6, this topic was addressed. Three-
dimensional gelatin-only constructs were fabricated by means of the 3D Bioplotter
technology. To this end, the device was adjusted to enhance the printing potential
for gelatin solutions. It was proven that gelatin-only hydrogels could be printed
in diﬀerent patterns having a high shape ﬁdelity over a broad range of hydrogel
precursor concentrations. Post-fabrication construct curing could be translated
from 2D ﬁlms to these 3D scaﬀolds. Due to the introduction of a macroporous
network, construct mechanical, degradation, and protein /polysaccharide release
properties are altered compared to simple 2D sheets. Based on this knowledge,
cell-laden constructs were generated whereby either a cell suspension or preformed
cell micro-aggregates were printed. High cell viability levels could be reached due
to an interdisciplinary approach studying chemistry, biology, and engineering feed-
back loops. These ﬁndings stipulate the potential of the technique for biomedical
applications. Finally, a proof-of-principle co-culture experiment demonstrating
the seeding of a second cell source on top of aggregate-laden scaﬀolds suggests
promising results for future research on cell culture models of higher complexity.
In chapters 7 and 8, the speciﬁc recognition of gelatin substrates by hepatocyte-like
cells was addressed by the immobilization of galactose-containing moieties. The
asioglycoprotein receptor (ASGPR) of hepatocytes speciﬁcally recognizes galactose
units. Bulk galactosylation of methacrylamide-functionalized gelatins improved
the functionality of encapsulated HepG2 cells. Moreover, the formation of round
morphologies was promoted, which has been correlated to an enhanced hepatocyte
function. In addition to the eﬀect on the hepatocyte functionality, galactose-
containing moieties were revealed to hamper the UV-A induced curing kinetics by
means of their free radical scavenging property. This led to slightly less cross-linked
gelatin methacrylamides having a greater swelling potential. A second strategy,
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based on the synthesis of a cyclic galactose-containing cross-linkable monomer,
demonstrated the possibility to selectively functionalize the gelatin surfaces and/or
bulk material. The developed strategies were capable of controlling the amount of
introduced biological ligands.
Finally, electrospraying was investigated as a processing technique for the produc-
tion of microparticles. The electrospraying of gelatin-sodium alginate solutions is
handled in chapter 9. Electrospraying was selected as a fabrication method capa-
ble of generating microparticles in all-aqueous conditions. This condition enabled
us to spray cell-laden solutions. A parametric study was performed in order to
perceive a mechanistic insight into the inﬂuence of the key electrospraying param-
eters on the spraying stabilization, particle dimensions, macro- and microscopic
morphology, and cell viability of sprayed HepG2 cells.
In summary, the research from the present work was able to demonstrate the
feasibility of modiﬁed gelatins for the fabrication of 3D geometries with high shape
ﬁdelity. In particular these systems were targeted at cell encapsulation purposes
of hepatocyte-like cells. Future research should be conducted to investigate the
possible translation towards other cell types, hereby broadening the application
potential of the presented materials/fabrication techniques.
10.2 | Future opportunities
A couple of interesting emerging trends tend to bring scaﬀold-based TE on the next
level. In example, the implementation of gradient techniques, in the general sense,
seems to provide some promising approaches. The utilization of blends layed down
the foundation of working with material gradients. Utilizing gradient techniques,
a more precise mimicking of the ECM composition and mechanical properties
will be possible, with spatial alterations throughout the scaﬀold. Of course, this
can be extended towards diﬀerent and multiple cell types, biomolecules, growth
factors, etc., deposited in predeﬁned patterns throughout the scaﬀold. Further-
more, gradients applied on the deposited scaﬀold pattern in itself (the deposited
strand conﬁguration) oﬀers interesting alternatives to alter the mechanical prop-
erties of the construct. Although some authors already performed some initial
experiments,226,250 the applicability of such approaches needs to be investigated in
depth.226,249
Alternatively, the combination of diﬀerent scaﬀolding techniques for the fabrication
of a single scaﬀold is another topic which I believe to oﬀer a variety of possibilities.
Combining electrospinning (∼ nanoporosity) and bioplotting (∼ microporosity) for
the production of a single scaﬀold was demonstrated by Kim et al.494 The combined
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eﬀect of diﬀerent techniques will most likely exhibit positive cooperative eﬀects on
cell biology. Thus, instead of focusing on the exploitation of one single technique,
it would be most fruitful to combine the positive eﬀects of diﬀerent techniques
into one operation procedure. In particular when multiple materials are processed
with diﬀerent techniques. For instance, during this work we experimented with the
combination of PCL and gelatin into one 3D scaﬀold as demonstrated in Figure
10.1. In the ﬁrst example a 3D printed gelatin scaﬀold was combined with a PCL
electrospun ﬁber network, in another PCL printed constructs were combined with
a gelatin freeze-dried network.
A B
a b
Figure 10.1: Combining multiple fabrication techniques. Gelatin printed scaﬀolds were
combined with PCL electrospinning (A,a) and PCL printed scaﬀolds were
ﬁlled with a freeze-dried gelatin matrix (B,b).
By doing this, 3D bioplotted structures could supply a highly porous structural
framework with desired mechanical properties, while a second material could sup-
ply nanoporosity without impairing the mechanical integrity of the total construct.
As a very fascinating trend, material scientists should incorporate the knowledge of
engineers into the designing step of the construct. This item is somewhat related
to the previous one, with a clear, distinct focus on the mechanical properties.
By means of ﬁnite element modeling, predicting the mechanical properties of the
construct can be helpful. More importantly, adjusting the (predicted) mechanical
properties of a model simply by varying the geometrical design of the material oﬀers
an interesting path to match its expected properties and the desired properties.
The principles, advantages, and possible applications of this so-called Bio-CAD
modeling in TE have been reviewed in 2005 by Sun et al.279,495 In the last couple
of years, more and more, bone-engineering scientists follow this methodology.496–498
However, in the case of soft tissue engineering and/or tailored hydrogel scaﬀolds,
this has not yet been intensively explored. In the next step, it would be helpful
to develop models that relate the mechanical forces exerted on a scaﬀold to the
viability of encapsulated cells and /or cell-aggregates.
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The developed gelatin hydrogel scaﬀolds should be tested in vivo to explore revas-
cularization of 3D printed constructs as well as inﬂammatory responses. As the
liver is a highly vascularized tissue, this still poses one of the main diﬃculties
in liver tissue engineering. Immobilization of vascular endothelial growth factor
(VEGF) could oﬀer opportunities. Additionally, in vitro cell culture models are
still far from the targeted in vivo tissue performances. Cell culture models of
higher complexity should be aimed at in order to converge to the in vivo situation.
For instance, 3D plotting could be applied to generate a closed construct with ﬂow
in- and outlet adaptors to speciﬁcally design bioreactors with the scaﬀolds directly
positioned in situ.
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11 | Techniques
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This section contains additional information on some of the techniques that were
used in the present studies. These techniques are classiﬁed into material processing,
material characterization and imaging techniques.
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11.1 | Material Processing Techniques
11.1.1 Hydrogel ﬁlm casting
2D hydrogel sheets were produced for a number of characterization techniques.
Two casting methodologies were followed: (i) production of 2D sheets with a thick-
ness of 300− 1000μm, and; (ii) spincoating of hydrogel building blocks on glass
cover slips to produce thin ﬁlms. In the former, spatial thickness is governed by
using silicon spacers with the appropriate height (Figure 11.1).
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Figure 11.1: Casting of 2D gelatin hydrogel building block ﬁlms: (A) the precursor so-
lution is injected in between two glass plates separated by a silicon spacer
of the appropriate height, or; (B) gelatin precursor solution is covalently
attached onto pretreated glass cover slips whereby the ﬁlm thickness is
manipulated by silicon spacers.
Mostly, thick hydrogel ﬁlms were prepared by simple casting in between two par-
allel glass plates (Figure 11.1 A). For some experiments, the potential ﬂoating
behavior of gelatin ﬁlms was countered by covalent coupling of the cross-linkable
gelatins to pretreated glass cover slips (Figure 11.1 B). These cover slips were
silanized using 3-(trimethoxysilyl)propyl methacrylate monomer, which enables
further reaction with the (meth)acrylamide functionalities of gel-MOD upon UV
irradiation.
11.1.2 The Bioscaﬀolder
As described previously in the introductionary chapter, the 3D Bioplotter or
Bioscaﬀolder is a rapid prototyping device suitable for the generation of 3D physi-
cal models generated from 3D virtual models. The Bioscaﬀolder used in this work
is depicted in Figure 11.2. As can be seen, the device is designed to operate either
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by the dispensing principle (I) or the extrusion principle (II). Dispensing is mainly
preoccupied for low-viscosity liquids, such as hydrogels, and the dispensing head
is equipped with a temperature control system for processing at 5− 50 ◦C using a
heating/cooling circuit (III). On the other hand, the extrusion head can be oper-
ated at elevated temperatures up to 250 ◦C using an electric heating circuit (IV)
and ﬁnds its primary application in the processing of melt polymers, i.e. PCL.
I
II
VI
VIII
V
IX
III
VII VII
IV
Figure 11.2: The 3D-Bioscaﬀolder used in this work consisting of a stationary built
platform, a moveable dispensing head (typically applied for hydrogel pro-
cessing), and a moveable extrusion head (typically used with melt poly-
mers).
Both heads are moveable in the X-,Y-,and Z-directions (V) while the built plat-
form (VI) remains stationary. Compressed air can supply the necessary processing
pressure (VII), and the whole setup can easily be placed in a sterile, laminar ﬂow
environment (VIII). The built platform has a temperature control unit, which en-
ables heating of the base plate. This was adapted and substituted to a Peltier ele-
ment based system capable of heating as well as cooling. This is situated beneath
the base plate, while a set of ventilators (IX) support removal of heated/cooled
air.
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Figure 11.3: The dispensing unit operating while plotting gelatin solutions. The system
was slightly changed for the production of cell-laden scaﬀolds, where an
additional ﬁlter sterilized the incoming compressed air.
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11.1.2.1 Dispensing of gelatin hydrogel building blocks
In this work, the main objective was the processing of hydrogel precursor solutions
for the fabrication of 3D open porous constructs. For these type of materials, the
dispensing principle was more suitable than the extrusion principle. A pressure-
driven liquid ejection according to a layer-by-layer deposition of material through
either a conical or cylindrical needle generates the 3D physical construct (Figure
11.3) . A couple of adaptation were speciﬁcally performed to improve the plot-
ting of gelatin solutions, but also to guarantee sterile environments for cell-laden
plotting:
1. Most importantly, temperature control over the mixture processing temper-
ature was improved by adapting the bottom part of the dispensing head;
2. Equally important proved the be control over the substrate temperature to
enhance the initial physical gelation. The importance increased at decreasing
mixture concentrations;
3. Although the Bioscaﬀolder was located in a laminar ﬂow cabinet, the machine
is often operational under non-sterile conditions. In order to reduce the risk
for bacterial contaminations, a simple construct equipping the syringe inlet
with a 0.2μm sterile air ﬁlter was designed.
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Figure 11.4: μ-CT images illustrating the plotting without precise temperature control
over the gelatin mixture and built platform.
In Figure 11.4 the result of processing 10 and 20w/v% gel-MOD mixtures before
temperature control adaptations were implemented is presented. As can be seen,
at lower concentration a complete collapse of the scaﬀold structure occurs, while at
253
higher concentrations some minor cross-sectional porosity occurs. However, even
at high concentration, subsequent layers melt together due to the combinatory
eﬀect of a too high plotting temperature (to enable liquid ﬂow) while triggering
and rate of the physical gelation is insuﬃcient.
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Figure 11.5: Data on optimization of the plotting process: hypothetical deposition pat-
terns in relation to the deposition speed (A) and the evolution of the de-
posited strut diameters as a function of the applied plotting speed and dis-
pensing inlet pressure (B-E). For 10w/v% solutions applying a conically
shaped needle (B) and the inﬂuence of needle design (C). For 20w/v%
(D), and for 10− 15− 20w/v% at 4 bar inlet pressure (E) using cylin-
drically shaped needles.
As partially described in chapter 4, the plotting was optimized in order to plot (cell-
laden) gelatin precursor solutions in the range of 10− 20w/v%. As the deposited
strut diameter will impact scaﬀold properties such as porosity and mechanical
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Figure 11.6: Shear stress and velocity proﬁles obtained by ﬁnite element simulations,
illustrating eﬀects such as: needle diameter, pressure, temperature, mix-
ture composition, and mixture concentration.
strength, knowledge on its dimensions is desired. The inﬂuence of cells, dispensing
pressure, temperature and needle internal diameter as a function of the deposition
speed were discussed for (cell-laden) 10w/v% gelatin building block mixtures using
cylindrically shaped needles. In Figure 11.5, optimization data illustrating the in-
ﬂuences of gelatin concentration, needle design (conical vs. cylindrical) and needle
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internal diameter are depicted as function of the deposition speed. Additionally,
a schematic representation explaining the relation between the deposition speed
and deposited strut is presented in part A. Three hypothetical deposition speeds
(v1, vopt and v2) explain the importance of optimization: at the optimal nozzle
traveling speed (vopt), the nozzle internal diameter (Dneedle) and the strut diam-
eter (Dopt) converge leading to an optimal depositing height. For higher speeds
(v1), the depositing height (i.e. layer height) will be too big relative to the strand
diameter (D1), while for lower speeds (v2) this will be too low. Furthermore, ﬁnite
element simulations on the liquid ﬂow behavior can help understand these eﬀects
and oﬀer a way to relate ﬂow behavior to cell survival rates. Some additional FEA
proﬁles are presented in Figure 11.6.
In Figure 11.7, the inﬂuence of drying method is illustrated. Microporosity can be
induced by freeze-drying. From the last μ-CT image, imperfections at the meander
feature (as described in Chapter 5) are illustrated. One parameter has not yet
been discussed: the scaﬀold porosity percentage. Considering a cube having an
edge length l, the porosity percentage can be theoretically calculated based on the
designed polymer volume (Vscaffold) and total volume of the scaﬀold, i.e. void and
material volume (Vcube). For a lay-down pattern of 0◦/90◦ following formulae can
be used:
l = nxy d2 = nz d3 (11.1)
Vstrut =
(π
4
d21
)
l (11.2)
Vlayer = nxy Vstrut (11.3)
Vscaffold = nz Vlayer (11.4)
Vcube = l
3 (11.5)
Porosity(%) = 1− Vscaffold
Vcube
=
⎛
⎝1− π
4
1(
d2
d1
) 1(
d3
d1
)
⎞
⎠× 100 (11.6)
However, these equations are not-valid for lay-down patterns where subsequent
layers are rotated 45◦ since Vstrut will be a function of the position and therefore
diﬀer in between adjacent struts. Also, nxy can be diﬀerent from layer-to-layer for
“shifted” designs while for all actual scaﬀolds imaging revealed partial remelting
at the strut knots of subsequent layers. Therefore, the calculated values of the
porosity for 90◦ patterns are overestimated. Nevertheless, a porosity range can be
calculated as presented in Table 11.1.
Although porosity by these calculations is probably overestimated, the calculated
porosity ranges indicate the possibility to closely match theoretically designed
porosity after optimization of the plotting process.
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Figure 11.7: μ-CT images demonstrating the inﬂuence of the drying method on scaﬀold
shrinkage as well as (micro)porosity.
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Table 11.1: Porosity of gelatin scaﬀolds based on idealized geometries and for plotting
with the optimized parameters. Dimension units represent μm.
SAMPLE PATTERN NEEDLE I.D. DIMENSIONStheor. POROSITYtheor. DIMENSIONS* POROSITYcalc.**
d1 = d3 d2 (%) d1 d2 d3 (%)
20w/v% 90◦ 200 240 500 62 219 511 212 59 - 70
90◦ 200 240 600 68 238 624 224 65 - 72
90◦ 200 240 700 73 245 729 234 62 - 76
90◦ 200 240 800 77 246 827 242 67 - 81
45◦ 200 240 600 237 638 222
90◦ + shift 200 240 700 74 234 733 229 66 - 77
10w/v% 90◦ 150 180 500 72 190 520 164 61 - 71
15w/v% 90◦ 200 240 700 73 254 708 233 64 - 73
* average values ** values based on upper and lower values of *
11.1.2.2 Extrusion of biodegradable polyesters
Another feature of the device is the plotting of melt polymers by means of the
extrusion principle. Here, in addition to pressure, solid material is molten and
an Auger screw transfers molten material to the extrusion needle. The setup is
depicted in Figure 11.8.
heating 
adaptor
base plate
material 
reservoir
glass
substrate
extrusion spindle
with Auger screw
Figure 11.8: The extrusion unit operating while plotting p(D,L-LA-co-ε-CL). Glass
cover slips were used as plotting substrate.
258
In this work, some preliminary testing on the plotting of elastic, biodegradable
p(D,L-lactide-co-ε-CL) was performed. Glass cover slips were used as substrate.
Due to continuous mixing and 100% material deposition, the plotting conditions
are more stable than in the case of dispensing and construct built-up closely re-
sembles the virtual model as can be seen from the μ-CT images (Figure 11.9).
Figure 11.9: μ-CT images illustrating the extrusion of poly(D,L-lactide-co-ε-CL).
11.1.3 Surface plasma treatment
Other than the well-known liquid, gas, and solid aggregation states, plasma is
regarded the fourth fundamental state of matter. Subjugation of materials to a
plasma environment opens possibilities in modiﬁcation of the materials surface.
Plasmas can be deﬁned as quasi electrically neutral medium of positive and nega-
tive ions, electrons and radicals (also containing atoms and molecules). The large
number of charge carriers make plasmas conductive so that it responds to induced
electromagnetic ﬁelds. Thus, although the particles are unbound, they are not
‘free’ (i.e. moving charges generate magnetic ﬁelds which aﬀect each other’s ﬁeld,
leading to a collective behavior). The typical luminosity (Figure 11.10 B) of a
plasma stems from particles returning from an excited state back to their ground
state.
As a result of their reactive environment, plasmas interact with material sur-
faces. Plasma polymerization, treatment and ablation are the main applications
of plasmas. So-called inert gases, i.e. He, Ar, O2 and N2, will not form reactive
polymerizable intermediates but create functional groups or radicals on the surface
(= plasma treatment).
Typically, plasmas can be generated by excitation of gases using radio frequency
(RF), microwave, or electrons from a hot ﬁlament discharge. A rough classiﬁcation
based on the plasma temperature can be performed: (i) non-equilibrium, i.e. non-
thermal or low-temperature; (ii) equilibrium, i.e. thermal or high temperature
plasmas. In this work, a cylindrical dielectric barrier discharge (DBD) setup at
low pressure was applied for plasma treatment of biomaterial surfaces (Figure 11.10
A). For DBDs, the electrical discharge between both electrodes is separated by an
insulating dielectric barrier.
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Figure 11.10: The Femto 3 (Diener Electronic) plasma reactor (A) with the plasma-
discharge typical luminosity for Argon plasma (B).
The formation of plasmas by DBDs typically applies high voltage alternating cur-
rents ranging from RF to microwave frequencies. Following ionization at a certain
location in the discharge gap, the dielectric surface accumulates the transported
charge which generates an electrical ﬁeld. Subsequently, the ﬁeld in the gap is re-
duced, interrupting very brieﬂy the current ﬂow. At voltages suﬃcient for break-
down, microdischarges are induced. The dielectric barrier has a dual purpose:
limiting charge transportation of single microdischarges, and spatial distribution
of them over the entire electrode.
11.1.4 Electrospraying
Electrospraying is a technique, which can be assessed for the generation of particles
from liquid solutions. The underlying principle is the physical process of inducing
electric force to the liquid surface causing elongation of the liquid meniscus at the
capillary outlet. The resulting cone and/or jet subsequently deforms and disrupts
into small droplets. The principle was schematically presented in Figure 9.2. As
a result, the droplets posses an electrical charge. The process was ﬁrst reported
by Bose in 1745, and later (1882) Rayleigh determined a stability criterion for the
charged droplet. Zeleny (1992) established a criterion for disruption of the jet.470
Disintegration of the jet into droplets, while issuing high voltage to the capillary,
can be established at many diﬀerent modes. Typically, the modes are classiﬁed
based on the geometry of the meniscus at needle outlet (drop, spindle, jet) and on
the mechanism of disintegration (type of instability). Some typical spraying modes
are illustrated in Figure 11.11. The process is governed by the physical properties
of the liquid solution (surface tension, viscosity, density, and conductivity), and
further also depends on the needle internal diameter, the applied voltage, and the
liquid volume ﬂow rate.
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Figure 11.11: Illustration of some important spraying modes for the production of mi-
croparticles.
For an extended description on the diﬀerent modes, readers are referred to the re-
view of Jaworek and Krupa.470 In this work, non-newtonian liquids were subjected
to high potential resulting mainly in dripping modes (dripping, microdripping,
spindle) as illustrated by Figure 9.5.
Electrospraying and electrospinning are both techniques which are used to process
polymers, based on the same underlying principle. If the formed polymer jet
turns into very ﬁne ﬁbers instead of breaking into small droplets, the process
is known as electrospinning (ESP). The main diﬀerence is based on the number
of polymer chain entanglements and the concentration of the polymer solution.
High concentrations are required to obtain spinning, while lower concentrations
generally result in spraying. In this work, two experimental setups were used:
(i) An adjusted stationary home-made ESP device, located in a wooden cabin (I,
Figure 11.12). This setup was mainly used for the parametric study of the spraying
process. The main components are the DC voltage generator (II) which provides
a potential diﬀerence between an extrusion needle connected to a syringe pump
(III) via an adjustable electrode (IV) and a stationary counterelectrode (V) on
which the Ca+2 cross-linking bath is placed. (ii) A more mobile setup which could
be constructed in a laminar ﬂow cabin, but which consists out of the same basic
components. This setup could be set up in a sterile environment and was therefore
used for the spraying of cell-suspensions. In all cases, a ‘clean’ production setup
was selected, i.e. no solvents other than water were applied.
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Figure 11.12: Electrospraying device used for the parametric study, located in a
wooden cabin (I). Main components are the DC voltage generator (II),
the syringe pump (III) and the electrodes (IV, V).
11.2 | Material Characterization Techniques
11.2.1 Gel yield and water uptake capacity
11.2.1.1 Equilibrium swelling studies
Swelling studies are a gravimetric sequence whereby cross-linked samples are dried
directly after cross-linking (mdi), after swelling (to equilibrium, mhe) in a 100%
relative sorbate humidity, and again after drying (mde). They reveal information on
the gel yield and sorbate uptake of a cross-linkable hydrogel according to following
formulae:
gel yield(%) =
mde
mdi
× 100% (11.7)
sorbate uptake(%) =
(mhe −mdi)
mdi
× 100% (11.8)
q =
mhe
mde
(11.9)
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here, q is the swelling ratio. The loss of dry mass after equilibrium swelling, i.e.
material leaching, is a measure for the gel yield. The relative error using Equation
11.8 when incomplete cross-linking is achieved can be overcome by expressing
swelling through q, or substituting mdi by mde.
For quantitative calculations, He-pycnometry (Accupyc 1330, Norcross, GA) was
used for the determination of the volumetric changes during the experiments
(Chapter 4). One cycle consisted out of 10 measurements to obtain an average
volume.
11.2.1.2 Dynamic Vapor Sorption (DVS)
Dynamic Vapor Sorption (DVS) is a gravimetric technique that measures the ab-
sorption capacity of a sample by controlling the temperature and humidity of the
environment as a result of varying the vapor concentration. Mass changes caused
by sorption and/or desorption of the vapor molecules are accurately monitored
at the hand of an ultra-microbalance. The principle is schematically presented in
Figure 11.13.
vacuum pump
(downstream)
upstream
sealed
downstream
sealed
mass ﬂow
controllers 
(upstream)
downstream
open
upstream
open
air
sample
pan
chamber evacuation filling with sorbate steady-state
Figure 11.13: Schematic illustration of the subsequent phases during a dynamic vapor
sorption measurement.
Generally, and also in this work, water vapor is exploited as sorbate, while a con-
trolled mass ﬂow of dry carrier gas (nitrogen) enables manipulation of the ratio of
saturated to dry gas ﬂow. The recording of water sorption isotherms, i.e. extract-
ing data on the equilibrium vapor sorption as a function of steady-state relative
humidity at a certain temperature, is the main application of DVS. For these ex-
periments, time-dependent mass changes of a sample are monitored by cycling
step changes in relative humidity. In between two steps, gravimetric equilibrium
should be reached before advancing to the next step. The resulting isotherms can
be divided in sorption (increasing humidity) and desorption (decreasing humidity).
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The sorption part can further be divided into adsorption (surface bound sorbate)
and adsorption (bulk penetration of the sorbate).
The diﬀerence between 2D sheets and 3D Bioplotted structures on the water vapor
isotherms was evaluated using a DVS-1 (Surface Measurement Systems). The
apparatus consists of a Cahn microbalance placed in a temperature-controlled
housing.
11.2.2 Rheology
The scientiﬁc domain concerning the study on the deformation behavior of solids
and the ﬂow behavior of liquids is called rheology (literally “ﬂow science”). Large
deformations resulting from shear forces cause many materials to ﬂow, indicating
the connection between both. Rheological data can be derived using rotational and
oscillatory rheometers. In this work, a Physica MCR 350 (Anton Paar) rheometer
consisting of a plate-plate geometry was applied (Figure 11.14). Viscous behav-
ior is generally investigated by rotational tests, while oscillatory tests (also called
dynamic mechanical analysis), relaxation tests and creep tests are typically per-
formed in the study of viscoelastic behavior.
Shear behavior, as described by rheology, can be subdivided in between two ex-
tremes: (i) the ﬂow of ideal viscous liquids following Newtons law (Equation 11.10),
and; (ii) the deformation of ideal elastic solids, which obey Hooke’s law (Equation
11.11):
τ = η γ˙ (11.10)
τ = G γ (11.11)
with τ the shear stress, η the viscosity, γ˙ the shear rate (or strain rate), G the
shear modulus, and γ the shear strain. For ideal viscous liquids, the viscosity is
independent from the applied deformation load (damper model). Upon removal of
a deformational load, an ideal elastic solid will fully return to its initial position
(spring model). The behavior of real materials however, is based on the com-
bination of both the viscous and the elastic portion, therefore called viscoelastic
behavior: viscoelastic ﬂuids and/or solids show time-delayed (nearly complete) ref-
ormation. Oscillatory tests can be used to examine viscoelastic properties, whereby
Newton’s law and Hooke’s law should be applied as follows:
τ(t) = η∗ γ˙(t) (11.12)
τ(t) = G∗ γ(t) (11.13)
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with η∗ the complex viscosity, G∗ the complex shear modulus, and the time-
dependent values of the sine functions of τ(t), γ˙(t), and γ(t). During oscilla-
tory testing, a preset sinusoidal shear strain (Equations 11.14) or shear stress
(Equations 11.15) function is applied. As a result of the viscoelastic behavior, the
measured shear stress curve respectively shear strain curve is a phase-shifted sine
function having the same frequency (Figure 11.14). The phase-shift is represented
by the δ value and is called the loss angle. It is a measure of the time delayed
reformation and is always 0 ◦ < δ < 90 ◦.
γ(t) = γ
A
sin (ωt) → τ(t) = τ
A
sin (ωt+ δ) (11.14)
τ(t) = τ
A
sin (ωt) → γ(t) = γ
A
sin (ωt+ δ) (11.15)
here, γ
A
and τ
A
represent the shear strain (deformation) and shear stress ampli-
tude, and w the frequency of the preset function.
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Figure 11.14: Schematical representation of the rheometer plate-plate geometry (left).
Illustration of the time-delayed response τ(t) of viscoelastic materials
upon a preset sinusoidal shear strain function γ(t) (right).
In this work, controlled shear strain in the form of oscillatory sine functions were
applied (Equations 11.14). Three important parameters describe the elastic and
viscous behavior and the ratio of the viscous and elastic portion and characterize
the viscoelastic behavior:
1. The storage modulus G′ (G-prime) as a measure of the deformation energy
stored during the shear process. Materials that completely store the deforma-
tion energy show reversible deformation behavior. Therefore, G′ represents
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the elastic behavior of a material:
G′ =
τ
A
γ
A
cos δ (11.16)
2. The loss modulus G′′ (G-double-prime) as a measure of deformation energy
consumed during the shear process. Energy losing materials demonstrate
irreversible deformation behavior. Thus, representing the viscous behavior
of a material:
G′′ =
τ
A
γ
A
sin δ (11.17)
3. The damping factor tan δ (loss factor) as the ratio of the viscous and the
elastic portion of a viscoelastic deformation:
tan δ =
G′′
G′
(11.18)
They relate to the complex shear modulus: G∗ = G′ + i G′′. Characteristic values
are represented in Table 11.2. Analogue, the complex viscosity η∗ can be written
as a complex form of η′′ and η′, with the former specifying elastic behavior and
the latter viscous behavior (tan δ = η′/η′′).
Table 11.2: Overview of rheological behavior and their relation to oscillatory test vari-
ables.
ideal viscous
ﬂow
behavior
behavior of a
viscoelastic
liquid
viscoelastic behavior
showing 50/50 ratio
of viscous and
elastic portions
behavior of a
viscoelastic gel
or solid
ideal elastic
deformation
behavior
δ = 90 ◦ 90 ◦ > δ > 45 ◦ δ = 45 ◦ 45 ◦ > δ > 0 ◦ δ = 0 ◦
tan δ → ∞ tan δ > 1 tan δ = 1 tan δ < 1 tan δ → 0
(G′ → 0) G′′ > G′ G′ = G′′ G′ > G′′ (G′′ → 0)
For hydrogels, the viscoelastic behavior was studied using dynamic oscillation mea-
surements: (i) Deformation scans (amplitude sweep), i.e. isothermal measurements
of G′ and G′′ as a function of shear strain at a constant frequency (1Hz), were
performed to determine the linear viscoleastic region. (ii) Mechanic spectra (fre-
quency sweep), were recorded as a function of the angular frequency at a constant
shear strain (0.1%). (iii) Physical and chemical cross-linking was followed as a
function of time at constant frequency (1Hz) and shear strain (0.1%) applying a
normal force FN = 0.1N. (iv) Temperature sweeps at a constant frequency and
shear strain were used to study the temperature dependance of G′ and G′′. A
linear ramp of 1 ◦Cmin−1 was used for heating or cooling.
For liquid precursors, rotational tests were performed to determine the ﬂow curve
τ(γ˙) and viscosity function η(γ˙) at constant temperature, illustrating shear load-
dependent ﬂow behavior (more speciﬁc shear thinning). The Ostwald-De Waele
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function (τ = K γ˙n) was used as model describing the shear thinning behavior.
Here, n is the ﬂow behavior index (< 1 for shear thinning behavior) and K the
consistency coeﬃcient. Additionally, the inﬂuence of temperature on the viscosity
η(T ) was followed using rotational measurements at a constant shear rate.
11.2.3 Static Contact Angle (SCA)
Static contact angle measurements can be used as an indicator of substrate surface
hydrophilic or hydrophobic properties. It measures the wettability of a solid surface
by a liquid via the Young’s equation based on the thermodynamic equilibrium
between the three phases (solid (S), liquid (L) and gas (S)):
γ
SG
− γ
LG
cos θc = γ LS (11.19)
whereby γSG represents the solid-gas interfacial energy, γLS the liquid-solid interfa-
cial energy, γLG the liquid-gas surface tension, and θc the Young’s contact angle at
equilibrium. Generally, the wettability characteristics can be subdivided based on
the contact angle (Figure 11.15): (i) non-wetting (θc > 90 ◦), (ii) partial wetting
(0 ◦ ≤ θc ≤ 90 ◦), (iii) complete wetting (θc > 0 ◦).
?C > 90°
?LG????SG
?C
?C
?C
?C??????
?LG????SG
?C < 90°
?LG????SG
solid (S)
liquid (L)
gas (G)
?LG
?SG
?LS
Figure 11.15: The physical principle behind static contact angle measurements with
the interfacial energy between solid and gas (γSG), the surface tension
between liquid and gas (γLG) and the interfacial energy between liquid
and solid (γLS) acting as determinants for the contact angle (θc).
The sessile drop method was used for contact angle measurements in air on an
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OCA 20 (Dataphysics) instrument, and Laplace-Young ﬁtting on the collected
movies for determination of the contact angle. Water was used as liquid phase,
and substrates were prepared by spincoating on glass cover slips. Laplace-Young
ﬁtting presumes smooth surfaces subjected to uniaxial liquid spreading (so the
drop is circular when viewed from above):
Δp =
2γ
LG
cos θc
R
(11.20)
with Δp the pressure drop across the liquid interface, and R the radius of the cir-
cular cross-section. For water-air, γLG is 0.0728 Jm−2. However, physical factors,
especially surface roughness, impact on the resulting wettability of a substrate.
11.2.4 Atomic Force Microscopy (AFM)
The working principle behind Atomic Force Microscopy (AFM) is schematically
presented in Figure 11.16. It is a technique that can be classiﬁed as material
surface image mapping and material surface characterization and is based on the
interaction forces between a very thin needle, the cantilever probe, and a material
surface.
laser diode
photodiode
detector
cantilever
moveable
sample
stage
sample
detector & AFM
controller
electronics
Figure 11.16: Illustration of the AFM working principle: a probe attached to the can-
tilever scans a sample surface area leading to variations in the cantilever
deﬂection (due to interaction forces). The deﬂections are recorded by an
array of photodiodes on which a reﬂecting laser spot is projected.
AFM is a type of scanning probe microscopy, whereby a mechanical probe (silicum-
nitride probe mounted onto the cantilever) gathers information by “feeling” the
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surface of a material at a resolution in the nanoscale. By bringing the tip into
proximity of a sample surface, the resulting varying interaction forces (ΔF ) cause
a cantilever deﬂection (Δz) according to Hooke’s law (ΔF = kΔz, whereby k rep-
resents a constant factor,the stiﬀness, of the probe). The imposed Δz deﬂection is
typically recorded using a laser spot reﬂected from the top surface of the cantilever
into an array of photodiodes (Figure 11.16). Gathering data by XY-translations
makes spatial mapping of the interactions possible. The measured interaction
forces can include, depending on the situation, mechanical contact force,Van der
Waals forces, chemical bonding, electrostatic forces, . . .
Three distinct modes of operation can be distinguished: direct contact mode, non-
contact mode, and tapping mode. The ﬁrst is a static mode whereby the interaction
(deﬂection) between tip and surface is kept constant during data recording. Thus,
the deﬂection is used as feedback signal and surface topology is directly measured
resulting in high resolution but possibly destructive imaging. Therefore, contact
mode is mostly performed when the resultant forces are repulsive.
For soft materials, both other modes are more suitable and dynamic of nature. The
cantilever is oscillated by a piezoelectric element close to its resonance frequency
and the oscillation amplitude, phase and frequency are altered by the interaction
forces. These variations provide characteristic information on the sample topology.
In non-contact mode, the oscillation amplitude or frequency is kept constant by
adjustment of the average tip-to-sample distance. Typically, Van der Waals forces
act as main interaction forces. The mode is non-destructive, however resolution
is impaired. Tapping mode more or less combines the principles of both contact
and non-contact mode. Thus, resulting in a higher resolution due to sample con-
tact, while lessening the sample damage. The image is generated by measuring
the interaction forces of the intermittent contact between the tip and the sample
surface.
A multimode scanning probe microscope (Digital Instruments - USA) equipped
with a Nanoscope IIIa controller was used for image recording in “tapping mode”.
Thin ﬁlm samples were prepared by spincoating on glass cover slips.
11.2.5 X-ray Photoelectron Spectroscopy (XPS)
X-ray photoelectron spectroscopy is a quantitative spectroscopic technique allow-
ing to evaluate the elemental surface composition of a sample (1− 10 nm). XPS is
also called ESCA (Electron Spectroscopy for Chemical Analysis), and is based on
low-energy X-ray interaction with surface atoms: the photoelectric eﬀect (Figure
11.17)
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Figure 11.17: The principle of XPS (the photoelectric eﬀect): emission of electrons
occurs after absorption of an X-ray.
During an XPS measurement, the kinetic energy and number of emitted electrons
(photoemission) escaping from the top 1− 10 nm of the sample, due to irradiation
with/absorption of an X-ray beam, are analyzed. The generated data are typi-
cally processed as a plot of the number of detected electrons in function of their
binding energy , i.e. the survey scan. Since each element relates to a character-
istic set of peaks at characteristic binding energies, corresponding to the electron
conﬁguration, and the detected number of electrons is directly related to the ele-
ment amount, these spectra reveal information on the elemental composition of the
surface layer. The technique requires ultra-high vacuum conditions to accurately
count the electron numbers at each kinetic energy value.
For insulating sample materials (no well-deﬁned Fermi level), the kinetic energy
(EK) can be calculated as a function of the X-ray photon energy (hν), the electron
binding energy (EB) and a factor that represents the spectrometer work function
(ϕ, typically around 4.5 eV):
EK = hν − EB − ϕ (11.21)
Additional spectra related to the chemical states of a detected element were re-
trieved: a detail scan. Deshielding of the nucleus positive charge due to electroneg-
ative eﬀects of α- and β-neighboring atoms causes variations in the necessary en-
ergy to emit an electron, therefore revealing information on the chemical state of
the element in consideration.
XPS spectra were collected on a ESCA S-probe VG monochromatized spectrom-
eter with an Al Kα X-ray source (1486 eV). In this work, the C-C/C-H signal
was chosen as reference and set on 285 eV. Dr. Tim Desmet, Valérie Kodeck,
Diana Giol, and dr. Els Vanderleyden were my colleagues responsible for XPS
measurements.
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11.2.6 High Resolution-Magic Angle Spinning (HR-MAS) NMR
spectroscopy
Conventionally, NMR spectroscopy applying high resolution characterizations is
limited to samples in solution, while Magic Angle Spinning (MAS) is reserved for
solid materials. Spinning a sample (usually at 1− 70 kHz) at the Magic Angle
(θM , cos 2θM = 1/3) with respect to to the direction of the magnetic ﬁeld (B0)
improves the resolution of the normally broad lines, thus making identiﬁcation and
spectrum analysis better. The principle is illustrated in Figure 11.18
The dipole-dipole, chemical shift anisotropy and quadrupolar interactions lead to
spectrum broadening. By utilizing MAS (θM), the time-dependent interactions are
averaged: (i) the nuclear dipole-dipole interactions are averaged to zero; (ii) the
chemical shift anisotropy to a non-zero value, and; (iii) the quadrupole partially
averaged. For solutions, these interactions typically average out due to rapid time-
averaged molecular motions. MAS mimicks this principle, leading to narrower
signals.
??????
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??
Figure 11.18: Magic Angle Spinning principle: an NMR rotor containing the sample is
spinning at a high frequency, tilted by the magic angle (θM ) relative to
the principle axis of the imposed magnetic ﬁeld (B0).
High Resolution-Magic Angle Spinning is a variation on the MAS principle, es-
pecially suitable for materials in between both states, i.e. solutions and gels con-
taining some internal molecular motion, but where the dipole-dipole interactions
are insuﬃciently averaged by their internal molecular motion. Broadening caused
by these dipole-dipole interaction is averaged out, resulting in the ability to apply
most of the high resolution quantitative characterization techniques.
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In this work, 1H HR-MAS measurements were performed to quantify the cross-
linking kinetics of photocross-linkable gelatin derivates. The 1H NMR spectra
were recorded on a Bruker Avance II spectrometer operating at a 1H frequency of
700.14MHz and a spinning frequency of 6 kHz for 4mm HR-MAS rotors. These
measurements were performed at the NMR and Structure Analysis Unit (UGhent)
in collaboration with dr. Björn Van Gasse and prof. dr. José Martins.
11.3 | Imaging Techniques
11.3.1 Scanning Electron Microscopy (SEM)
A scanning electron microscope (SEM) scans samples with a high-energy beam
of electrons to collect backscattered or secondary electrons for imaging (Figure
11.19). The captured electrons contain data on the sample surface topography as
well as the composition, and magniﬁcation potential is orders of magnitude higher
than that of optical microscopes.
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Figure 11.19: A schematic representation of the construction and working principle of
a SEM device: a focussed electron beam scans the sample surface and
the resultant emission of electrons is used to reconstitute the surface
image.
The incident electron beam is focussed on the sample surface to a spot of 1− 5 nm
by the condenser and objective lenses. Between the lens systems, a magnetic ﬁeld
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from the scan coils deﬂect the beam to scan the surface. Impact of the primary
electrons onto the sample surface results in the emission of secondary electrons, the
backscattering of electrons (by elastic scattering), and the emission of characteristic
X-rays. Collecting of the secondary electrons leads to high resolution reconstructed
images, while using backscattered electrons for image reconstruction results in a
deeper sampling depth and thus contains information on element distribution. The
characteristic X-ray spectrum can be used to study the distribution of the chemical
elements.
In this work, a FEI tabletop SEM instrument was used for imaging of hydrogel
samples in Secondary Electron Impact (SEI) imaging mode. Prior to analysis, the
samples were sputter coated with an approximately 20 nm gold layer.
11.3.2 Micro-Computed Tomography (μ-CT)
Micro-Computed Tomography (μ-CT) is a non-destructive 3D visualisation tech-
nique with resolution in the micrometer scale, useful for the visualization of pore
network interconnectivity of plotted constructs. The principle is illustrated by
Figure 11.20. X-rays create cross-sections of a 3D-sample, which can later be
reconstructed to a virtual model.
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Figure 11.20: Schematic illustration of a static μ-CT setup whereby the sample is ro-
tated during X-ray irradiation. The resulting projection images are sub-
sequently reconstructed to form a three-dimensional image of the sample.
Using reconstruction software algorithms, the capture projection images are used
to reconstruct the image cross-sections. The resultant slices can subsequently be
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stacked and rendered to obtain a 3D virtual model. It is possible to determine the
porosity of a 3D scaﬀold using this technique. However, due to the time consuming
calculations necessary as well as the expensive technique as such, idealized design
calculations were preferred.
μ-CT of 3D plotted scaﬀolds was performed using a VARIAN Paxscan 2520 V
Flatpanel detector and a Feinfocus X-ray tube. The resulting tomography data
has been reconstructed at a voxel size of 8μm using VGstudioMAX. Images were
taken at the UGhent Centre for X-ray Tomography (UGCT) in collaboration with
Thomas De Schryver.
11.3.3 (Confocal) Fluorescence Microscopy
Next to optical light microscopy, cell biology frequently makes use of ﬂuorescence
microscopy (biological ﬂuorescent stains, immunoﬂuorescence). For ﬂuorescent
imaging, a sample is irradiated at a speciﬁc wavelength which gets absorbed by
a ﬂuorophore (from a ﬂuorescent molecule within the sample) causing exciting of
some electrons and leading them to transfer to an excited state (Figure 11.21).
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Figure 11.21: Fluorescence: absorption of energy of a certain wavelength by a ﬂuo-
rophore causes electron excitation which, upon relaxation to the ground
state, dissipates longer wavelength energy.
Upon relaxation, the excited electron will dissipate part of its energy by emitting
light at a lower wavelength than the incident beam.
The majority of these microscopes are of the epiﬂuorescence design, i.e. excitation
of the ﬂuorophore and detection of the ﬂuorescence occurs on the same light path.
However, this design is subjected to high signal to noise ratio. A more advanced
design, confocal (ﬂuorescence) microscopes, aim to improve the optical resolu-
tion and contrast compared to the conventional design. Using point illumination
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combined with a pinhole in an optically conjugate plane to eliminate out-of-focus
signal, only ﬂuorescence near the focal plain is detected enhancing the resolution.
Long exposures are often required to overcome the decreased signal intensity due
to pinhole blocking. As a result of the point illumination, 2D or 3D imaging is pos-
sible by scanning the sample. The focal plane thickness is a among other function
of the optical properties of the specimen, but mainly dependent on the wavelength
of the used light. The thin optical slicing is especially suitable for 3D imaging and
surface proﬁling.
An inverted ﬂuorescence microscope (Olympus IX81) equipped with Xcellence soft-
ware (Olympus) was used for conventional ﬂuorescence and phase-contrast imag-
ing. The majority of cell culture and biological assays were a close collaboration
with Elien Gevaert from the Tissue Engineering Group (UGhent) of prof. dr. Ria
Cornelissen.
Confocal ﬂuorescence microscopy (CFM) was performed on a Leica SP5 confocal
laser scanning microscope with a 40X 1.25 oil immersion objective. Digital depth
slices were reconstructed using Velocity image analysis software. Confocal imaging
occurred at the Bio-imaging unit (VIB) in collaboration with dr. Eef Parthoens.
11.4 | Other Techniques
11.4.1 Amino acid analysis
For a number of characterizations, the amino acid composition of the used gelatins
was desired. These analyses were performed by dr. Barbara Kerkaert from the
nutriFOODchem group (UGhent). The technique is based on a HPLC quantitative
detection of hydrolyzed gelatin samples.
11.4.2 OPA assay
Quantiﬁcation of the primary amine (of gelatins) consumption during derivatiza-
tion reactions were determined spectrophotometrically by orhto-phtalic dialdehyde
(OPA) assay. The reaction scheme of OPA is given in Figure 11.22.
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Figure 11.22: Reaction scheme of ortho-phtalic dialdehyde with the primary amines of
gelatin.
Iso-indol chromophores are formed during the reaction, which possess an ab-
sorbance maximum at a wavelength of 335 nm (ε = ± 104M1 cm1). The reaction
proceeds fast and amine consumtions can be accurately obtained using calibration
curves (in this work n-butylamine). A UVIKON XL (Biotek) UV-VIS spectropho-
tometer was used.
11.4.3 Galactose oxidase assay
In the case of gelatin derivatization with 2-lactobionic acid analogues (bulk grafting
and surface grafting), a direct quantiﬁcation of the incorporated galactose moieties
was performed using the Amplex Red Galactose/Galactose Oxidase Assay Kit.
During reaction of galactose units with galactose oxidase and amplex red reagent
(Figure 11.23), the resultant resuroﬁn chromophore shows an absorption maximum
at a wavelength of 572 nm.
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Figure 11.23: Reaction sequence of the Amplex Red Galactose/Galactose Oxidase as-
say.
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List of Abbreviations
μ-CT Micro-computed tomography
μ-SLA Micro-stereolithography
1H NMR Proton nuclear magnetic resonance
2PP Two-photon polymerization
3DP 3D printing
AA Acrylic anhydride
Gelatin acrylamide
ADSC Adipose derived stem cell
AEMA 2-Aminoethyl methacrylate
AFM Atomic force microscopy
ASGPR Asioglycoprotein receptor
ATR Attenuated total reﬂection
ATRP Atom transfer radical polymerization
BAEC Bovine aortic endothelial cell
BAL Bioartiﬁcial liver device
BioLP Biological laser printing
BMSC Bone marrow stromal cell
BSA Bovine serum albumin
CAD Computer assisted design
Calcein-AM Calcein acetoxymethylester
CAM Computer assisted modeling
cDNA Complementary DNA
CFM Confocal ﬂuorescence microscopy
CHO Chinese hamster ovary
CQ Qamporquinone
Cx32 Connexin 32
Cyp1A2 Cytochroom P450 1A2
Cyp3A4 Cytochroom P450 3A4
DAPI 4’,6-diamidino-2-fenylindool
DBD Dielectric barrier discharge
DG Degree of galactosylation
DIW Direct ink writing
DLP Digital light projection
DMD Digital Micro-mirror Device
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DMEM Dulbecco’s modiﬁed eagle medium
DNA Deoxyribonucleic acid
DS Degree of substitution (for functionalization with (meth)acrylamides)
DTPH dithiopropionylhydrazide
DVS Dynamic vapor sorption
E-cad E-cadherin
ECM Extracellular matrix
EDC 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide
EDTA ehtylenediamine tetraacetic acid
EGF Epidermal growth factor
EHDA Electrohydrodynamic atomization
ELISA Enzym-linked immunosorbent assay
EO Ethylene oxide
ES Embryonic stem cell
ESP Electrospinning
FBS Fetal bovine serum
FDM Fused deposition modeling
FEA Finite element analysis
FITC-BSA Fluorescein isothiocyanate coupled bovine serum albumin
FITC-DEX Fluorescein isothiocyanate coupled dextran
FITC-GAM Fluorescein isothiocyanate conjugated goat anti-mouse IgG antibody
FMOC Fluorenylmethyloxycarbonyl chloride
FT-IR Fourier transform infrared spectroscopy
GAG Glycosaminoglycan
GAPDH Glyceraldehyde 3-phosphate dehydrogenase
GelA Type A gelatin
GelB Type B gelatin
GelGAL Galactose-functionalized gelatin
GelGAL-MOD Galactose-functionalized gelatin having methacrylamide moieties
Gel-MOD Methacrylamide-functionalized gelatin
GelMOD-GAL Methacrylamide-functionalized gelatin having galactose moieties
GRAS Generally recognized as safe
HA Hyaluronic acid
HDF Human dermal ﬁbroblast
HEMA Hydroxyethylmethacrylate
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
HepG2 Hepatocarcinoma cell line
HFP 1,1,1,3,3,3-Hexaﬂuoro-2-propanol
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HMVEC Human microvasculature endothelial cells
HMW High molecular weigth
HPLC High-performance liquid chromatography
HNF4α Hepatocyte nuclear factor 4 alpha
HR-MAS High resolution-magic angle spinning
HRP Horse radish peroxidase
HUVEC Human umbilical vein endothelial cell
I2959 Irgacure 2959
IEP Isoelectric point
IHC Immunohistochemistry
ITX isopropyl thioxanthone
LA Lactobionic acid
LAEMA 2-Lactobionamidoethyl methacrylate
LAD Liver assist device
LCD Liquid crystal display
LCST Lower critical solution temperature
LDM Low-temperature deposition modeling
LMW Low molecular weight
LWUV Long wave ultraviolet
MA Methacrylic anhydride
Gelatin methacrylamide
MAPLE DW Matrix assisted pulsed laser evaporation direct write
MAPS Microwave assisted polymerization synthesis
M(-L)DM Multi-nozzle (low-temperature) deposition modeling
MJS Multiphase jet solidiﬁcation
MRI Magnetic resonance imaging
MSC Multipotent stromal cell
mTGase Microbial transglutaminase
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
MW Molecular weight
MWD Molecular weight distribution
NC Numerical code
NHS N-hydroxysuccinimide
NVP N-vinyl pyrrolidone
OPA 2-orthophtalic dialdehyde
OPTN Organ procurement and transplantation network
PAA Poly(acrylic acid)
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PAH Poly(allylamine) hydrochloride
PAM pressure-assisted microsyringe
PAS Periodic acid-Schiﬀ
PBS Phosphate buﬀered saline
PCL Poly(ε-caprolactone)
PCL-LPS Poly(ε-caprolactone)-liposaccharide
PCNA Proliferating cell nuclear antigen
PCR Polymerase chain reaction
PDI Polydispersity index
PDL Poly(D-lysine)
PED Precision extrusion deposition
PEG Poly(ethylene glycol)
PEG-D(M)A Poly(ethylene glycol) di(meth)acrylate
PEI Poly(ethylene imine)
PEM Precise extrusion manufacturing
PEO Poly(ehtylene oxide)
PET Polyethylene terephthalate
PGA Poly(glycolic acid)
PI Photo-initiator
PLA Poly(lactic acid)
PLGA Poly(D,L-lactide-co-glycolide)
Plu F127 Poloxamer 407
PMA Poly(methyl acrylate)
PNIPAAm Poly(N-isopropylacrylamide)
PNIPAM Poly(N-isopropylacrylamide)
PO Propylene oxide
PPO Poly(propylene oxide)
PVA Poly(vinyl alcohol)
PVP Poly(vinyl pyrrolidone)
PZT Piezoelectric transducer
RGD Arginine-Glycine-Aspartic acid
RF Radio frequency
RH Relative humidity
RM Rapid manufacturing
RNA Ribonucleic acid
RP Rapid prototyping
RPBOD Rapid prototyping robotic dispensing
RT Rapid tooling
SCA Static contact angle
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SEC Size exclusion chromatography
sECM Synthetic extracellular matrix
SEM Scanning electron microscopy
SFF Solid freeform fabrication
SGC Solid ground curing
SLA Stereolithography
SLS Selective laser sintering
SRTR Scientiﬁc registry of transplant recipients
STL Stereolithography
TCP Tissue culture plastic
TE Tissue Engineering
TEMED N,N,N’,N’-tetramethylethylenediamine
TFE 2,2,2-Triﬂuoroethanol
TFA Triﬂuoroacetic acid
TGase Transglutaminase
TGFβ Transforming growth factor beta
TIA Titanium diisopropoxide bisacetylacetonate
TLC Thin layer chromatography
TMC Trimethylane carbonate
TMP Trimethylolpropane
TRITC tetramethylrhodamine
TTR Transthyretin
UCST Upper critical solution temperature
UV(-A) Ultraviolet (A)
UV-VIS Ultraviolet-visible light spectrofotometry
VA-086 2,2’-Azobis[2-methyl-N-(2-hydroxyethyl)propionamide]
VDI Volume-driven injection
XPS X-ray photoelectron spectroscopy
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Book Chapters
G. Graulus, T. Billiet, S. Van Vlierberghe, H. Thienpont, H. Ottevaere, P. Dubruel.
Biodegradable polyesters: from monomer to application, In Handbook of sustain-
able polymers: processing and applications, Ed. Takur, V. K., Stanford Publisher,
submitted
T. Billiet, M. Vandenhaute, J. Schelfhout, S. Van Vlierberghe, P. Dubruel. Ex-
ploring the future of hydrogels in rapid prototyping: a review on current trends
and limitations, In Biologically responsive biomaterials for tissue engineering, Ed.
Antoniac I., Springer, 2013, pp.201-249
Articles
E. Gevaert, L. Dolle, T. Billiet, P. Dubruel, L. Van Grunsven, A. Van Appel-
doorn, R. Cornelissen. High throughput micro-well generation of hepatocyte
micro-aggregates for tissue engineering. PLOS one, 9(8): e105171, 2014.
T. Billiet, E. Gevaert, T. De Schryver, R. Cornelissen, P. Dubruel. The 3D print-
ing of gelatin methacrylamide cell-laden tissue-engineered constructs with high cell
viability. Biomaterials, 35(1): 49-62, 2014.
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gelatin hydrogels improve the functionality of encapsulated HepG2 cells. Macro-
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Master Thesisses
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